{"meta":{"query_hash":"76b5e2e4f1f4","filters":{"venue":"Journal of Oncology Pharmacy Practice"},"cohort_total":250,"direct_labels_cover":0,"predictions_cover":250,"exported":250,"export_cap":100000,"truncated":false,"label_status":"direct model label, unvalidated","prediction_status":"machine_predicted_unvalidated (Codex and Gemma teacher distillation)","score_status":"score_only:v0-immature-baseline","snapshot":{"source":"OpenAlex, pinned release, all 482 partitions","release":"2026-06-24","frame_built":"2026-07-12"},"permalink":"https://metacan.xera.ac/q/76b5e2e4f1f4","api":"https://metacan.xera.ac/api/v1/cohort?venue=Journal+of+Oncology+Pharmacy+Practice"},"results":[{"id":"W1119150976","doi":"10.1177/1078155215598854","title":"Tolerability of Vidaza (azacitidine) subcutaneous administration using a maximum volume of 3 ml per injection","year":2015,"lang":"en","type":"article","venue":"Journal of Oncology Pharmacy Practice","topic":"Pneumocystis jirovecii pneumonia detection and treatment","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"Celgene","keywords":"Medicine; Tolerability; Azacitidine; Injection site; Anesthesia; Subcutaneous injection; Internal medicine; Adverse effect","score_opus":0.09519557321429206,"score_gpt":0.42182037277965306,"score_spread":0.326624799565361,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1119150976","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9906587,0.0002265158,0.0009790258,0.0037218905,0.000932998,0.00028313874,0.000009386853,0.000012981812,0.0031753723],"genre_scores_gemma":[0.9935924,0.000099409444,0.0056572496,0.00027908996,0.0002525062,0.0000028186291,0.0000024757835,0.000014534736,0.0000995466],"study_design_codex":"bench_or_experimental","study_design_gemma":"case_report","domain_scores_codex":[0.9975693,0.00047170662,0.0011141937,0.00016406934,0.0005122118,0.00016848353],"domain_scores_gemma":[0.9953915,0.0004143746,0.0020676474,0.00017548454,0.0016792952,0.00027168926],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013858074,0.00015792805,0.00063472823,0.00023634038,0.000044798977,0.000009983016,0.00008036167,0.00010826901,0.00013823315],"category_scores_gemma":[0.0016338441,0.00013738727,0.00018991405,0.00022889391,0.00011980004,0.00055530324,0.000026063208,0.00048906653,0.000008526858],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.07829787,0.013409343,0.046065334,0.00035988257,0.0020167101,0.0052230335,0.002803538,0.0021196331,0.7879431,0.000042340776,0.001165809,0.060553353],"study_design_scores_gemma":[0.034384746,0.059549972,0.010758777,0.00025245603,0.007229157,0.42824408,0.0045259367,0.006701374,0.18810777,0.00040661986,0.25935555,0.0004835877],"about_ca_topic_score_codex":0.00010639976,"about_ca_topic_score_gemma":0.00000857161,"teacher_disagreement_score":0.5998354,"about_ca_system_score_codex":0.0007855493,"about_ca_system_score_gemma":0.0017360562,"threshold_uncertainty_score":0.56024903},"labels":[],"label_agreement":null},{"id":"W1517518767","doi":"10.1191/1078155202jp100cr","title":"Cyclophosphamide-induced nasopharyngeal discomfort (wasabi nose): a report of two cases","year":2002,"lang":"en","type":"article","venue":"Journal of Oncology Pharmacy Practice","topic":"Olfactory and Sensory Function Studies","field":"Neuroscience","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Medicine; Nose; Cyclophosphamide; Adverse effect; Surgery; Anesthesia; Chemotherapy; Internal medicine","score_opus":0.27606341183008,"score_gpt":0.42436785421444684,"score_spread":0.14830444238436685,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1517518767","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9611771,0.00052947487,0.00004401306,0.005638517,0.0037891164,0.00020375213,0.000008696972,0.000029200372,0.02858011],"genre_scores_gemma":[0.9937015,0.0012241867,0.00057726307,0.002715741,0.00061087345,0.000005265935,3.5552475e-7,0.000022482658,0.0011423369],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.9965347,0.0007969938,0.0013764886,0.00031632496,0.0006395979,0.0003358912],"domain_scores_gemma":[0.9916654,0.0045888233,0.0029473556,0.0002562752,0.00033178262,0.00021031592],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011830778,0.00023752498,0.000674865,0.00020665817,0.0002750071,0.000028834967,0.0003138894,0.000065286855,0.0007598838],"category_scores_gemma":[0.0075725187,0.00019458178,0.00026314,0.00039307144,0.00023740524,0.0018246039,0.00010309071,0.0009096308,0.000047410012],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0049915183,0.005173445,0.009995667,0.00007384516,0.0005480112,0.10114842,0.0030508514,0.00027715796,0.8170501,0.00045820113,0.03381687,0.023415936],"study_design_scores_gemma":[0.005349306,0.0017244328,0.00044867067,0.000026447156,0.00052036735,0.115567364,0.00078903226,0.0001300375,0.20911938,0.00006200436,0.6660052,0.000257773],"about_ca_topic_score_codex":0.00002690269,"about_ca_topic_score_gemma":0.000003996325,"teacher_disagreement_score":0.6321883,"about_ca_system_score_codex":0.00016714096,"about_ca_system_score_gemma":0.00020661406,"threshold_uncertainty_score":0.90655595},"labels":[],"label_agreement":null},{"id":"W1539630599","doi":"10.1177/1078155215589980","title":"Evidence-based practice in times of drug shortage","year":2015,"lang":"en","type":"review","venue":"Journal of Oncology Pharmacy Practice","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Economic shortage; Medicine; Drug; Pharmacodynamics; Intensive care medicine; Clinical Practice; Pharmacokinetics; Drug development; Pharmacology; Family medicine","score_opus":0.6899323120443571,"score_gpt":0.6156431659316067,"score_spread":0.07428914611275039,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1539630599","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000016966374,0.93648386,0.00012358428,0.043522622,0.0020783374,0.0011030367,0.00009680852,0.000010717021,0.016564054],"genre_scores_gemma":[0.00009754608,0.97685903,0.011983022,0.00953387,0.001037975,0.00006214562,0.000012230142,0.00007519263,0.00033900802],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9749276,0.008424561,0.01517533,0.0005702809,0.0003917647,0.0005104651],"domain_scores_gemma":[0.89948505,0.0533292,0.04510525,0.0005881033,0.0010972226,0.0003952046],"candidate_categories":["metaresearch","metaepi_narrow","insufficient_payload"],"consensus_categories":["metaresearch","insufficient_payload"],"category_scores_codex":[0.13623373,0.00048498332,0.006564279,0.0016756762,0.00007122924,0.000073046634,0.0010730473,0.00040386315,0.0010503848],"category_scores_gemma":[0.1299002,0.0005214377,0.0007072868,0.0007204338,0.00015498794,0.004901207,0.00011628388,0.0021938044,0.0009022072],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014680119,0.004478985,0.00049661146,0.03184418,0.0028542008,0.0009106201,0.0044980687,0.0005531888,3.2267238e-7,0.008511064,0.4343018,0.51008296],"study_design_scores_gemma":[0.002027626,0.00037561884,0.000003866979,0.0071247984,0.00095654035,0.00077065884,0.00090668694,0.00015705236,4.7297942e-7,0.0003721188,0.9869246,0.00037995697],"about_ca_topic_score_codex":0.00044682832,"about_ca_topic_score_gemma":0.000021321992,"teacher_disagreement_score":0.5526228,"about_ca_system_score_codex":0.0034438637,"about_ca_system_score_gemma":0.010248724,"threshold_uncertainty_score":0.9998757},"labels":[],"label_agreement":null},{"id":"W1848562960","doi":"10.1177/1078155215587345","title":"Effects of gender on capecitabine toxicity in colorectal cancer","year":2015,"lang":"en","type":"article","venue":"Journal of Oncology Pharmacy Practice","topic":"Colorectal Cancer Treatments and Studies","field":"Medicine","cited_by":30,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Alberta Health Services; CancerCare Manitoba; Alberta Cancer Foundation","funders":"National Institutes of Health","keywords":"Capecitabine; Medicine; Colorectal cancer; Toxicity; Oncology; Internal medicine; Cancer","score_opus":0.07408878974539229,"score_gpt":0.4382115780210747,"score_spread":0.3641227882756824,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1848562960","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97198474,0.0047296183,0.000007308717,0.006166246,0.0009726827,0.00031694205,0.0000028346267,0.000005236956,0.015814409],"genre_scores_gemma":[0.9950119,0.0022933858,0.00060787157,0.0016101914,0.00036668192,0.000022294656,4.453676e-7,0.000012105874,0.00007510578],"study_design_codex":"randomized_trial","study_design_gemma":"not_applicable","domain_scores_codex":[0.9985565,0.0002633344,0.00048887904,0.00012476246,0.00037439427,0.00019213662],"domain_scores_gemma":[0.9972973,0.0012018585,0.0006677729,0.00005361641,0.00059331045,0.0001861516],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00071860966,0.00013895938,0.0006184357,0.00018636824,0.000025082629,0.000004017863,0.00007675453,0.000057234138,0.00006313768],"category_scores_gemma":[0.0015809658,0.00010020767,0.00010363882,0.00022761362,0.00007654659,0.00024486022,0.000036975194,0.0004984814,0.0000054004263],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.24394302,0.030944064,0.213211,0.00071237574,0.0068843192,0.020609204,0.019363092,0.00063160656,0.21063459,0.00021757408,0.057759967,0.19508919],"study_design_scores_gemma":[0.096652515,0.031068308,0.23320898,0.00036623597,0.0039176815,0.0040975497,0.0029911157,0.00020507404,0.2650295,0.00013946192,0.36194277,0.00038081745],"about_ca_topic_score_codex":0.0001746713,"about_ca_topic_score_gemma":0.000052729232,"teacher_disagreement_score":0.3041828,"about_ca_system_score_codex":0.001051063,"about_ca_system_score_gemma":0.0010403724,"threshold_uncertainty_score":0.40863502},"labels":[],"label_agreement":null},{"id":"W1969258524","doi":"10.1177/1078155211402106","title":"Pilot assessment of the antineoplastic drug contamination levels in British Columbian hospitals pre- and post-cleaning","year":2011,"lang":"en","type":"article","venue":"Journal of Oncology Pharmacy Practice","topic":"Safe Handling of Antineoplastic Drugs","field":"Health Professions","cited_by":60,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Fraser Health; Vancouver Coastal Health; University of British Columbia","funders":"University of British Columbia","keywords":"Contamination; Antineoplastic Drugs; Medicine; Drug; Toxicology; Pharmacology","score_opus":0.07159032852732863,"score_gpt":0.4467621365994111,"score_spread":0.3751718080720825,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1969258524","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98637754,0.00016449105,0.00023590153,0.0026106676,0.0024704246,0.00055659807,0.000012029695,0.0000101988535,0.00756213],"genre_scores_gemma":[0.9929729,0.0002470083,0.0049058236,0.001302944,0.00019352007,0.000010333522,7.1686037e-7,0.000023244378,0.00034349834],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99588335,0.0018755384,0.0013476422,0.0001757866,0.0003827247,0.0003349641],"domain_scores_gemma":[0.9883668,0.007217675,0.0030361805,0.00013147944,0.001130127,0.000117763244],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0047048675,0.00012974335,0.00049358635,0.00015944696,0.00027915745,0.000016344655,0.00030041704,0.00006979888,0.0002239747],"category_scores_gemma":[0.0072191255,0.00012452962,0.00006376035,0.00023750817,0.0001557577,0.0008848465,0.00017645532,0.001513478,0.000005205975],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009389984,0.0012693488,0.96478724,0.00023006828,0.0002023062,0.00030764125,0.011884985,0.00001430292,0.0064339447,0.00029527512,0.001625368,0.012010534],"study_design_scores_gemma":[0.006934438,0.00088425336,0.98022676,0.0007374849,0.00028629694,0.00068056665,0.0061375974,0.00023811744,0.0001690352,0.00006265849,0.0035277342,0.000115073075],"about_ca_topic_score_codex":0.0026421533,"about_ca_topic_score_gemma":0.0015809515,"teacher_disagreement_score":0.015439517,"about_ca_system_score_codex":0.00022464343,"about_ca_system_score_gemma":0.002502936,"threshold_uncertainty_score":0.86424893},"labels":[],"label_agreement":null},{"id":"W1973988504","doi":"10.1177/1078155209102339","title":"Assessment of gentamicin 7 mg/kg once daily for pediatric patients with febrile neutropenia: a pilot project","year":2009,"lang":"en","type":"article","venue":"Journal of Oncology Pharmacy Practice","topic":"Neutropenia and Cancer Infections","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Fraser Health; Surrey Memorial Hospital","funders":"","keywords":"Medicine; Gentamicin; Neutropenia; Febrile neutropenia; Pediatric oncology; Context (archaeology); Pediatrics; Intensive care medicine; Internal medicine; Emergency medicine; Antibiotics; Chemotherapy; Cancer","score_opus":0.049933720408659114,"score_gpt":0.4426054996223499,"score_spread":0.3926717792136908,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1973988504","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9823642,0.00025917665,0.0010271614,0.004761198,0.0006822087,0.0014058704,0.00001725749,0.000015952046,0.009466994],"genre_scores_gemma":[0.9806671,0.0006370238,0.014571497,0.0031111524,0.00081844174,0.000026182626,0.0000068253685,0.000023939254,0.00013780837],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.99809265,0.00022500688,0.00077021227,0.00020086585,0.00043626066,0.00027497718],"domain_scores_gemma":[0.9959757,0.00055651524,0.0017666427,0.00016937395,0.0013749702,0.00015680252],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007814303,0.0001818984,0.00061731815,0.00028318467,0.00011293221,0.000019732995,0.00016256186,0.00004539807,0.00006761292],"category_scores_gemma":[0.00023500578,0.00013451237,0.00014324315,0.0003992179,0.00004640903,0.00080997916,0.000024401174,0.0006717288,0.0000032390326],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.07415499,0.033953335,0.7042503,0.00047343315,0.0022055043,0.00085780805,0.0008595426,0.00061557465,0.053653516,0.00042634475,0.08076392,0.04778575],"study_design_scores_gemma":[0.060402054,0.06599254,0.42331025,0.000099608995,0.006890466,0.0021523212,0.00031500784,0.0001135065,0.001997095,0.000020088293,0.43841082,0.0002962144],"about_ca_topic_score_codex":0.00003455563,"about_ca_topic_score_gemma":0.0000047365993,"teacher_disagreement_score":0.3576469,"about_ca_system_score_codex":0.00047977737,"about_ca_system_score_gemma":0.0023943514,"threshold_uncertainty_score":0.5485255},"labels":[],"label_agreement":null},{"id":"W1976511979","doi":"10.1191/1078155204jp137oa","title":"Role of dimethylsulfoxide for management of chemotherapy extravasation","year":2004,"lang":"en","type":"article","venue":"Journal of Oncology Pharmacy Practice","topic":"Chemotherapy-related skin toxicity","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Extravasation; Medicine; Erythema; Antidote; Tissue necrosis; Chemotherapy; Adverse effect; Dimethyl sulfoxide; Surgery; Dermatology; Anesthesia; Toxicity; Pharmacology; Internal medicine; Pathology","score_opus":0.03141923979721942,"score_gpt":0.40923492479148804,"score_spread":0.37781568499426865,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1976511979","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9615531,0.0023943,0.01059385,0.015570357,0.00033323263,0.00089811184,0.000005221197,0.0000139825925,0.00863782],"genre_scores_gemma":[0.85862356,0.004143389,0.13548428,0.0014044325,0.00019264602,0.000007052354,0.0000018394396,0.000029959136,0.00011281303],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99833876,0.00010585884,0.00091108977,0.00012582562,0.0003508353,0.00016765177],"domain_scores_gemma":[0.99646646,0.00060939393,0.0019967812,0.00016293749,0.00066274125,0.00010169801],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0016112406,0.0001298755,0.00052450574,0.0001848993,0.000027693297,0.0000035243825,0.00014873869,0.00010033521,0.00011095071],"category_scores_gemma":[0.00028849725,0.00011449097,0.00022809408,0.00021528729,0.00008901263,0.0003492241,0.000016306,0.00038712606,0.0000025479085],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.014885959,0.003321461,0.00035985568,0.00022914837,0.0021496494,0.00009837442,0.0013067867,0.00034306236,0.83723795,0.0005760042,0.00061755104,0.13887417],"study_design_scores_gemma":[0.032241765,0.0022137763,0.001978259,0.00019592482,0.0014034153,0.0012069483,0.0009306229,0.00006884392,0.775721,0.0015020975,0.18243933,0.000097980555],"about_ca_topic_score_codex":0.000020684774,"about_ca_topic_score_gemma":7.011601e-7,"teacher_disagreement_score":0.18182178,"about_ca_system_score_codex":0.00033643298,"about_ca_system_score_gemma":0.00037832823,"threshold_uncertainty_score":0.46688062},"labels":[],"label_agreement":null},{"id":"W1979820749","doi":"10.1191/1078155203jp105oa","title":"Next-day chemotherapy scheduling: a multidisciplinary approach to solving workload issues in a tertiary oncology center","year":2003,"lang":"en","type":"article","venue":"Journal of Oncology Pharmacy Practice","topic":"Pharmaceutical Practices and Patient Outcomes","field":"Medicine","cited_by":39,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Alberta Cancer Foundation","funders":"","keywords":"Medicine; Pharmacy; Workload; Chemotherapy; Schedule; Ambulatory; Family medicine; Medical emergency; Internal medicine","score_opus":0.1461205958696747,"score_gpt":0.48738882819010915,"score_spread":0.34126823232043446,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1979820749","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.68612474,0.009147344,0.0028982225,0.17862342,0.0033991134,0.0020094295,0.0000032595005,0.00005987787,0.11773456],"genre_scores_gemma":[0.8483278,0.0051669567,0.11485583,0.03052237,0.00066847046,0.000030072948,0.0000023989192,0.000056769204,0.00036932016],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.9948329,0.0023164898,0.0013180177,0.00038595378,0.00051071355,0.0006359257],"domain_scores_gemma":[0.9937192,0.0038164195,0.0011616027,0.00024878187,0.00040069266,0.00065330573],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.005891535,0.00032707452,0.0009539523,0.00049247034,0.00013552925,0.000051017316,0.0002902097,0.0002117157,0.00033598885],"category_scores_gemma":[0.0054044016,0.0002655754,0.00025512508,0.00052115927,0.00010556489,0.0016970747,0.00010328669,0.0026708862,0.00008841702],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.051224776,0.056843285,0.52566016,0.0005084469,0.0028566488,0.010213741,0.027381351,0.0014487222,0.054892626,0.00046169726,0.016637351,0.25187123],"study_design_scores_gemma":[0.020906396,0.0018893871,0.0047025913,0.00019320294,0.0005254528,0.0077031506,0.0034265334,0.0027633747,0.0018195414,0.000054262247,0.9557251,0.00029103458],"about_ca_topic_score_codex":0.00002164476,"about_ca_topic_score_gemma":0.0000026971472,"teacher_disagreement_score":0.93908775,"about_ca_system_score_codex":0.0007542638,"about_ca_system_score_gemma":0.0009623058,"threshold_uncertainty_score":0.9999796},"labels":[],"label_agreement":null},{"id":"W1981256536","doi":"10.1177/1078155214522143","title":"Clinical efficacy of generic imatinib","year":2014,"lang":"en","type":"article","venue":"Journal of Oncology Pharmacy Practice","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":25,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Imatinib; Medicine; Myeloid leukemia; Imatinib mesylate; Internal medicine; Oncology; Pharmacology","score_opus":0.09526435613282552,"score_gpt":0.48579286121924914,"score_spread":0.3905285050864236,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1981256536","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95709515,0.0008932887,0.00062320783,0.009562429,0.0015043734,0.0002621677,0.0000015950172,0.00001542939,0.030042386],"genre_scores_gemma":[0.94088906,0.001884387,0.051221613,0.0039989245,0.0016588749,0.0000020975663,0.0000026087882,0.00002791004,0.0003145526],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9967498,0.00093513884,0.0015058102,0.00016525897,0.00041851852,0.00022545354],"domain_scores_gemma":[0.9905034,0.005681243,0.0025940256,0.00026952187,0.0006506493,0.00030121166],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.0036003396,0.00015060812,0.00085948646,0.00014490508,0.000037307782,0.000006132381,0.00019644725,0.00011111942,0.00042531046],"category_scores_gemma":[0.008803049,0.000115358525,0.00032472736,0.00018584501,0.00015513894,0.0003351988,0.000058717695,0.0009236034,0.00009003225],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.016460847,0.009900431,0.045717202,0.00015818546,0.0029353064,0.0016977667,0.0005459034,0.0001086242,0.015447685,0.00014559073,0.042779934,0.86410254],"study_design_scores_gemma":[0.042075038,0.004664287,0.017163578,0.00007822248,0.002640223,0.00936022,0.00009105286,0.0007531423,0.0028757772,0.00002252861,0.9201768,0.000099127734],"about_ca_topic_score_codex":0.000015552052,"about_ca_topic_score_gemma":5.320328e-7,"teacher_disagreement_score":0.8773969,"about_ca_system_score_codex":0.0005008395,"about_ca_system_score_gemma":0.0018158521,"threshold_uncertainty_score":0.99954623},"labels":[],"label_agreement":null},{"id":"W1986632087","doi":"10.1191/1078155204jp138oa","title":"Temozolomide for malignant gliomas in British Columbia: A population-based cost-effectiveness analysis","year":2004,"lang":"en","type":"article","venue":"Journal of Oncology Pharmacy Practice","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"BC Cancer Agency; University of British Columbia","funders":"","keywords":"Temozolomide; Lomustine; Medicine; Progression-free survival; Internal medicine; Dacarbazine; Population; Glioma; Chemotherapy; Oncology; Surgery; Vincristine; Cyclophosphamide","score_opus":0.04685100890727064,"score_gpt":0.41508613146085466,"score_spread":0.36823512255358404,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1986632087","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99109864,0.0006827759,0.0008826719,0.005642355,0.00029780157,0.001218106,0.000021405222,0.000011080671,0.00014514022],"genre_scores_gemma":[0.99086773,0.00017647712,0.007239119,0.0013395596,0.00014274006,0.00017684753,0.000027434311,0.000020174608,0.000009920075],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9979893,0.0004645499,0.00075368944,0.00022549868,0.00029326795,0.0002736747],"domain_scores_gemma":[0.9951482,0.0029331096,0.0009342855,0.00013152558,0.00064916984,0.00020371398],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0020748845,0.00011942961,0.00081810384,0.00042157777,0.000112312744,0.00007838529,0.0000908985,0.000096013915,0.000086082466],"category_scores_gemma":[0.0020326788,0.00014556851,0.00040470128,0.00089491706,0.000037706886,0.00039428906,0.000014689761,0.00036683318,0.000003872683],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0037528623,0.007681873,0.94050705,0.00008527593,0.0030961353,0.011688151,0.000058231606,0.01027657,0.002586318,0.00001828603,0.00042953694,0.019819679],"study_design_scores_gemma":[0.06410578,0.0026547783,0.88005894,0.00026002902,0.011948556,0.00588401,0.00022029686,0.0006540902,0.0029014887,0.00021145021,0.030898139,0.00020245089],"about_ca_topic_score_codex":0.015718441,"about_ca_topic_score_gemma":0.015606531,"teacher_disagreement_score":0.060448147,"about_ca_system_score_codex":0.0014896548,"about_ca_system_score_gemma":0.0008627164,"threshold_uncertainty_score":0.99083596},"labels":[],"label_agreement":null},{"id":"W1987479288","doi":"10.1191/1078155202jp093oa","title":"Chemotherapy order review and documentation: let’s put the anDROIDs to work!","year":2002,"lang":"en","type":"article","venue":"Journal of Oncology Pharmacy Practice","topic":"Pharmaceutical Practices and Patient Outcomes","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Alberta Cancer Foundation","funders":"","keywords":"Documentation; Medicine; Pharmacy; Acronym; Pharmacy practice; Medical education; Oncology; Computer science; Family medicine","score_opus":0.1695471220418957,"score_gpt":0.5000999234577579,"score_spread":0.3305528014158622,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1987479288","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.029307196,0.054424584,0.0001451695,0.89010024,0.00068359985,0.0008426067,0.0000010896326,0.00001286823,0.024482634],"genre_scores_gemma":[0.14373796,0.2682151,0.0076249437,0.5762982,0.0008298865,0.000020089878,0.0000011027595,0.00003226176,0.003240491],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9982573,0.00044631894,0.0005928132,0.00014029127,0.00035859444,0.00020470464],"domain_scores_gemma":[0.9965051,0.0018881647,0.0007064967,0.00015102711,0.0004467895,0.00030244066],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.001739862,0.00014211118,0.00043919185,0.00007347591,0.00010981126,0.00004198292,0.00014381048,0.000040261773,0.0033924447],"category_scores_gemma":[0.0018322204,0.00008613515,0.00008782409,0.00041631775,0.00007441714,0.0009545768,0.000042405805,0.00082006655,0.000121991485],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0049394937,0.0018018581,0.010798231,0.00046692067,0.0013445759,0.000792948,0.002019701,0.0000130445505,0.00072485773,0.000091207396,0.53703827,0.4399689],"study_design_scores_gemma":[0.0050687348,0.000851371,0.0009048476,0.00013702846,0.0019406067,0.005059526,0.00015184915,0.00006323037,0.00010005305,0.000011201672,0.985621,0.00009060228],"about_ca_topic_score_codex":0.000005539273,"about_ca_topic_score_gemma":3.9351576e-7,"teacher_disagreement_score":0.4485827,"about_ca_system_score_codex":0.000106306055,"about_ca_system_score_gemma":0.00009669982,"threshold_uncertainty_score":0.9975186},"labels":[],"label_agreement":null},{"id":"W1989949685","doi":"10.1191/1078155205jp164oa","title":"Leaching of diethylhexyl phthalate from polyvinyl chloride materials into etoposide intravenous solutions","year":2005,"lang":"en","type":"review","venue":"Journal of Oncology Pharmacy Practice","topic":"Safe Handling of Antineoplastic Drugs","field":"Health Professions","cited_by":14,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"BC Cancer Agency","keywords":"Phthalate; Polyvinyl chloride; Leaching (pedology); Medicine; Chlorinated polyvinyl chloride; Nuclear chemistry; Toxicology; Environmental chemistry; Waste management; Chromatography; Chemistry; Environmental science; Organic chemistry; Soil water","score_opus":0.20775544299665336,"score_gpt":0.5581298923391756,"score_spread":0.35037444934252227,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1989949685","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0018099528,0.974273,0.00043452665,0.0041237934,0.01366483,0.0011060251,0.00016702441,0.000049855942,0.004370954],"genre_scores_gemma":[0.0011022385,0.97905946,0.010237344,0.00089279644,0.008141497,0.000043663727,0.000052236624,0.00015013725,0.000320613],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9857202,0.006426109,0.0056569544,0.00047415905,0.00074373174,0.0009788433],"domain_scores_gemma":[0.95478183,0.027363773,0.015831947,0.000506151,0.0011084473,0.00040786492],"candidate_categories":["metaresearch","metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.009164511,0.00071302056,0.0045955502,0.00073187216,0.00079212064,0.000032285734,0.0011159609,0.0008513392,0.001517717],"category_scores_gemma":[0.010947315,0.0005879334,0.00071013294,0.00039276326,0.00022353888,0.0011001395,0.0005310918,0.0061163465,0.0005185346],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002055789,0.0013104231,0.000021871254,0.006383934,0.0033815757,0.0010052682,0.0054439483,0.000020003907,0.0009767252,0.00016876865,0.0070090066,0.9722227],"study_design_scores_gemma":[0.0028655762,0.0004178098,0.000012402999,0.013132422,0.00920044,0.0015496024,0.00086238835,0.0000060637976,0.0001227561,0.00011245755,0.9713112,0.00040684492],"about_ca_topic_score_codex":0.0017477268,"about_ca_topic_score_gemma":0.000062899264,"teacher_disagreement_score":0.9718158,"about_ca_system_score_codex":0.001481196,"about_ca_system_score_gemma":0.0123526715,"threshold_uncertainty_score":0.9996572},"labels":[],"label_agreement":null},{"id":"W1990795133","doi":"10.1177/1078155211426198","title":"Temozolomide plus radiotherapy for glioblastoma in a Canadian province: Efficacy versus effectiveness and the impact of O6-methylguanine-DNA-methyltransferase promoter methylation","year":2011,"lang":"en","type":"article","venue":"Journal of Oncology Pharmacy Practice","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Alberta Health Services","funders":"National Comprehensive Cancer Network","keywords":"Temozolomide; Medicine; Hazard ratio; Oncology; Population; Internal medicine; Regimen; Methyltransferase; Radiation therapy; Progression-free survival; Clinical trial; Methylation; Overall survival; Confidence interval","score_opus":0.045917709710597936,"score_gpt":0.4119399948427777,"score_spread":0.36602228513217977,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1990795133","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9920453,0.0019372742,0.00017106238,0.0030863981,0.00027073774,0.0020872687,0.000011846421,0.0000051249067,0.00038500916],"genre_scores_gemma":[0.9959031,0.00085676945,0.0028291133,0.00017900548,0.00012873739,0.00007168444,0.0000016163729,0.000026751648,0.000003244665],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99760205,0.0010852005,0.0006183973,0.0001848548,0.00018904252,0.0003204813],"domain_scores_gemma":[0.99264616,0.0058377944,0.0006446302,0.00015123928,0.00042064468,0.0002995317],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0035693692,0.00020906964,0.00077661284,0.0004422006,0.00007201109,0.000014361516,0.00011951369,0.000104511964,0.000053864926],"category_scores_gemma":[0.0019130796,0.00012508199,0.00028348682,0.00026632845,0.000176447,0.00041248702,0.000011055974,0.00041512813,9.58153e-7],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.6984527,0.006259082,0.036213968,0.00026588215,0.008822836,0.0030498179,0.009375092,0.00041915826,0.09225104,0.0003401707,0.00043340217,0.14411685],"study_design_scores_gemma":[0.5223651,0.049589522,0.21411054,0.00034743827,0.007041825,0.005994468,0.00073333125,0.0032200199,0.18220435,0.00019585859,0.013719031,0.00047849567],"about_ca_topic_score_codex":0.028943423,"about_ca_topic_score_gemma":0.00438611,"teacher_disagreement_score":0.17789657,"about_ca_system_score_codex":0.0013316318,"about_ca_system_score_gemma":0.0025630037,"threshold_uncertainty_score":0.9775229},"labels":[],"label_agreement":null},{"id":"W1990845522","doi":"10.1191/1078155205jp146oa","title":"Vinorelbine and venous irritation: optimal parenteral administration","year":2005,"lang":"en","type":"review","venue":"Journal of Oncology Pharmacy Practice","topic":"Chemotherapy-related skin toxicity","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Medicine; Vinorelbine; Irritation; Intensive care medicine; Chemotherapy; Anesthesia; Pharmacology; Surgery; Cisplatin","score_opus":0.10616627253436649,"score_gpt":0.5099528220016883,"score_spread":0.40378654946732184,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1990845522","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0003945385,0.9898948,0.00008130653,0.0061819437,0.0007071889,0.0005479374,0.000010558978,0.00001833614,0.0021633797],"genre_scores_gemma":[0.0003638551,0.98208475,0.013745604,0.0012666794,0.0022193324,0.000010599775,0.00003054481,0.000055338594,0.00022327018],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99697316,0.00061708497,0.0014986098,0.00025695137,0.00040475003,0.00024944078],"domain_scores_gemma":[0.994281,0.0015300101,0.0032054966,0.00017580698,0.0004979131,0.0003097672],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.001285616,0.00036187092,0.0019268651,0.00030273962,0.0000808295,0.000043000833,0.00016361747,0.00034730026,0.00035134723],"category_scores_gemma":[0.001002962,0.00029534905,0.0003925102,0.000219082,0.000111751404,0.00066193606,0.00003873093,0.002287936,0.000037206253],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0018755877,0.0018730022,0.0000056135905,0.0014955238,0.0013396197,0.0028988246,0.00025607224,0.0000026624682,0.000018250703,0.000009121859,0.0050762473,0.9851495],"study_design_scores_gemma":[0.0043386067,0.0030916203,0.0000062157933,0.0020520953,0.007425394,0.10776086,0.00005754941,0.000023537008,0.00001410914,0.0000027305484,0.87505263,0.00017467236],"about_ca_topic_score_codex":0.0000032783487,"about_ca_topic_score_gemma":0.0000012702216,"teacher_disagreement_score":0.9849748,"about_ca_system_score_codex":0.0007452944,"about_ca_system_score_gemma":0.0026040683,"threshold_uncertainty_score":0.9999499},"labels":[],"label_agreement":null},{"id":"W1991042912","doi":"10.1177/1078155207082017","title":"Impact on patient satisfaction with a structured counselling approach on natural health products","year":2008,"lang":"en","type":"article","venue":"Journal of Oncology Pharmacy Practice","topic":"Complementary and Alternative Medicine Studies","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Medicine; Patient satisfaction; Family medicine; Pharmacy; Workload; Intervention (counseling); Breast cancer; Physical therapy; Cancer; Nursing; Internal medicine","score_opus":0.08270727782431302,"score_gpt":0.4417445579801573,"score_spread":0.3590372801558443,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1991042912","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98490596,0.0010216977,0.00013541337,0.011502838,0.0008575463,0.00050424656,0.0000046617693,0.000012988325,0.0010546292],"genre_scores_gemma":[0.9887895,0.0021811842,0.004012309,0.0038811772,0.0010746531,0.0000047493613,0.000005996554,0.000016225713,0.000034198933],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9980005,0.00036330384,0.0005142633,0.00020514963,0.00066207675,0.00025470144],"domain_scores_gemma":[0.9972293,0.00062578445,0.0012432894,0.0001218844,0.0006061548,0.00017363823],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00056095177,0.0002107413,0.00055705215,0.00020429444,0.00023759405,0.000006053072,0.00005674035,0.0000097068205,0.00004779341],"category_scores_gemma":[0.00033787693,0.00011938882,0.000082809725,0.00021010652,0.00010525356,0.000316704,0.000009465996,0.0011585045,0.000003752559],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.1825999,0.008354147,0.20504718,0.00031255744,0.0072357543,0.0072731883,0.024655411,0.0034142598,0.005679427,0.000117053874,0.054285336,0.5010258],"study_design_scores_gemma":[0.04112094,0.12338683,0.41982308,0.0005080822,0.0012695276,0.08898297,0.0046635265,0.00050458126,0.0035836778,0.000030413636,0.315644,0.00048237396],"about_ca_topic_score_codex":0.00011139447,"about_ca_topic_score_gemma":0.000005559442,"teacher_disagreement_score":0.5005434,"about_ca_system_score_codex":0.0006158651,"about_ca_system_score_gemma":0.00072303886,"threshold_uncertainty_score":0.503319},"labels":[],"label_agreement":null},{"id":"W1992093804","doi":"10.1177/1078155213497070","title":"Examining factors that influence the effectiveness of cleaning antineoplastic drugs from drug preparation surfaces: A pilot study","year":2013,"lang":"en","type":"article","venue":"Journal of Oncology Pharmacy Practice","topic":"Safe Handling of Antineoplastic Drugs","field":"Health Professions","cited_by":27,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Workers Compensation Board of British Columbia; Fraser Health; Toronto Metropolitan University; University of British Columbia","funders":"WorkSafeBC","keywords":"Drug; Cleaning agent; Contamination; Medicine; Antineoplastic Drugs; Drug packaging; Isopropyl alcohol; Contamination control; Pharmacology; Chemistry","score_opus":0.10877103830834663,"score_gpt":0.45743917685341395,"score_spread":0.34866813854506734,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1992093804","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9929703,0.00015190711,0.0003210609,0.00046978492,0.0023554382,0.0015534058,0.000006187775,0.000035505847,0.0021364356],"genre_scores_gemma":[0.99829805,0.00009305271,0.00088610325,0.00034953642,0.00023273722,0.00004434277,0.0000027991646,0.000039277646,0.000054092056],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9869161,0.010044629,0.0015230611,0.00030467243,0.0007525192,0.00045899051],"domain_scores_gemma":[0.8889364,0.10511177,0.0040567466,0.00029058778,0.00144774,0.0001567874],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.009944867,0.00029607225,0.0008277924,0.00020407715,0.0006078193,0.0000419068,0.000599601,0.00007788128,0.0002507189],"category_scores_gemma":[0.013762809,0.00019618464,0.0000772607,0.0003556868,0.00015960063,0.0021795207,0.00022682277,0.0019129753,0.00011134876],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008424304,0.0019352041,0.91004795,0.00016386234,0.0007685846,0.000056069093,0.049815014,0.0022114373,0.025268305,0.000015923883,0.0006901962,0.0006031377],"study_design_scores_gemma":[0.009886455,0.003992569,0.84596163,0.00079480844,0.0011446859,0.000058432273,0.13166894,0.00091008045,0.002523512,0.00008951736,0.0027088386,0.00026051534],"about_ca_topic_score_codex":0.004476747,"about_ca_topic_score_gemma":0.000069411384,"teacher_disagreement_score":0.097979754,"about_ca_system_score_codex":0.00024663072,"about_ca_system_score_gemma":0.0016992019,"threshold_uncertainty_score":0.9945447},"labels":[],"label_agreement":null},{"id":"W1992816765","doi":"10.1177/1078155214556008","title":"Abraxane® versus Taxol® for patients with advanced breast cancer: A prospective time and motion analysis from a Chinese health care perspective","year":2014,"lang":"en","type":"article","venue":"Journal of Oncology Pharmacy Practice","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":49,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Augmentium Pharma Consulting (Canada)","funders":"","keywords":"Medicine; Breast cancer; Adverse effect; Premedication; Cancer; Paclitaxel; Emergency medicine; Internal medicine; Surgery","score_opus":0.011455966854408016,"score_gpt":0.41087533716621105,"score_spread":0.399419370311803,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1992816765","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9728353,0.0025759758,0.0003194869,0.020874998,0.00063231157,0.0012445747,0.0003242864,0.000020820537,0.0011722656],"genre_scores_gemma":[0.9922812,0.0008079643,0.004595551,0.0014501426,0.00067953847,0.000066227,0.000057857887,0.000023856657,0.00003766836],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99854517,0.00028674395,0.00037810835,0.00029863534,0.00025065584,0.00024068894],"domain_scores_gemma":[0.99543035,0.0012569699,0.0012544348,0.00010510511,0.0016882219,0.0002648977],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00030553289,0.0002134733,0.0008032903,0.00025427944,0.00014371054,0.000015799584,0.00007109833,0.000057150264,0.00017796463],"category_scores_gemma":[0.00030595277,0.00015328387,0.00015751585,0.00039641818,0.00008521198,0.0005440738,0.000021966254,0.00038794446,0.0000025968716],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.36274225,0.0054552895,0.39314142,0.0000954108,0.022077197,0.00009769772,0.013550458,0.0004447979,0.00063770125,0.00003078731,0.00204559,0.19968142],"study_design_scores_gemma":[0.24057765,0.039951798,0.5987189,0.00011182284,0.03746204,0.00046851634,0.0042384244,0.0016956192,0.0001715114,0.00006636497,0.07602461,0.00051272754],"about_ca_topic_score_codex":0.00075612776,"about_ca_topic_score_gemma":0.00026396962,"teacher_disagreement_score":0.2055775,"about_ca_system_score_codex":0.0018359119,"about_ca_system_score_gemma":0.0007266161,"threshold_uncertainty_score":0.6250735},"labels":[],"label_agreement":null},{"id":"W1994040984","doi":"10.1177/1078155207080804","title":"Overview of targeted therapies in Oncology","year":2007,"lang":"en","type":"article","venue":"Journal of Oncology Pharmacy Practice","topic":"Cancer Research and Treatment","field":"Medicine","cited_by":23,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Medicine; Monoclonal antibody; Angiogenesis; Targeted therapy; Cancer; Pharmacology; Cancer therapy; Oncology; Bioinformatics; Cancer research; Immunology; Internal medicine; Antibody","score_opus":0.16274462792214772,"score_gpt":0.5536878884596593,"score_spread":0.3909432605375116,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1994040984","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8418699,0.05880315,0.00016114385,0.060081147,0.00083535945,0.0006129929,0.0000062220715,0.000010741025,0.03761937],"genre_scores_gemma":[0.9647199,0.02574284,0.006165689,0.0028902532,0.0003236525,0.000004487992,0.0000017858973,0.00001371808,0.0001376927],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9980955,0.0003745632,0.0007718052,0.00010138559,0.0003724838,0.0002842211],"domain_scores_gemma":[0.99626476,0.0019857162,0.00088662154,0.00011114071,0.00053725555,0.00021448944],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0035305999,0.00010293706,0.0005785271,0.00037069764,0.000023019504,0.0000037941093,0.000111395995,0.00007342931,0.00057995255],"category_scores_gemma":[0.0011130875,0.00007692458,0.00013697146,0.00032967012,0.00011020935,0.00032534893,0.000032918393,0.00076325657,0.000013920543],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.06304525,0.011126367,0.033218402,0.00021135877,0.0022262263,0.024505299,0.0034758712,0.0000120079085,0.06715337,0.00035323232,0.011199036,0.7834736],"study_design_scores_gemma":[0.017131522,0.0058041937,0.015459006,0.00007585725,0.00035102243,0.0058786455,0.0011567187,0.00000919929,0.012258923,0.00008881059,0.94172895,0.000057127094],"about_ca_topic_score_codex":0.0002222755,"about_ca_topic_score_gemma":0.00010325097,"teacher_disagreement_score":0.93052995,"about_ca_system_score_codex":0.0009386387,"about_ca_system_score_gemma":0.001833184,"threshold_uncertainty_score":0.6350074},"labels":[],"label_agreement":null},{"id":"W1995674745","doi":"10.1177/1078155213506478","title":"Trastuzumab therapy in breast cancer: To reload or not to reload?","year":2013,"lang":"en","type":"editorial","venue":"Journal of Oncology Pharmacy Practice","topic":"HER2/EGFR in Cancer Research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Medicine; Trastuzumab; Breast cancer; Oncology; Internal medicine; Cancer","score_opus":0.10153406861746643,"score_gpt":0.5481237729204406,"score_spread":0.4465897043029741,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1995674745","genre_codex":"editorial","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"editorial","genre_consensus":"editorial","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.012761651,0.0020469339,0.000021539674,0.26864555,0.7095859,0.0027299887,0.0002115993,0.00004095817,0.003955851],"genre_scores_gemma":[0.002572056,0.07719156,0.00405274,0.021464905,0.88836527,0.0004088417,0.000015788499,0.00026449218,0.0056643705],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99174136,0.0015556925,0.0021103837,0.0007389314,0.0027278187,0.0011257988],"domain_scores_gemma":[0.9831182,0.008323625,0.0018996566,0.0006220666,0.0045299646,0.0015065352],"candidate_categories":["metaresearch","metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0060876952,0.0006325352,0.0021415453,0.0014053499,0.00011560112,0.00011847941,0.0011696399,0.00091247674,0.0047453237],"category_scores_gemma":[0.012078854,0.0004799809,0.0002979549,0.0012565599,0.000124095,0.0008704839,0.0002433429,0.008916247,0.00065161515],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.07886564,0.0012815904,0.00011419005,0.00015023972,0.0006440671,0.005042016,0.0011596499,0.000030964704,0.0031437038,9.191501e-7,0.73078895,0.17877807],"study_design_scores_gemma":[0.016441366,0.007966634,0.00043960378,0.00103001,0.0004866754,0.004050193,0.00039862172,0.000010998686,0.0007130074,0.0000034778332,0.968032,0.00042738166],"about_ca_topic_score_codex":0.0042053666,"about_ca_topic_score_gemma":0.00029449732,"teacher_disagreement_score":0.24718066,"about_ca_system_score_codex":0.008530559,"about_ca_system_score_gemma":0.027428856,"threshold_uncertainty_score":0.99976516},"labels":[],"label_agreement":null},{"id":"W1997842736","doi":"10.1191/1078155202jp090oa","title":"Development of a pharmacist-coordinated system of chemotherapy protocols in an integrated healthcare delivery organization","year":2002,"lang":"en","type":"article","venue":"Journal of Oncology Pharmacy Practice","topic":"Clinical practice guidelines implementation","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Medicine; Protocol (science); Pharmacist; Intranet; Credibility; Health care; Pharmacy; The Internet; Nursing; Alternative medicine; Computer science; World Wide Web; Pathology","score_opus":0.32126986827349624,"score_gpt":0.5543952731209133,"score_spread":0.23312540484741706,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1997842736","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98196214,0.00013862798,0.0017618024,0.010534604,0.00029039194,0.0050776815,0.000009503073,0.000024295794,0.00020093734],"genre_scores_gemma":[0.9494544,0.00023002793,0.048367262,0.0016592392,0.00013204779,0.000091240356,0.00001958464,0.000032284537,0.000013872633],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9949132,0.0009589361,0.0032731218,0.00017960448,0.00047885848,0.00019623095],"domain_scores_gemma":[0.98970914,0.0011421759,0.0044897133,0.00015940891,0.0043147244,0.00018483915],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003861002,0.00016584949,0.0007398746,0.00038960745,0.000043865264,0.000010126329,0.00018770149,0.00010949462,0.00038005668],"category_scores_gemma":[0.0039420296,0.00014494301,0.00006816897,0.0009148418,0.000055865923,0.0011487958,0.000030553543,0.0007218557,0.0000072331495],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.028576106,0.012392202,0.06659653,0.0015960969,0.00095594925,0.0008429487,0.010165125,0.00013217662,0.28971127,0.000035872356,0.0034637125,0.585532],"study_design_scores_gemma":[0.121642165,0.009853725,0.009994952,0.0021049192,0.0017280185,0.009356008,0.029991593,0.01653104,0.2676836,0.0000072252196,0.5305093,0.0005974626],"about_ca_topic_score_codex":0.00008713103,"about_ca_topic_score_gemma":0.00002303277,"teacher_disagreement_score":0.58493453,"about_ca_system_score_codex":0.000927008,"about_ca_system_score_gemma":0.0016356036,"threshold_uncertainty_score":0.59106046},"labels":[],"label_agreement":null},{"id":"W2001399765","doi":"10.1177/107815520100600401","title":"Prospective evaluation of a policy of early discontinuation of antibiotics and discharge from hospital in children with cancer who develop fever","year":2001,"lang":"en","type":"article","venue":"Journal of Oncology Pharmacy Practice","topic":"Neutropenia and Cancer Infections","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; McMaster Children's Hospital; Hamilton Health Sciences","funders":"International Society of Oncology Pharmacy Practitioners","keywords":"Medicine; Discontinuation; Antibiotics; Prospective cohort study; Pediatrics; Cancer; Cohort; Emergency medicine; Intensive care medicine; Surgery; Internal medicine","score_opus":0.032808497806714014,"score_gpt":0.4200506473248311,"score_spread":0.3872421495181171,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2001399765","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99517894,0.00045706276,0.000078514095,0.0027886368,0.000095028256,0.00051572826,0.000017840366,0.0000016781123,0.00086655805],"genre_scores_gemma":[0.99738,0.0014555604,0.0008485581,0.00008608594,0.00019317363,0.0000021385335,0.000002479502,0.000010301492,0.000021704314],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9986687,0.00021544896,0.0005228963,0.0001089474,0.00038194243,0.0001021075],"domain_scores_gemma":[0.9967493,0.00019579052,0.0014357162,0.00007402189,0.0014881176,0.000057087476],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007671791,0.00009096195,0.00041317462,0.00021777741,0.00002124141,0.0000049731243,0.00005250845,0.00004381123,0.000052274394],"category_scores_gemma":[0.00059510785,0.00006896128,0.000037534817,0.0004389414,0.00011247579,0.00067501696,0.000020268644,0.00029569547,3.041293e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0023519334,0.0011113805,0.96545666,0.000011796317,0.0006239874,0.000008767591,0.0024598707,0.000050431416,0.014253254,0.00005694073,0.000048267695,0.01356668],"study_design_scores_gemma":[0.0111642815,0.0016226525,0.95576763,0.00016314123,0.0015277268,0.00028158948,0.00043543,0.000051860843,0.028548488,0.000048899714,0.00032468938,0.000063595195],"about_ca_topic_score_codex":0.002299516,"about_ca_topic_score_gemma":0.00017537516,"teacher_disagreement_score":0.014295234,"about_ca_system_score_codex":0.00029508967,"about_ca_system_score_gemma":0.0017088058,"threshold_uncertainty_score":0.3476196},"labels":[],"label_agreement":null},{"id":"W2005204505","doi":"10.1177/1078155214533367","title":"Tolerability of Velcade (Bortezomib) subcutaneous administration using a maximum volume of 3 mL per injection site","year":2014,"lang":"en","type":"article","venue":"Journal of Oncology Pharmacy Practice","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Bortezomib; Tolerability; Dosing; Subcutaneous injection; Anesthesia; Route of administration; Multiple myeloma; Adverse effect; Pharmacology; Internal medicine","score_opus":0.0622537412032568,"score_gpt":0.4347714572492852,"score_spread":0.37251771604602835,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2005204505","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99380034,0.00014907801,0.0012057441,0.0025673192,0.0002922405,0.0002882859,0.000010530098,0.0000064037167,0.0016800403],"genre_scores_gemma":[0.98870075,0.00014532047,0.010579505,0.00019007796,0.00028310137,0.000002297454,0.000006240772,0.0000143579055,0.00007832967],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.9975208,0.00068821205,0.00091064617,0.0001540563,0.0005121377,0.00021416193],"domain_scores_gemma":[0.9959391,0.0008901718,0.0015892339,0.00017707223,0.0011818478,0.00022258837],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0017571535,0.00013047105,0.0005652233,0.00021100308,0.000058901518,0.0000095435,0.000090051486,0.000099325145,0.00026287374],"category_scores_gemma":[0.0027276475,0.00010967645,0.00016657093,0.00017239488,0.00013175956,0.00051388226,0.000030614432,0.000578736,0.000009473978],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0823749,0.00930896,0.25180522,0.0005470858,0.0018382655,0.0020889163,0.0015239241,0.0006015452,0.5068638,0.000022327196,0.00081975135,0.14220534],"study_design_scores_gemma":[0.06805747,0.079016656,0.1733832,0.00048071594,0.008452006,0.16043967,0.0020183625,0.04924692,0.18243945,0.00041036104,0.27538404,0.00067115837],"about_ca_topic_score_codex":0.00020110441,"about_ca_topic_score_gemma":0.000013320836,"teacher_disagreement_score":0.32442433,"about_ca_system_score_codex":0.00037976584,"about_ca_system_score_gemma":0.0010919578,"threshold_uncertainty_score":0.4472476},"labels":[],"label_agreement":null},{"id":"W2006163699","doi":"10.1191/1078155204jp127oa","title":"Effects of flaxseed on breast cancer growth","year":2004,"lang":"en","type":"article","venue":"Journal of Oncology Pharmacy Practice","topic":"Phytoestrogen effects and research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"BC Cancer Agency","keywords":"Medicine; Breast cancer; Tamoxifen; Cancer; Oncology; Internal medicine; Traditional medicine; Gynecology","score_opus":0.02737077248091464,"score_gpt":0.44521561162457973,"score_spread":0.4178448391436651,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2006163699","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.94675905,0.0014295457,0.000061020386,0.046019614,0.0008115064,0.0003717613,0.000004521309,0.000008983962,0.0045340303],"genre_scores_gemma":[0.99237853,0.0028545454,0.0008814446,0.00293687,0.00085308903,0.0000049863834,4.1127134e-7,0.000019851639,0.000070248236],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99835485,0.00032055646,0.00041950555,0.00012003436,0.0005283368,0.0002566992],"domain_scores_gemma":[0.9965501,0.0015117427,0.0007025677,0.0000958807,0.0008583276,0.00028138733],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010151948,0.0001281315,0.0004917123,0.00022950015,0.000052251864,0.000007376953,0.00014693607,0.000073312054,0.00010228571],"category_scores_gemma":[0.0011435717,0.00008646761,0.00017165231,0.00020182676,0.00011811438,0.0003505711,0.00003287615,0.001013346,0.000021933567],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.035499196,0.009562052,0.005790635,0.000909007,0.0021941185,0.010941938,0.00063451595,0.00022056936,0.8875508,0.0003756127,0.005864209,0.04045736],"study_design_scores_gemma":[0.04992491,0.012097533,0.049225982,0.00093134143,0.002495074,0.034226194,0.00015344225,0.00003905603,0.7717894,0.00019973256,0.07870569,0.00021169422],"about_ca_topic_score_codex":0.00011087101,"about_ca_topic_score_gemma":0.0000014069319,"teacher_disagreement_score":0.11576144,"about_ca_system_score_codex":0.00044042335,"about_ca_system_score_gemma":0.0015870853,"threshold_uncertainty_score":0.44025406},"labels":[],"label_agreement":null},{"id":"W2006689939","doi":"10.1177/1078155206075236","title":"Stability issues of parenteral chemotherapy drugs","year":2007,"lang":"en","type":"article","venue":"Journal of Oncology Pharmacy Practice","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":21,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"BC Cancer Agency; United States Pharmacopeia","keywords":"Medicine; Chemotherapy; Intensive care medicine; Pharmacology; Internal medicine","score_opus":0.06675610146510093,"score_gpt":0.49594687242619134,"score_spread":0.42919077096109043,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2006689939","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9474363,0.0027671747,0.000114188144,0.030881014,0.0012391417,0.00026717794,0.0000040245673,0.000012110048,0.017278882],"genre_scores_gemma":[0.9857995,0.0032525326,0.0046454733,0.0049664304,0.0010089324,0.000002132669,0.0000024300602,0.000016202566,0.00030636735],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.99821913,0.00024282538,0.00084116665,0.00012949997,0.00031914725,0.00024820314],"domain_scores_gemma":[0.99649346,0.0012529088,0.001195052,0.00012775321,0.00072230794,0.00020854601],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0025031178,0.0001413885,0.0005884421,0.00015696774,0.00003666753,0.0000050977105,0.00012446704,0.00007288534,0.0017326282],"category_scores_gemma":[0.00029453103,0.000112376256,0.00020750012,0.00018267757,0.00014764928,0.00040536182,0.000023841136,0.0005617868,0.000010588008],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.13901943,0.019199675,0.11201785,0.0002565257,0.004105283,0.0026655076,0.0147171235,0.0000058355654,0.39263937,0.00011499294,0.05808542,0.257173],"study_design_scores_gemma":[0.017711036,0.0034967372,0.0070230532,0.000025811305,0.0010213122,0.0021645173,0.0012504274,0.000009538738,0.14420079,0.000039820836,0.82297665,0.000080312195],"about_ca_topic_score_codex":0.00007428367,"about_ca_topic_score_gemma":0.000005731306,"teacher_disagreement_score":0.7648912,"about_ca_system_score_codex":0.00039462093,"about_ca_system_score_gemma":0.0005786516,"threshold_uncertainty_score":0.9991799},"labels":[],"label_agreement":null},{"id":"W2022953054","doi":"10.1177/1078155212442562","title":"Using expired supply in times of drug shortage","year":2012,"lang":"en","type":"letter","venue":"Journal of Oncology Pharmacy Practice","topic":"Pharmaceutical Economics and Policy","field":"Economics, Econometrics and Finance","cited_by":5,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Medicine; Economic shortage; Drug; Intensive care medicine; Pharmacology; Emergency medicine","score_opus":0.18364378929511835,"score_gpt":0.4199983429826919,"score_spread":0.23635455368757355,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2022953054","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.024723716,0.017779492,0.00006278824,0.84068304,0.0052731116,0.00043967058,0.00038096088,0.0000101751675,0.11064702],"genre_scores_gemma":[0.24278189,0.010089815,0.006142996,0.7297675,0.00995301,0.0000111982645,0.000023910523,0.00014933986,0.0010803584],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9958962,0.00031185668,0.0027787464,0.0002973127,0.00009325905,0.0006225814],"domain_scores_gemma":[0.9918785,0.001618954,0.0058795637,0.00027841088,0.00015931753,0.00018521726],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0035846815,0.00033880095,0.0016502229,0.0010026532,0.00004543853,0.000043807486,0.0006803033,0.00044812832,0.003421731],"category_scores_gemma":[0.000703357,0.00038408182,0.0004055249,0.0002507708,0.00014675241,0.0014420581,0.00013809893,0.0035979806,0.00016743499],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005084111,0.0007765817,0.0083021615,0.00021178571,0.00085597805,0.0010725883,0.001058041,0.00020791405,0.0001245335,0.002575331,0.9821721,0.0021345853],"study_design_scores_gemma":[0.0025714592,0.000091022725,0.00010292419,0.00004557577,0.00022695267,0.00067961373,0.00005943192,0.0008699605,0.0001961965,0.001991636,0.9928339,0.00033131635],"about_ca_topic_score_codex":0.00030114903,"about_ca_topic_score_gemma":0.0000052160685,"teacher_disagreement_score":0.21805818,"about_ca_system_score_codex":0.0007615424,"about_ca_system_score_gemma":0.00051172305,"threshold_uncertainty_score":0.9998611},"labels":[],"label_agreement":null},{"id":"W2023063845","doi":"10.1191/1078155202jp089oa","title":"Clinical effectiveness of trastuzumab: early experience","year":2002,"lang":"en","type":"article","venue":"Journal of Oncology Pharmacy Practice","topic":"HER2/EGFR in Cancer Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Baker Hughes (Canada); University of Alberta; Alberta Cancer Foundation","funders":"","keywords":"Medicine; Trastuzumab; Internal medicine; Cardiotoxicity; Clinical trial; Oncology; Breast cancer; Metastatic breast cancer; Adverse effect; Cancer; Incidence (geometry); Surgery; Chemotherapy","score_opus":0.25688355352266745,"score_gpt":0.5927217133347364,"score_spread":0.335838159812069,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2023063845","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9722401,0.0018190244,0.00027871664,0.0038614857,0.0012426215,0.00035183542,0.0000019360593,0.000010622792,0.020193676],"genre_scores_gemma":[0.991538,0.0036524935,0.003114051,0.00079039665,0.0006880272,0.000011620003,2.233051e-7,0.000023146,0.00018205612],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9952825,0.0023836081,0.001155393,0.00020311668,0.00066846464,0.00030694433],"domain_scores_gemma":[0.98949265,0.007629161,0.0010816583,0.00023572026,0.0011793362,0.00038144793],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0066110757,0.00013527912,0.0007904868,0.00019630515,0.00005261562,0.000012759967,0.00030695598,0.00012316518,0.001019053],"category_scores_gemma":[0.0065414305,0.000110077504,0.00026003274,0.00034620365,0.00038450025,0.0006405265,0.00006441271,0.001673494,0.00007718688],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.039972913,0.014288905,0.3394736,0.0007732089,0.0019126071,0.011794838,0.006156471,0.00003099268,0.09892056,0.0001655566,0.020428607,0.46608174],"study_design_scores_gemma":[0.020802945,0.015159347,0.07828908,0.00044310934,0.0008533422,0.011914155,0.00087421347,0.0002961064,0.025314014,0.000035203604,0.84582376,0.0001947306],"about_ca_topic_score_codex":0.000047583922,"about_ca_topic_score_gemma":7.1131143e-7,"teacher_disagreement_score":0.82539517,"about_ca_system_score_codex":0.00041423104,"about_ca_system_score_gemma":0.0007303439,"threshold_uncertainty_score":0.99989414},"labels":[],"label_agreement":null},{"id":"W2023645024","doi":"10.1177/1078155213495285","title":"What do Canadian uro-oncologists believe patients should know about androgen deprivation therapy?","year":2013,"lang":"en","type":"article","venue":"Journal of Oncology Pharmacy Practice","topic":"Hormonal and reproductive studies","field":"Medicine","cited_by":16,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Nova Scotia Health Authority; Capital District Health Authority; University of Toronto; Dalhousie University; Princess Margaret Cancer Centre; University of British Columbia; University of Calgary","funders":"","keywords":"Medicine; Androgen deprivation therapy; Family medicine; Erectile dysfunction; Psychological intervention; Hormone therapy; Prostate cancer; Gynecology; Cancer; Psychiatry; Internal medicine; Breast cancer","score_opus":0.06334315318679806,"score_gpt":0.3973897417244644,"score_spread":0.33404658853766633,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2023645024","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8818942,0.023670504,0.000010589288,0.07969855,0.002470607,0.0008152107,0.000003428115,0.000014992513,0.01142195],"genre_scores_gemma":[0.92775714,0.060237337,0.0010741379,0.009356042,0.0012005945,0.00002550711,0.0000063240786,0.000023992761,0.00031889995],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.997917,0.0003771424,0.00064717303,0.00024779502,0.000444371,0.00036653815],"domain_scores_gemma":[0.9952294,0.0006103627,0.0008884327,0.00017514362,0.002649112,0.00044752896],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011417166,0.00020298746,0.0005252765,0.00025709008,0.00020416903,0.000069526686,0.0001728341,0.00012303362,0.00040422927],"category_scores_gemma":[0.002183816,0.00013881348,0.00014685837,0.00024353871,0.00016495118,0.0021133553,0.000051328145,0.0008467248,0.00014613179],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0024328874,0.0019969149,0.17417403,0.000027295298,0.0015322237,0.00057988684,0.0024278772,0.000013970273,0.004984049,0.000028697543,0.042955127,0.76884705],"study_design_scores_gemma":[0.0055281892,0.0020201893,0.13144095,0.00006330356,0.00032997687,0.00091112603,0.0017298968,0.000008361893,0.0015907685,0.00009976937,0.8561367,0.00014079288],"about_ca_topic_score_codex":0.0030724702,"about_ca_topic_score_gemma":0.00046397207,"teacher_disagreement_score":0.8131815,"about_ca_system_score_codex":0.00071577076,"about_ca_system_score_gemma":0.0012620612,"threshold_uncertainty_score":0.56606495},"labels":[],"label_agreement":null},{"id":"W2031514510","doi":"10.1177/1078155210381794","title":"Should the concomitant use of erlotinib and acid-reducing agents be avoided? The drug interaction between erlotinib and acid-reducing agents","year":2010,"lang":"en","type":"review","venue":"Journal of Oncology Pharmacy Practice","topic":"Lung Cancer Treatments and Mutations","field":"Medicine","cited_by":29,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Credit Valley Hospital; University of Toronto","funders":"","keywords":"Erlotinib; Medicine; Pharmacology; Famotidine; Drug interaction; Drug; Ranitidine; Cimetidine; Context (archaeology); Pharmacokinetics; Epidermal growth factor receptor; Internal medicine; Cancer","score_opus":0.25394962200006704,"score_gpt":0.5227555704228933,"score_spread":0.2688059484228263,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2031514510","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.03773067,0.9301742,0.000037848586,0.02365828,0.0038807893,0.0029613804,0.00014545709,0.00002374073,0.001387655],"genre_scores_gemma":[0.025169872,0.96923333,0.0014353215,0.002021405,0.0014809285,0.00005631911,0.00003844184,0.00008493601,0.000479434],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.995231,0.0015574914,0.0018591245,0.00040947492,0.00057104975,0.0003718962],"domain_scores_gemma":[0.9861464,0.0072370893,0.005232715,0.00042658238,0.0006312002,0.0003260029],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.0028626746,0.0005224953,0.001985514,0.00030658318,0.0004331014,0.00014713006,0.00033465258,0.00026974283,0.00013149022],"category_scores_gemma":[0.003049695,0.00028204685,0.00044646405,0.00029920088,0.000348578,0.0012311582,0.00019386741,0.003517852,0.000005889798],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006187688,0.0006027467,0.00053189753,0.0016468439,0.0058169016,0.00034269446,0.0053691627,0.0000061913056,0.00027479156,0.000012991014,0.015130613,0.9696464],"study_design_scores_gemma":[0.0036584698,0.00049414684,0.00031047247,0.003162035,0.029636625,0.0070230504,0.0014226029,0.000029007075,0.00018917095,0.000005060448,0.9538662,0.00020317557],"about_ca_topic_score_codex":0.00033198035,"about_ca_topic_score_gemma":0.00002148515,"teacher_disagreement_score":0.9694432,"about_ca_system_score_codex":0.000558957,"about_ca_system_score_gemma":0.0017955232,"threshold_uncertainty_score":0.99996316},"labels":[],"label_agreement":null},{"id":"W2036005566","doi":"10.1177/1078155213482602","title":"High-dose methotrexate in adult oncology patients: A case-control study assessing the risk association between drug interactions and methotrexate toxicity","year":2013,"lang":"en","type":"article","venue":"Journal of Oncology Pharmacy Practice","topic":"Acute Lymphoblastic Leukemia research","field":"Medicine","cited_by":31,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"London Health Sciences Centre","funders":"London Health Sciences Centre","keywords":"Medicine; Methotrexate; Mucositis; Nephrotoxicity; Internal medicine; Toxicity; Regimen; Pharmacology; Renal function; Gastroenterology","score_opus":0.03695050119048455,"score_gpt":0.4405665699112882,"score_spread":0.40361606872080363,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2036005566","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9678393,0.00008557265,0.0007281317,0.028213818,0.0006831659,0.0015464134,0.0000203967,0.000016845504,0.00086636655],"genre_scores_gemma":[0.9864531,0.00039042745,0.009606026,0.00261343,0.0006660243,0.000076408316,0.00000233692,0.000034950604,0.00015726853],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.98573184,0.01118442,0.0014856904,0.00032821982,0.00075047236,0.00051935145],"domain_scores_gemma":[0.9530966,0.03984124,0.0037166658,0.0002524,0.0027323703,0.00036069474],"candidate_categories":["metaresearch","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.011483565,0.0002732789,0.0010454992,0.0004869218,0.00031816607,0.00013467454,0.00024398588,0.00013325161,0.00021726324],"category_scores_gemma":[0.03048261,0.00018342803,0.0001453552,0.0005402586,0.000118539225,0.002425651,0.00015749746,0.003411885,0.000040001858],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0030764511,0.00559857,0.73898613,0.000034863493,0.00445621,0.0059061297,0.007097903,0.00011220192,0.0015623438,0.0000059101644,0.0065876693,0.22657558],"study_design_scores_gemma":[0.09762108,0.0046669324,0.816848,0.00011381833,0.011993049,0.011757183,0.021401454,0.0070213582,0.0005879872,0.0001634236,0.02743969,0.00038603562],"about_ca_topic_score_codex":0.0047454312,"about_ca_topic_score_gemma":0.0003406252,"teacher_disagreement_score":0.22618955,"about_ca_system_score_codex":0.00560421,"about_ca_system_score_gemma":0.001554876,"threshold_uncertainty_score":0.9988873},"labels":[],"label_agreement":null},{"id":"W2044771549","doi":"10.1191/1078155204jp128oa","title":"Retinoic acid syndrome after one dose of all-transretinoic acid","year":2004,"lang":"en","type":"article","venue":"Journal of Oncology Pharmacy Practice","topic":"Retinoids in leukemia and cellular processes","field":"Biochemistry, Genetics and Molecular Biology","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Mount Sinai Hospital; University Health Network","funders":"","keywords":"Medicine; Retinoic acid; Acute promyelocytic leukemia; Chemotherapy; Pathophysiology; Tretinoin; Internal medicine; Pharmacology; Biochemistry; Gene","score_opus":0.023549602897649357,"score_gpt":0.34292394471747667,"score_spread":0.3193743418198273,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2044771549","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9795688,0.010188273,0.0019556773,0.0035681124,0.00061616703,0.00018586314,0.000008565451,0.0000083496425,0.0039001903],"genre_scores_gemma":[0.97887945,0.0054338733,0.0131782,0.0018786638,0.0004541546,0.000012902185,0.000010834082,0.00003832552,0.000113597474],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99761343,0.00036938218,0.00094056985,0.0002955632,0.00041667483,0.00036436814],"domain_scores_gemma":[0.99738497,0.0001034932,0.0013154589,0.00030797097,0.0006781469,0.00020999371],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013600482,0.00025178198,0.000494914,0.00012704777,0.000057245794,0.000022222715,0.0005080543,0.00025802827,0.00016761753],"category_scores_gemma":[0.0008254621,0.00023256405,0.00027330266,0.00018271712,0.00025547188,0.0000730414,0.00010719874,0.0007004693,0.000024113482],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0044491556,0.0009780831,0.00043365042,0.00012262934,0.0006110659,0.0011439061,0.00026931072,0.000097393226,0.9886514,0.000030781204,0.00048367752,0.002728952],"study_design_scores_gemma":[0.0055281725,0.0025602488,0.00032082136,0.00006512403,0.000618337,0.011270926,0.00017181419,0.0000017470992,0.7981683,0.0001430911,0.18092673,0.00022469954],"about_ca_topic_score_codex":0.000009367552,"about_ca_topic_score_gemma":0.0000022235995,"teacher_disagreement_score":0.19048311,"about_ca_system_score_codex":0.00012628551,"about_ca_system_score_gemma":0.0011167882,"threshold_uncertainty_score":0.94836867},"labels":[],"label_agreement":null},{"id":"W2045798533","doi":"10.1191/1078155205jp145oa","title":"Alendronate for steroid-induced osteopenia in children with acute lymphoblastic leukaemia or non-Hodgkin’s lymphoma: results of a pilot study","year":2005,"lang":"en","type":"article","venue":"Journal of Oncology Pharmacy Practice","topic":"Bone health and osteoporosis research","field":"Medicine","cited_by":51,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hamilton Health Sciences; McMaster University; McMaster Children's Hospital","funders":"","keywords":"Medicine; Hodgkin lymphoma; Osteopenia; Lymphoblastic lymphoma; Lymphoma; Lymphoblastic Leukemia; Pediatrics; Internal medicine; Oncology; Osteoporosis; Leukemia; Immunology; Bone mineral","score_opus":0.07171028973288934,"score_gpt":0.44252300373742975,"score_spread":0.3708127140045404,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2045798533","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9862942,0.00020343022,0.000038339196,0.00964931,0.00020303486,0.0027372376,0.00003003149,0.000011036936,0.0008333921],"genre_scores_gemma":[0.9901909,0.0005289943,0.006403604,0.001927622,0.00045289667,0.000087471395,0.000006920618,0.000053057825,0.00034849902],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9956526,0.0006554495,0.0018240283,0.00037597457,0.00083158625,0.0006603508],"domain_scores_gemma":[0.9934452,0.0025329818,0.002018628,0.00032252257,0.0011567032,0.00052395544],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004121463,0.00029420722,0.0011679188,0.00058826426,0.00010729712,0.000023869718,0.0003583316,0.000097555625,0.00005058429],"category_scores_gemma":[0.0019455184,0.00020228708,0.000099601086,0.0005418245,0.00009409204,0.0009541652,0.00009727969,0.00078116066,0.000018112982],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.7548434,0.02728623,0.037259102,0.00020489609,0.0026773154,0.0030875972,0.0027941645,0.00009374075,0.026160816,0.0000023590699,0.0058700484,0.1397203],"study_design_scores_gemma":[0.4043316,0.22921562,0.2602119,0.00039499224,0.0037686937,0.041185785,0.0024955377,0.00070153904,0.011182636,0.0000031031966,0.046060257,0.00044832396],"about_ca_topic_score_codex":0.0004330184,"about_ca_topic_score_gemma":0.0005429523,"teacher_disagreement_score":0.35051182,"about_ca_system_score_codex":0.0011597321,"about_ca_system_score_gemma":0.006590479,"threshold_uncertainty_score":0.99904126},"labels":[],"label_agreement":null},{"id":"W2045984347","doi":"10.1191/1078155201jp078oa","title":"Spearheading clinical intervention documentation into the future: an Alberta Cancer Board study","year":2001,"lang":"en","type":"article","venue":"Journal of Oncology Pharmacy Practice","topic":"Pharmaceutical Practices and Patient Outcomes","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"University of Alberta","keywords":"Documentation; Medicine; Psychological intervention; Pharmacy; Interview; Data extraction; Medical education; Intervention (counseling); Family medicine; MEDLINE; Nursing; Computer science","score_opus":0.21251276514917697,"score_gpt":0.6067075707956135,"score_spread":0.3941948056464366,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2045984347","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.90352434,0.0014774974,0.00013539972,0.08638916,0.004439956,0.0006066818,3.3259596e-7,0.000010608806,0.0034160279],"genre_scores_gemma":[0.9753885,0.007715797,0.0010029793,0.011739211,0.003566342,0.000013937846,0.000002353636,0.000020942383,0.0005499229],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.99542,0.0023603616,0.0012650099,0.00020764492,0.0005191942,0.00022779213],"domain_scores_gemma":[0.9941317,0.0030892726,0.0017675578,0.00019797406,0.000493399,0.00032013416],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.005356367,0.00016143685,0.00045642946,0.000117556105,0.00017953035,0.00007413529,0.00024105086,0.00007197544,0.0012697963],"category_scores_gemma":[0.0015916745,0.00010198923,0.0002481625,0.00026048205,0.00008468367,0.0028021624,0.000064994856,0.0015404922,0.000058012476],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.02046943,0.008537632,0.5188908,0.000028169685,0.0014090773,0.0008688096,0.0055055437,0.000026332751,0.00047524853,0.00004442105,0.0048247757,0.43891978],"study_design_scores_gemma":[0.014062387,0.005469069,0.036678433,0.000037255544,0.0032648903,0.0016047726,0.012340303,0.0007683508,0.00007038902,0.000039754872,0.9255533,0.00011105387],"about_ca_topic_score_codex":0.0009813627,"about_ca_topic_score_gemma":0.000505464,"teacher_disagreement_score":0.92072856,"about_ca_system_score_codex":0.0003081928,"about_ca_system_score_gemma":0.00029448772,"threshold_uncertainty_score":0.9996432},"labels":[],"label_agreement":null},{"id":"W2046437108","doi":"10.1177/1078155206069925","title":"Dose conversion and cost effectiveness of erythropoietic therapies in chemotherapy-related anemia: a Canadian application","year":2006,"lang":"en","type":"article","venue":"Journal of Oncology Pharmacy Practice","topic":"Erythropoietin and Anemia Treatment","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Darbepoetin alfa; Epoetin alfa; Medicine; Dosing; Anemia; Internal medicine; Chemotherapy; Regimen; Cost effectiveness; Oncology","score_opus":0.01595623342422359,"score_gpt":0.35424400997367267,"score_spread":0.3382877765494491,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2046437108","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97416157,0.0026527909,0.000032013668,0.017725663,0.00014716285,0.00060375745,0.0000024199703,0.0000062761974,0.0046683606],"genre_scores_gemma":[0.99546975,0.0028842718,0.00094948505,0.00055319135,0.000065409404,0.000009345708,0.0000066128027,0.000014355089,0.000047595393],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.99870497,0.00038510558,0.00045147006,0.0001302625,0.00015963873,0.0001685631],"domain_scores_gemma":[0.9980446,0.0009048446,0.00055431994,0.000090752525,0.00026969338,0.00013575102],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012201815,0.00012264145,0.00040546156,0.00023813662,0.000047340855,0.0000064240644,0.000055304863,0.00011272,0.000085062195],"category_scores_gemma":[0.00011255414,0.00009957266,0.000060743227,0.00021621297,0.00017644148,0.00021266534,0.000009705465,0.00042833333,0.000005033797],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.028073736,0.009271187,0.41146994,0.0013141138,0.0012323895,0.0046359687,0.003850677,0.0002540256,0.38355523,0.0008918316,0.005378903,0.15007201],"study_design_scores_gemma":[0.115780465,0.005749832,0.3384279,0.00083781086,0.0019311026,0.018423626,0.0036954242,0.0005895401,0.054622494,0.00053816114,0.45895448,0.00044915496],"about_ca_topic_score_codex":0.013324314,"about_ca_topic_score_gemma":0.00072069856,"teacher_disagreement_score":0.45357558,"about_ca_system_score_codex":0.00063012977,"about_ca_system_score_gemma":0.00069401937,"threshold_uncertainty_score":0.993246},"labels":[],"label_agreement":null},{"id":"W2051908585","doi":"10.1177/1078155209354135","title":"Look-alike, sound-alike drugs in oncology","year":2010,"lang":"en","type":"article","venue":"Journal of Oncology Pharmacy Practice","topic":"Pharmacovigilance and Adverse Drug Reactions","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":20,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Alberta Health Services","funders":"","keywords":"Medicine; Formulary; Bigram; Levenshtein distance; Drug; Internal medicine; Oncology; Emergency medicine; Medical emergency; Family medicine; Algorithm; Pharmacology; Artificial intelligence","score_opus":0.1372158935252119,"score_gpt":0.5370151428571186,"score_spread":0.3997992493319067,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2051908585","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.81183314,0.0008374797,0.000092419796,0.03199648,0.017752886,0.00058413163,0.000041496503,0.00008758101,0.13677438],"genre_scores_gemma":[0.96750975,0.0040103165,0.0024215179,0.02222099,0.0028432377,0.000046185276,0.00001124419,0.00006721004,0.0008695424],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.9938216,0.0022548498,0.00185909,0.0004936167,0.00052087894,0.0010499716],"domain_scores_gemma":[0.9889427,0.006619622,0.0024041305,0.00034222382,0.0008550453,0.000836292],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.007371878,0.0005023685,0.0010723514,0.0008276061,0.00036866224,0.0000513304,0.0010300955,0.0007606489,0.0038802032],"category_scores_gemma":[0.002028565,0.0004820691,0.0004033469,0.00078912097,0.00060499937,0.0023883735,0.00019960834,0.009995746,0.00071275444],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.018034432,0.015259682,0.032177653,0.00011337705,0.002168291,0.0098532345,0.008917656,0.0020194128,0.5641276,0.004047496,0.12847632,0.21480481],"study_design_scores_gemma":[0.01565412,0.0005865426,0.00043132744,0.000015651625,0.00091317744,0.0073778965,0.0025734557,0.0006531679,0.01513782,0.0008615688,0.955351,0.0004442659],"about_ca_topic_score_codex":0.00009377067,"about_ca_topic_score_gemma":0.00011169495,"teacher_disagreement_score":0.8268747,"about_ca_system_score_codex":0.0007634036,"about_ca_system_score_gemma":0.002428097,"threshold_uncertainty_score":0.9997631},"labels":[],"label_agreement":null},{"id":"W2063247791","doi":"10.1177/1078155213517729","title":"Medication safety and the administration of intravenous vincristine: International survey of oncology pharmacists","year":2014,"lang":"en","type":"article","venue":"Journal of Oncology Pharmacy Practice","topic":"Chemotherapy-related skin toxicity","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Alberta Health Services","funders":"","keywords":"Medicine; Administration (probate law); Vincristine; Intensive care medicine; Oncology; Internal medicine; Pharmacology; Chemotherapy; Cyclophosphamide","score_opus":0.03777028205804318,"score_gpt":0.42391691713200064,"score_spread":0.38614663507395747,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2063247791","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.85869753,0.0011345318,0.011790612,0.09440687,0.0025221284,0.00079507835,0.000036103313,0.00001854958,0.030598598],"genre_scores_gemma":[0.98964655,0.004977502,0.0031098658,0.0018210262,0.00036027597,0.000002313827,0.000015959868,0.00001383497,0.000052650594],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9961424,0.0017826309,0.0013271939,0.00013787975,0.00048062467,0.00012927759],"domain_scores_gemma":[0.98779577,0.0070730173,0.003380671,0.00015393904,0.001464702,0.0001318712],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.009662783,0.00012743117,0.0006503121,0.00014972145,0.000050557257,0.000006449456,0.00023387696,0.00013025836,0.0002591515],"category_scores_gemma":[0.009815562,0.00009080325,0.000090048445,0.00017584789,0.0005114516,0.00027639754,0.000043805325,0.0008322729,0.0000027370008],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.2895188,0.0056236167,0.007872508,0.00018882744,0.0032100012,0.0003136791,0.0043897606,0.000067613255,0.0840353,0.00089328416,0.0072504133,0.5966362],"study_design_scores_gemma":[0.101296626,0.0078489585,0.071227156,0.00016325498,0.003107897,0.03839674,0.00049208227,0.008002935,0.06741907,0.00034879244,0.70142615,0.00027031236],"about_ca_topic_score_codex":0.00010444879,"about_ca_topic_score_gemma":0.000016135526,"teacher_disagreement_score":0.6941758,"about_ca_system_score_codex":0.0002633249,"about_ca_system_score_gemma":0.0010935222,"threshold_uncertainty_score":0.9985252},"labels":[],"label_agreement":null},{"id":"W2065783129","doi":"10.1177/1078155210385160","title":"Key components of intravenous chemotherapy labeling: A systematic review and practice guideline","year":2010,"lang":"en","type":"review","venue":"Journal of Oncology Pharmacy Practice","topic":"Patient Safety and Medication Errors","field":"Health Professions","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Princess Margaret Cancer Centre; Regional Municipality of Durham; University Health Network; University of Toronto; McMaster University; Cancer Care Ontario; Sunnybrook Health Science Centre","funders":"Solar Energy Technologies Office; Canadian Patient Safety Institute; Sanofi","keywords":"Medicine; Guideline; MEDLINE; Data extraction; Systematic review; Medical physics; Randomized controlled trial; Evidence-based medicine; Disk formatting; Intensive care medicine; Alternative medicine; Surgery; Pathology; Computer science","score_opus":0.22696104157454305,"score_gpt":0.5853660332115278,"score_spread":0.35840499163698475,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2065783129","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0000011369269,0.96007186,0.00037449683,0.030421853,0.0019531401,0.003641189,0.000026956533,0.000015023194,0.0034943223],"genre_scores_gemma":[0.0000027383564,0.9594455,0.013162972,0.026477711,0.0005102673,0.00011174131,0.000036189947,0.000059494312,0.00019342486],"study_design_codex":"systematic_review","study_design_gemma":"not_applicable","domain_scores_codex":[0.9814579,0.010616414,0.0065738745,0.00027439964,0.00068399985,0.000393424],"domain_scores_gemma":[0.9431378,0.021148518,0.031947162,0.00046342704,0.002911472,0.00039156893],"candidate_categories":["metaresearch","metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.020411693,0.00042905417,0.00512946,0.00033647916,0.00025539284,0.0000027262795,0.0006420487,0.00056330085,0.00027155646],"category_scores_gemma":[0.050141145,0.0003032557,0.00036734354,0.00040552914,0.0001586603,0.00074083544,0.00013025997,0.005129033,0.00009565112],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00044521486,0.0012946533,9.693587e-7,0.87729716,0.0019132938,0.00013942244,0.0018515049,3.4426932e-7,0.00001692797,0.000072748226,0.017330734,0.09963701],"study_design_scores_gemma":[0.0018465219,0.00029008836,1.9327555e-7,0.21450534,0.023394909,0.0037920624,0.00041677128,0.0000026992207,2.6244854e-7,0.000005496653,0.755587,0.00015867397],"about_ca_topic_score_codex":0.000025560377,"about_ca_topic_score_gemma":0.0000016753902,"teacher_disagreement_score":0.7382562,"about_ca_system_score_codex":0.00040410814,"about_ca_system_score_gemma":0.004060693,"threshold_uncertainty_score":0.99994195},"labels":[],"label_agreement":null},{"id":"W2071188109","doi":"10.1177/1078155212464087","title":"Efficacy vs. effectiveness: Erlotinib in previously treated non-small-cell lung cancer","year":2012,"lang":"en","type":"article","venue":"Journal of Oncology Pharmacy Practice","topic":"Lung Cancer Treatments and Mutations","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Alberta Health Services","funders":"","keywords":"Medicine; Erlotinib; Lung cancer; Internal medicine; Oncology; Regimen; Erlotinib Hydrochloride; Chemotherapy; Cancer; Randomized controlled trial; Surgery; Epidermal growth factor receptor","score_opus":0.0349619244226064,"score_gpt":0.4534841221746531,"score_spread":0.4185221977520467,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2071188109","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97406584,0.008537378,0.000091390015,0.0037940915,0.001031716,0.0012104308,0.00000381673,0.000015893154,0.011249466],"genre_scores_gemma":[0.992214,0.003432546,0.0016077949,0.0015426843,0.0007329609,0.00009332025,0.0000050381386,0.00003455253,0.00033709063],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.9980705,0.0005510007,0.0005854562,0.000155539,0.00022298207,0.0004145289],"domain_scores_gemma":[0.99660397,0.0017036869,0.0008388385,0.00013412374,0.00038855377,0.00033082397],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013929696,0.00019646097,0.000589184,0.00024281983,0.000068902154,0.000015156427,0.0001088651,0.000090777576,0.00022636581],"category_scores_gemma":[0.00045956657,0.00015024682,0.00015095172,0.00033099603,0.000040583145,0.0007938764,0.000028240293,0.00069778814,0.000024732488],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.017959312,0.012397188,0.90239465,0.00044885627,0.002262711,0.0015867378,0.0060572186,0.00030803858,0.012997341,0.000013620523,0.0063686715,0.037205633],"study_design_scores_gemma":[0.08919303,0.0031854827,0.4342318,0.0007827722,0.013289954,0.004018052,0.0006525189,0.00024722095,0.017274547,0.0000032273815,0.43677136,0.0003500241],"about_ca_topic_score_codex":0.00035345284,"about_ca_topic_score_gemma":0.000013713473,"teacher_disagreement_score":0.46816286,"about_ca_system_score_codex":0.0013628853,"about_ca_system_score_gemma":0.0013522339,"threshold_uncertainty_score":0.6126888},"labels":[],"label_agreement":null},{"id":"W2072050498","doi":"10.1177/1078155207085387","title":"Efficacy vs. effectiveness — docetaxel and prednisone in hormone refractory prostate cancer","year":2008,"lang":"en","type":"article","venue":"Journal of Oncology Pharmacy Practice","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Docetaxel; Medicine; Prednisone; Internal medicine; Prostate cancer; Oncology; Cancer; Chemotherapy; Clinical trial; Retrospective cohort study","score_opus":0.06481101481439419,"score_gpt":0.45124613304170885,"score_spread":0.3864351182273147,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2072050498","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95334977,0.032985482,0.0000063986454,0.011110555,0.00027590687,0.00067382865,0.000005053716,0.000011365843,0.0015816448],"genre_scores_gemma":[0.8605004,0.13768478,0.0005294174,0.00057721545,0.00026999007,0.00003744928,0.0000023139148,0.00002197509,0.00037647694],"study_design_codex":"randomized_trial","study_design_gemma":"not_applicable","domain_scores_codex":[0.9979195,0.0006259772,0.00050309947,0.00021395685,0.00039858592,0.00033889536],"domain_scores_gemma":[0.99701947,0.0015484457,0.0005445133,0.000116736126,0.00048933586,0.00028150273],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0015004055,0.0001740024,0.0006072861,0.00029386746,0.00010720524,0.000012900611,0.00009643232,0.00008636439,0.000051950792],"category_scores_gemma":[0.00080265576,0.00012816938,0.000079750236,0.00030513594,0.00024402332,0.0008224435,0.000056713372,0.0011175164,0.000008705225],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.3292098,0.011655257,0.23352711,0.00048520658,0.00218979,0.038553976,0.0070755365,0.00009856734,0.15908004,0.000013321935,0.010368711,0.20774269],"study_design_scores_gemma":[0.08409297,0.0065340814,0.43264517,0.00026158072,0.0006960079,0.013390233,0.00027968586,0.000070116585,0.007456618,0.000016385526,0.45435828,0.00019889594],"about_ca_topic_score_codex":0.00014905194,"about_ca_topic_score_gemma":0.00000415636,"teacher_disagreement_score":0.44398955,"about_ca_system_score_codex":0.00076672854,"about_ca_system_score_gemma":0.0016375367,"threshold_uncertainty_score":0.5226596},"labels":[],"label_agreement":null},{"id":"W2076151388","doi":"10.1191/1078155203jp104oa","title":"Implementation of a telephone callback service for ambulatory oncology patients","year":2003,"lang":"en","type":"article","venue":"Journal of Oncology Pharmacy Practice","topic":"Pharmaceutical Practices and Patient Outcomes","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta; Alberta Cancer Foundation","funders":"Medical Research Council","keywords":"Callback; Medicine; Pharmacy; Ambulatory; Pharmacist; Workload; Service (business); Family medicine; Medical emergency; Surgery","score_opus":0.16839032234890056,"score_gpt":0.5364483731695158,"score_spread":0.3680580508206152,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2076151388","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96937275,0.00059148413,0.00061896286,0.016942823,0.0018723215,0.0012790561,0.00002178958,0.00001217668,0.009288614],"genre_scores_gemma":[0.96119165,0.00072519283,0.019477155,0.018214341,0.0002610656,0.000020001758,0.000011359261,0.000031520733,0.00006768187],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.99703383,0.0007491973,0.0012793777,0.00017580911,0.00044259615,0.0003192052],"domain_scores_gemma":[0.9912043,0.00350548,0.0027116423,0.0001451793,0.0021031892,0.00033019602],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0024055408,0.00018056475,0.00069594866,0.00019561985,0.000076306904,0.00000894614,0.00014127206,0.00012339966,0.0005969493],"category_scores_gemma":[0.002430727,0.00015169228,0.00021304865,0.00028195922,0.00006312827,0.00093220396,0.000032493746,0.0006954975,0.000021258233],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.06359255,0.024318477,0.5014789,0.0016536966,0.0058522015,0.0006346136,0.0060205045,0.00012416884,0.068278305,0.0013854435,0.05617749,0.27048364],"study_design_scores_gemma":[0.030507931,0.005328051,0.0059235175,0.000026662725,0.0022314093,0.00086432,0.0017101658,0.00009404403,0.0154143255,0.00006181855,0.9377078,0.00012994927],"about_ca_topic_score_codex":0.000050953317,"about_ca_topic_score_gemma":0.000013746036,"teacher_disagreement_score":0.88153034,"about_ca_system_score_codex":0.00046609863,"about_ca_system_score_gemma":0.0016219745,"threshold_uncertainty_score":0.6536176},"labels":[],"label_agreement":null},{"id":"W2077187626","doi":"10.1177/1078155214556522","title":"Establishing an international baseline for medication safety in oncology: Findings from the 2012 ISMP International Medication Safety Self Assessment® for Oncology","year":2014,"lang":"en","type":"article","venue":"Journal of Oncology Pharmacy Practice","topic":"Safe Handling of Antineoplastic Drugs","field":"Health Professions","cited_by":15,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Alberta Health Services","funders":"","keywords":"Medicine; Oncology; Snapshot (computer storage); Family medicine; Internal medicine","score_opus":0.07633583662662666,"score_gpt":0.5294997772461671,"score_spread":0.45316394061954046,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2077187626","genre_codex":"commentary","genre_gemma":"methods","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"methods","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.030182667,0.00012436071,0.43758786,0.48623952,0.02886626,0.0019747717,0.00025732515,0.00007474218,0.014692516],"genre_scores_gemma":[0.35867202,0.004985293,0.5500701,0.059910946,0.023461135,0.0005887868,0.0016607969,0.00014466856,0.0005062701],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9917473,0.0039492683,0.002562975,0.00044127658,0.0007625102,0.0005366787],"domain_scores_gemma":[0.9024608,0.09037824,0.004376129,0.00029583924,0.0022054485,0.00028352655],"candidate_categories":["metaresearch","research_integrity"],"consensus_categories":["metaresearch"],"category_scores_codex":[0.033424634,0.00025897517,0.0007001914,0.00037821924,0.00066454906,0.000041832,0.0013518311,0.0004601809,0.00085772306],"category_scores_gemma":[0.033792537,0.00020627979,0.00015874897,0.00020449527,0.00014190412,0.0031696314,0.00019696809,0.0023541476,0.00002893796],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.03902504,0.007041986,0.0736216,0.00013816707,0.0023309393,0.00007551881,0.024843842,0.0011126442,0.004216607,0.012234728,0.29044634,0.5449126],"study_design_scores_gemma":[0.018374879,0.0008101638,0.01585616,0.00013995559,0.00051397586,0.0001129586,0.004208277,0.052976776,0.00003163693,0.00069337955,0.90611446,0.00016739107],"about_ca_topic_score_codex":0.00026223448,"about_ca_topic_score_gemma":0.00044701266,"teacher_disagreement_score":0.6156681,"about_ca_system_score_codex":0.003231838,"about_ca_system_score_gemma":0.0070769563,"threshold_uncertainty_score":0.9999475},"labels":[],"label_agreement":null},{"id":"W2081475049","doi":"10.1177/1078155214556009","title":"Worksheets with embedded checklists support IV chemotherapy safer practice","year":2014,"lang":"en","type":"article","venue":"Journal of Oncology Pharmacy Practice","topic":"Patient Safety and Medication Errors","field":"Health Professions","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Alberta Health Services","funders":"","keywords":"SAFER; Medicine; Usability; Chemotherapy; Patient safety; Adverse effect; Identification (biology); Intensive care medicine; Medical physics; Surgery; Pharmacology; Computer science; Human–computer interaction; Health care","score_opus":0.07100531266920483,"score_gpt":0.5073369435292618,"score_spread":0.436331630860057,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2081475049","genre_codex":"other","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.040062662,0.00027446487,0.029845783,0.44331607,0.005909706,0.0012680826,0.000005718985,0.000102223625,0.4792153],"genre_scores_gemma":[0.79436773,0.002094403,0.039594717,0.1555358,0.0027524326,0.00006550973,0.000014648294,0.00008383905,0.005490944],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9936613,0.0034159273,0.001345425,0.00025297512,0.0007598586,0.00056454237],"domain_scores_gemma":[0.983481,0.008481468,0.005325262,0.00032989559,0.001874007,0.00050838717],"candidate_categories":["metaresearch","research_integrity","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.008127849,0.00023819001,0.0005905642,0.00020463557,0.00046676747,0.00000488776,0.00041039864,0.00024037727,0.0022813694],"category_scores_gemma":[0.010298524,0.0001784552,0.000104961095,0.00036322002,0.00015582498,0.0021785474,0.000057132762,0.0027774582,0.00060008105],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.07480721,0.007653795,0.014374758,0.0003558776,0.002499654,0.0012013685,0.053004235,0.00064286724,0.0035556392,0.0023361805,0.69079727,0.14877114],"study_design_scores_gemma":[0.012776693,0.001333229,0.002154953,0.00011771374,0.00053525006,0.0012464477,0.0045834114,0.00013144936,0.00013966474,0.000043731052,0.97674984,0.00018760521],"about_ca_topic_score_codex":0.00001623031,"about_ca_topic_score_gemma":0.000007546552,"teacher_disagreement_score":0.75430506,"about_ca_system_score_codex":0.0004662612,"about_ca_system_score_gemma":0.0028170769,"threshold_uncertainty_score":0.99952316},"labels":[],"label_agreement":null},{"id":"W2085190055","doi":"10.1177/1078155211402104","title":"Optimizing pain relief in a specialized outpatient palliative radiotherapy clinic: Contributions of a clinical pharmacist","year":2011,"lang":"en","type":"article","venue":"Journal of Oncology Pharmacy Practice","topic":"Management of metastatic bone disease","field":"Medicine","cited_by":36,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Alberta Health Services","funders":"","keywords":"Medicine; Pharmacist; Palliative care; Outpatient clinic; Clinical pharmacy; Pharmacy; Cancer pain; Opioid; Cancer; Morphine; Internal medicine; Physical therapy; Family medicine; Nursing","score_opus":0.22394029381555416,"score_gpt":0.5295370681369619,"score_spread":0.30559677432140775,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2085190055","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.62927437,0.014255393,0.09301271,0.09229196,0.011267656,0.008415826,0.00017013904,0.00011918448,0.15119274],"genre_scores_gemma":[0.72614527,0.016968796,0.23761421,0.017799923,0.0009952046,0.00003993205,0.000011853463,0.000056765315,0.00036801706],"study_design_codex":"randomized_trial","study_design_gemma":"not_applicable","domain_scores_codex":[0.9913872,0.0042796624,0.003205277,0.00024615985,0.0005693006,0.00031242843],"domain_scores_gemma":[0.9881014,0.005509665,0.004586255,0.00024550248,0.0011458419,0.0004112982],"candidate_categories":["metaresearch","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.018699257,0.00020655368,0.0013655502,0.0003741822,0.000043048876,0.000009152133,0.00024761312,0.000104609135,0.0025104578],"category_scores_gemma":[0.018858358,0.00017608114,0.0004737293,0.00034979178,0.00030917148,0.00049979985,0.000055121276,0.0013132617,0.00002197527],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.37855142,0.08799965,0.13207279,0.0006016043,0.011166574,0.018435443,0.0217961,0.00007375468,0.0019957302,0.0009647573,0.08794822,0.25839394],"study_design_scores_gemma":[0.1273083,0.010839527,0.012222748,0.00029508644,0.004572024,0.00037879506,0.0051211347,0.00335099,0.00091566594,0.00018287067,0.8344922,0.00032067954],"about_ca_topic_score_codex":0.000048464946,"about_ca_topic_score_gemma":0.0000033064568,"teacher_disagreement_score":0.74654394,"about_ca_system_score_codex":0.0003398455,"about_ca_system_score_gemma":0.0012858737,"threshold_uncertainty_score":0.9984014},"labels":[],"label_agreement":null},{"id":"W2089069721","doi":"10.1177/1078155208099284","title":"A Medication Error Prevention Survey: five years of results","year":2008,"lang":"en","type":"article","venue":"Journal of Oncology Pharmacy Practice","topic":"Patient Safety and Medication Errors","field":"Health Professions","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Cancer prevention; Pharmacy; Family medicine; Pharmacist; Cancer; Medication error; Environmental health; Health care; Patient safety; Internal medicine","score_opus":0.29143253438943634,"score_gpt":0.5724556806054031,"score_spread":0.28102314621596675,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2089069721","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.94118184,0.00040753174,0.0031922336,0.035560697,0.0041098706,0.0006776575,0.000048283462,0.00002150779,0.014800365],"genre_scores_gemma":[0.9905772,0.0024739648,0.0033001467,0.0018112821,0.00036501372,0.000012784996,0.000035496912,0.0000110042565,0.0014130896],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99387294,0.0038415946,0.0014708004,0.00011911647,0.0004968112,0.00019874398],"domain_scores_gemma":[0.98694706,0.0059131235,0.005647502,0.00015868453,0.0011545282,0.00017908974],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.007821068,0.00007778955,0.00032792724,0.0001942898,0.00019587047,2.81162e-7,0.00022249721,0.00013768916,0.0002047244],"category_scores_gemma":[0.019407628,0.00007223877,0.000080673664,0.00027189683,0.00013773711,0.0006656599,0.00004307468,0.0010340548,0.00009451404],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.055117108,0.007949994,0.08302979,0.0003269294,0.0014923906,0.00068062305,0.106314994,0.0005180211,0.0046795197,0.00031083106,0.66221786,0.077361956],"study_design_scores_gemma":[0.008314147,0.000697188,0.18020561,0.00011165031,0.00017964873,0.00024761146,0.0021060093,0.00008730976,0.00011656297,0.000042291816,0.80782586,0.00006609347],"about_ca_topic_score_codex":0.00015035573,"about_ca_topic_score_gemma":0.00003128103,"teacher_disagreement_score":0.14560804,"about_ca_system_score_codex":0.0002449273,"about_ca_system_score_gemma":0.0029252595,"threshold_uncertainty_score":0.9888523},"labels":[],"label_agreement":null},{"id":"W2092555277","doi":"10.1177/1078155214537926","title":"Adherence to imatinib among patients attending Saskatchewan Cancer Agency Pharmacies","year":2014,"lang":"en","type":"article","venue":"Journal of Oncology Pharmacy Practice","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Saskatchewan","funders":"","keywords":"Medicine; Imatinib; Imatinib mesylate; Cancer; Pharmacy; Pharmacist; Myeloid leukemia; Family medicine; Internal medicine","score_opus":0.053762430460891374,"score_gpt":0.4259535604798781,"score_spread":0.37219113001898674,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2092555277","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98247343,0.00032513408,0.00024408374,0.004721697,0.0019335635,0.0005110615,0.000008467641,0.00002883296,0.009753729],"genre_scores_gemma":[0.98318046,0.00044602607,0.00876063,0.0055632982,0.0009396493,0.000037627247,0.0000047092108,0.000040661675,0.00102692],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99722725,0.00046344916,0.00094652065,0.0002711055,0.00064196397,0.0004497366],"domain_scores_gemma":[0.99567384,0.0010827362,0.001557909,0.00021939725,0.00089479476,0.00057133526],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0012880537,0.00026557097,0.00067187735,0.00024410126,0.00013385231,0.00003053578,0.00027543036,0.00008171705,0.0012889042],"category_scores_gemma":[0.0020355766,0.00021903127,0.0001845936,0.000314252,0.00009172838,0.0010060726,0.00010315441,0.00088681484,0.00014947409],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0052176416,0.0027213416,0.30574414,0.00017267311,0.0015018696,0.00090813916,0.008146797,0.00014269233,0.027962629,0.000008024007,0.042940993,0.6045331],"study_design_scores_gemma":[0.04076126,0.0063164756,0.06868763,0.00047790082,0.0036240092,0.0019249407,0.0014251434,0.0005608437,0.021244051,0.000026359663,0.854479,0.00047238474],"about_ca_topic_score_codex":0.00033946478,"about_ca_topic_score_gemma":0.000031864205,"teacher_disagreement_score":0.811538,"about_ca_system_score_codex":0.0019661256,"about_ca_system_score_gemma":0.001617886,"threshold_uncertainty_score":0.9996241},"labels":[],"label_agreement":null},{"id":"W2093894651","doi":"10.1177/1078155209337661","title":"Use of combined androgen blockade for advanced prostate cancer in British Columbia","year":2009,"lang":"en","type":"article","venue":"Journal of Oncology Pharmacy Practice","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"BC Cancer Agency; Ottawa Hospital","funders":"","keywords":"Medicine; Prostate cancer; Antiandrogen; Androgen deprivation therapy; Agonist; Cancer; Population; Urology; Androgen; Blockade; Internal medicine; Goserelin; Gynecology; Oncology; Hormone; Receptor","score_opus":0.06731656353968259,"score_gpt":0.4495899731008029,"score_spread":0.3822734095611203,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2093894651","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9761378,0.0039032877,0.00000813402,0.018338202,0.00027119298,0.0010355543,0.000046107976,0.0000070209576,0.00025266348],"genre_scores_gemma":[0.9716802,0.01976244,0.0048417114,0.0015630604,0.00017274565,0.000045222347,0.000008134926,0.00001941106,0.0019070555],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99848276,0.00015991993,0.00063981244,0.00014570332,0.00027684396,0.00029498406],"domain_scores_gemma":[0.99734896,0.0007106026,0.00075379235,0.00009139261,0.0009188093,0.00017644749],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00072335365,0.00008661098,0.0005344634,0.00011321369,0.000053036947,0.000042780077,0.00009494727,0.000062790205,0.00011918246],"category_scores_gemma":[0.00083688326,0.0001007322,0.00011724679,0.00025583667,0.00007890985,0.00076424505,0.00001731115,0.00046246458,7.5929137e-7],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.055845965,0.0061929733,0.13410805,0.0002245682,0.0009632765,0.004694078,0.00086528674,0.0002279437,0.11102655,0.0000037694494,0.024882765,0.6609648],"study_design_scores_gemma":[0.09768997,0.016071642,0.05003171,0.0006779153,0.001407763,0.0040859133,0.00064037327,0.00043364987,0.03024518,0.0001939737,0.7982628,0.0002591397],"about_ca_topic_score_codex":0.0009917765,"about_ca_topic_score_gemma":0.0009863065,"teacher_disagreement_score":0.77338,"about_ca_system_score_codex":0.000420343,"about_ca_system_score_gemma":0.0013508354,"threshold_uncertainty_score":0.41077396},"labels":[],"label_agreement":null},{"id":"W2095680003","doi":"10.1177/1078155214528830","title":"Oral chemotherapy practices at Ontario cancer centres","year":2014,"lang":"en","type":"article","venue":"Journal of Oncology Pharmacy Practice","topic":"Medication Adherence and Compliance","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Princess Margaret Cancer Centre; Credit Valley Hospital; Cancer Care Ontario","funders":"Ontario Ministry of Health and Long-Term Care; Cancer Care Ontario","keywords":"Medicine; Medical prescription; Chemotherapy; Cancer; Family medicine; Phone; Regimen; Nursing; Surgery; Internal medicine","score_opus":0.12332332690882523,"score_gpt":0.4882904987376371,"score_spread":0.36496717182881183,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2095680003","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.66340774,0.0015934632,0.00037593403,0.22630109,0.0018783143,0.00030872872,0.0000010408444,0.000024415114,0.10610926],"genre_scores_gemma":[0.80779624,0.0094802715,0.019981224,0.10793086,0.0027125012,0.000029313847,0.0000045828774,0.0000439894,0.052020997],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9982894,0.00034194058,0.00053863536,0.00015947926,0.00044765385,0.00022291219],"domain_scores_gemma":[0.9949025,0.0009448514,0.0030373023,0.00017644564,0.00064273196,0.00029617286],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0014430179,0.00013050747,0.00041051998,0.00008300734,0.000090881906,0.000018792394,0.00019629198,0.00006782325,0.011716516],"category_scores_gemma":[0.0018552311,0.00010044209,0.00010169831,0.00012544237,0.000084151776,0.0007063247,0.000031911433,0.00077849213,0.00041270463],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.014781506,0.0023816202,0.1953035,0.000077601355,0.0010778824,0.0005050788,0.0021661627,0.000021507807,0.01997752,0.0001426481,0.53836817,0.2251968],"study_design_scores_gemma":[0.007508348,0.0007836777,0.013379208,0.00006264462,0.00056230614,0.0031881058,0.00021717288,0.00012586257,0.0028100237,0.000028826056,0.97124314,0.000090695845],"about_ca_topic_score_codex":0.0019358821,"about_ca_topic_score_gemma":0.00088424754,"teacher_disagreement_score":0.43287495,"about_ca_system_score_codex":0.00075769174,"about_ca_system_score_gemma":0.0017584886,"threshold_uncertainty_score":0.9891869},"labels":[],"label_agreement":null},{"id":"W2099297375","doi":"10.1191/1078155204jp126oa","title":"Rationing costly treatments: can it be fair?","year":2004,"lang":"en","type":"article","venue":"Journal of Oncology Pharmacy Practice","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Rationing; Medicine; Health care rationing; Health care; Actuarial science; Distribution (mathematics); Intensive care medicine; Risk analysis (engineering); Law and economics; Economics; Economic growth","score_opus":0.5389202458124981,"score_gpt":0.5647943332140691,"score_spread":0.025874087401571044,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2099297375","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.1050739,0.0023912115,0.0055864346,0.8497362,0.002583814,0.00053090777,0.00007763027,0.000027037579,0.033992883],"genre_scores_gemma":[0.7547458,0.0026762655,0.037804384,0.2016464,0.0019464304,0.000046765435,0.000018264642,0.000060133098,0.001055599],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99412537,0.0007141892,0.0043812,0.00027968345,0.00014908894,0.0003504526],"domain_scores_gemma":[0.98820686,0.0027608394,0.008159806,0.00022809883,0.00035097453,0.00029339932],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.017903775,0.00018415967,0.0009409044,0.0003755925,0.00026437375,0.00009130448,0.00030887217,0.00011164012,0.000601073],"category_scores_gemma":[0.011088911,0.00021516049,0.0001761474,0.00020535414,0.000073118084,0.002328855,0.000036738988,0.0005615873,0.0006168758],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0029222376,0.009097751,0.041589018,0.00048084022,0.007152707,0.0012381498,0.0582435,0.024697306,0.00059158896,0.2141328,0.62724614,0.012607938],"study_design_scores_gemma":[0.008278042,0.0006255032,0.0008716795,0.000044860222,0.00013059296,0.0009606863,0.003859847,0.00021944955,0.000086030836,0.0034929225,0.9812153,0.00021511257],"about_ca_topic_score_codex":0.00074762484,"about_ca_topic_score_gemma":0.000097774624,"teacher_disagreement_score":0.64967185,"about_ca_system_score_codex":0.0032310388,"about_ca_system_score_gemma":0.0015070932,"threshold_uncertainty_score":0.9972411},"labels":[],"label_agreement":null},{"id":"W2101295467","doi":"10.1177/1078155214553143","title":"The effect of race on the CYP3A-mediated metabolism of vincristine in pediatric patients with acute lymphoblastic leukemia","year":2014,"lang":"en","type":"article","venue":"Journal of Oncology Pharmacy Practice","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":35,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"International Society of Oncology Pharmacy Practitioners","keywords":"Medicine; Vincristine; Neurotoxicity; Internal medicine; Genotyping; Acute lymphocytic leukemia; Gastroenterology; Incidence (geometry); Leukemia; Chemotherapy; Lymphoblastic Leukemia; Genotype; Toxicity; Gene","score_opus":0.010044189550483045,"score_gpt":0.34122279438766634,"score_spread":0.3311786048371833,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2101295467","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9900751,0.00065944786,0.000017491899,0.006115997,0.0007043381,0.00052729883,0.000008297383,0.000004917859,0.0018870806],"genre_scores_gemma":[0.9964905,0.0019561986,0.000117133095,0.00090352196,0.00041949475,0.000017564711,0.0000042736306,0.000020234293,0.00007108748],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9968828,0.0014862906,0.0007681628,0.0001383123,0.00047365582,0.00025079885],"domain_scores_gemma":[0.97973585,0.017423851,0.0020376407,0.0001829449,0.0005005506,0.00011916856],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0025365732,0.00020047804,0.00073985435,0.00020883446,0.00007719525,0.0000066260045,0.00024398192,0.00006976894,0.00007748198],"category_scores_gemma":[0.0028842555,0.00009170128,0.00012959802,0.0004496615,0.00017632157,0.00019135639,0.00004217649,0.00071482663,0.000010391356],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.39499483,0.0063567655,0.49176422,0.00035003776,0.006944184,0.0010960113,0.0017259746,0.00095869444,0.016126966,0.0002159918,0.03622774,0.0432386],"study_design_scores_gemma":[0.16611813,0.05304803,0.3878523,0.00017516543,0.02746964,0.0012810448,0.00013629721,0.0012257181,0.027540687,0.00003430328,0.33474788,0.00037077707],"about_ca_topic_score_codex":0.000045829485,"about_ca_topic_score_gemma":0.000008028076,"teacher_disagreement_score":0.29852015,"about_ca_system_score_codex":0.0003845451,"about_ca_system_score_gemma":0.00078653055,"threshold_uncertainty_score":0.37394696},"labels":[],"label_agreement":null},{"id":"W2103672719","doi":"10.1177/107815520100600402","title":"Documentation of capecitabine usage as a third-line chemotherapy option for metastatic breast cancer patients","year":2001,"lang":"en","type":"article","venue":"Journal of Oncology Pharmacy Practice","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of British Columbia; Alberta Cancer Foundation; University of Alberta","funders":"","keywords":"Capecitabine; Medicine; Taxane; Metastatic breast cancer; Vinorelbine; Internal medicine; Nausea; Oncology; Cancer; Breast cancer; Chemotherapy; Colorectal cancer; Cisplatin","score_opus":0.04922793063149728,"score_gpt":0.47197149728347854,"score_spread":0.42274356665198126,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2103672719","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9589999,0.0010375096,0.0006338937,0.035403498,0.0011477635,0.000948338,0.00004521976,0.00001057098,0.0017733037],"genre_scores_gemma":[0.9708356,0.013215244,0.0065389825,0.0074476255,0.0008895134,0.000075404154,0.00003287755,0.000032431213,0.00093229086],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99836814,0.00021257323,0.00075709337,0.00014619423,0.00030622425,0.00020977316],"domain_scores_gemma":[0.99620515,0.0007533889,0.0016227212,0.00007766906,0.0011820528,0.0001589909],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0007529477,0.00016162316,0.00054331287,0.00020485448,0.00005693357,0.000010214113,0.00009030511,0.000051587856,0.0016137403],"category_scores_gemma":[0.0001906417,0.00012987446,0.00018347324,0.00022679135,0.00006399722,0.0008319296,0.000012796874,0.0002918082,0.000009107374],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.21633725,0.029419307,0.051430557,0.0004134672,0.007820217,0.0007118995,0.0034828517,0.00039307497,0.20214528,0.00013646191,0.03932695,0.44838268],"study_design_scores_gemma":[0.13171083,0.014728833,0.016957318,0.00013187109,0.009317318,0.0068588615,0.0005920872,0.00070535555,0.026553327,0.0002478179,0.7919324,0.000263962],"about_ca_topic_score_codex":0.00017966802,"about_ca_topic_score_gemma":0.000013357605,"teacher_disagreement_score":0.75260544,"about_ca_system_score_codex":0.00055282196,"about_ca_system_score_gemma":0.0006491251,"threshold_uncertainty_score":0.99929893},"labels":[],"label_agreement":null},{"id":"W2107358512","doi":"10.1191/1078155202jp108oa","title":"Interacting with drugs used in oncology: an Alberta Cancer Board initiative","year":2003,"lang":"en","type":"article","venue":"Journal of Oncology Pharmacy Practice","topic":"Pharmaceutical Practices and Patient Outcomes","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Pharmacy; Drug; The Internet; Cancer; Family medicine; Pharmacology; Medical education; World Wide Web; Internal medicine; Computer science","score_opus":0.21014512922801698,"score_gpt":0.5320286905245449,"score_spread":0.32188356129652795,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2107358512","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.85039055,0.0006077972,0.000077424775,0.04269191,0.001635041,0.00056030526,0.000002453688,0.000013966814,0.10402052],"genre_scores_gemma":[0.97159386,0.0011813261,0.0066278907,0.019950552,0.00033445403,0.000021603493,0.0000022131378,0.000038881768,0.0002491954],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.9956844,0.0021168184,0.0010022107,0.00027150766,0.00048257623,0.00044250884],"domain_scores_gemma":[0.9849939,0.011602333,0.0020996712,0.0001704148,0.00064173195,0.00049200066],"candidate_categories":["research_integrity","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0028048768,0.0002592392,0.0008428351,0.00032688168,0.00009246346,0.000034374316,0.00018263781,0.0001312838,0.00096388295],"category_scores_gemma":[0.0058682445,0.000191172,0.000121453595,0.0004308672,0.00012884245,0.0032460664,0.000036299487,0.0025822627,0.000029115417],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.092713155,0.018219486,0.70373636,0.0002561783,0.003594724,0.013841467,0.042785008,0.0006683945,0.01011547,0.0006837106,0.0057553547,0.107630715],"study_design_scores_gemma":[0.022437945,0.00491845,0.0016287484,0.00019419457,0.0015497453,0.005008614,0.010231283,0.0006540142,0.0031227726,0.000028570908,0.94998646,0.0002392222],"about_ca_topic_score_codex":0.00044588154,"about_ca_topic_score_gemma":0.00030001006,"teacher_disagreement_score":0.9442311,"about_ca_system_score_codex":0.0010245892,"about_ca_system_score_gemma":0.0024596613,"threshold_uncertainty_score":0.9999494},"labels":[],"label_agreement":null},{"id":"W2108304820","doi":"10.1191/1078155202jp099oa","title":"Physician order entry: a mixed blessing to pharmacy?","year":2002,"lang":"en","type":"article","venue":"Journal of Oncology Pharmacy Practice","topic":"Pharmaceutical Practices and Patient Outcomes","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Alberta Cancer Foundation; University of Alberta","funders":"University of Alberta","keywords":"Pharmacist; Medicine; Pharmacy; Medical prescription; Workload; Electronic prescribing; Order entry; Clinical pharmacy; Intervention (counseling); Psychological intervention; Computerized physician order entry; Family medicine; Medical emergency; Emergency medicine; Nursing; Health care","score_opus":0.2150804031220603,"score_gpt":0.4949927990087716,"score_spread":0.27991239588671124,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2108304820","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.40118507,0.0046772445,0.0014238894,0.36202142,0.0062543023,0.0012390029,0.000010847744,0.000097355594,0.22309086],"genre_scores_gemma":[0.8712538,0.003005134,0.017179752,0.10487323,0.002155676,0.000010851883,0.0000025029178,0.00005922989,0.0014598574],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9967846,0.00068815396,0.0009911358,0.00026815626,0.00073242636,0.0005355105],"domain_scores_gemma":[0.9943815,0.002317435,0.0013221785,0.00021716104,0.0009273529,0.0008343899],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0014121195,0.0002826888,0.0007457918,0.00030514,0.00017138684,0.0000662032,0.00027298267,0.000069982394,0.0017584529],"category_scores_gemma":[0.002875601,0.0002313559,0.00024359296,0.00070466823,0.00008505193,0.0017766145,0.00010334666,0.0016059098,0.00058508565],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.016330604,0.009872733,0.009638326,0.00019401906,0.0022491917,0.006122432,0.0025982326,0.00020318593,0.056629974,0.00012504148,0.25037324,0.645663],"study_design_scores_gemma":[0.013579773,0.0011548001,0.00021795799,0.00008963963,0.0021033662,0.0042697135,0.0005361631,0.0037591867,0.00603671,0.000015803786,0.968012,0.0002248851],"about_ca_topic_score_codex":0.000018499944,"about_ca_topic_score_gemma":0.0000011208633,"teacher_disagreement_score":0.71763873,"about_ca_system_score_codex":0.0003584366,"about_ca_system_score_gemma":0.00035763928,"threshold_uncertainty_score":0.9991541},"labels":[],"label_agreement":null},{"id":"W2108578379","doi":"10.1177/1078155213501100","title":"Assessing adherence to oral chemotherapy using different measurement methods: Lessons learned from capecitabine","year":2013,"lang":"en","type":"article","venue":"Journal of Oncology Pharmacy Practice","topic":"Medication Adherence and Compliance","field":"Medicine","cited_by":30,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Princess Margaret Cancer Centre","funders":"","keywords":"Capecitabine; Medicine; Pill; Internal medicine; Prospective cohort study; Cancer; Oncology; Colorectal cancer; Pharmacology","score_opus":0.5500743065446398,"score_gpt":0.5845884328257962,"score_spread":0.034514126281156354,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2108578379","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.65482503,0.0013036556,0.18418549,0.15340167,0.0014306946,0.0007168804,0.0000014038579,0.000031401953,0.004103785],"genre_scores_gemma":[0.55693585,0.0007558437,0.42314455,0.01813343,0.0006975038,0.000028771845,0.0000015399627,0.000029363488,0.00027316238],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9968473,0.0009479883,0.00085757265,0.00026414625,0.0007772093,0.0003058175],"domain_scores_gemma":[0.99533486,0.0008858441,0.001315172,0.0002673546,0.0016731411,0.000523615],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0023529523,0.00020804786,0.0006793604,0.00015296682,0.0001080969,0.00009666319,0.00027782592,0.00008084632,0.004792844],"category_scores_gemma":[0.0027517353,0.00015875507,0.00013133381,0.00025876242,0.000064913336,0.0011278663,0.000051581585,0.00086688256,0.00028642558],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006268445,0.0008279225,0.0008567181,0.000015256539,0.00032837564,0.00006801766,0.00036989225,0.000017024553,0.4700055,0.000008751669,0.0062521985,0.5206235],"study_design_scores_gemma":[0.021598624,0.0031424498,0.02580289,0.0009298011,0.002156546,0.0022076792,0.0070251976,0.007525607,0.09534197,0.0009924027,0.83267707,0.0005997514],"about_ca_topic_score_codex":0.0002877835,"about_ca_topic_score_gemma":0.0000029268074,"teacher_disagreement_score":0.8264249,"about_ca_system_score_codex":0.0006558069,"about_ca_system_score_gemma":0.0011097272,"threshold_uncertainty_score":0.99611694},"labels":[],"label_agreement":null},{"id":"W2109308320","doi":"10.1177/1078155214527145","title":"Does gastric acid suppression affect sunitinib efficacy in patients with advanced or metastatic renal cell cancer?","year":2014,"lang":"en","type":"article","venue":"Journal of Oncology Pharmacy Practice","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":48,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ontario Institute for Cancer Research; University of Alberta","funders":"","keywords":"Sunitinib; Medicine; Internal medicine; Hazard ratio; Cancer; Progression-free survival; Proportional hazards model; Gastroenterology; Population; Univariate analysis; Retrospective cohort study; Tyrosine-kinase inhibitor; Oncology; Surgery; Chemotherapy; Multivariate analysis; Confidence interval","score_opus":0.03492748437011041,"score_gpt":0.38559231009288814,"score_spread":0.35066482572277774,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2109308320","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99373484,0.00032682306,0.000101944184,0.0029724783,0.00052868406,0.0007241633,0.0000059260515,0.000012570572,0.0015925522],"genre_scores_gemma":[0.9856842,0.0005287091,0.012442801,0.0008713067,0.0002309786,0.000026637163,0.0000099856015,0.00003805992,0.000167285],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99687314,0.0011307481,0.00073163107,0.00025693348,0.00062188884,0.00038563632],"domain_scores_gemma":[0.9948831,0.002445426,0.001539307,0.0002139076,0.0005820199,0.00033621004],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010875365,0.00027412619,0.0007776912,0.0003671021,0.00006915268,0.000019187286,0.00017168238,0.000053612883,0.00034380142],"category_scores_gemma":[0.001240805,0.00012983054,0.00011193752,0.00039008557,0.000073080635,0.00071629556,0.00004695703,0.00092299987,0.000013842518],"study_design_candidate":"randomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.31330863,0.02759902,0.16243282,0.00061705936,0.0016079511,0.010287163,0.0016009265,0.001638624,0.10792949,0.000005726522,0.0040094014,0.36896318],"study_design_scores_gemma":[0.20386997,0.052727897,0.33055216,0.0010624775,0.006990631,0.0032558932,0.0006452219,0.00021068937,0.21834843,0.000008508068,0.18174604,0.00058207347],"about_ca_topic_score_codex":0.00003124159,"about_ca_topic_score_gemma":0.00001460338,"teacher_disagreement_score":0.3683811,"about_ca_system_score_codex":0.000641815,"about_ca_system_score_gemma":0.0008250404,"threshold_uncertainty_score":0.5294336},"labels":[],"label_agreement":null},{"id":"W2112205736","doi":"10.1177/1078155208095141","title":"In vitro evaluation of the effects of gefitinib on the cytotoxic activity of selected anticancer agents in a panel of human endometrial cancer cell lines","year":2008,"lang":"en","type":"article","venue":"Journal of Oncology Pharmacy Practice","topic":"Drug Transport and Resistance Mechanisms","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"University of Texas MD Anderson Cancer Center; International Society of Oncology Pharmacy Practitioners","keywords":"Gefitinib; Medicine; Endometrial cancer; Cytotoxic T cell; In vitro; Cancer; Pharmacology; Oncology; Cancer research; Internal medicine; Epidermal growth factor receptor; Biology; Genetics","score_opus":0.1376462551986086,"score_gpt":0.4433970072707447,"score_spread":0.3057507520721361,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2112205736","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9964065,0.00058924855,0.000006248714,0.0011633104,0.000562349,0.0008031866,0.000008089567,0.0000013185588,0.00045977003],"genre_scores_gemma":[0.9976517,0.0018548629,0.00010848728,0.00017523106,0.00015091842,0.000017641049,6.752873e-7,0.000011637972,0.000028843253],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99682903,0.0011654004,0.00086239446,0.00011239984,0.00087349454,0.00015729057],"domain_scores_gemma":[0.9939633,0.0024473846,0.0024344176,0.00015391006,0.00095944095,0.000041547064],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0028672523,0.00012289056,0.00070578454,0.0002455399,0.00003409493,0.0000010149714,0.0001853781,0.00008269718,0.00010438644],"category_scores_gemma":[0.0023048727,0.00007228608,0.00016008258,0.00080132537,0.00015777207,0.00020792011,0.000017057928,0.0005938611,1.8301715e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.013843395,0.0030912948,0.005491512,0.00027785727,0.00021606128,0.000072812945,0.0011442164,0.00010464296,0.9743007,0.000005083688,0.00008093966,0.001371521],"study_design_scores_gemma":[0.018380756,0.00096109323,0.06305393,0.00029882437,0.0009615732,0.000055222277,0.00013973443,0.00016445,0.9157062,0.000013712652,0.00021584387,0.000048621878],"about_ca_topic_score_codex":0.00040132913,"about_ca_topic_score_gemma":0.00009262556,"teacher_disagreement_score":0.058594424,"about_ca_system_score_codex":0.0002946794,"about_ca_system_score_gemma":0.001324702,"threshold_uncertainty_score":0.29477406},"labels":[],"label_agreement":null},{"id":"W2113176208","doi":"10.1177/1078155207077335","title":"Chemotherapy induced diarrhea","year":2007,"lang":"en","type":"review","venue":"Journal of Oncology Pharmacy Practice","topic":"Oral health in cancer treatment","field":"Medicine","cited_by":137,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Alberta Cancer Foundation","funders":"National Cancer Institute","keywords":"Medicine; MEDLINE; Cochrane Library; Intensive care medicine; Diarrhea; Data extraction; Systematic review; Internal medicine; Randomized controlled trial","score_opus":0.35390555964002646,"score_gpt":0.6235067227358282,"score_spread":0.26960116309580173,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2113176208","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000034774275,0.9750034,0.000020386515,0.009561865,0.003376443,0.001124246,0.0000058465785,0.000021569685,0.010851461],"genre_scores_gemma":[0.000015957576,0.977451,0.008416969,0.00943401,0.0041886917,0.000026913496,0.0000067566775,0.00010417798,0.00035551793],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9954059,0.00082214584,0.0022375707,0.00029575915,0.00066933,0.0005692541],"domain_scores_gemma":[0.9895284,0.0034766493,0.005172392,0.00034147387,0.0007549443,0.000726112],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.0040751086,0.00048628828,0.0033882444,0.00059009524,0.00007824728,0.000016713608,0.00029111785,0.00049298897,0.00055055483],"category_scores_gemma":[0.000947497,0.00034460335,0.00079366803,0.0005279981,0.00007410499,0.00040588976,0.00004392193,0.0034900184,0.00020479025],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.001943584,0.0015558943,0.000010790183,0.005948913,0.0017626785,0.00545514,0.00009813319,5.74564e-8,0.0000031743562,0.000006736981,0.013300555,0.9699143],"study_design_scores_gemma":[0.006820665,0.0032403835,0.0000031671148,0.004917882,0.008743693,0.04206014,0.000035319037,6.2825643e-7,0.000031104664,0.0000046934633,0.9339429,0.00019943468],"about_ca_topic_score_codex":0.000030815776,"about_ca_topic_score_gemma":0.0000014148098,"teacher_disagreement_score":0.9697149,"about_ca_system_score_codex":0.00460929,"about_ca_system_score_gemma":0.010805731,"threshold_uncertainty_score":0.9999006},"labels":[],"label_agreement":null},{"id":"W2113298091","doi":"10.1177/1078155213504975","title":"Are community pharmacists equipped to ensure the safe use of oral anticancer therapy in the community setting? Results of a cross-country survey of community pharmacists in Canada","year":2013,"lang":"en","type":"article","venue":"Journal of Oncology Pharmacy Practice","topic":"Medication Adherence and Compliance","field":"Medicine","cited_by":66,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Dr. H. Bliss Murphy Cancer Centre","funders":"","keywords":"Medicine; Pharmacy; Family medicine; Medical prescription; Cancer; Pharmacist; Nursing; Internal medicine","score_opus":0.30676219689613604,"score_gpt":0.5024666138799242,"score_spread":0.19570441698378815,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2113298091","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9891208,0.000248937,0.000008518175,0.0083505185,0.00028021424,0.00085666374,0.00015271419,0.0000032820321,0.0009783709],"genre_scores_gemma":[0.9827421,0.00095619005,0.00026532495,0.015904592,0.00003669005,0.000025291525,0.000019219426,0.000015503789,0.000035117795],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9779761,0.01875757,0.0019731487,0.000094620904,0.0008608921,0.00033769532],"domain_scores_gemma":[0.97066766,0.020802408,0.004471042,0.0009731185,0.002899407,0.00018638042],"candidate_categories":["metaresearch","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.019833822,0.00023257133,0.00094936835,0.00017301367,0.00026587685,0.000026548762,0.0014388228,0.00008137151,0.00022487451],"category_scores_gemma":[0.013605143,0.00015052716,0.00008979646,0.0010164791,0.0005383673,0.00068734563,0.0001983768,0.0053184447,0.000005066527],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.022045868,0.006901204,0.84802854,0.00032606252,0.00055879477,0.00015106473,0.017360823,0.00031807288,0.023526756,0.000003906357,0.05621296,0.024565928],"study_design_scores_gemma":[0.014098067,0.00073441816,0.95328015,0.00023847441,0.00013520938,0.00058389804,0.00812283,0.00020733563,0.005647782,0.000022543883,0.016798839,0.0001304601],"about_ca_topic_score_codex":0.7163741,"about_ca_topic_score_gemma":0.19009922,"teacher_disagreement_score":0.52627486,"about_ca_system_score_codex":0.00046614616,"about_ca_system_score_gemma":0.0032716934,"threshold_uncertainty_score":0.9969763},"labels":[],"label_agreement":null},{"id":"W2115123976","doi":"10.1177/1078155208093929","title":"Pharmaceutical care in an inpatient pediatric hematopoietic stem cell transplant service","year":2008,"lang":"en","type":"article","venue":"Journal of Oncology Pharmacy Practice","topic":"Hematopoietic Stem Cell Transplantation","field":"Medicine","cited_by":24,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier Universitaire Sainte-Justine","funders":"","keywords":"Medicine; Hematopoietic stem cell; Stem cell; Intensive care medicine; Haematopoiesis; Oncology","score_opus":0.06754681610924824,"score_gpt":0.3915713188160119,"score_spread":0.3240245027067637,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2115123976","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9882423,0.0023806675,0.0002527961,0.0034438458,0.0006895358,0.0005231186,0.00000914099,0.000027619946,0.004430921],"genre_scores_gemma":[0.9869558,0.006143811,0.00272787,0.0036509836,0.0004277331,0.00001342984,0.000012010501,0.000042051535,0.000026290301],"study_design_codex":"observational","study_design_gemma":"case_report","domain_scores_codex":[0.9964514,0.0007816084,0.0013159851,0.00028252433,0.0007490367,0.00041944653],"domain_scores_gemma":[0.99656564,0.0010633782,0.00079110864,0.0002048748,0.0008345751,0.0005404391],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00097313663,0.0002654699,0.000707359,0.00044663748,0.00009585913,0.000012667552,0.00024036529,0.00016625368,0.00018261344],"category_scores_gemma":[0.000037555074,0.00023705051,0.00014334434,0.00058304705,0.000057522186,0.0008820324,0.000018515851,0.0013357121,0.000075840995],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.050603285,0.019990845,0.45233527,0.007726225,0.00050902105,0.10770449,0.28099275,0.0012038177,0.059887208,0.00006533156,0.0016181676,0.017363608],"study_design_scores_gemma":[0.14492586,0.017054431,0.030756803,0.00086670567,0.013328754,0.33837813,0.046567917,0.0030013882,0.16348626,0.000020359274,0.23979288,0.0018204864],"about_ca_topic_score_codex":0.000019629506,"about_ca_topic_score_gemma":0.000010044464,"teacher_disagreement_score":0.42157847,"about_ca_system_score_codex":0.00045598618,"about_ca_system_score_gemma":0.0015468926,"threshold_uncertainty_score":0.96666396},"labels":[],"label_agreement":null},{"id":"W2117050757","doi":"10.1177/1078155208101097","title":"Antineoplastic agent workplace contamination study: the Alberta Cancer Board Pharmacy perspective Phase III","year":2009,"lang":"en","type":"article","venue":"Journal of Oncology Pharmacy Practice","topic":"Safe Handling of Antineoplastic Drugs","field":"Health Professions","cited_by":38,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Alberta Cancer Foundation","funders":"","keywords":"Medicine; Pharmacy; Perspective (graphical); Cancer; Antineoplastic Drugs; Contamination; Phase (matter); Cancer drugs; Family medicine; Pharmacology; Internal medicine","score_opus":0.09178912142410763,"score_gpt":0.5349185322970967,"score_spread":0.4431294108729891,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2117050757","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8215949,0.0013347863,0.001148548,0.13888566,0.008098793,0.0019492699,0.000008043912,0.000049747545,0.026930267],"genre_scores_gemma":[0.98134035,0.0015049649,0.00043935946,0.010793783,0.002808072,0.00005290476,0.000001842773,0.00003798386,0.0030207264],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9931785,0.003289148,0.0016553099,0.0003689758,0.00079964695,0.00070841954],"domain_scores_gemma":[0.9754828,0.017678192,0.0037581727,0.0002741035,0.0024967347,0.00030997238],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0047896225,0.00036007637,0.0007992392,0.0002947217,0.0010919193,0.000042551073,0.000628701,0.00010699136,0.0011352572],"category_scores_gemma":[0.008070523,0.00025284765,0.00018698207,0.0005641938,0.00012583185,0.0012115975,0.000112683534,0.0030730094,0.00018916978],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.12224128,0.0362555,0.050362084,0.00013386898,0.006951845,0.004956628,0.24479873,0.0017247285,0.012426112,0.0026211883,0.36082074,0.1567073],"study_design_scores_gemma":[0.07284543,0.0027173026,0.005932933,0.00022392758,0.0035679874,0.0006291824,0.066265054,0.0018702968,0.00030858858,0.00007965182,0.84519,0.00036967575],"about_ca_topic_score_codex":0.0023571348,"about_ca_topic_score_gemma":0.00058336934,"teacher_disagreement_score":0.48436925,"about_ca_system_score_codex":0.0011996302,"about_ca_system_score_gemma":0.0042946544,"threshold_uncertainty_score":0.9999924},"labels":[],"label_agreement":null},{"id":"W2121170439","doi":"10.1191/1078155204jp139oa","title":"Developing a targeted pharmacy oncology guide","year":2004,"lang":"en","type":"article","venue":"Journal of Oncology Pharmacy Practice","topic":"Economic and Financial Impacts of Cancer","field":"Economics, Econometrics and Finance","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Medicine; Pharmacy; Oncology; Internal medicine; Agency (philosophy); Clinical pharmacy; Family medicine","score_opus":0.10681591881013026,"score_gpt":0.408982632555235,"score_spread":0.30216671374510473,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2121170439","genre_codex":"other","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.19039984,0.024602253,0.055821057,0.22000168,0.0128434915,0.00071171153,0.00008113577,0.000091877584,0.49544695],"genre_scores_gemma":[0.8441637,0.018621227,0.09790522,0.03554063,0.0027898476,0.000021913245,0.000005579731,0.00008723794,0.0008646224],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"not_applicable","domain_scores_codex":[0.996729,0.000109873596,0.0021976416,0.00032643552,0.00007894292,0.0005581053],"domain_scores_gemma":[0.9943892,0.00058450684,0.0040710843,0.0002011203,0.00044313047,0.00031096477],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0033097225,0.00026294714,0.0010181024,0.00045913772,0.00017474638,0.0000688953,0.0005810919,0.00014706573,0.00066968525],"category_scores_gemma":[0.0025326805,0.000290681,0.00026953564,0.00032097005,0.00014653348,0.0027227046,0.00010581894,0.001007103,0.0007648026],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0081816465,0.004384051,0.014351503,0.0001415783,0.003645735,0.0050652847,0.007764537,0.0048355814,0.003762526,0.5263001,0.120313406,0.30125406],"study_design_scores_gemma":[0.010216076,0.0005809816,0.0005517523,0.000022639586,0.00009528153,0.0019334636,0.00026758737,0.00005673999,0.0015055726,0.016188368,0.96826196,0.00031960497],"about_ca_topic_score_codex":0.0005300047,"about_ca_topic_score_gemma":0.00002732881,"teacher_disagreement_score":0.84794855,"about_ca_system_score_codex":0.0032894646,"about_ca_system_score_gemma":0.0028032253,"threshold_uncertainty_score":0.9999545},"labels":[],"label_agreement":null},{"id":"W2121301515","doi":"10.1177/1078155214531609","title":"Practical considerations in the use of intravenous tacrolimus in hematopoietic stem cell transplantation patients","year":2014,"lang":"en","type":"letter","venue":"Journal of Oncology Pharmacy Practice","topic":"Hematopoietic Stem Cell Transplantation","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier Universitaire Sainte-Justine","funders":"","keywords":"Tacrolimus; Medicine; Calcineurin; Transplantation; Pharmacology; Hematopoietic stem cell transplantation; Graft-versus-host disease; Sirolimus; Surgery","score_opus":0.11454234255156505,"score_gpt":0.38884682231072004,"score_spread":0.274304479759155,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2121301515","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.11636242,0.00021742613,0.002211065,0.8747603,0.0011276291,0.00219269,0.000048831924,0.000013401823,0.0030661924],"genre_scores_gemma":[0.5983186,0.001923781,0.008728779,0.39000142,0.0007740759,0.000039588504,0.00010236064,0.000069136615,0.000042270272],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9927526,0.0032952179,0.0023008815,0.0002730336,0.0010014931,0.00037674914],"domain_scores_gemma":[0.97910553,0.016999617,0.0027449657,0.00028201204,0.0007736448,0.0000942074],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.0024785027,0.00032479916,0.0011113257,0.00063483143,0.00005055997,0.00004676223,0.00014861459,0.0005813178,0.00011627964],"category_scores_gemma":[0.0007851021,0.0002496871,0.00019984823,0.0003136583,0.00014325372,0.00076762616,0.000010742608,0.0046279742,0.000020390435],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.009009385,0.011233768,0.009706447,0.008088656,0.0008194451,0.13471423,0.04738993,0.0005774273,0.0019541734,0.0001472216,0.7734488,0.0029104783],"study_design_scores_gemma":[0.027768778,0.003547689,0.003166058,0.001442359,0.0059799743,0.10802978,0.0014416849,0.00022585629,0.0027905528,0.000083393614,0.8450269,0.0004969796],"about_ca_topic_score_codex":0.00006569962,"about_ca_topic_score_gemma":0.000015888352,"teacher_disagreement_score":0.4847589,"about_ca_system_score_codex":0.00033805153,"about_ca_system_score_gemma":0.001492535,"threshold_uncertainty_score":0.9999955},"labels":[],"label_agreement":null},{"id":"W2123031775","doi":"10.1177/1078155208099281","title":"A feasibility study to assess the integration of a pharmacist into neurooncology clinic","year":2008,"lang":"en","type":"article","venue":"Journal of Oncology Pharmacy Practice","topic":"Healthcare Decision-Making and Restraints","field":"Psychology","cited_by":23,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary; Alberta Cancer Foundation","funders":"","keywords":"Pharmacist; Medicine; Outpatient clinic; Family medicine; Neurooncology; Psychological intervention; Clinical pharmacy; Feeling; Nursing; Medical emergency; Pharmacy; Internal medicine; Surgery","score_opus":0.48830413709177123,"score_gpt":0.6271375867684428,"score_spread":0.13883344967667155,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2123031775","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9681606,0.00022482502,0.0010519943,0.017935826,0.0057384,0.0009972521,0.000004401926,0.000017387489,0.00586929],"genre_scores_gemma":[0.9911158,0.00021028037,0.0021272385,0.0055432804,0.00067769835,0.000026754939,6.70439e-7,0.000024366565,0.0002738866],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.98855215,0.008094483,0.0020115504,0.00036900718,0.0006050651,0.0003677521],"domain_scores_gemma":[0.9836268,0.011598404,0.0024084,0.00049671426,0.0015533615,0.00031632386],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.010391801,0.0002219173,0.00075900834,0.00032645042,0.000295681,0.00001704433,0.0008057546,0.00012343595,0.0006952692],"category_scores_gemma":[0.010236224,0.00014566025,0.00023169036,0.00063871435,0.00028153454,0.0003954783,0.00012888706,0.0020051547,0.00023517187],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.07113529,0.060194436,0.06610415,0.00006048264,0.002483996,0.054926798,0.18077074,0.00013576068,0.013016997,0.000103533705,0.07234381,0.478724],"study_design_scores_gemma":[0.020728292,0.022063892,0.1350888,0.000057764126,0.0011064763,0.07376977,0.06620866,0.00009239868,0.00047122303,0.00032953641,0.6796772,0.0004059919],"about_ca_topic_score_codex":0.00026869064,"about_ca_topic_score_gemma":0.000064376196,"teacher_disagreement_score":0.60733336,"about_ca_system_score_codex":0.0003544416,"about_ca_system_score_gemma":0.0014552877,"threshold_uncertainty_score":0.998101},"labels":[],"label_agreement":null},{"id":"W2125833278","doi":"10.1177/1078155211429384","title":"Chemotherapy-induced infiltrative pneumonitis cases in breast cancer patients","year":2012,"lang":"en","type":"review","venue":"Journal of Oncology Pharmacy Practice","topic":"Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis","field":"Medicine","cited_by":22,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Juravinski Cancer Centre; Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Chemotherapy; Docetaxel; Pneumonitis; Breast cancer; Cyclophosphamide; Gemcitabine; Lung cancer; Incidence (geometry); Cancer; Adverse effect; Internal medicine; Oncology; Lung","score_opus":0.09187344097115692,"score_gpt":0.46291375392893713,"score_spread":0.3710403129577802,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2125833278","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0009909038,0.98962414,7.448109e-7,0.0020616823,0.001928339,0.0007664777,0.00019436533,0.000009709834,0.004423613],"genre_scores_gemma":[0.013163411,0.9824083,0.00008392656,0.0019040322,0.0022169687,0.000052441126,0.000027089543,0.00007035801,0.00007351447],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99645346,0.0009468161,0.0014708439,0.00024443024,0.0004537506,0.00043069304],"domain_scores_gemma":[0.994429,0.0011336011,0.0029922908,0.00016527386,0.00085180777,0.00042801705],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00077573827,0.00044920252,0.0022880351,0.00045521714,0.000060245256,0.00002449735,0.00023554811,0.00031105883,0.0006430522],"category_scores_gemma":[0.00032465043,0.0003391227,0.00070903543,0.0003651843,0.000077385426,0.0010128656,0.00005612443,0.0020912623,0.00003777828],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.007634295,0.003726226,0.0006188893,0.0037255269,0.001130381,0.0036868511,0.00021911677,9.472552e-8,0.000022773975,0.0000063965945,0.0017128207,0.97751665],"study_design_scores_gemma":[0.003432715,0.003019978,0.00034891462,0.00891929,0.008472041,0.027255123,0.00010171437,0.0000011448292,0.0000044984345,0.0000011905836,0.9481759,0.00026746065],"about_ca_topic_score_codex":0.00016455697,"about_ca_topic_score_gemma":0.0000025710874,"teacher_disagreement_score":0.97724915,"about_ca_system_score_codex":0.001643858,"about_ca_system_score_gemma":0.0029399716,"threshold_uncertainty_score":0.99990606},"labels":[],"label_agreement":null},{"id":"W2125952502","doi":"10.1177/1078155207080802","title":"Interaction between mercaptopurine and milk","year":2007,"lang":"en","type":"article","venue":"Journal of Oncology Pharmacy Practice","topic":"Acute Lymphoblastic Leukemia research","field":"Medicine","cited_by":32,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Mercaptopurine; Bioavailability; Medicine; Xanthine oxidase; Pharmacology; Purine; In vivo; Purine analogue; Theophylline; Biotechnology; Chemistry; Biochemistry; Enzyme; Biology","score_opus":0.06535646130096556,"score_gpt":0.4676410016685943,"score_spread":0.40228454036762873,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2125952502","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.94238216,0.0007011992,0.003392148,0.027079534,0.0006588162,0.00021706196,0.0000014949883,0.000016211661,0.025551373],"genre_scores_gemma":[0.9795958,0.001582224,0.0141510805,0.0025187118,0.0017963449,0.0000010545037,0.0000018575965,0.000020462885,0.00033251022],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9981862,0.00020925004,0.00068298186,0.00013598247,0.00049777573,0.0002878414],"domain_scores_gemma":[0.9941212,0.003887076,0.000733235,0.000108446795,0.00074117805,0.00040884604],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00367852,0.00012074846,0.000410062,0.00034067477,0.00006417413,0.000017052493,0.0001091865,0.000091272836,0.00016696555],"category_scores_gemma":[0.0029434212,0.000096105316,0.00007864344,0.00020756385,0.000120033925,0.00080850255,0.00007664557,0.0011644579,0.0000407532],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.029403964,0.0015392692,0.050952457,0.00013630165,0.0021407336,0.014729622,0.0015258562,0.000006252903,0.094281346,0.000111279245,0.037528683,0.7676442],"study_design_scores_gemma":[0.012057371,0.0019007435,0.011035351,0.000047409674,0.0009724065,0.037127517,0.0009448759,0.000105297,0.01903012,0.000024977391,0.9166662,0.000087696375],"about_ca_topic_score_codex":0.000043535652,"about_ca_topic_score_gemma":0.0000020982998,"teacher_disagreement_score":0.8791376,"about_ca_system_score_codex":0.0010110871,"about_ca_system_score_gemma":0.000865013,"threshold_uncertainty_score":0.50590545},"labels":[],"label_agreement":null},{"id":"W2127016949","doi":"10.1191/1078155202jp098oa","title":"Updating a survey for medication error prevention","year":2002,"lang":"en","type":"article","venue":"Journal of Oncology Pharmacy Practice","topic":"Pharmaceutical Practices and Patient Outcomes","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Alberta Cancer Foundation; University of Alberta","funders":"","keywords":"Medicine; Pharmacy; MEDLINE; Family medicine","score_opus":0.4440676569020101,"score_gpt":0.5651284326373278,"score_spread":0.1210607757353177,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2127016949","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.63615716,0.005633203,0.01716731,0.27048627,0.007056115,0.003101726,0.000027425689,0.00008635065,0.06028447],"genre_scores_gemma":[0.97048986,0.0015356614,0.018308237,0.008135392,0.0007428899,0.000015771306,0.000016111493,0.00002261699,0.0007334685],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99762344,0.00078070007,0.00084299396,0.0001400755,0.00039247662,0.00022032158],"domain_scores_gemma":[0.99135685,0.005613228,0.0018646733,0.00011545528,0.0007938939,0.00025591438],"candidate_categories":["metaresearch","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0046671755,0.00011892493,0.00038363558,0.00014022508,0.00010215647,0.000019181738,0.0001267621,0.00007678161,0.0009215221],"category_scores_gemma":[0.012235211,0.00009619547,0.00016920174,0.00017939019,0.000050297134,0.0012170793,0.000025488522,0.0006784941,0.000050450926],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.033770274,0.013947263,0.09691536,0.0004935287,0.0032944477,0.00060775486,0.0026809643,0.00007423367,0.014440983,0.0004425021,0.24230723,0.5910255],"study_design_scores_gemma":[0.0116153415,0.0022162218,0.003092592,0.000050373852,0.0015274298,0.0022921748,0.00032233947,0.010921325,0.00078222586,0.000057294914,0.9670179,0.00010477891],"about_ca_topic_score_codex":0.000011957308,"about_ca_topic_score_gemma":0.0000033215094,"teacher_disagreement_score":0.72471064,"about_ca_system_score_codex":0.00019001945,"about_ca_system_score_gemma":0.00023151796,"threshold_uncertainty_score":0.9999918},"labels":[],"label_agreement":null},{"id":"W2128690699","doi":"10.1177/1078155206069164","title":"Defining the clinical improvement in cancer drug therapy: implications for priority setting in healthcare","year":2006,"lang":"en","type":"review","venue":"Journal of Oncology Pharmacy Practice","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Medicine; Consistency (knowledge bases); Health care; Intensive care medicine","score_opus":0.6336268699544115,"score_gpt":0.6600073452440877,"score_spread":0.02638047528967613,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2128690699","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00019999697,0.7685634,0.000099250065,0.22696832,0.0015419482,0.002086838,0.00024690654,0.00000586504,0.00028750804],"genre_scores_gemma":[0.00023824991,0.9709621,0.0036218783,0.022948053,0.0013685299,0.0007320876,0.000023580997,0.00005262019,0.000052881715],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9818005,0.0036137125,0.01343535,0.0005195872,0.0000992623,0.00053159444],"domain_scores_gemma":[0.94939125,0.026619446,0.023173027,0.0003597332,0.00030382886,0.00015273388],"candidate_categories":["metaresearch","metaepi_narrow"],"consensus_categories":["metaresearch"],"category_scores_codex":[0.09274568,0.00031751167,0.003449379,0.00056379865,0.00020501018,0.00007185302,0.0006999576,0.0002975566,0.00002761859],"category_scores_gemma":[0.010876343,0.0002868141,0.00059252547,0.0003991494,0.000076522905,0.00076269667,0.0000784634,0.0021925736,0.000040318824],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000113622016,0.0007937656,0.015204895,0.003434534,0.00033621557,0.0000067568926,0.00058728846,0.000047685946,3.574771e-8,0.0077840425,0.038414903,0.93327624],"study_design_scores_gemma":[0.0026761056,0.00019143026,0.0013226001,0.0010012392,0.00012518973,0.00007282309,0.00021631819,0.000077872464,4.995454e-8,0.0013533166,0.9927315,0.00023155035],"about_ca_topic_score_codex":0.0034177005,"about_ca_topic_score_gemma":0.0012347959,"teacher_disagreement_score":0.9543166,"about_ca_system_score_codex":0.0037727924,"about_ca_system_score_gemma":0.0056324955,"threshold_uncertainty_score":0.9999584},"labels":[],"label_agreement":null},{"id":"W2128822306","doi":"10.1177/1078155213517127","title":"Impact and appreciation of two methods aiming at reducing hazardous drug environmental contamination: The centralization of the priming of IV tubing in the pharmacy and use of a closed-system transfer device","year":2014,"lang":"en","type":"article","venue":"Journal of Oncology Pharmacy Practice","topic":"Safe Handling of Antineoplastic Drugs","field":"Health Professions","cited_by":41,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Centre Hospitalier Universitaire Sainte-Justine","funders":"","keywords":"Medicine; Ifosfamide; Pharmacy; Cyclophosphamide; Pharmacy technician; Methotrexate; Priming (agriculture); Mesna; Significant difference; Pharmacology; Chemotherapy; Internal medicine; Nursing","score_opus":0.08939353870294188,"score_gpt":0.48754432529429026,"score_spread":0.3981507865913484,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2128822306","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99146324,0.00040120404,0.0049716486,0.0018797568,0.00046887362,0.00061848754,0.00000819999,0.0000027322496,0.000185835],"genre_scores_gemma":[0.9953765,0.0005313086,0.0037100785,0.00022716286,0.00012229076,0.000005830645,0.0000013917803,0.000014783748,0.0000106383795],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99119794,0.006649158,0.0014299797,0.00013139874,0.00038981353,0.00020171964],"domain_scores_gemma":[0.97857666,0.018114863,0.0028555873,0.00015434246,0.00025160462,0.000046946043],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.009946582,0.0001386179,0.00048925786,0.00013643203,0.00025714564,0.00000791958,0.00021412993,0.000056234,0.0000138149335],"category_scores_gemma":[0.0024207386,0.0000802824,0.0000955086,0.00020312933,0.00016979437,0.0006468584,0.00008410807,0.00065120717,1.7804386e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004232595,0.00075658795,0.40027723,0.0012296916,0.0005898723,0.000009635016,0.15155698,0.0044137198,0.3586071,0.00044944978,0.00015605126,0.07772107],"study_design_scores_gemma":[0.047593787,0.0011515862,0.50865006,0.005369383,0.007086811,0.0020080216,0.088894546,0.12832542,0.1842124,0.00007956102,0.02607767,0.00055076525],"about_ca_topic_score_codex":0.00035002775,"about_ca_topic_score_gemma":0.00003041108,"teacher_disagreement_score":0.17439471,"about_ca_system_score_codex":0.00024135261,"about_ca_system_score_gemma":0.00044631536,"threshold_uncertainty_score":0.34473065},"labels":[],"label_agreement":null},{"id":"W2131280296","doi":"10.1177/1078155208096902","title":"Evaluation of osmolality and pH of various concentrations of methotrexate, cytarabine, and thiotepa prepared in normal saline, sterile water for injection, and lactated Ringer's solution for intrathecal administration","year":2008,"lang":"en","type":"review","venue":"Journal of Oncology Pharmacy Practice","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Medicine; Saline; Intrathecal; ThioTEPA; Anesthesia; Sterile water; Methotrexate; Ringer's solution; Surgery; Chemotherapy; Cyclophosphamide; Chemistry","score_opus":0.15626656441589343,"score_gpt":0.5113434548060312,"score_spread":0.35507689039013773,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2131280296","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.13845496,0.85268474,0.0013371627,0.00085310533,0.0007315085,0.0054140375,0.0002495212,0.000008128881,0.00026683742],"genre_scores_gemma":[0.09985959,0.8940216,0.0055360976,0.00004899445,0.00023609222,0.00013495289,0.00012706486,0.000020245796,0.00001540749],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9968074,0.0010845957,0.0014868489,0.00020556692,0.00025549144,0.00016009848],"domain_scores_gemma":[0.9942559,0.0017087286,0.0023377258,0.00007918327,0.001530765,0.00008771396],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0033658163,0.00020722866,0.0013745344,0.00026343935,0.00005406743,0.0000068395607,0.0000469126,0.00020888782,0.000022103677],"category_scores_gemma":[0.0008347223,0.0001594341,0.00014564011,0.00013186499,0.00017909084,0.00042335695,0.000022541175,0.0003178739,4.849859e-8],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.025795836,0.0033932065,0.00066486694,0.0099101905,0.003750693,0.00003609056,0.0032161807,0.00005895779,0.013458457,0.000028977354,0.0007888704,0.93889767],"study_design_scores_gemma":[0.06689188,0.026926875,0.001402146,0.0029304856,0.0695906,0.015851513,0.00039007422,0.00874907,0.015797704,0.00023941975,0.7906644,0.0005658375],"about_ca_topic_score_codex":0.00009008417,"about_ca_topic_score_gemma":0.000071217415,"teacher_disagreement_score":0.93833184,"about_ca_system_score_codex":0.000292761,"about_ca_system_score_gemma":0.002078259,"threshold_uncertainty_score":0.6501534},"labels":[],"label_agreement":null},{"id":"W2132053614","doi":"10.1177/1078155212473000","title":"Intravenous chemotherapy preparation errors: Patient safety risks identified in a pan-Canadian exploratory study","year":2013,"lang":"en","type":"article","venue":"Journal of Oncology Pharmacy Practice","topic":"Patient Safety and Medication Errors","field":"Health Professions","cited_by":24,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Toronto; University of Alberta; Alberta Health Services; University Health Network","funders":"","keywords":"Medicine; Pharmacy; Patient safety; Intensive care medicine; Ambulatory; Cancer chemotherapy; Exploratory research; Adverse effect; Cancer; Medical emergency; Family medicine; Surgery; Internal medicine; Health care","score_opus":0.14805242021169487,"score_gpt":0.5126107606527117,"score_spread":0.36455834044101687,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2132053614","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9589176,0.00018417508,0.00035858652,0.026732016,0.0026974434,0.0026365381,0.0000051086477,0.00001917858,0.008449329],"genre_scores_gemma":[0.9880971,0.0006630819,0.0005777521,0.009942393,0.00032825978,0.00022630962,0.0000063711836,0.000022952994,0.00013579671],"study_design_codex":"qualitative","study_design_gemma":"not_applicable","domain_scores_codex":[0.9932896,0.0037875199,0.001775903,0.00021769693,0.00044716403,0.00048210024],"domain_scores_gemma":[0.99402,0.0015598376,0.0027895959,0.00023627128,0.000935644,0.00045864112],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0039266674,0.00017420905,0.0004468379,0.00049099035,0.00040803247,0.000005524818,0.00027846757,0.00017190729,0.0014736874],"category_scores_gemma":[0.0022762278,0.00015472791,0.00006938479,0.00037760296,0.00006030402,0.0018957143,0.000040384748,0.0017800387,0.0005733431],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.012610791,0.013504094,0.12410019,0.00012610698,0.0009788596,0.0008084849,0.5579706,0.0010209546,0.002449744,0.000102166436,0.07689943,0.20942856],"study_design_scores_gemma":[0.010906641,0.002149458,0.08405335,0.0001003665,0.00016326162,0.000081385275,0.10501187,0.00023074663,0.0000763826,0.000105312756,0.7969216,0.00019958925],"about_ca_topic_score_codex":0.011487439,"about_ca_topic_score_gemma":0.016549997,"teacher_disagreement_score":0.7200222,"about_ca_system_score_codex":0.0015740157,"about_ca_system_score_gemma":0.0038243404,"threshold_uncertainty_score":0.9994391},"labels":[],"label_agreement":null},{"id":"W2132076511","doi":"10.1177/1078155214540317","title":"Feasibility of using the Multinational Association of Supportive Care in Cancer Antiemesis Tool for assessment of chemotherapy-induced nausea and vomiting at the Tom Baker Cancer Centre","year":2014,"lang":"en","type":"article","venue":"Journal of Oncology Pharmacy Practice","topic":"Nausea and vomiting management","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Medicine; Nausea; Antiemetic; Chemotherapy-induced nausea and vomiting; Vomiting; Cancer; Anxiety; Chemotherapy; Intensive care medicine; Internal medicine; Quality of life (healthcare); Oncology; Physical therapy; Nursing; Psychiatry","score_opus":0.09027429011468012,"score_gpt":0.4988146104899062,"score_spread":0.4085403203752261,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2132076511","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98385817,0.0002302826,0.00019054415,0.01464675,0.00020251013,0.00063392933,0.000022006172,0.00000142998,0.00021440248],"genre_scores_gemma":[0.996638,0.00035374012,0.0020490345,0.00071816094,0.00016911185,0.000009349044,0.0000018704594,0.000009463679,0.000051266295],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9981613,0.0005130998,0.0006999709,0.000112588874,0.00037222158,0.0001408165],"domain_scores_gemma":[0.9923391,0.002841047,0.0033425472,0.00009073839,0.0013565592,0.000030050742],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0036351061,0.00008894066,0.000389756,0.00007500597,0.00006851164,0.0000057567386,0.0000805863,0.00005041578,0.00006909048],"category_scores_gemma":[0.0019949232,0.000056794095,0.000099454744,0.00012807942,0.00005234963,0.00018836516,0.000044242883,0.0002611705,3.1332764e-8],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00223117,0.0004684263,0.9207696,0.00030295798,0.00059573544,0.0000030362992,0.002278043,0.00029177815,0.05654876,0.000037377285,0.0004560089,0.016017156],"study_design_scores_gemma":[0.023961788,0.00066565984,0.8756591,0.0003500115,0.0023876773,0.000032740347,0.006163631,0.008443206,0.06586525,0.000025002359,0.016316447,0.00012947453],"about_ca_topic_score_codex":0.0002552894,"about_ca_topic_score_gemma":0.00015638497,"teacher_disagreement_score":0.045110438,"about_ca_system_score_codex":0.0011159363,"about_ca_system_score_gemma":0.0006383015,"threshold_uncertainty_score":0.2918135},"labels":[],"label_agreement":null},{"id":"W2136970657","doi":"10.1177/1078155214525369","title":"A comparison of toxicity and health care resource use between eribulin, capecitabine, gemcitabine, and vinorelbine in patients with metastatic breast cancer treated in a community oncology setting","year":2014,"lang":"en","type":"article","venue":"Journal of Oncology Pharmacy Practice","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":20,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Augmentium Pharma Consulting (Canada)","funders":"","keywords":"Medicine; Eribulin; Metastatic breast cancer; Internal medicine; Gemcitabine; Vinorelbine; Neutropenia; Oncology; Breast cancer; Anemia; Capecitabine; Adverse effect; Cancer; Toxicity; Chemotherapy; Colorectal cancer","score_opus":0.06450904396762154,"score_gpt":0.4532250343000936,"score_spread":0.38871599033247206,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2136970657","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9853946,0.0016593235,0.000013005872,0.01196365,0.00006666976,0.0006215327,0.00006963214,0.000007354847,0.00020426158],"genre_scores_gemma":[0.99517196,0.00046206886,0.00219247,0.0019903658,0.000097856115,0.000016472532,0.000037851303,0.000023581613,0.0000073982483],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99564356,0.002438558,0.0011253292,0.00019998779,0.000249091,0.0003435013],"domain_scores_gemma":[0.99440986,0.0028865002,0.0017690952,0.00013928696,0.0005137061,0.00028153486],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0018462883,0.00024466077,0.0014816405,0.0004186388,0.00010541663,0.000012077022,0.000106200125,0.00009154802,0.000031268417],"category_scores_gemma":[0.00034174105,0.00019374999,0.000047658392,0.00038132677,0.00021430089,0.00045551243,0.000081077145,0.0014719021,2.8443344e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.013858587,0.003988312,0.90781575,0.00024663442,0.00043467045,0.00007132169,0.006019519,0.000059607937,0.00023501765,0.0000021922997,0.0006303219,0.06663806],"study_design_scores_gemma":[0.051420406,0.011156066,0.9142675,0.00023169351,0.0012393651,0.00039471308,0.0020594166,0.00017417532,0.00021705255,0.000002750642,0.018696373,0.00014052789],"about_ca_topic_score_codex":0.0044241888,"about_ca_topic_score_gemma":0.0033935779,"teacher_disagreement_score":0.06649753,"about_ca_system_score_codex":0.0011637773,"about_ca_system_score_gemma":0.00070042873,"threshold_uncertainty_score":0.79008955},"labels":[],"label_agreement":null},{"id":"W2137664975","doi":"10.1177/1078155206073520","title":"Renal safety of 1-hour pamidronate infusion for breast cancer and multiple myeloma patients: comparison between clinical trials and population-based database","year":2006,"lang":"en","type":"article","venue":"Journal of Oncology Pharmacy Practice","topic":"Bone health and treatments","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Medicine; Zoledronic acid; Multiple myeloma; Breast cancer; Population; Clinical trial; Creatinine; Urology; Bisphosphonate; Internal medicine; Cancer; Surgery; Osteoporosis","score_opus":0.15569577953064376,"score_gpt":0.5284559983317456,"score_spread":0.3727602188011019,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2137664975","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9880264,0.0007604151,0.0003230329,0.009207661,0.00033184097,0.0007882387,0.00051555847,0.000005816086,0.00004108332],"genre_scores_gemma":[0.9893855,0.00072748883,0.008423585,0.00084871304,0.0004442242,0.00000734261,0.00013696628,0.00001439604,0.000011775298],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9964767,0.0008985037,0.002031805,0.00016520871,0.00024927844,0.0001785038],"domain_scores_gemma":[0.98724216,0.008672892,0.0031211998,0.000089326,0.0006097275,0.00026472122],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0043317075,0.0001336621,0.0010579712,0.0001270466,0.00010649474,0.000007591429,0.000042280757,0.00010329648,0.00002869074],"category_scores_gemma":[0.0031131543,0.00009937079,0.00011272755,0.00008248707,0.000065774744,0.00037149113,0.000025102872,0.00040503248,5.0594736e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.027161565,0.0013414597,0.7792551,0.000094644194,0.0002348408,0.000019542698,0.000019084348,0.000017766031,0.00015165524,0.0000035595247,0.0011952798,0.1905055],"study_design_scores_gemma":[0.054497443,0.0016151682,0.89725983,0.00014332222,0.00209151,0.00010667857,0.000021654843,0.001142626,0.00017858439,0.000012884975,0.042859077,0.00007122529],"about_ca_topic_score_codex":0.0011798003,"about_ca_topic_score_gemma":0.0000889205,"teacher_disagreement_score":0.19043428,"about_ca_system_score_codex":0.00016487006,"about_ca_system_score_gemma":0.00064089923,"threshold_uncertainty_score":0.40522233},"labels":[],"label_agreement":null},{"id":"W2138727105","doi":"10.1191/1078155201jp077oa","title":"Zoledronic acid versus pamidronate as palliative therapy in cancer patients: A Canadian time and motion analysis","year":2001,"lang":"en","type":"article","venue":"Journal of Oncology Pharmacy Practice","topic":"Bone health and treatments","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Novartis (Canada); Princess Margaret Cancer Centre; Ontario Institute for Cancer Research","funders":"Novartis Pharmaceuticals Canada","keywords":"Zoledronic acid; Medicine; Bisphosphonate; Palliative care; Cancer; Outpatient clinic; Internal medicine; Osteoporosis; Nursing","score_opus":0.05877844720783541,"score_gpt":0.45060400744547263,"score_spread":0.3918255602376372,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2138727105","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97418624,0.0026392122,0.0000027950505,0.019519044,0.00027306817,0.0002676469,0.000007575641,0.000004232354,0.0031001752],"genre_scores_gemma":[0.97401744,0.021386782,0.00019529539,0.0041487687,0.000072132585,0.000011567312,0.000011237807,0.000010733591,0.00014602611],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9986293,0.0002989921,0.00042448472,0.00014177187,0.00021258144,0.00029287217],"domain_scores_gemma":[0.9981647,0.00033337006,0.00058349915,0.000071007846,0.00038778267,0.0004595979],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00050881365,0.00012371772,0.00041136052,0.000501947,0.00007096393,0.0000102760305,0.00005054155,0.00007527346,0.00058984663],"category_scores_gemma":[0.0003319631,0.00010050796,0.00007938838,0.0005277139,0.00003742498,0.0004813135,0.000008520322,0.00049579295,0.000032785683],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.025439454,0.0022209352,0.7212989,0.000010613888,0.00411893,0.00242798,0.0012327725,0.0000742768,0.00015501314,0.000005559581,0.00049115455,0.24252442],"study_design_scores_gemma":[0.067349344,0.00663399,0.63097465,0.00004405105,0.0043796473,0.0004252793,0.00022876389,0.0010204226,0.00019132765,0.000023631581,0.288554,0.00017491714],"about_ca_topic_score_codex":0.056441195,"about_ca_topic_score_gemma":0.033932358,"teacher_disagreement_score":0.28806284,"about_ca_system_score_codex":0.001652495,"about_ca_system_score_gemma":0.001635161,"threshold_uncertainty_score":0.98369586},"labels":[],"label_agreement":null},{"id":"W2138894610","doi":"10.1177/1078155209337663","title":"Evaluation of creatinine-based formulas in dosing adjustment of cancer drugs other than carboplatin","year":2009,"lang":"en","type":"article","venue":"Journal of Oncology Pharmacy Practice","topic":"Chemotherapy-induced organ toxicity mitigation","field":"Medicine","cited_by":20,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Medicine; Dosing; Renal function; Concordance; Carboplatin; Urology; Creatinine; Cancer; Population; Internal medicine; Chemotherapy; Cisplatin","score_opus":0.07709017014051144,"score_gpt":0.4697982283140929,"score_spread":0.39270805817358145,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2138894610","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98243964,0.0013300042,0.00009149143,0.011197881,0.00019200933,0.0004474717,0.0000030996478,0.000005059119,0.0042933654],"genre_scores_gemma":[0.9915939,0.00022759469,0.005750629,0.002114544,0.000273887,0.0000049904834,0.0000016680523,0.000016703358,0.000016111819],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99728775,0.00057450746,0.0009390695,0.00011855824,0.00092732004,0.00015279018],"domain_scores_gemma":[0.9955412,0.00066989113,0.002216886,0.0001280084,0.0013592074,0.00008476407],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004009507,0.00012843996,0.00049178256,0.00032292228,0.000018508536,0.0000038445846,0.000085852334,0.000090023146,0.00032135734],"category_scores_gemma":[0.0013360336,0.000113277434,0.00011004558,0.00031569463,0.00004607221,0.0003869244,0.000006670301,0.00043792662,9.636286e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004151198,0.0017554202,0.0060857404,0.000047992904,0.00026587216,0.000019000216,0.0030270827,0.001902218,0.7817235,0.000015060554,0.00020463145,0.20080228],"study_design_scores_gemma":[0.026542885,0.0017232669,0.027814476,0.0004110306,0.002067645,0.00013902305,0.0008051732,0.0087565705,0.92908716,0.00009508653,0.002457664,0.0001000284],"about_ca_topic_score_codex":0.00030273676,"about_ca_topic_score_gemma":0.000045446144,"teacher_disagreement_score":0.20070226,"about_ca_system_score_codex":0.0011041744,"about_ca_system_score_gemma":0.00213706,"threshold_uncertainty_score":0.46193197},"labels":[],"label_agreement":null},{"id":"W2139358417","doi":"10.1177/1078155208101960","title":"Examining the safety and efficacy of a chemotherapy dosing method in Allogeneic Stem Cell Transplant patients of extreme body size","year":2009,"lang":"en","type":"article","venue":"Journal of Oncology Pharmacy Practice","topic":"Hematopoietic Stem Cell Transplantation","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Medicine; Dosing; Chemotherapy; Regimen; Cyclophosphamide; Internal medicine; Surgery","score_opus":0.05740986971328053,"score_gpt":0.38088597773612665,"score_spread":0.3234761080228461,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2139358417","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9913754,0.00071928976,0.0026387654,0.002673853,0.00013307168,0.0004143266,0.0000039495835,0.00000406465,0.0020372632],"genre_scores_gemma":[0.9803983,0.0031649857,0.01538422,0.000963535,0.00005493673,9.911056e-7,0.0000012563637,0.000013399669,0.000018382892],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99732244,0.00083419314,0.0011619554,0.0001421542,0.00036149216,0.00017773619],"domain_scores_gemma":[0.99226975,0.0058561806,0.0014033897,0.00012265993,0.000253763,0.00009425508],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0029109246,0.00014395073,0.0006293649,0.00014024656,0.000033843025,0.0000051680017,0.00012344948,0.00008204611,0.000037262314],"category_scores_gemma":[0.0001937265,0.000101315956,0.00008466807,0.00020934336,0.000059519974,0.00023378462,0.00000623326,0.00048254913,4.641319e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.032472327,0.0036290535,0.04751471,0.00037405817,0.0003874297,0.00044779526,0.019654134,0.00014708895,0.73825276,0.000021629947,0.0000440328,0.15705498],"study_design_scores_gemma":[0.09325358,0.007468259,0.4789929,0.0011745006,0.0034685216,0.0057693245,0.003234364,0.00078354566,0.3936844,0.000026913101,0.0118371,0.00030657568],"about_ca_topic_score_codex":0.000012727167,"about_ca_topic_score_gemma":8.471721e-7,"teacher_disagreement_score":0.4314782,"about_ca_system_score_codex":0.00009846256,"about_ca_system_score_gemma":0.00027423567,"threshold_uncertainty_score":0.41315448},"labels":[],"label_agreement":null},{"id":"W2140450024","doi":"10.1177/1078155211412991","title":"A fatal case of <i>Pneumocystis jirovecii</i> pneumonia in a breast cancer patient receiving weekly paclitaxel and trastuzumab","year":2011,"lang":"en","type":"article","venue":"Journal of Oncology Pharmacy Practice","topic":"Pneumocystis jirovecii pneumonia detection and treatment","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto General Hospital; University Health Network; McMaster University; Juravinski Cancer Centre; Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Paclitaxel; Pneumocystis carinii; Trastuzumab; Dexamethasone; Internal medicine; Chemotherapy; Pneumonia; Breast cancer; Cancer; Surgery; Oncology; Gastroenterology; Pneumocystis jirovecii","score_opus":0.04043549870684363,"score_gpt":0.36265644267616093,"score_spread":0.3222209439693173,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2140450024","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98821837,0.0012467327,0.00003200268,0.006670432,0.0006329468,0.00040796542,0.000059237973,0.000016044434,0.0027162537],"genre_scores_gemma":[0.994047,0.0027739746,0.001916113,0.0010245047,0.00013178347,0.000028569932,8.983194e-7,0.000035486482,0.00004168366],"study_design_codex":"design_other","study_design_gemma":"case_report","domain_scores_codex":[0.9972361,0.00046353095,0.0012703955,0.00030769536,0.00035429452,0.00036801276],"domain_scores_gemma":[0.9964865,0.0007514063,0.0016571146,0.00020071899,0.00049686036,0.0004074279],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008018483,0.00029327517,0.00087696407,0.00044822035,0.00008397486,0.000015361346,0.00010369231,0.00012218986,0.0001711789],"category_scores_gemma":[0.0004453859,0.00024480105,0.00017755105,0.00036572386,0.00016401222,0.0007761076,0.00007671665,0.0009342097,0.000005908378],"study_design_candidate":"case_report","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.027058018,0.010981544,0.078371525,0.00032304123,0.0018662337,0.16054702,0.013701574,0.000024171597,0.2544327,0.00005165829,0.0006517886,0.45199072],"study_design_scores_gemma":[0.020369679,0.006977284,0.11260893,0.00047874334,0.0021530672,0.8219082,0.0055118133,0.00028541288,0.011613191,0.00004753313,0.017683018,0.00036316234],"about_ca_topic_score_codex":0.0014069605,"about_ca_topic_score_gemma":0.00014754597,"teacher_disagreement_score":0.66136116,"about_ca_system_score_codex":0.0006999217,"about_ca_system_score_gemma":0.00069724966,"threshold_uncertainty_score":0.99826974},"labels":[],"label_agreement":null},{"id":"W2144211082","doi":"10.1177/1078155213484786","title":"Templates of patient brochures for the preparation, administration and safe-handling of oral chemotherapy","year":2013,"lang":"en","type":"article","venue":"Journal of Oncology Pharmacy Practice","topic":"Safe Handling of Antineoplastic Drugs","field":"Health Professions","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Medicine; Dosing; Specialty; Drug administration; Drug; Pharmacology; Family medicine","score_opus":0.06774177070420548,"score_gpt":0.5035914161417157,"score_spread":0.43584964543751015,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2144211082","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9742613,0.00065139576,0.0024988325,0.019561838,0.0009355754,0.0009821351,0.000005795459,0.000005828475,0.0010973063],"genre_scores_gemma":[0.9844189,0.0006907105,0.013387376,0.0011573692,0.00022193925,0.000030081124,0.0000013936725,0.000011747775,0.00008043548],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9980238,0.00042242723,0.0010955072,0.00009093811,0.00020394195,0.00016336123],"domain_scores_gemma":[0.9833667,0.012024046,0.0029550039,0.00009483722,0.0014955774,0.000063824606],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0017628949,0.00009677818,0.00033284715,0.00007851764,0.00023002399,0.000008258163,0.00012474449,0.00007846153,0.0002031153],"category_scores_gemma":[0.0032736817,0.00006324159,0.00006324621,0.00008468278,0.0000976634,0.0005345585,0.000026792379,0.00037418224,0.0000042142547],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.08584646,0.0055909716,0.10008215,0.0022429186,0.00476068,0.000047779085,0.09249213,0.0016459769,0.18799701,0.0029087374,0.20267197,0.3137132],"study_design_scores_gemma":[0.023448948,0.009251003,0.018934863,0.00056135404,0.0015933487,0.0008160452,0.02778368,0.005872292,0.060200136,0.001281465,0.8499318,0.00032511487],"about_ca_topic_score_codex":0.000095786636,"about_ca_topic_score_gemma":0.000014187222,"teacher_disagreement_score":0.6472598,"about_ca_system_score_codex":0.00004354666,"about_ca_system_score_gemma":0.0012129553,"threshold_uncertainty_score":0.39191395},"labels":[],"label_agreement":null},{"id":"W2147340368","doi":"10.1177/1078155211431858","title":"Telepharmacy in a rural Alberta Community Cancer Network","year":2012,"lang":"en","type":"article","venue":"Journal of Oncology Pharmacy Practice","topic":"Neutropenia and Cancer Infections","field":"Medicine","cited_by":18,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Alberta Cancer Foundation; Alberta Health Services","funders":"","keywords":"Medicine; Telehealth; Pharmacy; Pharmacist; Certification; Pharmacy technician; Family medicine; Cancer; Medical emergency; Clinical pharmacy; Nursing; Telemedicine; Health care; Internal medicine","score_opus":0.07793116137621099,"score_gpt":0.47447789060052686,"score_spread":0.3965467292243159,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2147340368","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.925764,0.0038339754,0.000021343574,0.02355813,0.0029599615,0.0002699024,0.0000014794616,0.000011103135,0.043580092],"genre_scores_gemma":[0.9797159,0.0042651338,0.0007714324,0.011917959,0.0028603263,0.000015784053,0.0000012982042,0.000021990285,0.0004302064],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.99756163,0.0011105123,0.00061032415,0.000058387523,0.00022064286,0.00043850084],"domain_scores_gemma":[0.9966353,0.0018160106,0.00074095384,0.00015176821,0.00031585668,0.00034006892],"candidate_categories":["research_integrity","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0021792087,0.00014312184,0.00046419454,0.00014358491,0.00016021922,0.000013672266,0.00016410416,0.000062424275,0.0011344643],"category_scores_gemma":[0.00057036383,0.000119366254,0.00013648256,0.00040092415,0.00007626102,0.0013579843,0.000065259395,0.0024060993,0.000048802776],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0108025605,0.005925944,0.7752035,0.000077363096,0.0010038337,0.00040820817,0.003962312,0.0004026035,0.011001295,0.00016862745,0.109197415,0.08184628],"study_design_scores_gemma":[0.008615227,0.00049593847,0.029772539,0.00008809152,0.00097423245,0.0087246755,0.0008934249,0.00002623868,0.0009790146,0.000017919501,0.94929975,0.0001129203],"about_ca_topic_score_codex":0.0034048054,"about_ca_topic_score_gemma":0.00029551706,"teacher_disagreement_score":0.8401024,"about_ca_system_score_codex":0.00066098786,"about_ca_system_score_gemma":0.0008020096,"threshold_uncertainty_score":0.9998954},"labels":[],"label_agreement":null},{"id":"W2148022235","doi":"10.1177/107815520000600201","title":"The cost of blood transfusions in cancer patients: a reanalysis of a Canadian economic evaluation","year":2000,"lang":"en","type":"article","venue":"Journal of Oncology Pharmacy Practice","topic":"Blood transfusion and management","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Princess Margaret Cancer Centre; Ontario Institute for Cancer Research","funders":"Canadian Blood Services","keywords":"Medicine; Activity-based costing; Blood transfusion; Pharmacoeconomics; Cancer; Intensive care medicine; Intensive care unit; Anemia; Indirect costs; Emergency medicine; Cost driver; Unit cost; Blood supply; Medical emergency; Surgery; Internal medicine","score_opus":0.05225483039074251,"score_gpt":0.41695355061708533,"score_spread":0.3646987202263428,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2148022235","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.93791115,0.00096856995,0.0000039379806,0.035653755,0.0002555001,0.0006725635,0.000014600875,0.0000015894808,0.024518348],"genre_scores_gemma":[0.967715,0.030676693,0.00020836167,0.0012040846,0.000059970025,0.000021710583,0.000002301805,0.000007750493,0.000104125094],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9982463,0.00040389705,0.00081228977,0.00009160637,0.00029446348,0.00015145799],"domain_scores_gemma":[0.99822724,0.0004588853,0.0005588788,0.0001234494,0.00047727302,0.00015427124],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0022909814,0.000078219324,0.00034158255,0.00053930085,0.000058817895,0.000004856698,0.000121440746,0.000042117397,0.0023859446],"category_scores_gemma":[0.00026514882,0.00005681804,0.00013039609,0.00039484736,0.0000626858,0.00022121143,0.0000052609157,0.00032867756,0.0000042827824],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.006887651,0.005053477,0.02101479,0.00006500523,0.0035674453,0.00014447355,0.0031398707,0.0030614706,0.0030108232,0.00016930664,0.0062847794,0.9476009],"study_design_scores_gemma":[0.02233418,0.0011119088,0.023478538,0.00009536239,0.010783223,0.00013577967,0.00093709416,0.0011805388,0.0014701321,0.000017738934,0.9383754,0.0000800696],"about_ca_topic_score_codex":0.07267757,"about_ca_topic_score_gemma":0.13359651,"teacher_disagreement_score":0.94752085,"about_ca_system_score_codex":0.00041698286,"about_ca_system_score_gemma":0.0019213277,"threshold_uncertainty_score":0.99852604},"labels":[],"label_agreement":null},{"id":"W2148274830","doi":"10.1177/1078155213520261","title":"Medication adherence among adults prescribed imatinib, dasatinib, or nilotinib for the treatment of chronic myeloid leukemia","year":2014,"lang":"en","type":"article","venue":"Journal of Oncology Pharmacy Practice","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":44,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Occupational Cancer Research Centre; Foothills Medical Centre","funders":"","keywords":"Nilotinib; Medicine; Dasatinib; Myeloid leukemia; Imatinib; Chronic myeloid leukaemia; Tyrosine-kinase inhibitor; Internal medicine; Imatinib mesylate; Pharmacology; Oncology; Cancer","score_opus":0.05700371716467508,"score_gpt":0.4052629115430166,"score_spread":0.3482591943783415,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2148274830","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96808505,0.004382363,0.0034006883,0.013000132,0.00267134,0.0040533934,0.000034082055,0.000056285473,0.0043166424],"genre_scores_gemma":[0.9765835,0.009183759,0.010328174,0.00073373405,0.001961832,0.00024228307,0.000023446166,0.000054515793,0.0008887997],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99669963,0.0005289456,0.0014531707,0.00030419911,0.00060951593,0.00040451658],"domain_scores_gemma":[0.98579276,0.009110712,0.0033915127,0.00048916007,0.00093578757,0.0002801002],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0018550693,0.0003155009,0.00089063664,0.00015053949,0.00016022015,0.00001852024,0.00036610683,0.00015038792,0.00048480826],"category_scores_gemma":[0.0044204737,0.00018041545,0.00031055816,0.0002253215,0.00030658286,0.00057161605,0.000036098307,0.00048696084,0.000021735832],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.041248456,0.0054095713,0.0041009667,0.0004929429,0.003327652,0.00019406067,0.0050212853,0.00022453385,0.007722313,0.000075119686,0.013285342,0.91889775],"study_design_scores_gemma":[0.08563846,0.040770587,0.007585769,0.00050961325,0.0060252016,0.002793932,0.0011548912,0.022388704,0.023756547,0.000028261335,0.8091004,0.00024762648],"about_ca_topic_score_codex":0.00027576103,"about_ca_topic_score_gemma":0.000075991855,"teacher_disagreement_score":0.91865015,"about_ca_system_score_codex":0.0041301297,"about_ca_system_score_gemma":0.0053668674,"threshold_uncertainty_score":0.99969286},"labels":[],"label_agreement":null},{"id":"W2148493940","doi":"10.1177/1078155208098584","title":"Economic analysis of albumin-bound paclitaxel for the treatment of metastatic breast cancer","year":2008,"lang":"en","type":"article","venue":"Journal of Oncology Pharmacy Practice","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":55,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Ottawa Regional Cancer Foundation; Princess Margaret Cancer Centre","funders":"","keywords":"Docetaxel; Medicine; Paclitaxel; Metastatic breast cancer; Oncology; Breast cancer; Internal medicine; Chemotherapy; Toxicity; Nab-paclitaxel; Cancer","score_opus":0.1128865310209775,"score_gpt":0.4903383100464727,"score_spread":0.3774517790254952,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2148493940","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9652643,0.010101641,0.000115084295,0.022092488,0.00089755823,0.0006237053,0.00025618533,0.0000039420734,0.0006451023],"genre_scores_gemma":[0.9524239,0.044334706,0.0012915997,0.00086537126,0.0004877332,0.000063160114,0.00000845862,0.000016918297,0.0005082085],"study_design_codex":"meta_analysis","study_design_gemma":"not_applicable","domain_scores_codex":[0.9984121,0.00021949719,0.0008655003,0.00013869422,0.00016783497,0.00019638243],"domain_scores_gemma":[0.99317557,0.0041014175,0.0019371229,0.00016011106,0.00049872557,0.00012703231],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00056748884,0.00016487556,0.0010665025,0.0003347084,0.00008963644,0.0000036528602,0.00012310338,0.00003997106,0.0010703099],"category_scores_gemma":[0.00007603545,0.00010214202,0.00065848057,0.00028321895,0.00024487986,0.00023887446,0.00001071771,0.00015504543,0.000002924592],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.13429505,0.0367969,0.17640191,0.0003078633,0.32465184,0.001686392,0.014254579,0.010425856,0.047415137,0.00019544357,0.049106028,0.204463],"study_design_scores_gemma":[0.034698933,0.009355462,0.03341336,0.000021328058,0.15678443,0.005440774,0.0009448613,0.002676853,0.012079639,0.000019305675,0.74441075,0.00015430126],"about_ca_topic_score_codex":0.0010364816,"about_ca_topic_score_gemma":0.00015435136,"teacher_disagreement_score":0.6953047,"about_ca_system_score_codex":0.0008438652,"about_ca_system_score_gemma":0.0015830658,"threshold_uncertainty_score":0.9998428},"labels":[],"label_agreement":null},{"id":"W2150180063","doi":"10.1191/1078155202jp095oa","title":"Standardization of body surface area calculations","year":2002,"lang":"en","type":"article","venue":"Journal of Oncology Pharmacy Practice","topic":"Safe Handling of Antineoplastic Drugs","field":"Health Professions","cited_by":15,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Alberta Cancer Foundation","funders":"","keywords":"Body surface area; Medicine; Pharmacy; Dosing; Standardization; Medical physics; Family medicine; Surgery; Pharmacology; Computer science","score_opus":0.15201721680733796,"score_gpt":0.5117210028426117,"score_spread":0.35970378603527375,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2150180063","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.6698214,0.001679281,0.099235125,0.054468106,0.008152245,0.0008799212,0.000056774214,0.00007149269,0.16563568],"genre_scores_gemma":[0.98078126,0.0011363674,0.015118712,0.0013153596,0.00050638564,0.000002237485,0.0000025477682,0.00002309484,0.0011140665],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9966261,0.0012241699,0.0012879698,0.00011693997,0.00046506347,0.00027978962],"domain_scores_gemma":[0.98730665,0.007472736,0.0029207135,0.00015121626,0.001994661,0.00015403374],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0027063722,0.000121609446,0.00044257904,0.00016179509,0.000307018,0.0000059234117,0.0001921756,0.00011957323,0.0023003516],"category_scores_gemma":[0.007154866,0.0001056179,0.00010367363,0.00032164852,0.00008095529,0.00076889474,0.000054225427,0.0010606641,0.000116882664],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008911677,0.006582721,0.13474312,0.0006233733,0.0025524579,0.0012170011,0.031123197,0.06865641,0.06806617,0.0039668237,0.6519092,0.021647878],"study_design_scores_gemma":[0.006078562,0.00040106676,0.0015594737,0.00014608767,0.0005680705,0.0003346069,0.0018949113,0.0071212603,0.0007844049,0.000059347072,0.9809392,0.000112999296],"about_ca_topic_score_codex":0.000038351263,"about_ca_topic_score_gemma":0.00000628676,"teacher_disagreement_score":0.32903004,"about_ca_system_score_codex":0.0002675811,"about_ca_system_score_gemma":0.0010996643,"threshold_uncertainty_score":0.9986117},"labels":[],"label_agreement":null},{"id":"W2151289323","doi":"10.1177/1078155208088695","title":"Verification of imatinib cost-effectiveness in advanced gastrointestinal stromal tumor in British Columbia (VINCE-BC study)","year":2008,"lang":"en","type":"article","venue":"Journal of Oncology Pharmacy Practice","topic":"Gastrointestinal Tumor Research and Treatment","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"BC Cancer Agency; University of British Columbia","funders":"BC Cancer Agency; Michael Smith Health Research BC","keywords":"Medicine; Imatinib; GiST; Stromal tumor; Imatinib mesylate; Internal medicine; Oncology; Stromal cell; General surgery; Intensive care medicine","score_opus":0.07987342428515348,"score_gpt":0.43006699291198847,"score_spread":0.350193568626835,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2151289323","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9971715,0.00014345841,0.00009691008,0.00042525318,0.000085552485,0.0014542134,0.0000066789166,0.000007989907,0.0006084346],"genre_scores_gemma":[0.9859881,0.00011049723,0.013640641,0.00006192502,0.00006545558,0.00007710422,0.0000038522808,0.00001876261,0.00003366527],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99672854,0.001122704,0.0009953191,0.00023560565,0.0005429729,0.00037486112],"domain_scores_gemma":[0.9959934,0.0017168642,0.0010585746,0.000150402,0.00083995296,0.0002408306],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0021170164,0.00013210053,0.00071029767,0.00022997486,0.000061030314,0.000022052353,0.0001671675,0.000018953488,0.00011871105],"category_scores_gemma":[0.0050127115,0.00016751688,0.000101165424,0.00043951464,0.00016194256,0.0006175251,0.000049174407,0.0010058869,0.0000072576117],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.010154294,0.011806398,0.89826816,0.00007942764,0.00007368038,0.055957235,0.00015329085,0.00012543447,0.012065879,8.3489164e-7,0.00011822084,0.011197121],"study_design_scores_gemma":[0.026903568,0.014071864,0.83466244,0.0005569258,0.00012264638,0.12063752,0.0015259145,0.00019249134,0.00060423685,0.000007664913,0.00063806213,0.0000766503],"about_ca_topic_score_codex":0.005672916,"about_ca_topic_score_gemma":0.0029439868,"teacher_disagreement_score":0.064680286,"about_ca_system_score_codex":0.0009354239,"about_ca_system_score_gemma":0.0015159196,"threshold_uncertainty_score":0.85757893},"labels":[],"label_agreement":null},{"id":"W2151481343","doi":"10.1191/1078155204jp135cr","title":"Quercetin/bromelain use associated with increased liver enzymes","year":2004,"lang":"en","type":"article","venue":"Journal of Oncology Pharmacy Practice","topic":"Pineapple and bromelain studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"London Health Sciences Centre","funders":"","keywords":"Medicine; Bromelain; Adverse effect; Alternative medicine; Intensive care medicine; Liver enzyme; Traditional medicine; Pharmacology; Internal medicine; Enzyme; Pathology","score_opus":0.03548960805135392,"score_gpt":0.3431028845520222,"score_spread":0.3076132765006683,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2151481343","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9897305,0.003566772,0.00064036134,0.0027485553,0.00022908412,0.00016221055,0.000014451744,0.000011485812,0.002896597],"genre_scores_gemma":[0.9877991,0.0034727913,0.0047887047,0.003199453,0.00043446186,0.0000066823472,0.000017455695,0.000025361074,0.0002559616],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.9984955,0.00039733542,0.00040113306,0.00018839033,0.00024889718,0.0002687083],"domain_scores_gemma":[0.99778545,0.0004142882,0.0008480128,0.00014234665,0.00066570897,0.00014418684],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009654778,0.00018465231,0.0003296349,0.00011082618,0.0001219147,0.000032737633,0.00020907001,0.00011957275,0.00003352152],"category_scores_gemma":[0.0025027534,0.00014150156,0.00011397833,0.00019711695,0.00014684156,0.00007250938,0.00008771036,0.00041417984,0.000012104802],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.021984525,0.009402446,0.0298539,0.00007169299,0.01086572,0.009061609,0.0016650006,0.0011654343,0.8002867,0.00097616715,0.09905857,0.0156082185],"study_design_scores_gemma":[0.010566857,0.0030708862,0.0053956555,0.000053820084,0.0006471298,0.0029600267,0.00042760393,0.000006454464,0.07977727,0.000022579285,0.89679706,0.00027462546],"about_ca_topic_score_codex":0.000105158746,"about_ca_topic_score_gemma":0.00006447582,"teacher_disagreement_score":0.7977385,"about_ca_system_score_codex":0.00014001987,"about_ca_system_score_gemma":0.00062474236,"threshold_uncertainty_score":0.5770266},"labels":[],"label_agreement":null},{"id":"W2151593637","doi":"10.1177/1078155211434852","title":"The oncology pharmacy in cancer care delivery in a resource-constrained setting in western Kenya","year":2012,"lang":"en","type":"article","venue":"Journal of Oncology Pharmacy Practice","topic":"Safe Handling of Antineoplastic Drugs","field":"Health Professions","cited_by":22,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"Eli Lilly and Company","keywords":"Medicine; Pharmacy; Multidisciplinary approach; Health care; Cancer; Resource (disambiguation); Oncology; Intensive care medicine; Family medicine; Nursing; Internal medicine; Economic growth","score_opus":0.09835412392973755,"score_gpt":0.5221202188851748,"score_spread":0.42376609495543727,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2151593637","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.92883986,0.0058554616,0.000013284781,0.047117956,0.003803735,0.00069429964,0.000007999769,0.000018071712,0.013649321],"genre_scores_gemma":[0.9839507,0.0037287548,0.0010771729,0.009107168,0.0018188998,0.00008578487,0.0000023679236,0.000044357723,0.00018479888],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.9899023,0.005953534,0.0022111114,0.0002461262,0.00041894885,0.0012679448],"domain_scores_gemma":[0.97016895,0.026309945,0.002542794,0.00018422974,0.0005077491,0.00028630678],"candidate_categories":["research_integrity"],"consensus_categories":[],"category_scores_codex":[0.01101884,0.0002740175,0.00075942295,0.0005912466,0.00037110786,0.000016871236,0.00053673045,0.00022920886,0.00020590534],"category_scores_gemma":[0.0057526394,0.00021560452,0.00010700343,0.0005940023,0.00017896762,0.0012230653,0.00023716186,0.005011476,0.00007365667],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0066994103,0.0008660341,0.844139,0.00011519194,0.00011414414,0.0012570744,0.050255354,0.00037998846,0.0010423693,0.000026558522,0.0047792746,0.090325594],"study_design_scores_gemma":[0.017745351,0.00020680796,0.043269087,0.0004949586,0.000172333,0.0005934453,0.048155572,0.0002897263,0.00010719716,0.000009383768,0.8887539,0.00020224495],"about_ca_topic_score_codex":0.0016391652,"about_ca_topic_score_gemma":0.004127425,"teacher_disagreement_score":0.8839746,"about_ca_system_score_codex":0.0026921534,"about_ca_system_score_gemma":0.0072448202,"threshold_uncertainty_score":0.99838316},"labels":[],"label_agreement":null},{"id":"W2157527150","doi":"10.1177/1078155208097634","title":"Oncology medication safety: A 3D status report 2008","year":2008,"lang":"en","type":"article","venue":"Journal of Oncology Pharmacy Practice","topic":"Safe Handling of Antineoplastic Drugs","field":"Health Professions","cited_by":21,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Alberta Cancer Foundation","funders":"","keywords":"Medicine; Pharmacy; Family medicine; Vincristine; Best practice; Internal medicine; Chemotherapy","score_opus":0.1261452344844468,"score_gpt":0.5311838587467712,"score_spread":0.4050386242623244,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2157527150","genre_codex":"other","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.32650506,0.0031294485,0.013659808,0.19592787,0.032362968,0.0015438643,0.000026755946,0.00020974834,0.42663446],"genre_scores_gemma":[0.71128577,0.054220684,0.16225626,0.045114245,0.014501948,0.0001010957,0.00007374273,0.00021627174,0.012229967],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99236864,0.002985278,0.0027267688,0.0002984334,0.0008155003,0.0008053863],"domain_scores_gemma":[0.9738886,0.015730815,0.006692514,0.00032645435,0.0027742018,0.0005874166],"candidate_categories":["metaresearch","research_integrity","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.007846068,0.00023707401,0.00086636463,0.00038090334,0.0009264502,0.000004851699,0.00037302665,0.00033733257,0.0017972854],"category_scores_gemma":[0.029015874,0.00020357671,0.00013258445,0.00045253724,0.00029760355,0.0010531025,0.00014860836,0.0033075595,0.00067378016],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.017475381,0.0032313308,0.09298117,0.00013356392,0.0012219263,0.054363772,0.018707851,0.00014334146,0.0028547158,0.0002039335,0.7352157,0.07346727],"study_design_scores_gemma":[0.009022381,0.00082207395,0.011330818,0.00008106687,0.0004916252,0.043221626,0.0023948206,0.00014544802,0.00006408587,0.000032642136,0.9322304,0.00016300703],"about_ca_topic_score_codex":0.00028084466,"about_ca_topic_score_gemma":0.00003265615,"teacher_disagreement_score":0.4144045,"about_ca_system_score_codex":0.0014468876,"about_ca_system_score_gemma":0.024510982,"threshold_uncertainty_score":0.9991152},"labels":[],"label_agreement":null},{"id":"W2158556490","doi":"10.1177/1078155206074045","title":"The oncology impact of highly active antiretroviral therapy","year":2007,"lang":"en","type":"article","venue":"Journal of Oncology Pharmacy Practice","topic":"Viral-associated cancers and disorders","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Alberta Hip and Knee Clinic; Alberta Cancer Foundation; University of Saskatchewan","funders":"","keywords":"Medicine; Chemotherapy; Incidence (geometry); Cancer; Internal medicine; Pharmacy; Population; Human immunodeficiency virus (HIV); Oncology; Antiretroviral therapy; Intensive care medicine; Viral load; Immunology; Family medicine; Environmental health","score_opus":0.04294212985874755,"score_gpt":0.4620958465046519,"score_spread":0.41915371664590434,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2158556490","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9337352,0.004217435,0.00009234778,0.014796127,0.0010692151,0.00029650418,0.0000052047917,0.000011849215,0.045776125],"genre_scores_gemma":[0.9819974,0.01395824,0.0005441441,0.0026997149,0.0005896506,0.0000020821542,0.0000014776,0.000022720942,0.00018459691],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9976196,0.00048302475,0.00088543264,0.00013210949,0.00044674397,0.00043307245],"domain_scores_gemma":[0.9928151,0.0030852626,0.0026474034,0.00016209138,0.001054696,0.00023549626],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0037076012,0.00017891364,0.0006519528,0.00019279575,0.00016086904,0.0000137481975,0.00023720041,0.00016740774,0.00012889627],"category_scores_gemma":[0.001656837,0.00010645021,0.0004625671,0.00036681895,0.00026635447,0.0005654583,0.000031071686,0.0012409318,0.000009487377],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.10044093,0.0027398106,0.018225908,0.000011213709,0.003517494,0.0013348926,0.0018506328,0.00003431543,0.07137326,0.000118603115,0.03275078,0.76760215],"study_design_scores_gemma":[0.03208553,0.03148312,0.028955411,0.000027357855,0.000940167,0.0030533192,0.0042588115,0.00003770231,0.013620637,0.00013745393,0.8852415,0.00015897666],"about_ca_topic_score_codex":0.00027827424,"about_ca_topic_score_gemma":0.000017110355,"teacher_disagreement_score":0.8524907,"about_ca_system_score_codex":0.0015179729,"about_ca_system_score_gemma":0.0031693815,"threshold_uncertainty_score":0.56223464},"labels":[],"label_agreement":null},{"id":"W2158888632","doi":"10.1177/1078155206069163","title":"Acute reactions to chemotherapy agents","year":2006,"lang":"en","type":"review","venue":"Journal of Oncology Pharmacy Practice","topic":"HER2/EGFR in Cancer Research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"BC Cancer Agency","keywords":"Medicine; Chemotherapy; Drug reaction; Cancer chemotherapy; Intensive care medicine; Hypersensitivity reaction; Pharmacology; Drug; Internal medicine","score_opus":0.29334632879909167,"score_gpt":0.6308276500863238,"score_spread":0.3374813212872321,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2158888632","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000012446453,0.93577725,0.000092775575,0.02087704,0.0021110026,0.0013184721,0.000027155065,0.0000252512,0.0397586],"genre_scores_gemma":[0.00000236323,0.9737418,0.007540188,0.0057390877,0.003375042,0.000066359506,0.000015587435,0.0001243553,0.009395194],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99524415,0.0010972121,0.0018693778,0.00035713526,0.00088793406,0.00054420833],"domain_scores_gemma":[0.99293435,0.002074328,0.0026699072,0.00044873066,0.0011717225,0.0007009886],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.003103474,0.00042411993,0.0025939932,0.0009065959,0.000087573055,0.000052581094,0.00056273845,0.0003441541,0.0013750007],"category_scores_gemma":[0.0017194264,0.00033118724,0.00084853644,0.00092470617,0.00008831318,0.00044602086,0.000104310544,0.0038997629,0.00065227377],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006999333,0.0007488403,0.0000026161588,0.001720105,0.0018064596,0.0039417804,0.00005294725,9.730745e-7,0.00002735794,0.0000039887072,0.3802084,0.6107866],"study_design_scores_gemma":[0.0031731387,0.0014147996,0.0000028411748,0.0035192242,0.008015379,0.04108031,0.000024150326,0.0000022854765,0.000019921625,0.000004812413,0.9425286,0.00021452285],"about_ca_topic_score_codex":0.00008556741,"about_ca_topic_score_gemma":0.0000023441182,"teacher_disagreement_score":0.6105721,"about_ca_system_score_codex":0.002952137,"about_ca_system_score_gemma":0.0070815883,"threshold_uncertainty_score":0.999914},"labels":[],"label_agreement":null},{"id":"W2159160631","doi":"10.1177/1078155213503591","title":"Administration of budesonide in children with graft-versus-host disease","year":2013,"lang":"en","type":"editorial","venue":"Journal of Oncology Pharmacy Practice","topic":"Hematopoietic Stem Cell Transplantation","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier Universitaire Sainte-Justine","funders":"","keywords":"Medicine; Budesonide; Graft-versus-host disease; Host (biology); Administration (probate law); Disease; Internal medicine; Intensive care medicine; Corticosteroid","score_opus":0.0254638218905697,"score_gpt":0.3944965902531243,"score_spread":0.3690327683625546,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2159160631","genre_codex":"editorial","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"editorial","genre_consensus":"editorial","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.2894476,0.002081714,0.00040099604,0.011345132,0.6852185,0.0032087085,0.0002073431,0.000041144536,0.008048854],"genre_scores_gemma":[0.39279622,0.012247356,0.012738153,0.0005124466,0.5804333,0.000075940174,0.00048764265,0.00018929523,0.00051967],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9964302,0.0005158232,0.0013219902,0.00025797062,0.0012128929,0.0002610855],"domain_scores_gemma":[0.9909293,0.004033692,0.0030327735,0.00023042777,0.0013977779,0.00037600854],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001434564,0.00030222494,0.00095758366,0.0004048874,0.00003172379,0.000023351133,0.00022650046,0.00035056812,0.00022278198],"category_scores_gemma":[0.0031283197,0.00024346734,0.00015520057,0.00025208137,0.0001310225,0.00075574045,0.000018395485,0.002032607,0.00002681313],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.21503465,0.006639093,0.026173165,0.0016495181,0.0043149805,0.007942417,0.0009733162,0.00004520232,0.0023375833,0.000034975223,0.73040015,0.0044549718],"study_design_scores_gemma":[0.043560844,0.0069945976,0.011094474,0.0012572305,0.009754355,0.003672455,0.00029451164,0.000028930252,0.0011363873,0.0000061234914,0.9218486,0.00035150975],"about_ca_topic_score_codex":0.00010050598,"about_ca_topic_score_gemma":0.00002710947,"teacher_disagreement_score":0.19144845,"about_ca_system_score_codex":0.00047916366,"about_ca_system_score_gemma":0.0069207563,"threshold_uncertainty_score":0.9987091},"labels":[],"label_agreement":null},{"id":"W2161866421","doi":"10.1177/1078155206072982","title":"Laboratory monitoring in oncology","year":2006,"lang":"en","type":"review","venue":"Journal of Oncology Pharmacy Practice","topic":"Safe Handling of Antineoplastic Drugs","field":"Health Professions","cited_by":17,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Alberta Cancer Foundation","funders":"","keywords":"Medicine; Cardiotoxicity; Pharmacy; Intensive care medicine; Oncology; Cancer; Pharmacist; Internal medicine; MEDLINE; Cancer chemotherapy; Pharmacotherapy; Chemotherapy; Toxicity; Family medicine","score_opus":0.23903834207829994,"score_gpt":0.6166432076090078,"score_spread":0.3776048655307079,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2161866421","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00009900951,0.95053077,0.000030707608,0.0017536734,0.015785968,0.00079408864,0.000019842104,0.000032935874,0.030952979],"genre_scores_gemma":[0.000020622794,0.98572135,0.00533919,0.0007287997,0.0073914113,0.00006937082,0.0000068043987,0.00011052231,0.0006119121],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9846157,0.009182939,0.004381955,0.00037840934,0.00055892655,0.0008820917],"domain_scores_gemma":[0.95045143,0.03715197,0.010478994,0.00030329885,0.0013254328,0.00028888127],"candidate_categories":["metaresearch","metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.010524269,0.0005388104,0.0038415638,0.0011585361,0.0002910518,0.00001502389,0.00080554286,0.0010530245,0.00023834467],"category_scores_gemma":[0.009863516,0.00044835094,0.00043501027,0.00092551997,0.00012110959,0.0008402123,0.0002484547,0.010065046,0.000638039],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00060118194,0.0011523576,0.0007690286,0.0070741666,0.00053275406,0.0067040455,0.0007438245,0.000012025971,0.000005993,0.000040800358,0.04607578,0.93628806],"study_design_scores_gemma":[0.0041695866,0.000399871,0.00002709903,0.011171132,0.0026335788,0.001265365,0.0007989602,0.0000025570687,0.0000013007458,0.000011798468,0.97921014,0.000308615],"about_ca_topic_score_codex":0.00015826002,"about_ca_topic_score_gemma":0.000026165682,"teacher_disagreement_score":0.9359794,"about_ca_system_score_codex":0.0037624135,"about_ca_system_score_gemma":0.03349826,"threshold_uncertainty_score":0.9997968},"labels":[],"label_agreement":null},{"id":"W2164740567","doi":"10.1177/1078155213496675","title":"Hazards in determining whether a drug is hazardous","year":2013,"lang":"en","type":"article","venue":"Journal of Oncology Pharmacy Practice","topic":"Safe Handling of Antineoplastic Drugs","field":"Health Professions","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Hazardous waste; Formulary; Medicine; Scope (computer science); Risk analysis (engineering); Occupational safety and health; Environmental health; Pharmacology; Engineering; Computer science","score_opus":0.07286304680203594,"score_gpt":0.49734782216446694,"score_spread":0.424484775362431,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2164740567","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8737353,0.00041285035,0.00024879476,0.06839072,0.0041357432,0.00051742897,0.000002359081,0.000031107225,0.052525718],"genre_scores_gemma":[0.9503161,0.0005803338,0.015454873,0.02907675,0.0014351434,0.00004521305,5.7495635e-7,0.000056967914,0.0030340946],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9952575,0.0018859389,0.001560461,0.00021435371,0.00044753487,0.0006341912],"domain_scores_gemma":[0.9862742,0.009836057,0.0023605854,0.00020384623,0.0010590256,0.0002663053],"candidate_categories":["research_integrity","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.004469675,0.00021031995,0.00062596827,0.00039136974,0.00026227735,0.00002468437,0.00040470978,0.00016183613,0.003561597],"category_scores_gemma":[0.0055537634,0.00017593372,0.00012582543,0.00028705713,0.000085553045,0.0015457093,0.00014618941,0.002755485,0.0015843174],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0030816132,0.0017716232,0.17045157,0.00023450087,0.0005514917,0.002595848,0.05908285,0.00011074672,0.007924911,0.00009691292,0.5805165,0.17358139],"study_design_scores_gemma":[0.01017071,0.00030895512,0.0085428255,0.00035211022,0.00023651587,0.001145939,0.010559519,0.0014579906,0.00035459865,0.0002514898,0.9663875,0.00023182896],"about_ca_topic_score_codex":0.0005379407,"about_ca_topic_score_gemma":0.0000546019,"teacher_disagreement_score":0.38587096,"about_ca_system_score_codex":0.00043232573,"about_ca_system_score_gemma":0.0035911354,"threshold_uncertainty_score":0.9995452},"labels":[],"label_agreement":null},{"id":"W2165391596","doi":"10.1191/1078155205jp165oa","title":"Management of extravasation of oxaliplatin","year":2005,"lang":"en","type":"review","venue":"Journal of Oncology Pharmacy Practice","topic":"Chemotherapy-related skin toxicity","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"Sanofi","keywords":"Medicine; Oxaliplatin; Extravasation; Intensive care medicine; Pharmacology; Oncology; Internal medicine; Cancer; Colorectal cancer; Pathology","score_opus":0.13657433855565457,"score_gpt":0.5212253246911213,"score_spread":0.38465098613546667,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2165391596","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00013565371,0.97730684,0.00020412783,0.0010717905,0.0005143658,0.00072072155,0.000007919338,0.000007818394,0.020030787],"genre_scores_gemma":[0.00019742126,0.97350013,0.024956135,0.0002290563,0.00052582484,0.000005713857,0.0000078298235,0.000049319173,0.00052856124],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99575067,0.0006932997,0.002535904,0.0001904677,0.0006323492,0.00019729082],"domain_scores_gemma":[0.9885471,0.0016295477,0.008758625,0.00028696534,0.00063399586,0.00014378993],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0027541511,0.00030018378,0.0024682167,0.0004592838,0.000023605042,0.0000049120767,0.00028320387,0.0003153455,0.00074416405],"category_scores_gemma":[0.00045703026,0.00024052267,0.00069977075,0.00041809975,0.00011114811,0.00034505717,0.000055140128,0.0015824183,0.000020245025],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010422255,0.0016482333,0.0000055853056,0.009004189,0.004292225,0.00081629766,0.00015498202,0.00000752075,0.00012881112,0.00005016607,0.0028223854,0.9800274],"study_design_scores_gemma":[0.0048465217,0.00071066,0.000010054241,0.008725061,0.01642538,0.0075425864,0.00008998387,0.000008939887,0.0002742264,0.00000934731,0.96122354,0.00013370324],"about_ca_topic_score_codex":0.0000065552426,"about_ca_topic_score_gemma":3.659864e-7,"teacher_disagreement_score":0.9798937,"about_ca_system_score_codex":0.0006497209,"about_ca_system_score_gemma":0.001092582,"threshold_uncertainty_score":0.980823},"labels":[],"label_agreement":null},{"id":"W2166370227","doi":"10.1191/1078155205jp155oa","title":"Are health care providers who work with cancer drugs at an increased risk for toxic events? A systematic review and meta-analysis of the literature","year":2005,"lang":"en","type":"review","venue":"Journal of Oncology Pharmacy Practice","topic":"Safe Handling of Antineoplastic Drugs","field":"Health Professions","cited_by":165,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre; Cancer Care Ontario","funders":"","keywords":"Medicine; Odds ratio; Meta-analysis; Confidence interval; CINAHL; MEDLINE; Cochrane Library; Cancer; Relative risk; Health care; Epidemiology; Internal medicine; Intensive care medicine; Psychological intervention; Psychiatry","score_opus":0.14696912199608408,"score_gpt":0.5418271636651654,"score_spread":0.3948580416690813,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2166370227","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000043282656,0.9812605,0.000015109159,0.009390114,0.0003556364,0.008125594,0.00074843393,0.000011708766,0.000049655733],"genre_scores_gemma":[0.000053642216,0.98559344,0.0013967842,0.011095467,0.00031520287,0.00095627736,0.00003216615,0.00008302642,0.00047398277],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.97792053,0.016402882,0.0039083487,0.0004907444,0.00073537265,0.00054213277],"domain_scores_gemma":[0.94215685,0.01558205,0.03894594,0.0006856997,0.0022507682,0.00037869977],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.009062487,0.00066376245,0.012075864,0.0005305344,0.0007548238,0.000024546056,0.00074309885,0.00033761328,0.00016858621],"category_scores_gemma":[0.006793328,0.00032339053,0.002213482,0.0017559911,0.0000990065,0.0006115165,0.00016875428,0.0030030818,0.0000032986852],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007071229,0.000238741,0.00013494733,0.809315,0.17192264,0.000024321678,0.005221728,0.000016003449,1.990636e-8,0.000002903454,0.0068038017,0.0056127557],"study_design_scores_gemma":[0.00093770836,0.00014880502,0.000011173636,0.1079703,0.5061491,0.00012417145,0.0009972501,0.0000022957863,3.6000625e-8,4.2158942e-7,0.3835117,0.00014706061],"about_ca_topic_score_codex":0.00017273288,"about_ca_topic_score_gemma":0.00043205873,"teacher_disagreement_score":0.7013447,"about_ca_system_score_codex":0.0015544635,"about_ca_system_score_gemma":0.008418409,"threshold_uncertainty_score":0.9999218},"labels":[],"label_agreement":null},{"id":"W2167283073","doi":"10.1177/1078155208096904","title":"Evaluation of surface contamination in a hospital hematology—oncology pharmacy","year":2008,"lang":"en","type":"article","venue":"Journal of Oncology Pharmacy Practice","topic":"Safe Handling of Antineoplastic Drugs","field":"Health Professions","cited_by":46,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institut National de Santé Publique du Québec; Centre Hospitalier Universitaire Sainte-Justine","funders":"","keywords":"Medicine; Pharmacy; Hematology; Internal medicine; Contamination; Clinical Oncology; Oncology; Intensive care medicine; Cancer; Family medicine","score_opus":0.1750958365335434,"score_gpt":0.5471299552066452,"score_spread":0.37203411867310177,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2167283073","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9543565,0.0012092433,0.00035113483,0.020445129,0.004524679,0.00088942173,0.00000496789,0.000019071822,0.018199867],"genre_scores_gemma":[0.9918564,0.0017794181,0.0045599323,0.001169077,0.00045814985,0.000024232279,0.000004121849,0.000028618491,0.00012007555],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.98839784,0.0073924535,0.0023046564,0.00025194185,0.0011467356,0.0005063713],"domain_scores_gemma":[0.97637975,0.013007047,0.005059853,0.00017537862,0.0052002673,0.00017770717],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.018314803,0.00021846387,0.0009469169,0.00043042767,0.00026434567,0.0000030837602,0.00034978508,0.000232272,0.0007107825],"category_scores_gemma":[0.018443799,0.000204436,0.00013369604,0.0004745082,0.00023788396,0.0011943545,0.00010623414,0.0020824668,0.00012342376],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.02173582,0.02210396,0.61459136,0.00056174275,0.002417897,0.006275069,0.09260865,0.005027665,0.028373014,0.0013159541,0.10626025,0.09872858],"study_design_scores_gemma":[0.1128809,0.0047914535,0.04438638,0.00060188887,0.0038227201,0.008902106,0.020743093,0.018508345,0.007673943,0.00045911185,0.77657783,0.0006522141],"about_ca_topic_score_codex":0.0002654169,"about_ca_topic_score_gemma":0.00006542323,"teacher_disagreement_score":0.6703176,"about_ca_system_score_codex":0.0014097379,"about_ca_system_score_gemma":0.013063415,"threshold_uncertainty_score":0.9925316},"labels":[],"label_agreement":null},{"id":"W2168718641","doi":"10.1177/1078155206069161","title":"Re-evaluation of the cost effectiveness of temozolomide for malignant gliomas in British Columbia","year":2006,"lang":"en","type":"article","venue":"Journal of Oncology Pharmacy Practice","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"BC Cancer Agency; University of British Columbia","funders":"BC Cancer Agency","keywords":"Temozolomide; Medicine; Oncology; Glioblastoma; Glioma; Internal medicine; Intensive care medicine; Cancer research","score_opus":0.06406174344425247,"score_gpt":0.4230406319521479,"score_spread":0.35897888850789544,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2168718641","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9934578,0.0012812997,0.000022555738,0.0019628748,0.00042265365,0.0014778078,0.000016080547,0.0000020150324,0.0013569072],"genre_scores_gemma":[0.99869263,0.00016772984,0.0007727545,0.0001478414,0.00010853804,0.00007982735,0.0000036066358,0.000012094133,0.000014990715],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99711835,0.0014058985,0.0007489977,0.00011620665,0.00046445875,0.00014609013],"domain_scores_gemma":[0.99328345,0.0036099153,0.0015005294,0.00012348342,0.0014359641,0.00004666196],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0067273625,0.0000726007,0.0005026283,0.0000957909,0.000050487237,0.000015550411,0.00010223421,0.000064892774,0.00005794682],"category_scores_gemma":[0.0028553586,0.000070103,0.00018684816,0.00027953397,0.0000871593,0.00022987161,0.000024663172,0.0002321161,6.3439455e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0064435443,0.011942085,0.769391,0.00042281536,0.00088030286,0.0008852017,0.00013814872,0.0010975024,0.144107,0.000047726207,0.0111834165,0.05346123],"study_design_scores_gemma":[0.050738864,0.0020128277,0.7943367,0.0008230195,0.0042625633,0.0036760725,0.0004690479,0.00047770838,0.11600183,0.000494257,0.026609277,0.00009785708],"about_ca_topic_score_codex":0.005088313,"about_ca_topic_score_gemma":0.0049886103,"teacher_disagreement_score":0.05336337,"about_ca_system_score_codex":0.00051742874,"about_ca_system_score_gemma":0.00078179,"threshold_uncertainty_score":0.76920414},"labels":[],"label_agreement":null},{"id":"W2335967795","doi":"10.1177/1078155216637218","title":"Ibrutinib-associated tumor lysis syndrome in a patient with mantle cell lymphoma: A case report","year":2016,"lang":"en","type":"article","venue":"Journal of Oncology Pharmacy Practice","topic":"Methemoglobinemia and Tumor Lysis Syndrome","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Mantle cell lymphoma; Ibrutinib; Tumor lysis syndrome; Medicine; Lymphoma; Cancer research; Oncology; Internal medicine; Pathology; Leukemia; Chemotherapy; Chronic lymphocytic leukemia","score_opus":0.023043965985297944,"score_gpt":0.3389743104693426,"score_spread":0.31593034448404467,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2335967795","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98119223,0.00023772969,0.00006232732,0.008742613,0.00033283836,0.00032342382,0.0000062118147,0.000020131141,0.009082508],"genre_scores_gemma":[0.9933892,0.000117765994,0.0041849473,0.0012996962,0.00008401145,0.00001699389,0.0000020004984,0.000039280745,0.0008660888],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.99649006,0.000706773,0.0014168472,0.0003179777,0.00062363833,0.00044471776],"domain_scores_gemma":[0.9938328,0.0017200208,0.0029954982,0.00031873505,0.0007418103,0.00039113],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0025145146,0.0002601829,0.0010301858,0.00047552824,0.000072414296,0.000016691218,0.00014195987,0.00008943463,0.00047610735],"category_scores_gemma":[0.0024201146,0.00015464936,0.0002189486,0.0006314036,0.00010274086,0.00064617686,0.00006001483,0.00046539455,0.000061507824],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0038359559,0.0040749083,0.009248474,0.0000376153,0.0005569475,0.967612,0.00027248755,0.0000039746956,0.0073777726,0.0000036126742,0.001665465,0.005310775],"study_design_scores_gemma":[0.025305886,0.0032491253,0.0015104194,0.00020756078,0.0016919154,0.91331923,0.0006050661,0.00003126987,0.0044709276,0.000015858835,0.049408454,0.00018428726],"about_ca_topic_score_codex":0.0001388513,"about_ca_topic_score_gemma":0.000014728026,"teacher_disagreement_score":0.054292783,"about_ca_system_score_codex":0.0010633765,"about_ca_system_score_gemma":0.0015114044,"threshold_uncertainty_score":0.63064176},"labels":[],"label_agreement":null},{"id":"W2339672514","doi":"10.1177/1078155216634180","title":"Evaluating the patient-perceived impact of clinical pharmacy services and proactive follow-up care in an ambulatory chemotherapy unit","year":2016,"lang":"en","type":"article","venue":"Journal of Oncology Pharmacy Practice","topic":"Pharmaceutical Practices and Patient Outcomes","field":"Medicine","cited_by":40,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Pharmacist; Pharmacy; Clinical pharmacy; Ambulatory; Family medicine; Regimen; Patient satisfaction; Ambulatory care; Medication therapy management; Nursing; Pharmacy practice; Health care; Internal medicine","score_opus":0.3481103082943572,"score_gpt":0.6065087190202229,"score_spread":0.25839841072586567,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2339672514","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98925185,0.001296824,0.0000058408405,0.0070620575,0.00068305276,0.0007579755,0.000010238071,0.000009704397,0.0009224263],"genre_scores_gemma":[0.99147964,0.003065614,0.0010280928,0.00397956,0.00037960248,0.000009274999,0.0000022053046,0.000030894542,0.00002514337],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99458086,0.002674712,0.0015350536,0.00027764146,0.0006036292,0.0003281245],"domain_scores_gemma":[0.98904186,0.0064591733,0.0026385621,0.00024765197,0.0012181097,0.00039462448],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0037492497,0.00025284544,0.000847724,0.0001813735,0.000097232434,0.00002308034,0.00025857915,0.00010292314,0.0003031939],"category_scores_gemma":[0.0020773916,0.00012905677,0.00031476415,0.00023317225,0.00023687807,0.00213784,0.00007842999,0.0012142258,0.000005954235],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.051230848,0.0013293996,0.53084457,0.00007774124,0.00096783554,0.0001349236,0.0060039745,0.000017088267,0.022860833,0.0000033858976,0.000058911646,0.3864705],"study_design_scores_gemma":[0.1257526,0.03435817,0.6926449,0.00054642145,0.0046090623,0.0023481254,0.013023425,0.0051631522,0.00510576,0.00006394613,0.115878694,0.00050576206],"about_ca_topic_score_codex":0.00013356462,"about_ca_topic_score_gemma":0.000015823465,"teacher_disagreement_score":0.38596475,"about_ca_system_score_codex":0.00026436665,"about_ca_system_score_gemma":0.0013546618,"threshold_uncertainty_score":0.52752745},"labels":[],"label_agreement":null},{"id":"W2341523177","doi":"10.1177/1078155216631406","title":"Evaluation of a rapid hydration protocol: Safety and effectiveness","year":2016,"lang":"en","type":"article","venue":"Journal of Oncology Pharmacy Practice","topic":"Childhood Cancer Survivors' Quality of Life","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Children's Hospital of Eastern Ontario; Government of Canada; Department of National Defence","funders":"","keywords":"Medicine; Chemotherapy; Urine specific gravity; Urine; Staffing; Protocol (science); Cyclophosphamide; Ifosfamide; Adverse effect; Urology; Internal medicine; Cisplatin; Nursing; Pathology","score_opus":0.10518973022127787,"score_gpt":0.5030573286227796,"score_spread":0.39786759840150177,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2341523177","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.82366014,0.0010663995,0.0069563133,0.094659545,0.0013549582,0.05611523,0.000011423242,0.000035574074,0.016140448],"genre_scores_gemma":[0.99478555,0.0003231989,0.001953982,0.0011469752,0.00058386225,0.0011707927,6.7722954e-7,0.00001846965,0.000016521864],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9939389,0.0038891213,0.000867191,0.0001473366,0.0010293763,0.00012806729],"domain_scores_gemma":[0.99161816,0.0038029526,0.001887107,0.00013948852,0.0024111315,0.00014114764],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.023388067,0.00011408838,0.0004951726,0.00015578726,0.000046999223,0.0000068759105,0.00007520673,0.000070032234,0.00022728664],"category_scores_gemma":[0.010202435,0.00007593273,0.00009026697,0.00013993504,0.00011467867,0.0009298315,0.0000313393,0.00028908654,0.000005428948],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.054456484,0.0020539553,0.008662693,0.00046257573,0.0012467332,0.000075966076,0.0015958514,0.000024792058,0.1199452,0.00012999456,0.0012193109,0.8101264],"study_design_scores_gemma":[0.11196413,0.010447292,0.11246195,0.0013405978,0.0058184215,0.006192994,0.0006209635,0.00042308605,0.081152596,0.0006552014,0.6686575,0.00026528796],"about_ca_topic_score_codex":0.000023818593,"about_ca_topic_score_gemma":0.000005288505,"teacher_disagreement_score":0.8098612,"about_ca_system_score_codex":0.00051169185,"about_ca_system_score_gemma":0.0018327185,"threshold_uncertainty_score":0.99813503},"labels":[],"label_agreement":null},{"id":"W2341576176","doi":"10.1177/1078155216643860","title":"Pilot study of biological monitoring of four antineoplastic drugs among Canadian healthcare workers","year":2016,"lang":"en","type":"article","venue":"Journal of Oncology Pharmacy Practice","topic":"Safe Handling of Antineoplastic Drugs","field":"Health Professions","cited_by":25,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Université de Montréal; Institut National de Santé Publique du Québec; Centre Hospitalier Universitaire Sainte-Justine","funders":"","keywords":"Medicine; Pharmacy; Antineoplastic Drugs; Personal protective equipment; Health care; Family medicine; Internal medicine; Pharmacology","score_opus":0.20553509175868948,"score_gpt":0.49055970285928513,"score_spread":0.2850246111005956,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2341576176","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9837218,0.0001891234,0.00009081339,0.008150952,0.005619735,0.0005985679,0.0000137601155,0.000017683225,0.0015975932],"genre_scores_gemma":[0.99640346,0.00043849007,0.0016615671,0.00028599743,0.0010236163,0.000013319912,4.1091005e-7,0.000032324628,0.00014082203],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9935941,0.0027673552,0.0021247796,0.0002579271,0.0005456271,0.000710215],"domain_scores_gemma":[0.973653,0.019370953,0.004222626,0.00024789115,0.0019120428,0.0005934779],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.004706222,0.00024290147,0.0009412484,0.0005746728,0.00033482103,0.0000049485093,0.000505756,0.0001296395,0.00019158381],"category_scores_gemma":[0.011003951,0.00016061742,0.00010463331,0.00042703978,0.00019925126,0.00056953623,0.00012673129,0.0014174875,0.00003688955],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0043097623,0.0012031576,0.9806907,0.00009145585,0.00036341645,0.0003670449,0.0031594841,0.000022372633,0.0029550267,0.00001996278,0.0016789383,0.005138683],"study_design_scores_gemma":[0.022966115,0.016020328,0.8720843,0.0020666781,0.0007881953,0.00035686116,0.058427874,0.000021416727,0.0006783818,0.00004494038,0.026188398,0.00035648013],"about_ca_topic_score_codex":0.04261696,"about_ca_topic_score_gemma":0.007034519,"teacher_disagreement_score":0.10860636,"about_ca_system_score_codex":0.00054902537,"about_ca_system_score_gemma":0.006047741,"threshold_uncertainty_score":0.99958706},"labels":[],"label_agreement":null},{"id":"W2345159752","doi":"10.1177/1078155215620920","title":"Icing oral mucositis: Oral cryotherapy in multiple myeloma patients undergoing autologous hematopoietic stem cell transplant","year":2015,"lang":"en","type":"article","venue":"Journal of Oncology Pharmacy Practice","topic":"Oral health in cancer treatment","field":"Medicine","cited_by":25,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"London Health Sciences Centre; Alberta Health Services","funders":"","keywords":"Medicine; Mucositis; Cryotherapy; Multiple myeloma; Hematopoietic stem cell transplantation; Hematopoietic stem cell; Stem cell; Stomatitis; Plasma Cell Myeloma; Surgery; Internal medicine; Haematopoiesis; Transplantation; Chemotherapy","score_opus":0.10066832000404236,"score_gpt":0.42101859092038635,"score_spread":0.320350270916344,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2345159752","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9834345,0.0023681214,0.00025886213,0.010118808,0.00166468,0.00064844906,0.0000071498916,0.00003275201,0.0014666767],"genre_scores_gemma":[0.9828585,0.0011780388,0.010725287,0.004860644,0.00022501785,0.000017447222,0.0000045139377,0.000046630044,0.00008396113],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.9964806,0.00087814336,0.0012140723,0.0002614007,0.0005933693,0.00057241233],"domain_scores_gemma":[0.99598247,0.0014702153,0.001252151,0.00017772045,0.00052178215,0.00059564353],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0018150542,0.00026808496,0.00086183794,0.00030765185,0.00008566017,0.000020494057,0.00017299308,0.00014632974,0.00005534835],"category_scores_gemma":[0.0001840124,0.00022444816,0.00012824112,0.00028904947,0.000076346165,0.0007502133,0.000027635997,0.0010207428,0.0000406399],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.048854623,0.0127201695,0.69917667,0.00075636886,0.0007589818,0.020396702,0.019600498,0.00085754873,0.0014563166,0.000022007323,0.0078040906,0.18759605],"study_design_scores_gemma":[0.37187004,0.052703742,0.07122796,0.002318331,0.004259896,0.03931347,0.01544468,0.0050081857,0.024742503,0.00020319711,0.4115492,0.0013587822],"about_ca_topic_score_codex":0.00023631849,"about_ca_topic_score_gemma":0.0001471599,"teacher_disagreement_score":0.6279487,"about_ca_system_score_codex":0.0028159209,"about_ca_system_score_gemma":0.0027596934,"threshold_uncertainty_score":0.9152731},"labels":[],"label_agreement":null},{"id":"W2368261462","doi":"10.1177/1078155215627502","title":"Taxane-induced arthralgia and myalgia: A literature review","year":2016,"lang":"en","type":"review","venue":"Journal of Oncology Pharmacy Practice","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":44,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Sunnybrook Health Science Centre","funders":"","keywords":"myalgia; Taxane; Medicine; Docetaxel; Paclitaxel; Internal medicine; Chemotherapy; Oncology; Breast cancer; Cancer","score_opus":0.09835431357604807,"score_gpt":0.5213771832342611,"score_spread":0.423022869658213,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2368261462","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00001007357,0.9736243,0.0000026823088,0.018168643,0.0017954834,0.0012517571,0.00002846386,0.000018363617,0.0051002284],"genre_scores_gemma":[0.0000041962053,0.9887628,0.00069151085,0.0066738985,0.0022467077,0.00006272414,0.000020608963,0.000069088084,0.0014684931],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9957535,0.0014189796,0.0016572658,0.00038755313,0.0003811895,0.00040151144],"domain_scores_gemma":[0.9915381,0.0025727185,0.0042949035,0.00027875323,0.0007964907,0.0005190197],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0018436436,0.0005953366,0.0039979545,0.0004258177,0.00008411842,0.000032634234,0.00024143393,0.0004270748,0.00093515526],"category_scores_gemma":[0.0012154541,0.00035268522,0.00084749423,0.00045400698,0.0001050385,0.00065552536,0.000102885424,0.0026128357,0.00012839079],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00080322754,0.00060146913,0.0000022516754,0.038424715,0.0025830795,0.011284711,0.000057681285,2.0665314e-9,0.000045320816,0.00001404487,0.101361446,0.84482205],"study_design_scores_gemma":[0.004910637,0.0018018978,7.866224e-7,0.10620912,0.02341668,0.12383531,0.000006299751,8.082781e-8,0.0000062786494,0.000005363352,0.7396,0.0002075433],"about_ca_topic_score_codex":0.0000024259368,"about_ca_topic_score_gemma":4.7103904e-7,"teacher_disagreement_score":0.8446145,"about_ca_system_score_codex":0.0006855176,"about_ca_system_score_gemma":0.0030301807,"threshold_uncertainty_score":0.9999781},"labels":[],"label_agreement":null},{"id":"W2405394407","doi":"10.1177/1078155216650986","title":"Rationalizing the use of auxiliary label for oral oncology drugs","year":2016,"lang":"en","type":"article","venue":"Journal of Oncology Pharmacy Practice","topic":"Pharmaceutical studies and practices","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"BC Cancer Agency","keywords":"Medicine; Formulary; Medical physics; Standardization; Agency (philosophy); Pharmacy; Package insert; Inclusion (mineral); Family medicine; Pharmacology; Computer science; Psychology","score_opus":0.3696067230437272,"score_gpt":0.5393909137530707,"score_spread":0.16978419070934347,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2405394407","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.08885412,0.0039572204,0.0044818157,0.8897542,0.0025610325,0.001038216,0.000036629906,0.000020331081,0.0092964815],"genre_scores_gemma":[0.76362365,0.03163938,0.09777829,0.10113445,0.0034709019,0.000078436584,0.000004719288,0.00007481906,0.0021953331],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99750483,0.0008285605,0.00087493134,0.00014359335,0.00037060544,0.0002774829],"domain_scores_gemma":[0.9698616,0.026647443,0.0018280441,0.00013584644,0.0013453877,0.00018165888],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.003636347,0.00014385671,0.0005617678,0.00008687253,0.00017256083,0.000015855447,0.00018984747,0.00008813715,0.00029934396],"category_scores_gemma":[0.010213351,0.00007167677,0.0001902178,0.00015809199,0.000278411,0.0014089782,0.00008782733,0.00056248385,0.00001554527],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.03913899,0.00296356,0.00201349,0.00009736298,0.002701006,0.00034903418,0.00095494324,0.000013882286,0.068972975,0.0016879038,0.22436047,0.6567464],"study_design_scores_gemma":[0.012918482,0.00217365,0.0002049176,0.00005112408,0.0020624795,0.0020491711,0.00055018073,0.00021460612,0.0041663633,0.00016146165,0.97536486,0.00008267282],"about_ca_topic_score_codex":0.000032433378,"about_ca_topic_score_gemma":0.0000046732175,"teacher_disagreement_score":0.7886197,"about_ca_system_score_codex":0.00031549713,"about_ca_system_score_gemma":0.0010212634,"threshold_uncertainty_score":0.99812406},"labels":[],"label_agreement":null},{"id":"W2463802265","doi":"10.1177/1078155216656928","title":"Baxter elastomeric pumps: Feasibility of weight estimates","year":2016,"lang":"en","type":"article","venue":"Journal of Oncology Pharmacy Practice","topic":"Chemotherapy-related skin toxicity","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Alberta Innovates; Alberta Health Services","funders":"","keywords":"Medicine; Pharmacy; Infusion pump; Anesthesia; Nursing","score_opus":0.0567887396634437,"score_gpt":0.4350797763739987,"score_spread":0.378291036710555,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2463802265","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.94425386,0.0012309168,0.002109332,0.041897718,0.00093069,0.0003194412,0.0000059725458,0.000027228463,0.0092248265],"genre_scores_gemma":[0.97387534,0.002076666,0.020891922,0.0023851295,0.00040853172,0.0000026375583,4.7248764e-7,0.000031750606,0.00032754018],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.9976341,0.00038268807,0.0010364493,0.00020496215,0.00046253722,0.00027926106],"domain_scores_gemma":[0.9930589,0.0035014283,0.0019488183,0.0002865308,0.0009337597,0.00027056536],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.002060097,0.00019167153,0.0007366919,0.00021894643,0.000042978903,0.000006725048,0.00021654225,0.0001390166,0.0018800236],"category_scores_gemma":[0.0043584793,0.00011709453,0.00025157252,0.00027169645,0.000277055,0.00086792454,0.000050219198,0.0007186222,0.00007423339],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.018320624,0.0041894056,0.078803554,0.00010086586,0.0014192108,0.0011557231,0.0005096405,0.00000894059,0.79165393,0.00003192419,0.0124760205,0.09133016],"study_design_scores_gemma":[0.034133006,0.003941658,0.020990271,0.00037923615,0.002378272,0.02220699,0.00015709642,0.0001232762,0.40750173,0.00041450004,0.5074978,0.00027615373],"about_ca_topic_score_codex":0.00001250029,"about_ca_topic_score_gemma":8.2321327e-7,"teacher_disagreement_score":0.4950218,"about_ca_system_score_codex":0.0005576203,"about_ca_system_score_gemma":0.0008002261,"threshold_uncertainty_score":0.9990324},"labels":[],"label_agreement":null},{"id":"W2505248710","doi":"10.1177/1078155216660184","title":"Safe administration of docetaxel after weekly paclitaxel-induced acute pancreatitis","year":2016,"lang":"en","type":"article","venue":"Journal of Oncology Pharmacy Practice","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Centre Hospitalier de l’Université de Montréal","funders":"","keywords":"Medicine; Acute pancreatitis; Docetaxel; Carboplatin; Paclitaxel; Pancreatitis; Adverse effect; Chemotherapy; Pancreatic cancer; Internal medicine; Gastroenterology; Cancer; Cisplatin","score_opus":0.04567577280500804,"score_gpt":0.4385017096093566,"score_spread":0.3928259368043485,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2505248710","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.91077083,0.0008648967,0.00014767464,0.069878034,0.0012748635,0.00033205637,0.000033420176,0.000012653495,0.016685586],"genre_scores_gemma":[0.98648137,0.004531278,0.0032219228,0.0028679427,0.00093852833,0.000023488921,0.0000029780897,0.00002150051,0.0019110041],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.99792635,0.00039828822,0.00088955,0.00017887907,0.0003454872,0.0002614147],"domain_scores_gemma":[0.99591804,0.0013773716,0.0015083441,0.00016349593,0.00076693465,0.0002658266],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00082957745,0.00019009512,0.00067002507,0.00020308243,0.00004171879,0.000008773291,0.00012128481,0.00011953206,0.0022678534],"category_scores_gemma":[0.00049215124,0.0001239171,0.0002406962,0.00016918537,0.00011685819,0.0008633482,0.000031517153,0.00039963156,0.00006497234],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.09226061,0.00468304,0.016777342,0.000084936095,0.0047217906,0.012122131,0.00057518954,3.4915556e-7,0.67120385,0.00010802885,0.035227336,0.16223542],"study_design_scores_gemma":[0.030352915,0.01429201,0.012629134,0.00014286248,0.0074449754,0.024530366,0.00014696752,0.0000049186883,0.1365417,0.00009001078,0.7736371,0.00018702498],"about_ca_topic_score_codex":0.000024423205,"about_ca_topic_score_gemma":0.000008411143,"teacher_disagreement_score":0.73840976,"about_ca_system_score_codex":0.00040793276,"about_ca_system_score_gemma":0.0014623472,"threshold_uncertainty_score":0.99864423},"labels":[],"label_agreement":null},{"id":"W2507286557","doi":"10.1177/1078155216665245","title":"A rare case of blastic plasmacytoid dendritic cell neoplasm with deletion 7q.31, in the setting of heavy pre-treatment with alkylating chemotherapy","year":2016,"lang":"en","type":"article","venue":"Journal of Oncology Pharmacy Practice","topic":"Cutaneous lymphoproliferative disorders research","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Medicine; Interleukin-3 receptor; Plasmacytoid dendritic cell; Neoplasm; Bone marrow; Pathology; Myeloid; Myeloid leukemia; Lymph node; Dermis; Leukemia; Chemotherapy; Dendritic cell; Cancer research; Immunology; Internal medicine; Immune system","score_opus":0.02534637620104926,"score_gpt":0.3832707602306541,"score_spread":0.35792438402960486,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2507286557","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9875538,0.0004041974,0.00062099757,0.009389749,0.000039133956,0.0007649408,0.0000067560086,0.000005176497,0.0012152889],"genre_scores_gemma":[0.9936022,0.00073029153,0.004984548,0.0004533151,0.00009591934,0.000023957671,0.0000011425133,0.00002899949,0.000079621124],"study_design_codex":"bench_or_experimental","study_design_gemma":"case_report","domain_scores_codex":[0.9975177,0.0007201883,0.0007392343,0.00019042548,0.0005180721,0.00031435315],"domain_scores_gemma":[0.992208,0.0053193173,0.0012799568,0.00018445926,0.0008892639,0.00011899863],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012169223,0.00020451863,0.00059508235,0.00025777819,0.00008141276,0.0000127748535,0.00013599677,0.00006284665,0.000065393586],"category_scores_gemma":[0.00077566254,0.00009982716,0.00008696305,0.00035645827,0.00019590008,0.0003680266,0.000020238169,0.0004229,0.0000023297112],"study_design_candidate":"case_report","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.13874474,0.01179712,0.23078641,0.0008258148,0.0019116059,0.07505979,0.030739509,0.0010319251,0.38593212,0.000020575368,0.00050208555,0.12264831],"study_design_scores_gemma":[0.06961335,0.034637947,0.001960721,0.0011580874,0.0015252476,0.6697457,0.015264702,0.0023701428,0.19554141,0.000018585668,0.007878194,0.00028594746],"about_ca_topic_score_codex":0.00019014471,"about_ca_topic_score_gemma":0.00026464224,"teacher_disagreement_score":0.59468585,"about_ca_system_score_codex":0.00058901485,"about_ca_system_score_gemma":0.0018026442,"threshold_uncertainty_score":0.40708333},"labels":[],"label_agreement":null},{"id":"W2539944401","doi":"10.1177/1078155216676632","title":"Multicenter study of environmental contamination with cyclophosphamide, ifosfamide, and methotrexate in 48 Canadian hospitals","year":2016,"lang":"en","type":"article","venue":"Journal of Oncology Pharmacy Practice","topic":"Safe Handling of Antineoplastic Drugs","field":"Health Professions","cited_by":30,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Institut National de Santé Publique du Québec; Centre Hospitalier Universitaire Sainte-Justine","funders":"","keywords":"Medicine; Ifosfamide; Methotrexate; Cyclophosphamide; Contamination; Antineoplastic Drugs; Chemotherapy; Emergency medicine; Internal medicine; Intensive care medicine; Pharmacology; Cisplatin","score_opus":0.032098385770829616,"score_gpt":0.4165334557517296,"score_spread":0.3844350699809,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2539944401","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9921743,0.00015553978,0.00007553215,0.004108621,0.0007490003,0.0006534006,0.000012841647,0.0000048224783,0.0020658958],"genre_scores_gemma":[0.9968137,0.0005217003,0.0013949303,0.00082564866,0.0001076582,0.00001488262,5.485283e-7,0.000022528295,0.0002984002],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99590415,0.002232291,0.0010317408,0.00016836205,0.00030611941,0.0003573612],"domain_scores_gemma":[0.99087787,0.006718596,0.0017772677,0.0001240056,0.0002457183,0.00025657355],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0038488389,0.00015916994,0.0004818724,0.00037209323,0.00018081086,0.0000048763895,0.00016175614,0.000091620466,0.0002126631],"category_scores_gemma":[0.0023483282,0.0001037757,0.000029590974,0.00013195034,0.000109615234,0.0008290364,0.00005726543,0.0008740584,0.000029789722],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0034172786,0.001300517,0.95791936,0.000034278662,0.0002484082,0.00071067293,0.011628077,0.0000074889304,0.0037839944,0.000012616967,0.0005932986,0.020344019],"study_design_scores_gemma":[0.028568255,0.001981648,0.9108437,0.00029262836,0.00039650197,0.0001669796,0.030173324,0.000024847286,0.00039281478,0.00001867957,0.026986098,0.00015452916],"about_ca_topic_score_codex":0.0092525715,"about_ca_topic_score_gemma":0.018592818,"teacher_disagreement_score":0.047075655,"about_ca_system_score_codex":0.0006077198,"about_ca_system_score_gemma":0.0011412437,"threshold_uncertainty_score":0.9993153},"labels":[],"label_agreement":null},{"id":"W2546363677","doi":"10.1177/1078155216676631","title":"Adherence with capecitabine: A population-based analysis based on prescription refill data","year":2016,"lang":"en","type":"article","venue":"Journal of Oncology Pharmacy Practice","topic":"Medication Adherence and Compliance","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Medicine; Capecitabine; Medical prescription; Population; Family medicine; Emergency medicine; Intensive care medicine; Internal medicine; Pharmacology; Environmental health; Cancer; Colorectal cancer","score_opus":0.12305768815289346,"score_gpt":0.44592161540552244,"score_spread":0.32286392725262897,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2546363677","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.38989684,0.0009049562,0.22807172,0.3284293,0.0017890949,0.00169982,0.00012715386,0.00014582019,0.048935283],"genre_scores_gemma":[0.96992546,0.00013522022,0.019332297,0.00954259,0.00028554344,0.000012797138,0.000040738596,0.000012811517,0.00071256515],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.9978678,0.00038800001,0.00060224836,0.00027817755,0.00068307883,0.00018068824],"domain_scores_gemma":[0.995535,0.0014861722,0.0014581978,0.0006404159,0.0006321897,0.00024802718],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0012199478,0.00014036053,0.00042867835,0.0003395715,0.00006477288,0.000016038824,0.0003511469,0.000058727208,0.002583717],"category_scores_gemma":[0.0025052715,0.0000806201,0.00008768798,0.00062565313,0.000063201354,0.0008051781,0.000021536533,0.00038939682,0.00017176544],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.05782771,0.0075317305,0.55980635,0.00017895325,0.0040095258,0.0018965862,0.00011357236,0.0022520898,0.032642465,0.0001466691,0.098947465,0.23464692],"study_design_scores_gemma":[0.032225717,0.0073483307,0.16009386,0.00084778055,0.011129419,0.00085719896,0.00020064537,0.048361775,0.001847914,0.00002368166,0.7366749,0.00038875663],"about_ca_topic_score_codex":0.00006523854,"about_ca_topic_score_gemma":0.000007789556,"teacher_disagreement_score":0.63772744,"about_ca_system_score_codex":0.00020860409,"about_ca_system_score_gemma":0.0012610243,"threshold_uncertainty_score":0.99832803},"labels":[],"label_agreement":null},{"id":"W2550602224","doi":"10.1177/1078155216677854","title":"Development of a systematic approach to pharmaceutical industry’s patient assistance programs on accessing unfunded cancer drugs","year":2016,"lang":"en","type":"article","venue":"Journal of Oncology Pharmacy Practice","topic":"Pharmacy and Medical Practices","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"Health Canada","keywords":"Medicine; Pharmacist; Process (computing); Pharmacy; Family medicine; Computer science","score_opus":0.3718943334638246,"score_gpt":0.5608156648585646,"score_spread":0.18892133139474,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2550602224","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.87349564,0.0050595067,0.0044050016,0.0504203,0.009065619,0.0040094694,0.000050202387,0.00013799082,0.05335628],"genre_scores_gemma":[0.96563876,0.0010817657,0.015433389,0.016484248,0.0006544442,0.0003123484,0.000002035809,0.000057575733,0.00033543006],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9907216,0.0037901446,0.0027761916,0.0005324806,0.0012586958,0.00092092523],"domain_scores_gemma":[0.9867178,0.00629797,0.004220974,0.00029755465,0.0011227838,0.0013429133],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.007999701,0.00051917916,0.0012800135,0.00045310878,0.00034840018,0.00005270832,0.0010362765,0.0005448898,0.0006278128],"category_scores_gemma":[0.004248919,0.00034227074,0.0002676549,0.000682957,0.0003857126,0.0015526116,0.00024054149,0.0036399122,0.00009157239],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.02245076,0.015348691,0.0010843471,0.0043250746,0.0037337465,0.0005075889,0.011623882,0.0002461354,0.100997336,0.00061247026,0.01383363,0.8252363],"study_design_scores_gemma":[0.009718692,0.00081135053,0.00007389543,0.0022861483,0.0019989382,0.0006336985,0.0022860114,0.00025661744,0.099810235,0.00003600341,0.8816294,0.00045899858],"about_ca_topic_score_codex":0.0000069710945,"about_ca_topic_score_gemma":0.0000021231674,"teacher_disagreement_score":0.86779577,"about_ca_system_score_codex":0.0011772265,"about_ca_system_score_gemma":0.002481367,"threshold_uncertainty_score":0.9999029},"labels":[],"label_agreement":null},{"id":"W2553411963","doi":"10.1177/1078155216679028","title":"Prevention of carboplatin-induced hypersensitivity reactions in women with ovarian cancer","year":2016,"lang":"en","type":"article","venue":"Journal of Oncology Pharmacy Practice","topic":"Drug-Induced Adverse Reactions","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network; University of Toronto; Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Carboplatin; Ovarian cancer; Hypersensitivity reaction; Oncology; Internal medicine; Cancer; Dermatology; Gynecology; Pharmacology; Chemotherapy; Cisplatin","score_opus":0.06301764527040747,"score_gpt":0.4185180363633262,"score_spread":0.3555003910929187,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2553411963","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9516885,0.00003614328,0.000147651,0.019034853,0.00053284195,0.0002756902,0.0000043931896,0.000011921312,0.02826799],"genre_scores_gemma":[0.9963065,0.00052911806,0.002079946,0.00036826482,0.00030586994,0.000018218607,3.3053834e-7,0.0000213684,0.00037041577],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.9981425,0.00044595962,0.0006568062,0.00016031478,0.0003395182,0.0002549022],"domain_scores_gemma":[0.9962023,0.0012117958,0.0015265185,0.00016680681,0.00068775896,0.00020484794],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014484411,0.00013629705,0.0005051953,0.00037989242,0.000043835407,0.0000048221714,0.00006502995,0.00008998604,0.00006088481],"category_scores_gemma":[0.0012694242,0.000091332215,0.00007951617,0.00038489111,0.00007331544,0.0011132488,0.000020858057,0.00068076747,0.000008725482],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0032687627,0.0015230491,0.00146884,0.000028700653,0.00056755467,0.0007648041,0.0006344477,0.000024835552,0.6893577,0.00003987929,0.00005115573,0.30227026],"study_design_scores_gemma":[0.052202493,0.002945759,0.19157338,0.0015527545,0.002766978,0.029210698,0.008247986,0.00007760441,0.09724837,0.00012296502,0.6136157,0.00043531778],"about_ca_topic_score_codex":0.00035687565,"about_ca_topic_score_gemma":0.00009076848,"teacher_disagreement_score":0.61356455,"about_ca_system_score_codex":0.0015792412,"about_ca_system_score_gemma":0.002196586,"threshold_uncertainty_score":0.41296607},"labels":[],"label_agreement":null},{"id":"W2559612723","doi":"10.1177/1078155216681191","title":"Clinical effectiveness of bevacizumab in patients with recurrent brain tumours: A population-based evaluation","year":2016,"lang":"en","type":"article","venue":"Journal of Oncology Pharmacy Practice","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Medicine; Bevacizumab; Temozolomide; Internal medicine; Population; Progression-free survival; Lomustine; Discontinuation; Surgery; Oncology; Chemotherapy; Cyclophosphamide; Vincristine","score_opus":0.05332702560261797,"score_gpt":0.48243508416870495,"score_spread":0.42910805856608697,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2559612723","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99184495,0.00017650853,0.000066400346,0.0066899955,0.00036760356,0.0007000683,0.00000468577,0.0000032340415,0.00014657721],"genre_scores_gemma":[0.9982208,0.000050088478,0.0012796461,0.00031790958,0.0000867061,0.000023271075,0.000008768598,0.000011679768,0.0000011475714],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9960569,0.0022565844,0.00081530045,0.00015442155,0.0005813165,0.00013545362],"domain_scores_gemma":[0.9894287,0.0076118023,0.0014538761,0.00012461742,0.0012583289,0.00012265285],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0054189,0.000114361144,0.00052487414,0.00024649498,0.000020965123,0.0000043054642,0.00006420484,0.000058795405,0.00008048528],"category_scores_gemma":[0.005811503,0.00006460922,0.00011735097,0.00019140374,0.00004458402,0.00036974624,0.000011995305,0.00025301776,0.0000050867784],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.027938114,0.0075570857,0.83306706,0.00003535462,0.00023075163,0.000118897624,0.000025208667,0.000050210492,0.00027130282,0.000009446925,0.00015006137,0.13054651],"study_design_scores_gemma":[0.07529693,0.0075482456,0.9124083,0.0006874078,0.0011049792,0.00008527434,0.000015536767,0.00009616564,0.0007738396,0.000025425892,0.001894888,0.00006300598],"about_ca_topic_score_codex":0.000030238416,"about_ca_topic_score_gemma":0.000008433567,"teacher_disagreement_score":0.1304835,"about_ca_system_score_codex":0.00077158294,"about_ca_system_score_gemma":0.00090344995,"threshold_uncertainty_score":0.6957332},"labels":[],"label_agreement":null},{"id":"W2577366119","doi":"10.1177/1078155216687153","title":"Baxter elastomeric pumps: Weighing as an alternative to visual inspection","year":2017,"lang":"en","type":"article","venue":"Journal of Oncology Pharmacy Practice","topic":"Neutropenia and Cancer Infections","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Alberta Health Services; University of Calgary; University of Alberta; University of Ottawa","funders":"","keywords":"Medicine; Infusion pump; Preference; Dosing; Surgery; Anesthesia; Statistics; Mathematics; Internal medicine","score_opus":0.06497122907716572,"score_gpt":0.5163810874338346,"score_spread":0.45140985835666886,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2577366119","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.91515166,0.000060812028,0.00077781145,0.02733173,0.004159911,0.00023834454,0.000001085289,0.000026893897,0.052251756],"genre_scores_gemma":[0.98664945,0.0004891265,0.0015689601,0.0076675494,0.0031620488,0.000011950532,6.0535524e-7,0.000023771507,0.00042653418],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9985782,0.00025722457,0.0004310566,0.00018652268,0.00033241912,0.00021457813],"domain_scores_gemma":[0.9971798,0.00026291606,0.001227562,0.0002207251,0.000720107,0.00038889554],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009006784,0.000135838,0.0003587741,0.0002503493,0.00048440273,0.00011395198,0.00022682932,0.00005226624,0.0003998768],"category_scores_gemma":[0.0011934295,0.00011513677,0.00011488116,0.00010888756,0.00008473439,0.0027362942,0.000072832394,0.00089842215,0.00022974894],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.04694982,0.011200637,0.04552819,0.00007728499,0.0033709197,0.011898688,0.008213721,0.0004655444,0.2673907,0.0008701622,0.026482379,0.57755196],"study_design_scores_gemma":[0.0067481888,0.007039852,0.012918459,0.00005857222,0.0009231817,0.015116355,0.0008257776,0.00020705155,0.015142167,0.00007157313,0.9408015,0.00014734971],"about_ca_topic_score_codex":0.00033604202,"about_ca_topic_score_gemma":0.000020488353,"teacher_disagreement_score":0.9143191,"about_ca_system_score_codex":0.000542448,"about_ca_system_score_gemma":0.0006361803,"threshold_uncertainty_score":0.4695141},"labels":[],"label_agreement":null},{"id":"W2585427049","doi":"10.1177/1078155216689381","title":"A case report of enzalutamide administration in a dialysis-dependent patient with castration-resistant prostate cancer","year":2017,"lang":"en","type":"article","venue":"Journal of Oncology Pharmacy Practice","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Enzalutamide; Medicine; Prostate cancer; Dialysis; Internal medicine; Urology; Population; Oncology; Cancer; Clinical trial; Androgen receptor","score_opus":0.0805586320688406,"score_gpt":0.4702348691241038,"score_spread":0.38967623705526316,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2585427049","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9829151,0.0006673728,0.00001051436,0.013036143,0.0002029127,0.00054032553,0.0000146052425,0.0000031288096,0.002609879],"genre_scores_gemma":[0.9971886,0.0010342816,0.0011471265,0.00012378873,0.00013584818,0.000046143196,0.0000043673836,0.000012846789,0.00030697466],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.99805355,0.00021521513,0.00083303085,0.00017226166,0.00052149897,0.0002044365],"domain_scores_gemma":[0.9955947,0.00028675693,0.002657328,0.00025564904,0.0010309236,0.00017464711],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012388991,0.00012726236,0.00043708945,0.00018559044,0.0001394902,0.000042426447,0.00009343147,0.000049337337,0.00006810247],"category_scores_gemma":[0.00090517214,0.00008643513,0.000075897995,0.00010157359,0.00014460647,0.00080873404,0.00003131525,0.00050716626,0.00000115272],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.046555854,0.0020395846,0.029719738,0.00010526528,0.0007587079,0.8610963,0.002042829,0.00008810648,0.03233113,0.000007850526,0.00022367656,0.02503096],"study_design_scores_gemma":[0.03040103,0.012135656,0.010480997,0.00042037305,0.0024696558,0.8002126,0.0036537051,0.00013107224,0.105592325,0.00002314105,0.034255054,0.00022436822],"about_ca_topic_score_codex":0.0010412476,"about_ca_topic_score_gemma":0.0011958806,"teacher_disagreement_score":0.073261194,"about_ca_system_score_codex":0.00057282974,"about_ca_system_score_gemma":0.0039976924,"threshold_uncertainty_score":0.7091735},"labels":[],"label_agreement":null},{"id":"W2589696207","doi":"10.1177/1078155217694493","title":"Stability of sodium bicarbonate injection 8.4% in syringes over a six-week period in refrigerated temperature","year":2017,"lang":"en","type":"article","venue":"Journal of Oncology Pharmacy Practice","topic":"Methemoglobinemia and Tumor Lysis Syndrome","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Mount Sinai Hospital; Princess Margaret Cancer Centre; University of Toronto; University Health Network","funders":"Abbott Diagnostics","keywords":"Sodium bicarbonate; Medicine; Bicarbonate; Carbon dioxide; pH meter; Incubation period; Sodium; Incubation; Chromatography; Anesthesia; Chemistry; Biochemistry; Internal medicine","score_opus":0.05739433356511643,"score_gpt":0.4062935453483829,"score_spread":0.3488992117832665,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2589696207","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9830803,0.0003992351,0.0000013562506,0.00980113,0.0006453672,0.00025837563,0.00000289185,0.000006536417,0.005804758],"genre_scores_gemma":[0.9979232,0.00040928682,0.0010217797,0.00033450502,0.00019125121,0.000006244629,0.0000014388927,0.000017083985,0.00009522681],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99731326,0.0007380754,0.0010712536,0.00022724192,0.00039228253,0.0002578766],"domain_scores_gemma":[0.9962941,0.0006004057,0.0019967773,0.00036345518,0.0005970001,0.00014828765],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0037908007,0.00017918587,0.0008861085,0.00041260844,0.00008423106,0.000036064717,0.00024364704,0.0001616504,0.0002591429],"category_scores_gemma":[0.005593753,0.00014472038,0.00014242966,0.00028466544,0.00015985382,0.0009666849,0.00007226065,0.0016359193,0.000004081971],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.017385095,0.0044131535,0.2799239,0.00022603266,0.00033164135,0.006302114,0.0021080952,0.000023402006,0.686173,0.000030599298,0.00038155034,0.0027014085],"study_design_scores_gemma":[0.062475704,0.0074605723,0.6195581,0.00083106465,0.0016048207,0.03124066,0.0038487755,0.00093255396,0.21393025,0.0001986854,0.057359915,0.000558916],"about_ca_topic_score_codex":0.00027123766,"about_ca_topic_score_gemma":0.00007215604,"teacher_disagreement_score":0.47224277,"about_ca_system_score_codex":0.0005259335,"about_ca_system_score_gemma":0.0010134625,"threshold_uncertainty_score":0.71073467},"labels":[],"label_agreement":null},{"id":"W2595991451","doi":"10.1177/1078155217698846","title":"Safe handling of monoclonal antibodies: Too large to be hazardous?","year":2017,"lang":"en","type":"review","venue":"Journal of Oncology Pharmacy Practice","topic":"Safe Handling of Antineoplastic Drugs","field":"Health Professions","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Monoclonal antibody; Medicine; Hazardous waste; Occupational exposure; Drug; Monoclonal; Immunology; Antibody; Pharmacology; Environmental health; Waste management","score_opus":0.4405719605430867,"score_gpt":0.6411255606374046,"score_spread":0.20055360009431783,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2595991451","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0002634986,0.94873506,0.00059091003,0.008104841,0.011554475,0.0014247255,0.00018989362,0.000028425096,0.02910819],"genre_scores_gemma":[0.00008445386,0.97567695,0.015204853,0.0035096803,0.0035116062,0.000035396075,0.000018119184,0.00011786707,0.0018410613],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.98958266,0.003475866,0.0044932375,0.00047779898,0.0009299822,0.0010404587],"domain_scores_gemma":[0.95648384,0.022882553,0.01694879,0.00069495884,0.0024152945,0.00057453546],"candidate_categories":["metaresearch","metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.012219344,0.00066215673,0.005031352,0.00089152995,0.0010688519,0.000041026047,0.0015961892,0.0007047161,0.00069821376],"category_scores_gemma":[0.029537348,0.0005267278,0.0009973771,0.00030597064,0.00016042267,0.0009850428,0.00069782307,0.0054160208,0.0005132137],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0026765473,0.0015433748,0.0004775948,0.017868241,0.0036936065,0.0022478935,0.003912943,0.000011780075,0.000020535468,0.0003070946,0.15623507,0.81100535],"study_design_scores_gemma":[0.003998222,0.00057577767,0.000020475536,0.015808089,0.005810187,0.0015619411,0.0008639302,0.000011965455,0.000004837889,0.000016105929,0.9709346,0.00039386904],"about_ca_topic_score_codex":0.000112750895,"about_ca_topic_score_gemma":0.000027168146,"teacher_disagreement_score":0.81469953,"about_ca_system_score_codex":0.0007237919,"about_ca_system_score_gemma":0.018707609,"threshold_uncertainty_score":0.9997184},"labels":[],"label_agreement":null},{"id":"W2600741732","doi":"10.1177/1078155217701293","title":"Clinical impact and management of fluconazole discontinuation on sirolimus levels in bone marrow transplant patients","year":2017,"lang":"en","type":"article","venue":"Journal of Oncology Pharmacy Practice","topic":"Hematopoietic Stem Cell Transplantation","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Alberta Children's Hospital; Alberta Health Services","funders":"","keywords":"Sirolimus; Medicine; Fluconazole; Discontinuation; CYP3A4; Pharmacology; Internal medicine; Gastroenterology; Metabolism; Cytochrome P450; Antifungal","score_opus":0.09453958013113745,"score_gpt":0.47714750302053943,"score_spread":0.382607922889402,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2600741732","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9901296,0.0001549266,0.00013916478,0.0034120237,0.0003977826,0.00038540812,0.000013916998,0.0000028281083,0.005364387],"genre_scores_gemma":[0.9939228,0.0034815948,0.002112182,0.00032637222,0.00009485201,0.0000034756497,0.0000047343797,0.000012162967,0.000041808613],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99794734,0.00033014422,0.0010481067,0.00014585418,0.00035182547,0.00017674114],"domain_scores_gemma":[0.99700093,0.0008394087,0.0016204574,0.00017838013,0.00020636972,0.00015442244],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0025623774,0.00012449722,0.00053521304,0.00014900058,0.000059215672,0.000016425372,0.000115023206,0.000081027836,0.000051334744],"category_scores_gemma":[0.00031402087,0.00009669668,0.00011953943,0.00004252369,0.00009643914,0.00054707285,0.000018210496,0.0004722681,0.0000057804177],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.020085078,0.0054222723,0.80183935,0.0005011121,0.00087604526,0.0033925024,0.0013465886,0.000026549687,0.0043820436,0.000081679595,0.00029936875,0.1617474],"study_design_scores_gemma":[0.026849158,0.0025104505,0.9614898,0.00061533734,0.0010508506,0.0008719547,0.00016387862,0.00014707571,0.0019190215,0.000021696153,0.004273545,0.00008721347],"about_ca_topic_score_codex":0.000019927675,"about_ca_topic_score_gemma":0.0000040991376,"teacher_disagreement_score":0.16166018,"about_ca_system_score_codex":0.000113302,"about_ca_system_score_gemma":0.0001486779,"threshold_uncertainty_score":0.39431763},"labels":[],"label_agreement":null},{"id":"W2602198097","doi":"10.1177/1078155217702214","title":"Incidence of late onset neutropenia associated with rituximab use in B cell lymphoma patients undergoing autologous stem cell transplantation","year":2017,"lang":"en","type":"article","venue":"Journal of Oncology Pharmacy Practice","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary; Baker Hughes (Canada)","funders":"","keywords":"Medicine; Rituximab; Neutropenia; Autologous stem-cell transplantation; Transplantation; Febrile neutropenia; Internal medicine; Absolute neutrophil count; Lymphoma; Chemotherapy; Surgery; Hematopoietic stem cell transplantation; Incidence (geometry); Gastroenterology; Immunology","score_opus":0.047840597583751185,"score_gpt":0.3740233987825826,"score_spread":0.3261828011988314,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2602198097","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99601424,0.00013911653,0.000044823217,0.0008075043,0.0002419183,0.00040707935,0.000012807663,0.000009119585,0.0023234126],"genre_scores_gemma":[0.99657536,0.0014383441,0.0012128818,0.00040260708,0.00004358781,0.0000050929816,0.000007682114,0.000030978645,0.00028345943],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99690187,0.0008022087,0.0009164208,0.00023198836,0.0007513033,0.00039618538],"domain_scores_gemma":[0.9915086,0.0039030188,0.0030489757,0.00032204235,0.0010076581,0.00020973067],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0017527054,0.00019574122,0.0007115081,0.000278722,0.00015915491,0.0000646061,0.00041013057,0.00014784276,0.00003145802],"category_scores_gemma":[0.0014583868,0.00015958278,0.00009428811,0.00017614062,0.00021540055,0.0019890536,0.00007772524,0.0006979761,0.000015090836],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.12201249,0.027463011,0.7209357,0.0015616385,0.0013389228,0.06809782,0.007321021,0.0013306089,0.013175131,0.000010336706,0.0023634334,0.034389857],"study_design_scores_gemma":[0.43894726,0.007905097,0.49794412,0.0012220877,0.0023232044,0.0077062165,0.00054378714,0.0064911577,0.033360843,0.000013295035,0.003152701,0.00039024165],"about_ca_topic_score_codex":0.0007784519,"about_ca_topic_score_gemma":0.00038518402,"teacher_disagreement_score":0.31693476,"about_ca_system_score_codex":0.0077130985,"about_ca_system_score_gemma":0.012960704,"threshold_uncertainty_score":0.99609613},"labels":[],"label_agreement":null},{"id":"W2736583131","doi":"10.1177/1078155217718384","title":"Loperamide and cardiac events: Is high-dose use still safe for chemotherapy-induced diarrhea?","year":2017,"lang":"en","type":"review","venue":"Journal of Oncology Pharmacy Practice","topic":"Neutropenia and Cancer Infections","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Loperamide; Medicine; Diarrhea; Chemotherapy; Dosing; Adverse effect; Anesthesia; Torsades de pointes; Incidence (geometry); QT interval; Internal medicine","score_opus":0.23018749822189583,"score_gpt":0.5265286030856199,"score_spread":0.29634110486372406,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2736583131","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0014351774,0.9823391,0.000033850607,0.00901316,0.0042158403,0.0020257537,0.000098945595,0.000015207901,0.000823003],"genre_scores_gemma":[0.00026884177,0.9905265,0.0016112276,0.0031374737,0.0027587293,0.00011714304,0.0000134816555,0.0000877277,0.0014788511],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9970837,0.0006230494,0.0012215168,0.00037289032,0.00032858818,0.0003702033],"domain_scores_gemma":[0.9919751,0.0026854298,0.0035326683,0.00046111215,0.0009265736,0.0004190605],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0016966496,0.00046397757,0.0030634084,0.00029950647,0.0002372624,0.000095995114,0.0002864099,0.00032699973,0.00017926218],"category_scores_gemma":[0.0018113616,0.00034907757,0.00089936884,0.00012997205,0.00009364322,0.0012952414,0.00007272556,0.0017665697,0.000029537965],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0017916446,0.0005630446,0.00006920417,0.0024931238,0.003800123,0.00031882763,0.00012938317,1.6387988e-7,0.00008772668,0.000022537164,0.020094814,0.9706294],"study_design_scores_gemma":[0.007437004,0.0013915048,0.00006332641,0.0024935224,0.017091034,0.0055928035,0.00002381016,7.5631624e-7,0.000055818822,0.0000112445005,0.96556145,0.000277701],"about_ca_topic_score_codex":0.00009807808,"about_ca_topic_score_gemma":0.0000022974184,"teacher_disagreement_score":0.9703517,"about_ca_system_score_codex":0.00077180454,"about_ca_system_score_gemma":0.0033699884,"threshold_uncertainty_score":0.9998961},"labels":[],"label_agreement":null},{"id":"W2737770503","doi":"10.1177/1078155217718381","title":"Utilization of capecitabine plus oxaliplatin and 5-fluorouracil/folinic acid plus oxaliplatin in the adjuvant treatment of stage IIB and stage III colon cancer: A multi-centre, retrospective, chart review study","year":2017,"lang":"en","type":"article","venue":"Journal of Oncology Pharmacy Practice","topic":"Colorectal Cancer Treatments and Studies","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"BC Cancer Agency","keywords":"Oxaliplatin; Medicine; Folinic acid; FOLFOX; Capecitabine; Colorectal cancer; Fluorouracil; Tolerability; Regimen; Internal medicine; Stage (stratigraphy); Surgery; Cancer; Oncology; Gastroenterology; Adverse effect","score_opus":0.1493973258693315,"score_gpt":0.4807132871241634,"score_spread":0.33131596125483187,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2737770503","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.92057806,0.06922752,0.000008488972,0.0071400832,0.00024443076,0.0020779113,0.00007313291,0.000004482618,0.00064588734],"genre_scores_gemma":[0.8244708,0.17449723,0.0002961156,0.000251052,0.000103076425,0.00005329433,0.0000035860091,0.000013442434,0.0003113902],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9974322,0.0005575199,0.0010868779,0.0002696601,0.00042875163,0.0002250208],"domain_scores_gemma":[0.9952687,0.0006409027,0.003100587,0.00029085355,0.00058898353,0.0001099953],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0015234725,0.0002637094,0.0014879493,0.00012346124,0.0002239936,0.000021632457,0.00014706803,0.000059021946,0.00011222882],"category_scores_gemma":[0.0011241387,0.00016585052,0.00010970305,0.00014545154,0.00021044238,0.00046441244,0.00008864372,0.00034099244,4.4860968e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.038496554,0.01454166,0.71418154,0.0014725738,0.0040823705,0.002567395,0.046605684,0.000028686303,0.0032662798,0.000057386555,0.00082883803,0.17387104],"study_design_scores_gemma":[0.1523333,0.029059602,0.7114316,0.0017739089,0.008639041,0.0008454365,0.0272655,0.001207396,0.002015121,0.000006741185,0.06503869,0.00038360426],"about_ca_topic_score_codex":0.0017395212,"about_ca_topic_score_gemma":0.0020641538,"teacher_disagreement_score":0.17348744,"about_ca_system_score_codex":0.00087758707,"about_ca_system_score_gemma":0.00067267497,"threshold_uncertainty_score":0.67631876},"labels":[],"label_agreement":null},{"id":"W2739865956","doi":"10.1177/1078155217722047","title":"A deliberative framework to identify the need for real-life evidence building of new cancer drugs after interim funding decision","year":2017,"lang":"en","type":"article","venue":"Journal of Oncology Pharmacy Practice","topic":"Economic and Financial Impacts of Cancer","field":"Economics, Econometrics and Finance","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"Cancer Care Ontario","keywords":"Concordance; Interim; Medicine; Observational study; Interim analysis; Process management; Clinical trial; Management science; Political science; Business; Internal medicine; Engineering","score_opus":0.2165385595721144,"score_gpt":0.5102166603720768,"score_spread":0.29367810079996237,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2739865956","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8083568,0.008092557,0.12371847,0.051869217,0.0049790544,0.0005127229,0.000045237426,0.000005983285,0.0024199272],"genre_scores_gemma":[0.9552811,0.008297613,0.028917354,0.0056558703,0.0015677965,0.000038192382,1.3275465e-7,0.000028298207,0.00021366551],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9978858,0.000059837148,0.0013763986,0.00026353903,0.00008078711,0.00033364416],"domain_scores_gemma":[0.9910293,0.0031531078,0.0047122715,0.00038534668,0.00043407286,0.00028587712],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.0035965147,0.00017998333,0.0007311222,0.00022148425,0.00031240948,0.0002633288,0.0009133548,0.00012147966,0.00028835182],"category_scores_gemma":[0.015954977,0.00015679443,0.00026081232,0.00011074553,0.00011076314,0.0032664395,0.00020812081,0.00056667184,0.000031857227],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.06307465,0.00092218554,0.10699154,0.0002532808,0.0032562222,0.0001428933,0.04631924,0.0030738856,0.004354651,0.092027746,0.15075283,0.5288309],"study_design_scores_gemma":[0.0046208645,0.0011725673,0.055327408,0.0010490527,0.00037882663,0.00008498247,0.0013553754,0.00072930835,0.0015024099,0.03878914,0.89450526,0.00048479612],"about_ca_topic_score_codex":0.0011159483,"about_ca_topic_score_gemma":0.000053279036,"teacher_disagreement_score":0.7437524,"about_ca_system_score_codex":0.0005724211,"about_ca_system_score_gemma":0.000676643,"threshold_uncertainty_score":0.99233407},"labels":[],"label_agreement":null},{"id":"W2747083578","doi":"10.1177/1078155217726160","title":"Survey of guidelines and current practices for safe handling of antineoplastic and other hazardous drugs used in 24 countries","year":2017,"lang":"en","type":"article","venue":"Journal of Oncology Pharmacy Practice","topic":"Safe Handling of Antineoplastic Drugs","field":"Health Professions","cited_by":49,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Clinical Oncological Society of Australia; National Institutes of Health; International Society of Oncology Pharmacy Practitioners","keywords":"Medicine; Antineoplastic Drugs; Hazardous waste; Pharmacology; Waste management","score_opus":0.3626607821254592,"score_gpt":0.5916071912413206,"score_spread":0.22894640911586134,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2747083578","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98075175,0.004764939,0.0008364005,0.008965777,0.003415118,0.00060177676,0.00008097736,0.000006373263,0.00057688507],"genre_scores_gemma":[0.9845897,0.0047780056,0.009422595,0.0005527976,0.0005139667,0.000011886118,0.0000020615735,0.000034528985,0.00009447953],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.99575746,0.0012333294,0.0020546357,0.0002290868,0.00037196666,0.00035350418],"domain_scores_gemma":[0.94797385,0.0361692,0.012674914,0.00022544569,0.0028212084,0.00013540412],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.013049621,0.00020633296,0.0009828185,0.0002915588,0.0004315984,0.00003349327,0.0003243277,0.0001392229,0.00003521095],"category_scores_gemma":[0.08785779,0.00016992941,0.00006155051,0.00009272399,0.0003419371,0.0010620931,0.00017577734,0.0008855317,0.000002799359],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.011081875,0.0005360245,0.9611812,0.0012547276,0.0003234157,0.0000348614,0.0048857913,0.000047235506,0.0014075423,0.00015847014,0.0041542603,0.0149345845],"study_design_scores_gemma":[0.035390858,0.0013696442,0.22473647,0.0029311816,0.0014802215,0.00033578236,0.005371549,0.0048213247,0.0011921471,0.00016998609,0.7217812,0.00041962753],"about_ca_topic_score_codex":0.001805514,"about_ca_topic_score_gemma":0.0008585041,"teacher_disagreement_score":0.7364447,"about_ca_system_score_codex":0.000063042695,"about_ca_system_score_gemma":0.002766864,"threshold_uncertainty_score":0.91982555},"labels":[],"label_agreement":null},{"id":"W2747972503","doi":"10.1177/1078155217724595","title":"Effectiveness of adjuvant carboplatin-based chemotherapy compared to cisplatin in non-small cell lung cancer","year":2017,"lang":"en","type":"article","venue":"Journal of Oncology Pharmacy Practice","topic":"Lung Cancer Diagnosis and Treatment","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Université Laval; Hôpital Saint-François d'Assise; Institut universitaire de cardiologie et de pneumologie de Québec","funders":"","keywords":"Vinorelbine; Carboplatin; Medicine; Lung cancer; Cisplatin; Chemotherapy; Oncology; Internal medicine","score_opus":0.03448883472081306,"score_gpt":0.43717604190763587,"score_spread":0.4026872071868228,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2747972503","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9859034,0.00096179364,0.00014881275,0.008364033,0.00069448067,0.00084049144,0.000008628526,0.0000039620554,0.0030744136],"genre_scores_gemma":[0.9949741,0.0006657341,0.0027898292,0.0012603946,0.00019317427,0.00006529073,0.0000015098947,0.000024695335,0.000025297557],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9983815,0.00032027927,0.00059901766,0.00019479233,0.00027650117,0.00022791255],"domain_scores_gemma":[0.9956962,0.0017288552,0.0015692643,0.00028703365,0.00051013776,0.00020854105],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014899072,0.00018017307,0.000852556,0.0001829525,0.000076313074,0.000019924857,0.00022474094,0.00006832752,0.000103727216],"category_scores_gemma":[0.00035756736,0.00014409746,0.00014795462,0.00010389923,0.00005233785,0.00022796507,0.000034294135,0.00045079153,0.000003242801],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.021000901,0.004298894,0.8901006,0.0009295261,0.00078335544,0.0015591267,0.0012169164,0.0033683772,0.06166695,0.0000028861973,0.0016507527,0.013421689],"study_design_scores_gemma":[0.05452667,0.0020111862,0.7394252,0.0016522434,0.0016416478,0.00016933757,0.0001652293,0.0029128294,0.18760657,0.0000034404804,0.0097076595,0.00017800323],"about_ca_topic_score_codex":0.0011823225,"about_ca_topic_score_gemma":0.000099428595,"teacher_disagreement_score":0.15067545,"about_ca_system_score_codex":0.0011237466,"about_ca_system_score_gemma":0.0013502148,"threshold_uncertainty_score":0.5876124},"labels":[],"label_agreement":null},{"id":"W2751383086","doi":"10.1177/1078155217727140","title":"Low-molecular-weight heparins for the prevention of recurrent venous thromboembolism in patients with cancer: A systematic literature review of efficacy and cost-effectiveness","year":2017,"lang":"en","type":"review","venue":"Journal of Oncology Pharmacy Practice","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Augmentium Pharma Consulting (Canada)","funders":"","keywords":"Medicine; Low molecular weight heparin; Randomized controlled trial; Clinical trial; Intensive care medicine; Adverse effect; Cancer; Venous thromboembolism; Vitamin K antagonist; Surgery; Heparin; Internal medicine; Warfarin; Thrombosis","score_opus":0.07988792753790282,"score_gpt":0.4762088049066638,"score_spread":0.396320877368761,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2751383086","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00037971482,0.984505,0.000059297123,0.00040541956,0.0007327565,0.013748165,0.00003825131,0.0000029018117,0.00012849926],"genre_scores_gemma":[0.0008229716,0.99768996,0.00022135739,0.0002180547,0.00013926988,0.0008299178,0.000026503489,0.00004437872,0.000007564457],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.99563444,0.0015770626,0.0017737808,0.00027313852,0.0005038188,0.00023775878],"domain_scores_gemma":[0.9871221,0.0028020341,0.008218917,0.00045299702,0.0012949685,0.00010898552],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0037876132,0.00037763597,0.005717391,0.00027909453,0.00007840316,0.000026638327,0.00038092522,0.00015269345,0.0000104123],"category_scores_gemma":[0.0021317473,0.00020937262,0.00051031966,0.00027590495,0.00011514564,0.0003173772,0.000104307204,0.0008415677,4.3993137e-7],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008686493,0.00464636,0.000020990748,0.609429,0.003472291,0.000083803636,0.0001392328,0.000001744636,8.89071e-7,0.00003739988,0.0003380285,0.38096163],"study_design_scores_gemma":[0.0057700514,0.0028362905,0.0004799201,0.6017606,0.035006676,0.00025139257,0.000009505073,0.0000024254432,0.000005336385,0.0000029809776,0.3537539,0.00012088655],"about_ca_topic_score_codex":0.000013344345,"about_ca_topic_score_gemma":0.000004225171,"teacher_disagreement_score":0.38084075,"about_ca_system_score_codex":0.00042115312,"about_ca_system_score_gemma":0.0012479699,"threshold_uncertainty_score":0.8537968},"labels":[],"label_agreement":null},{"id":"W2757929633","doi":"10.1177/1078155217730130","title":"Durable complete remission following anti-EGFR antibodies in recurrent metastatic colorectal cancer","year":2017,"lang":"en","type":"article","venue":"Journal of Oncology Pharmacy Practice","topic":"Colorectal Cancer Treatments and Studies","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier de l’Université de Montréal; Hôpital Maisonneuve-Rosemont; Université de Montréal","funders":"","keywords":"Medicine; Discontinuation; Hypomagnesemia; Panitumumab; Cetuximab; Internal medicine; Adverse effect; Colorectal cancer; Cancer; Surgery; Oncology; Pediatrics","score_opus":0.11362827524337277,"score_gpt":0.4824869010611484,"score_spread":0.3688586258177756,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2757929633","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95007527,0.008069618,0.000007758369,0.02765119,0.002192293,0.00033328249,0.000008478797,0.0000090888225,0.0116530275],"genre_scores_gemma":[0.98227024,0.014555214,0.0020674432,0.0006246141,0.00028017958,0.000017431412,0.0000017983745,0.000017671045,0.00016540273],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.9981616,0.00025477662,0.0006752365,0.00020556779,0.00038251982,0.00032029438],"domain_scores_gemma":[0.9971225,0.0007014936,0.0014712935,0.00015841621,0.00037708617,0.00016921284],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011784172,0.00020226065,0.0009095918,0.00017349685,0.00042834846,0.000057096764,0.00019981594,0.000042714935,0.0001313018],"category_scores_gemma":[0.0020172414,0.00014755731,0.0002344229,0.0001026574,0.00011989145,0.0009260501,0.000112694885,0.0006764779,0.000007923915],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.030492943,0.0054730144,0.54692614,0.00030490264,0.0062721632,0.027440691,0.00463928,0.0000759607,0.1382039,0.000042749758,0.019321932,0.2208063],"study_design_scores_gemma":[0.028624883,0.0040074303,0.30209887,0.0008948905,0.0040285117,0.003917985,0.0020691652,0.00044818682,0.0075325705,0.00006822812,0.6459795,0.00032973348],"about_ca_topic_score_codex":0.0004679242,"about_ca_topic_score_gemma":0.00013127537,"teacher_disagreement_score":0.6266576,"about_ca_system_score_codex":0.00081385684,"about_ca_system_score_gemma":0.00076576177,"threshold_uncertainty_score":0.6017212},"labels":[],"label_agreement":null},{"id":"W2761051584","doi":"10.1177/1078155217732400","title":"Optimizing patient education of oncology medications: A descriptive survey of pharmacist-provided patient education in Canada","year":2017,"lang":"en","type":"article","venue":"Journal of Oncology Pharmacy Practice","topic":"Pharmaceutical Practices and Patient Outcomes","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Cancer Care Nova Scotia; Nova Scotia Health Authority","funders":"Dalhousie University","keywords":"Medicine; Pharmacist; Pharmacy; Family medicine; Clinical pharmacy; Patient education; Descriptive statistics; Oncology nursing; Nursing; Oncology; Nurse education","score_opus":0.19454874108068795,"score_gpt":0.49677453778279024,"score_spread":0.30222579670210226,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2761051584","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9644401,0.0027731615,0.00006326312,0.01188702,0.0045243013,0.0010069355,0.00002944386,0.0000041295552,0.015271633],"genre_scores_gemma":[0.98628426,0.0025740196,0.0071698246,0.0037215606,0.0001353158,0.000030726325,0.000020153406,0.000020469086,0.00004367666],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.995311,0.0015116358,0.0019330201,0.00023577629,0.00071892777,0.00028959714],"domain_scores_gemma":[0.98519343,0.00351847,0.007657875,0.0003833316,0.0028598898,0.00038700606],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.002334035,0.00021249741,0.000874238,0.00033777612,0.0001346458,0.000017760922,0.00038418398,0.00009794541,0.00017530994],"category_scores_gemma":[0.011779789,0.00018719505,0.00011794176,0.00023153418,0.00016861713,0.0014186893,0.00011821049,0.0010753059,0.0000039051993],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.016297944,0.011216864,0.19050948,0.000298367,0.00087573053,0.00019152368,0.0051303953,0.0001376386,0.006283383,0.00006173813,0.01035164,0.7586453],"study_design_scores_gemma":[0.015573486,0.0066199293,0.10369314,0.0008854804,0.0034879125,0.0027466088,0.020248929,0.0031015377,0.032837283,0.00008164196,0.8101986,0.00052545813],"about_ca_topic_score_codex":0.33507797,"about_ca_topic_score_gemma":0.04121676,"teacher_disagreement_score":0.79984695,"about_ca_system_score_codex":0.0026080967,"about_ca_system_score_gemma":0.05018872,"threshold_uncertainty_score":0.9965444},"labels":[],"label_agreement":null},{"id":"W2774074342","doi":"10.1177/1078155217743311","title":"A “chamber of errors” adaptation to assess pharmaceutical assistants’ knowledge in chemotherapy preparation","year":2017,"lang":"en","type":"article","venue":"Journal of Oncology Pharmacy Practice","topic":"Pharmaceutical Practices and Patient Outcomes","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Pharmacy; Pharmacist; Listing (finance); Pharmaceutical care; Medical education; Nursing","score_opus":0.3870703681985413,"score_gpt":0.5860764264337797,"score_spread":0.19900605823523837,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2774074342","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9052139,0.0006284725,0.0021292274,0.041948907,0.0018300298,0.00086644845,0.000005374648,0.000013471636,0.04736415],"genre_scores_gemma":[0.9846929,0.00093593256,0.010283064,0.0034349975,0.0003609856,0.000010672666,0.0000016686847,0.00002295942,0.0002568717],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99730676,0.00062848843,0.0010867668,0.00021015228,0.00048600775,0.00028183006],"domain_scores_gemma":[0.99450326,0.0018810472,0.0021071595,0.00028460394,0.0008580128,0.00036590005],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0032181274,0.00018546979,0.0006640662,0.00027952736,0.00011756944,0.000045149056,0.00024011593,0.00011237405,0.0003044648],"category_scores_gemma":[0.0040540816,0.00015653096,0.00016440249,0.00018773806,0.00011651318,0.0018870682,0.00007664089,0.00095624547,0.000038893257],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.2497486,0.029898262,0.19149145,0.0010056831,0.0030856517,0.0041718935,0.018882094,0.0013534443,0.18473141,0.0010074284,0.01765747,0.2969666],"study_design_scores_gemma":[0.022992786,0.0027322425,0.034867812,0.00021953895,0.001122309,0.0018509876,0.0010553554,0.01916871,0.019312523,0.000037186568,0.8964083,0.0002322423],"about_ca_topic_score_codex":0.00004106744,"about_ca_topic_score_gemma":0.000018224002,"teacher_disagreement_score":0.87875086,"about_ca_system_score_codex":0.00034445518,"about_ca_system_score_gemma":0.0008843844,"threshold_uncertainty_score":0.6383147},"labels":[],"label_agreement":null},{"id":"W2782528556","doi":"10.1177/1078155217748735","title":"Approach to initiating QT-prolonging oncology drugs in the ambulatory setting","year":2018,"lang":"en","type":"review","venue":"Journal of Oncology Pharmacy Practice","topic":"Cardiac electrophysiology and arrhythmias","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Medicine; QT interval; Torsades de pointes; Intensive care medicine; Ambulatory; Drug; Internal medicine; Cancer; Oncology; Pharmacology","score_opus":0.08855229204534298,"score_gpt":0.4709454513604985,"score_spread":0.3823931593151555,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2782528556","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.001161921,0.9512363,0.000052331838,0.005304474,0.0014323266,0.0013476762,0.000004217743,0.000020788044,0.03943993],"genre_scores_gemma":[0.0020874436,0.9706415,0.007919526,0.012382822,0.0067214724,0.000102090344,0.000015560032,0.00007662589,0.000052982276],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9912444,0.005157683,0.0019743291,0.00045529628,0.00047839494,0.0006899448],"domain_scores_gemma":[0.9873655,0.00795734,0.0035266508,0.0003870461,0.0005184125,0.00024507567],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.01038299,0.000485911,0.003038754,0.0007515293,0.00022249976,0.00003166297,0.0005335003,0.0005325269,0.000033176842],"category_scores_gemma":[0.0046575614,0.00032239547,0.00087280374,0.00084460154,0.0001971153,0.00044462472,0.00018349633,0.00567712,0.00010601747],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001448866,0.001070693,0.000011234766,0.0027142393,0.0015094011,0.0072502843,0.0050306018,0.000024240642,0.000025385576,0.000070522256,0.014813169,0.9660314],"study_design_scores_gemma":[0.002024715,0.0015972244,0.00001046061,0.0018618598,0.0048123994,0.09161047,0.0012879514,0.000026213705,0.0000041477415,0.000013838595,0.89651877,0.00023197493],"about_ca_topic_score_codex":0.000009087833,"about_ca_topic_score_gemma":7.013021e-7,"teacher_disagreement_score":0.9657994,"about_ca_system_score_codex":0.0012514044,"about_ca_system_score_gemma":0.004584558,"threshold_uncertainty_score":0.9999228},"labels":[],"label_agreement":null},{"id":"W2789266762","doi":"10.1177/1078155218760704","title":"ClotAssist: A program to treat cancer-associated thrombosis in an outpatient pharmacy setting","year":2018,"lang":"en","type":"article","venue":"Journal of Oncology Pharmacy Practice","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Thornhill Medical (Canada); University of Alberta","funders":"","keywords":"Medicine; Emergency department; Deep vein; Pharmacy; Cancer; Thrombosis; Venous thrombosis; Pharmacist; Patient education; Pulmonary embolism; Patient satisfaction; Intensive care medicine; Outpatient clinic; Emergency medicine; Internal medicine; Surgery; Nursing","score_opus":0.08972178726377769,"score_gpt":0.49879988555861304,"score_spread":0.4090780982948353,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2789266762","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9381788,0.00035208548,0.000020798867,0.05273059,0.0012383789,0.0012928315,0.000007881443,0.00005300131,0.0061256397],"genre_scores_gemma":[0.9760053,0.001477284,0.0050037736,0.016105203,0.0011029918,0.00015880635,0.000006057228,0.000047614463,0.00009292909],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9968241,0.00068380014,0.001037742,0.00032904284,0.00055485166,0.00057046436],"domain_scores_gemma":[0.99641633,0.0004668533,0.0012605105,0.00020981654,0.0011246729,0.00052182435],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0022071595,0.00026061398,0.00090894994,0.00043523437,0.00015614199,0.00006223665,0.00026739505,0.00008069368,0.00047946445],"category_scores_gemma":[0.0012096901,0.00022345701,0.00015973052,0.00063208,0.00009221764,0.00094556366,0.00011445533,0.00077813474,0.000039880077],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.006499771,0.046716593,0.1111212,0.00017282744,0.0017191957,0.0020828613,0.012000194,0.00011410672,0.017310126,0.00003590658,0.10016006,0.70206714],"study_design_scores_gemma":[0.018905425,0.01803483,0.06567839,0.0004128057,0.0038964623,0.0004074721,0.0020288853,0.0011164008,0.0074070715,0.000011704916,0.88173515,0.00036540118],"about_ca_topic_score_codex":0.0008096616,"about_ca_topic_score_gemma":0.00028574743,"teacher_disagreement_score":0.7815751,"about_ca_system_score_codex":0.0014676333,"about_ca_system_score_gemma":0.00085074524,"threshold_uncertainty_score":0.9112313},"labels":[],"label_agreement":null},{"id":"W2789751197","doi":"10.1177/1078155217752076","title":"Implementation of additional prescribing authorization among oncology pharmacists in Alberta","year":2018,"lang":"en","type":"article","venue":"Journal of Oncology Pharmacy Practice","topic":"Pharmaceutical Practices and Patient Outcomes","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Alberta; Alberta Health Services","funders":"","keywords":"Medicine; Prior authorization; Family medicine; Pharmacy; Descriptive statistics; Medical prescription; Pharmacist; Ambulatory care; Ambulatory; Nursing; Health care; Internal medicine","score_opus":0.15210245188081975,"score_gpt":0.5274901880963858,"score_spread":0.3753877362155661,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2789751197","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9327637,0.00019455627,0.0007582607,0.022480719,0.0025095695,0.0009296715,0.000063289444,0.000015240856,0.04028497],"genre_scores_gemma":[0.9912219,0.0004192929,0.0043930956,0.0028712507,0.0008623657,0.000013037354,0.000046728594,0.000019140369,0.00015320009],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.9967227,0.0010434736,0.0012909158,0.0001842503,0.00048011367,0.00027857168],"domain_scores_gemma":[0.99158555,0.004752351,0.002336757,0.00010257025,0.0009794504,0.00024333334],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.002330333,0.00015671711,0.00051809516,0.00037240368,0.00008233173,0.000012687542,0.00015136127,0.00010804869,0.0075445706],"category_scores_gemma":[0.0031901933,0.00013970742,0.0001317965,0.00038977576,0.00020703273,0.0018376238,0.00005967246,0.0010068762,0.000033738655],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.03664345,0.008491605,0.47984463,0.00034512032,0.0020435802,0.0018947923,0.0102113085,0.000077951685,0.056436006,0.001362597,0.10228872,0.30036023],"study_design_scores_gemma":[0.018493297,0.0042304806,0.020833397,0.00009819157,0.0012764335,0.0030402443,0.0015534586,0.002168758,0.020396331,0.00010774355,0.9276321,0.00016955675],"about_ca_topic_score_codex":0.00019402095,"about_ca_topic_score_gemma":0.00008449913,"teacher_disagreement_score":0.8253434,"about_ca_system_score_codex":0.00047678244,"about_ca_system_score_gemma":0.0011484653,"threshold_uncertainty_score":0.99336267},"labels":[],"label_agreement":null},{"id":"W2791012194","doi":"10.1177/1078155217752534","title":"Integration of clinical pharmacists into an ambulatory, pediatric hematology/oncology/transplant clinic","year":2018,"lang":"en","type":"article","venue":"Journal of Oncology Pharmacy Practice","topic":"Pharmaceutical Practices and Patient Outcomes","field":"Medicine","cited_by":16,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta; Alberta Health Services; Alberta Children's Hospital","funders":"","keywords":"Medicine; Pharmacist; Clinical pharmacy; Pharmacy; Outpatient clinic; Ambulatory; Internal medicine; Hematology; Family medicine; Oncology; Intensive care medicine","score_opus":0.3215229400368311,"score_gpt":0.6011754592993891,"score_spread":0.279652519262558,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2791012194","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96687907,0.0012633307,0.0010384402,0.010591182,0.006036168,0.00056070846,0.0000078958765,0.00003708141,0.013586096],"genre_scores_gemma":[0.9624104,0.007075067,0.018119482,0.008783509,0.003453088,0.0000060392504,0.000010202387,0.00003598562,0.000106230225],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.9922894,0.0027446167,0.0034972376,0.0003829659,0.0006766354,0.00040913688],"domain_scores_gemma":[0.9847213,0.0070978417,0.0051261084,0.0003315871,0.0019343048,0.0007888676],"candidate_categories":["research_integrity","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0093481215,0.00030702696,0.0015683944,0.00041356182,0.00013890483,0.000017669672,0.00042024386,0.00037284684,0.0012946995],"category_scores_gemma":[0.0056027323,0.00023748538,0.00048372903,0.00043246074,0.0005780317,0.0018757656,0.00007640424,0.0025856628,0.00021425028],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.1335932,0.025750842,0.5104487,0.00058135885,0.003003901,0.0059884847,0.0055714757,0.000005475794,0.031635642,0.00040605536,0.030181777,0.2528331],"study_design_scores_gemma":[0.03644788,0.028823547,0.01329185,0.00010657502,0.010569657,0.020893004,0.00094453694,0.0024478978,0.012959466,0.0003069252,0.87276775,0.00044091622],"about_ca_topic_score_codex":0.000017005832,"about_ca_topic_score_gemma":0.0000051887687,"teacher_disagreement_score":0.842586,"about_ca_system_score_codex":0.0002180383,"about_ca_system_score_gemma":0.0021589545,"threshold_uncertainty_score":0.9997154},"labels":[],"label_agreement":null},{"id":"W2800852263","doi":"10.1177/1078155218771461","title":"A case–control study analyzing mannitol dosing for prevention of cisplatin-induced acute nephrotoxicity","year":2018,"lang":"en","type":"article","venue":"Journal of Oncology Pharmacy Practice","topic":"Chemotherapy-induced organ toxicity mitigation","field":"Medicine","cited_by":17,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto General Hospital; University of Toronto; Princess Margaret Cancer Centre","funders":"University Health Network","keywords":"Nephrotoxicity; Medicine; Renal function; Urology; Dosing; Cisplatin; Mannitol; Odds ratio; Internal medicine; Toxicity; Chemotherapy; Chemistry","score_opus":0.07868815350006637,"score_gpt":0.4609149688159561,"score_spread":0.38222681531588976,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2800852263","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98381317,0.00006025288,0.00993441,0.0033619318,0.0004897773,0.0019333098,0.000008527394,0.000018421795,0.0003802163],"genre_scores_gemma":[0.98046035,0.000026046098,0.016984984,0.0009530448,0.0014744137,0.00001920034,0.000001297579,0.000038818966,0.00004182412],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99719363,0.0006725682,0.0012335932,0.00023307298,0.00039388004,0.00027324568],"domain_scores_gemma":[0.9933747,0.0015342081,0.0029100515,0.00022099384,0.0017746392,0.00018538462],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003120669,0.00020572134,0.00076407363,0.00037811004,0.00018582551,0.000026334932,0.00014330952,0.00012736555,0.00013616268],"category_scores_gemma":[0.001960881,0.00018825349,0.0002641668,0.00038485468,0.00008403459,0.0010006215,0.000028357183,0.00066136516,0.0000050321055],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.012228156,0.0029026913,0.0030826505,0.00005184407,0.002931922,0.0019250113,0.002373947,0.000003965466,0.91756666,0.000005280129,0.00038592063,0.05654195],"study_design_scores_gemma":[0.049785446,0.019505838,0.003817623,0.00015070294,0.010828378,0.054008316,0.0027858438,0.0017922691,0.8531257,0.000073791416,0.0038918857,0.0002342115],"about_ca_topic_score_codex":0.000025431607,"about_ca_topic_score_gemma":0.000015388792,"teacher_disagreement_score":0.064440966,"about_ca_system_score_codex":0.00045629233,"about_ca_system_score_gemma":0.00063268264,"threshold_uncertainty_score":0.7676754},"labels":[],"label_agreement":null},{"id":"W2801969419","doi":"10.1177/1078155218773862","title":"Surface contamination with ten antineoplastic drugs in 83 Canadian centers","year":2018,"lang":"en","type":"article","venue":"Journal of Oncology Pharmacy Practice","topic":"Safe Handling of Antineoplastic Drugs","field":"Health Professions","cited_by":51,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Université de Montréal; Institut de recherche Robert-Sauvé en santé et en sécurité du travail; Institut National de Santé Publique du Québec; Centre Hospitalier Universitaire Sainte-Justine","funders":"","keywords":"Medicine; Antineoplastic Drugs; Docetaxel; Pharmacy; Contamination; Ifosfamide; Vinorelbine; Cabazitaxel; Cytarabine; Internal medicine; Cancer; Pharmacology; Family medicine; Chemotherapy; Prostate cancer","score_opus":0.046898613899876714,"score_gpt":0.4504586978067135,"score_spread":0.4035600839068368,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2801969419","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9270167,0.00007166088,0.00032947073,0.02450453,0.003300136,0.00037635225,0.0000070393808,0.00001802773,0.044376127],"genre_scores_gemma":[0.98939556,0.00014441776,0.0041050166,0.00485198,0.00087851286,0.0000038113915,0.0000031601223,0.000032815802,0.000584703],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.99646324,0.0012829129,0.0009884284,0.0002050639,0.00038934444,0.0006710218],"domain_scores_gemma":[0.9899337,0.006257151,0.0016589737,0.00014211095,0.0016003241,0.0004077164],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0036142112,0.0001898528,0.00046225954,0.00046579662,0.00038141935,0.000015604899,0.00029313038,0.00014063137,0.00047980555],"category_scores_gemma":[0.0036568327,0.00015364346,0.00004586227,0.00046266397,0.00016612005,0.00094340043,0.000045761113,0.0015924285,0.00031134015],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.012566638,0.00093434483,0.89881057,0.00014997394,0.0004936575,0.0023573516,0.026285736,0.0002806673,0.0022314664,0.000335347,0.04678428,0.008769985],"study_design_scores_gemma":[0.020252531,0.0018670234,0.10479613,0.0006609515,0.00045394732,0.0013938624,0.01585231,0.0014532107,0.00036261443,0.00002075512,0.8525603,0.000326372],"about_ca_topic_score_codex":0.01932756,"about_ca_topic_score_gemma":0.042499997,"teacher_disagreement_score":0.805776,"about_ca_system_score_codex":0.0009833379,"about_ca_system_score_gemma":0.0082489215,"threshold_uncertainty_score":0.9973734},"labels":[],"label_agreement":null},{"id":"W2803561168","doi":"10.1177/1078155218774871","title":"Capecitabine-induced myopericarditis – A case report and review of literature","year":2018,"lang":"en","type":"review","venue":"Journal of Oncology Pharmacy Practice","topic":"Colorectal Cancer Treatments and Studies","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Alberta Health Services","funders":"","keywords":"Capecitabine; Medicine; Myopericarditis; Oxaliplatin; Discontinuation; Internal medicine; Cardiotoxicity; Exemestane; Oncology; Surgery; Colorectal cancer; Chemotherapy; Cancer; Pericarditis; Tamoxifen; Breast cancer","score_opus":0.10637401030030615,"score_gpt":0.501616162044704,"score_spread":0.3952421517443979,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2803561168","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0000761581,0.9855772,0.0000011043688,0.0024410423,0.0010269072,0.0008224574,0.000030628547,0.000006090547,0.010018394],"genre_scores_gemma":[0.000032150547,0.99564815,0.0014242479,0.001183287,0.001353708,0.000040065326,0.000013569019,0.00003502828,0.00026978436],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99668986,0.0006529867,0.0018023713,0.00029120315,0.00036145805,0.00020213347],"domain_scores_gemma":[0.9916548,0.0012312613,0.0047060093,0.00027610868,0.0019029836,0.00022883515],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001808965,0.0003782779,0.0038965347,0.00022617738,0.00008077919,0.00001637675,0.00010258641,0.00017407369,0.00013667397],"category_scores_gemma":[0.003814962,0.00023546373,0.0007345628,0.00046390094,0.0001259671,0.00032393704,0.0001081753,0.0011252958,0.0000048639645],"study_design_candidate":"case_report","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002775526,0.0002957397,0.0000028096974,0.038524486,0.0028482932,0.3746039,0.00014102577,1.135025e-9,0.0000010852692,0.0000011186818,0.022939602,0.56036437],"study_design_scores_gemma":[0.0009275889,0.0014035769,0.0000011206608,0.043797903,0.014027555,0.45567143,0.000037305097,6.8336384e-8,0.000001081129,5.207549e-7,0.48405465,0.00007720648],"about_ca_topic_score_codex":0.000026185011,"about_ca_topic_score_gemma":0.0000021648036,"teacher_disagreement_score":0.5602872,"about_ca_system_score_codex":0.00051449036,"about_ca_system_score_gemma":0.0021865559,"threshold_uncertainty_score":0.9601932},"labels":[],"label_agreement":null},{"id":"W2809872660","doi":"10.1177/1078155218784716","title":"Real world evidence: Abiraterone use post-docetaxel in metastatic castrate-resistant prostate cancer","year":2018,"lang":"en","type":"article","venue":"Journal of Oncology Pharmacy Practice","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Docetaxel; Medicine; Abiraterone; Prostate cancer; Context (archaeology); Oncology; Pharmacy; Abiraterone acetate; Internal medicine; Clinical trial; Chemotherapy; Cancer; Family medicine; Androgen deprivation therapy","score_opus":0.1885419126451846,"score_gpt":0.5200089429495252,"score_spread":0.33146703030434055,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2809872660","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9529263,0.0037634731,0.0000051177944,0.03994021,0.00074016233,0.00073501415,0.000023926712,0.000014920692,0.0018509106],"genre_scores_gemma":[0.9671994,0.021055339,0.004035826,0.002374852,0.0006952279,0.000049543505,0.0000049388877,0.000041091847,0.0045438227],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.99668294,0.00078465877,0.0010040812,0.00028514024,0.0006661339,0.00057703874],"domain_scores_gemma":[0.99474955,0.0014990655,0.0010338218,0.00020602156,0.0021184064,0.0003931504],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0023801355,0.00024415765,0.0006937977,0.0006073883,0.000116045994,0.00008464833,0.00019524698,0.000051561736,0.0007079155],"category_scores_gemma":[0.0013519659,0.00017299454,0.00012407848,0.00074466213,0.00034982138,0.002421927,0.00006673432,0.0011171061,0.000058792582],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.23930691,0.0052868365,0.10418909,0.0005070642,0.002974414,0.045134503,0.006592746,0.000056361987,0.5237188,0.000056814006,0.021639626,0.050536826],"study_design_scores_gemma":[0.06851525,0.02688627,0.15406136,0.0027100316,0.0057793255,0.008888084,0.0042857244,0.0005187572,0.086992756,0.000103761144,0.64046293,0.0007957227],"about_ca_topic_score_codex":0.0030916422,"about_ca_topic_score_gemma":0.0013450218,"teacher_disagreement_score":0.61882335,"about_ca_system_score_codex":0.0015076833,"about_ca_system_score_gemma":0.0045735464,"threshold_uncertainty_score":0.8113275},"labels":[],"label_agreement":null},{"id":"W2809947581","doi":"10.1177/1078155218783238","title":"The use of sacubitril/valsartan in anthracycline-induced cardiomyopathy: A mini case series","year":2018,"lang":"en","type":"article","venue":"Journal of Oncology Pharmacy Practice","topic":"Chemotherapy-induced cardiotoxicity and mitigation","field":"Medicine","cited_by":34,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Alberta Health Services","funders":"","keywords":"Sacubitril, Valsartan; Medicine; Valsartan; Anthracycline; Cardiomyopathy; Sacubitril; Internal medicine; Heart failure; Cardiology; Pharmacology; Cancer; Blood pressure","score_opus":0.12280379569286283,"score_gpt":0.4354991659880195,"score_spread":0.3126953702951567,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2809947581","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9828131,0.0005071611,0.000099268436,0.014079728,0.0009307669,0.00033565148,0.000004401096,0.000008652154,0.0012212405],"genre_scores_gemma":[0.9913712,0.0018127314,0.0035944984,0.0018732306,0.0012210528,0.000003956482,0.0000010108619,0.00002172046,0.00010060178],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.99755764,0.0007260701,0.0009586415,0.00015110639,0.0003603021,0.0002462304],"domain_scores_gemma":[0.9947249,0.002370711,0.0013273194,0.000251622,0.0011758223,0.00014958356],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0025306328,0.00015603275,0.0007572437,0.0001998964,0.00014959965,0.00003149494,0.00012187263,0.00012412871,0.000030364517],"category_scores_gemma":[0.0040167533,0.00011310583,0.00021908912,0.00038938478,0.000273612,0.0012221404,0.00003660792,0.00077630306,0.0000056303397],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.012521418,0.00075752946,0.0022408597,0.00004372565,0.00066559203,0.015178513,0.0031068106,0.000012997795,0.8924911,0.00005874646,0.0033786143,0.069544084],"study_design_scores_gemma":[0.0063522505,0.0019289372,0.00042344237,0.00007809476,0.0006592571,0.16923897,0.00244835,0.00009873992,0.40117985,0.000026648873,0.41746598,0.00009946748],"about_ca_topic_score_codex":0.00012009764,"about_ca_topic_score_gemma":0.00007403695,"teacher_disagreement_score":0.49131125,"about_ca_system_score_codex":0.00025476312,"about_ca_system_score_gemma":0.0009704225,"threshold_uncertainty_score":0.48087192},"labels":[],"label_agreement":null},{"id":"W2810807790","doi":"10.1177/1078155218784760","title":"Efficacy of bevacizumab and temozolomide therapy in locally advanced, recurrent, and metastatic malignant solitary fibrous tumour: A population-based analysis","year":2018,"lang":"en","type":"article","venue":"Journal of Oncology Pharmacy Practice","topic":"Soft tissue tumor case studies","field":"Medicine","cited_by":23,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Medicine; Temozolomide; Bevacizumab; Solitary fibrous tumor; Regimen; Progression-free survival; Population; Surgery; Internal medicine; Oncology; Chemotherapy","score_opus":0.04501833263111176,"score_gpt":0.41924313128775564,"score_spread":0.3742247986566439,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2810807790","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9843166,0.009827337,0.0001847888,0.0049515474,0.00015991519,0.0003850054,0.00000704991,0.000008979694,0.00015881464],"genre_scores_gemma":[0.9803678,0.002933995,0.015675468,0.0008467956,0.00013673902,0.00000670451,0.000004420244,0.000017393058,0.000010712103],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9976953,0.0005446219,0.0009798786,0.00022792535,0.0003197114,0.00023250653],"domain_scores_gemma":[0.9946756,0.0031468598,0.001275381,0.00014541789,0.0005917022,0.00016507426],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001452051,0.00019217067,0.0009906801,0.00063445256,0.00007166259,0.000009296659,0.00008150942,0.000037074842,0.000056558016],"category_scores_gemma":[0.0027914282,0.00015213378,0.00013244525,0.0006219179,0.00023675333,0.00038096844,0.000039943756,0.00041006092,0.0000018501803],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.13747074,0.005408683,0.4313857,0.00044712136,0.009838658,0.007847305,0.00514952,0.0005280535,0.024635859,0.000054463206,0.0008151828,0.3764187],"study_design_scores_gemma":[0.107506014,0.026776846,0.7884577,0.0007040975,0.018283704,0.014464998,0.0037117132,0.005874518,0.0076286746,0.00022384043,0.02574216,0.00062572636],"about_ca_topic_score_codex":0.00020244013,"about_ca_topic_score_gemma":0.000073015726,"teacher_disagreement_score":0.37579298,"about_ca_system_score_codex":0.00019043902,"about_ca_system_score_gemma":0.00039839122,"threshold_uncertainty_score":0.62038356},"labels":[],"label_agreement":null},{"id":"W2887065191","doi":"10.1177/1078155218790801","title":"Patient monitoring programs in oncology pharmacy practice: A survey of oncology pharmacists in Atlantic Canada","year":2018,"lang":"en","type":"article","venue":"Journal of Oncology Pharmacy Practice","topic":"Medication Adherence and Compliance","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Augmentium Pharma Consulting (Canada); Dr. H. Bliss Murphy Cancer Centre; Memorial University of Newfoundland","funders":"","keywords":"Medicine; Respondent; Pharmacy; Staffing; Family medicine; Pharmacist; Gynecologic oncology; Pharmacy technician; Oncology; Nursing","score_opus":0.19264057973995066,"score_gpt":0.4929369162646226,"score_spread":0.3002963365246719,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2887065191","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95977217,0.0012368113,0.000049942304,0.019347142,0.0035068335,0.00097402185,0.0000051671177,0.000014027489,0.015093882],"genre_scores_gemma":[0.98616296,0.003664973,0.004309999,0.004928699,0.0007199138,0.00005797512,0.000010687103,0.000031105556,0.0001136591],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.99268854,0.0029883983,0.0023457746,0.00039091535,0.0009302814,0.0006560669],"domain_scores_gemma":[0.9874628,0.0049180673,0.004009199,0.00029488764,0.002800113,0.0005149039],"candidate_categories":["metaresearch","metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0059281313,0.0003038913,0.001241243,0.00045228572,0.00007481011,0.000015371843,0.00043508958,0.00016048909,0.0005528952],"category_scores_gemma":[0.00854503,0.00027813276,0.00009711177,0.0011469893,0.00031485478,0.0009380953,0.00012209918,0.0021557251,0.000065699125],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.030139603,0.010389391,0.45861718,0.00017290266,0.0006228901,0.012660167,0.003587471,0.000024418072,0.008656509,0.000012579809,0.022133648,0.45298323],"study_design_scores_gemma":[0.022713268,0.0059580375,0.028838424,0.00030433948,0.0005036438,0.012130277,0.0029750806,0.00045291233,0.0036876223,0.00000859525,0.92217755,0.0002502498],"about_ca_topic_score_codex":0.12293031,"about_ca_topic_score_gemma":0.027442306,"teacher_disagreement_score":0.9000439,"about_ca_system_score_codex":0.0029083958,"about_ca_system_score_gemma":0.017302744,"threshold_uncertainty_score":0.9999671},"labels":[],"label_agreement":null},{"id":"W2888297957","doi":"10.1177/1078155218792985","title":"Evaluation of laboratory disturbance risk when adding low-dose cotrimoxazole for PJP prophylaxis to regimens of high-grade glioma patients taking RAAS inhibitors","year":2018,"lang":"en","type":"article","venue":"Journal of Oncology Pharmacy Practice","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Alberta Health Services","funders":"","keywords":"Medicine; Renin–angiotensin system; Internal medicine; Aldosterone; Endocrinology; Urology; Blood pressure","score_opus":0.04978829066442618,"score_gpt":0.4044276425102027,"score_spread":0.3546393518457765,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2888297957","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.994521,0.0007421398,0.00007601448,0.0019573432,0.0011267195,0.001293419,0.0000743422,0.0000071221925,0.0002018701],"genre_scores_gemma":[0.98822767,0.00011752223,0.010617619,0.0002937241,0.00064347574,0.00005948986,0.00000747736,0.000027289852,0.0000057395982],"study_design_codex":"design_other","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9967662,0.00073748664,0.0010128819,0.00022811143,0.0010121055,0.00024322388],"domain_scores_gemma":[0.9876613,0.0012819902,0.004213759,0.00021769902,0.006417842,0.00020739158],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.003722803,0.00018582573,0.0006326033,0.0003864087,0.00010966036,0.00001228734,0.00013717767,0.00009195534,0.00006853466],"category_scores_gemma":[0.009047806,0.00013878845,0.00015377709,0.00044851305,0.00011713628,0.00053700944,0.00004999405,0.0003007196,0.000006446159],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.03295036,0.028789567,0.14638194,0.00050604256,0.0052889395,0.0003921717,0.00861507,0.0004439429,0.29575452,0.00007948841,0.058617778,0.42218018],"study_design_scores_gemma":[0.053256985,0.019938912,0.04735604,0.00066026306,0.008385472,0.00018778541,0.00069601,0.0004236006,0.7893865,0.0001276,0.07932292,0.00025790007],"about_ca_topic_score_codex":0.00009588814,"about_ca_topic_score_gemma":0.0000097107995,"teacher_disagreement_score":0.493632,"about_ca_system_score_codex":0.0007316251,"about_ca_system_score_gemma":0.0009539899,"threshold_uncertainty_score":0.9992994},"labels":[],"label_agreement":null},{"id":"W2892317516","doi":"10.1177/1078155218796182","title":"Developing recommendations for the safe handling of oral anti-cancer drugs in community pharmacies: A pan-Canadian consensus approach","year":2018,"lang":"en","type":"review","venue":"Journal of Oncology Pharmacy Practice","topic":"Pharmaceutical Practices and Patient Outcomes","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"CancerCare Manitoba; St. John’s Health Sciences Centre; Neighbourhood Pharmacy Association of Canada; Ministère de la Santé et des Services Sociaux (Québec); Canadian Pharmacists Association; Cancer Care Ontario; University of Toronto","funders":"Association des pharmaciens du Canada","keywords":"Medicine; Pharmacy; Delphi method; Grey literature; Delphi; Medical education; Relevance (law); Family medicine; MEDLINE; Political science; Computer science","score_opus":0.5862096122925438,"score_gpt":0.5982760421431328,"score_spread":0.012066429850589033,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2892317516","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00032729725,0.9644703,0.00035818943,0.027472597,0.0020499548,0.002413098,0.00013781033,0.000008472612,0.002762251],"genre_scores_gemma":[0.00097594596,0.975268,0.018444661,0.0045487927,0.00046919705,0.00009796963,0.00004027022,0.00005227457,0.000102880855],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9934851,0.0031822491,0.0022465992,0.00021919975,0.00035589264,0.00051098765],"domain_scores_gemma":[0.9717368,0.022082128,0.004418075,0.0002984394,0.001137606,0.00032694833],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.009473174,0.00040065643,0.002323836,0.0006315863,0.00043856763,0.00004291075,0.0006119482,0.00024132097,0.00018235866],"category_scores_gemma":[0.0052310815,0.00026699578,0.0006084835,0.0006790664,0.00032267347,0.0004888406,0.00012096664,0.003841127,0.000009960434],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016750309,0.0013021126,0.0002827358,0.00910299,0.0038641524,0.00005057903,0.00178161,0.000007529212,0.000007960485,0.000083221224,0.013421093,0.968421],"study_design_scores_gemma":[0.0056710243,0.00037287312,0.000008274501,0.0031331622,0.009864857,0.0015151448,0.0018360814,0.00041189516,0.000024615149,0.000012500999,0.9769101,0.00023944082],"about_ca_topic_score_codex":0.0038999838,"about_ca_topic_score_gemma":0.00042442794,"teacher_disagreement_score":0.96818155,"about_ca_system_score_codex":0.0013274532,"about_ca_system_score_gemma":0.008536992,"threshold_uncertainty_score":0.99997824},"labels":[],"label_agreement":null},{"id":"W2896528559","doi":"10.1177/1078155218804293","title":"Risk of pulmonary toxicity of bleomycin and filgrastim","year":2018,"lang":"en","type":"article","venue":"Journal of Oncology Pharmacy Practice","topic":"Neutropenia and Cancer Infections","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval; The Quebec Population Health Research Network; Centre intégré universitaire de santé et de services sociaux de la Mauricie-et-du-Centre-du-Québec; Centre intégré de santé et de services sociaux de Chaudière-Appalaches","funders":"","keywords":"Medicine; Filgrastim; Pulmonary toxicity; Bleomycin; Internal medicine; Toxicity; Odds ratio; Etoposide; Concomitant; Lung cancer; Chemotherapy; Surgery; Oncology; Gastroenterology; Neutropenia","score_opus":0.03659143879223954,"score_gpt":0.41773289620522913,"score_spread":0.3811414574129896,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2896528559","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96849155,0.00068732275,0.0002908965,0.0048314934,0.0005385394,0.00013460645,0.000008928767,0.0000046197056,0.02501201],"genre_scores_gemma":[0.9926712,0.0027246906,0.0030054164,0.00089892076,0.0005691829,0.0000016048948,3.6698503e-7,0.000008757618,0.0001198744],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.9987725,0.00027981176,0.0005459992,0.00009066977,0.00019534412,0.00011565394],"domain_scores_gemma":[0.9963849,0.00085463363,0.0014210079,0.0001067934,0.0011001806,0.0001324794],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010156214,0.000083552986,0.00040864074,0.00014347752,0.00005731943,0.0000032907608,0.000073895295,0.00005215342,0.0004162272],"category_scores_gemma":[0.0011096201,0.000066214656,0.000093682764,0.00018399395,0.0002640324,0.00036061357,0.000038334467,0.0005058631,0.00000577481],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.017782168,0.0034747564,0.1569392,0.00018635172,0.0016329957,0.0006556975,0.00086524535,0.00001978251,0.69140923,0.00010068605,0.01882357,0.10811032],"study_design_scores_gemma":[0.009062138,0.00789964,0.051272795,0.00013841868,0.004592749,0.022251554,0.0007855471,0.00022587526,0.2911685,0.00016861153,0.61230123,0.00013289442],"about_ca_topic_score_codex":0.00006685965,"about_ca_topic_score_gemma":0.0000055493842,"teacher_disagreement_score":0.59347767,"about_ca_system_score_codex":0.00006946575,"about_ca_system_score_gemma":0.00047887457,"threshold_uncertainty_score":0.4557396},"labels":[],"label_agreement":null},{"id":"W2898849184","doi":"10.1177/1078155218808354","title":"Centralized preparation of chemotherapy for remote administration","year":2018,"lang":"en","type":"article","venue":"Journal of Oncology Pharmacy Practice","topic":"Safe Handling of Antineoplastic Drugs","field":"Health Professions","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Alberta Health Services","funders":"","keywords":"Medicine; Pharmacy; Service delivery framework; Service (business); Operations management; Nursing; Business; Engineering; Marketing","score_opus":0.1134769843646694,"score_gpt":0.5759547935993498,"score_spread":0.46247780923468035,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2898849184","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.84946996,0.00018384698,0.06344209,0.04927436,0.008094315,0.0016050306,0.000015898164,0.000038590155,0.027875928],"genre_scores_gemma":[0.89943993,0.00047349127,0.09252592,0.003934501,0.0028971417,0.0000064363844,0.0000048881743,0.000025248028,0.00069244485],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9975056,0.0007072019,0.00117119,0.000119394645,0.00024335092,0.00025323796],"domain_scores_gemma":[0.9891733,0.0050502354,0.0033727167,0.0001224984,0.0021763148,0.00010495494],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0032920286,0.00010516314,0.0003672831,0.00011256006,0.00022887628,0.000005558138,0.00016662573,0.00012068317,0.0003734338],"category_scores_gemma":[0.0051819044,0.000090642556,0.000100645106,0.0001331471,0.00009765231,0.0005682764,0.000017506914,0.00043265504,0.000033754324],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.27477887,0.0035875186,0.0066559855,0.0007941725,0.0018127192,0.00010156359,0.031835865,0.000048492424,0.21103753,0.0027366988,0.31210333,0.15450725],"study_design_scores_gemma":[0.013382115,0.0033240912,0.00056770456,0.00012178464,0.00034779447,0.00020349844,0.0010551083,0.0014933866,0.022537135,0.00033996892,0.95653826,0.00008917905],"about_ca_topic_score_codex":0.000023324605,"about_ca_topic_score_gemma":0.000014437492,"teacher_disagreement_score":0.64443487,"about_ca_system_score_codex":0.0001575326,"about_ca_system_score_gemma":0.0031379496,"threshold_uncertainty_score":0.6203598},"labels":[],"label_agreement":null},{"id":"W2901645458","doi":"10.1177/1078155218812945","title":"A case of severe, irreversible hypocalcemia after one dose of pamidronate administered for hypercalcemia of malignancy","year":2018,"lang":"en","type":"article","venue":"Journal of Oncology Pharmacy Practice","topic":"Bone health and treatments","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Bisphosphonate; Malignancy; vitamin D deficiency; Incidence (geometry); Vitamin D and neurology; Cancer; Internal medicine; Osteoporosis; Gastroenterology; Surgery","score_opus":0.10198953141690957,"score_gpt":0.4462119020234829,"score_spread":0.3442223706065733,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2901645458","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9903224,0.001094981,0.0001242892,0.0026939157,0.0005517713,0.0006809729,0.000073553434,0.0000053053514,0.0044528088],"genre_scores_gemma":[0.961837,0.0005450866,0.035671834,0.0013199138,0.0001793746,0.000016816595,0.0000034150637,0.00002397597,0.0004026102],"study_design_codex":"randomized_trial","study_design_gemma":"case_report","domain_scores_codex":[0.99764043,0.00025643225,0.001342389,0.00017302383,0.0002877868,0.00029991046],"domain_scores_gemma":[0.9939525,0.0013511606,0.00245962,0.00023423524,0.0016823835,0.00032010122],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010695639,0.00017443881,0.00094624644,0.00024163314,0.00004686475,0.0000026852663,0.000111173365,0.00014893089,0.00031422343],"category_scores_gemma":[0.0010872104,0.00014542835,0.00025142732,0.00022969511,0.0002461077,0.00041678268,0.000048783597,0.00036180147,0.000009244075],"study_design_candidate":"randomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.50031066,0.03161486,0.058269925,0.006579784,0.008094486,0.03716082,0.0050472096,0.00000634249,0.096692346,0.00018751904,0.017083779,0.23895225],"study_design_scores_gemma":[0.17618021,0.078172125,0.021344502,0.0020682078,0.019950276,0.30880424,0.0019740753,0.00034096368,0.12882659,0.0006229499,0.26106304,0.0006528145],"about_ca_topic_score_codex":0.000119214936,"about_ca_topic_score_gemma":0.00001510095,"teacher_disagreement_score":0.32413045,"about_ca_system_score_codex":0.00020599579,"about_ca_system_score_gemma":0.001677728,"threshold_uncertainty_score":0.5930396},"labels":[],"label_agreement":null},{"id":"W2913849805","doi":"10.1177/1078155219828806","title":"Relative bioavailability of an extemporaneously prepared aprepitant oral suspension in healthy adults","year":2019,"lang":"en","type":"article","venue":"Journal of Oncology Pharmacy Practice","topic":"Nausea and vomiting management","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Health Sciences Centre; Sunnybrook Health Science Centre; Institute for Clinical Evaluative Sciences; Pediatric Oncology Group; University of Toronto; SickKids Foundation; Hospital for Sick Children","funders":"Garron Family Cancer Centre; Hospital for Sick Children; Pediatric Oncology Group of Ontario","keywords":"Aprepitant; Bioavailability; Bioequivalence; Capsule; Medicine; Pharmacokinetics; Nausea; Pharmacology; Vomiting; Crossover study; Chemotherapy-induced nausea and vomiting; Cmax; Anesthesia; Antiemetic; Placebo; Pathology","score_opus":0.0467665615634192,"score_gpt":0.4289969711107242,"score_spread":0.38223040954730503,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2913849805","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98413444,0.0003217516,0.000016921533,0.007218559,0.000528248,0.00079304154,0.0000019273007,0.000012049122,0.006973067],"genre_scores_gemma":[0.9910425,0.00041195485,0.0069775376,0.0013137984,0.00011482164,0.000002851509,0.0000033468507,0.000016105758,0.00011708544],"study_design_codex":"randomized_trial","study_design_gemma":"not_applicable","domain_scores_codex":[0.99679536,0.0011122605,0.0011783856,0.00025558783,0.00041855077,0.00023988211],"domain_scores_gemma":[0.995478,0.0014113893,0.0018741909,0.00028775953,0.0007436962,0.0002049952],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0044490895,0.00014211486,0.00068941107,0.00027196226,0.000028969862,0.0000070519036,0.0001479571,0.0000904163,0.0002757232],"category_scores_gemma":[0.0022734227,0.000116602765,0.000113006216,0.00027030465,0.000079708916,0.0009729255,0.00006489132,0.0007949597,0.0000319112],"study_design_candidate":"randomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.67102206,0.021821119,0.1512685,0.0013675345,0.0011869683,0.009871638,0.013117054,0.000296281,0.051648166,0.00038845115,0.0039992887,0.074012935],"study_design_scores_gemma":[0.19584714,0.13919918,0.08366213,0.0018486178,0.0032405728,0.018568007,0.020792693,0.008463863,0.014574973,0.00084416167,0.5120172,0.0009414544],"about_ca_topic_score_codex":0.00022028516,"about_ca_topic_score_gemma":0.00003757937,"teacher_disagreement_score":0.5080179,"about_ca_system_score_codex":0.00047429532,"about_ca_system_score_gemma":0.000772028,"threshold_uncertainty_score":0.47549227},"labels":[],"label_agreement":null},{"id":"W2925036534","doi":"10.1177/1078155219837333","title":"Survival outcomes associated with different sunitinib dosing regimens in metastatic renal cell carcinoma","year":2019,"lang":"en","type":"article","venue":"Journal of Oncology Pharmacy Practice","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Dosing; Medicine; Sunitinib; Renal cell carcinoma; Discontinuation; Internal medicine; Surgery","score_opus":0.07079760148535519,"score_gpt":0.37716953225057115,"score_spread":0.30637193076521596,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2925036534","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97911274,0.00045540187,0.000020976524,0.0057619493,0.0005197248,0.0005395889,0.0000044402536,0.0000129362215,0.013572236],"genre_scores_gemma":[0.9962526,0.000105585226,0.0013251461,0.0010849173,0.00009995348,0.000007955023,0.000011009642,0.00004574042,0.0010670794],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9962571,0.001293698,0.00095251005,0.00026169367,0.000779047,0.00045589596],"domain_scores_gemma":[0.9932981,0.0037990264,0.001781254,0.00024721347,0.00057336624,0.0003010153],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0017336548,0.00032405424,0.0012492889,0.00040753995,0.000052600844,0.00002915824,0.00017062413,0.000076273296,0.00029584765],"category_scores_gemma":[0.0007455669,0.0002129606,0.0002193533,0.00030774347,0.00007360526,0.00054637605,0.000054498818,0.0012678755,0.000030507625],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0102329925,0.0056600748,0.93983805,0.00009259028,0.0013151658,0.016994309,0.001075767,0.00011781168,0.022962734,0.000022868926,0.0004998531,0.0011877933],"study_design_scores_gemma":[0.07196965,0.010523339,0.86082727,0.00024918327,0.005107353,0.006871654,0.0025188706,0.00016996305,0.02726003,0.000017110347,0.014086119,0.00039948113],"about_ca_topic_score_codex":0.00009595066,"about_ca_topic_score_gemma":0.000036095145,"teacher_disagreement_score":0.07901079,"about_ca_system_score_codex":0.0013395845,"about_ca_system_score_gemma":0.0009430614,"threshold_uncertainty_score":0.8684282},"labels":[],"label_agreement":null},{"id":"W2934475215","doi":"10.1177/1078155219839458","title":"Lanreotide vs octreotide LAR for patients with advanced gastroenteropancreatic neuroendocrine tumors: An observational time and motion analysis","year":2019,"lang":"en","type":"article","venue":"Journal of Oncology Pharmacy Practice","topic":"Neuroendocrine Tumor Research Advances","field":"Medicine","cited_by":19,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Augmentium Pharma Consulting (Canada)","funders":"Ipsen Biopharmaceuticals","keywords":"Medicine; Lanreotide; Octreotide; Neuroendocrine tumors; Observational study; Internal medicine; Neuroendocrine carcinoma; Oncology; Somatostatin; Gastroenterology; Growth hormone; Acromegaly; Carcinoma; Hormone","score_opus":0.0331734117751259,"score_gpt":0.3898444417554972,"score_spread":0.3566710299803713,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2934475215","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99237245,0.00006732155,0.00017191943,0.006169995,0.000102771235,0.00087996945,0.000028130818,0.000019435072,0.00018800891],"genre_scores_gemma":[0.9748073,0.0001788942,0.022289569,0.002066003,0.00015837538,0.000020695668,0.0000871592,0.000039256545,0.00035274477],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9976156,0.00041907007,0.00064972637,0.00031608506,0.0005975039,0.00040203857],"domain_scores_gemma":[0.9958386,0.0012946291,0.0010796526,0.00022122785,0.001201517,0.00036437798],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00045568022,0.00021236757,0.0007634492,0.00043928451,0.00007124559,0.00003474448,0.00016051583,0.000005484412,0.00016245486],"category_scores_gemma":[0.0016781942,0.00016462494,0.0001339006,0.00039310977,0.000077331846,0.0021463498,0.00004906154,0.0005129748,0.00001499019],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.04733376,0.0028678766,0.93149614,0.00015529721,0.0015292164,0.0030535099,0.00004404169,0.0016728104,0.0070453184,0.000018689168,0.00049659883,0.0042867344],"study_design_scores_gemma":[0.06943728,0.05714957,0.7207623,0.00019743733,0.008695079,0.022359744,0.00028465973,0.010134865,0.0033366398,0.00005358773,0.10715939,0.00042944468],"about_ca_topic_score_codex":0.00001248008,"about_ca_topic_score_gemma":0.0000055250534,"teacher_disagreement_score":0.21073385,"about_ca_system_score_codex":0.00017405885,"about_ca_system_score_gemma":0.0002463002,"threshold_uncertainty_score":0.67132103},"labels":[],"label_agreement":null},{"id":"W2937090821","doi":"10.1177/1078155219842329","title":"Impact of the introduction of novel hormonal agents on metastatic castration-resistant prostate cancer treatment choice","year":2019,"lang":"en","type":"article","venue":"Journal of Oncology Pharmacy Practice","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"McGill University; McGill University Health Centre; Université de Montréal","funders":"Réseau de cancérologie Rossy","keywords":"Medicine; Docetaxel; Enzalutamide; Prostate cancer; Internal medicine; Cohort; Abiraterone acetate; Oncology; Medical prescription; Cancer; Hormonal therapy; Androgen deprivation therapy; Pharmacology","score_opus":0.11467175331138577,"score_gpt":0.49921140993396806,"score_spread":0.38453965662258227,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2937090821","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98367566,0.0008489936,0.000003005899,0.013316661,0.0005203048,0.00077836914,0.000053643245,0.0000024797957,0.0008009006],"genre_scores_gemma":[0.9958836,0.002073133,0.00043188082,0.00014695335,0.00036228425,0.000016572143,0.000007067061,0.000014921221,0.0010635997],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.998299,0.00021313132,0.0006004194,0.00014541898,0.0005424612,0.0001995494],"domain_scores_gemma":[0.99693424,0.00049720454,0.00143535,0.00018657075,0.0008310227,0.00011563234],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006086232,0.00015163497,0.00047168208,0.00015872697,0.000048443082,0.000008657999,0.00011105904,0.000032798136,0.00038275262],"category_scores_gemma":[0.000312183,0.00007852469,0.00026814244,0.00026943383,0.00010072794,0.0003658627,0.000021320227,0.0003754697,0.000005086812],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.057724748,0.011412775,0.086453,0.00019826871,0.0071143582,0.00015267968,0.0017124593,0.0037741454,0.79927814,0.000034754456,0.006962132,0.025182517],"study_design_scores_gemma":[0.08703526,0.048681557,0.4944979,0.00033307105,0.006620013,0.0021925978,0.0010984626,0.0009790922,0.15990034,0.000019055396,0.19837059,0.000272045],"about_ca_topic_score_codex":0.00053256005,"about_ca_topic_score_gemma":0.000013806018,"teacher_disagreement_score":0.63937783,"about_ca_system_score_codex":0.0013547613,"about_ca_system_score_gemma":0.0025540467,"threshold_uncertainty_score":0.45307693},"labels":[],"label_agreement":null},{"id":"W2940319705","doi":"10.1177/1078155219843675","title":"Optimizing patient education of oncology medications: A quantitative analysis of the patient perspective","year":2019,"lang":"en","type":"article","venue":"Journal of Oncology Pharmacy Practice","topic":"Medication Adherence and Compliance","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Aberdeen Regional Hospital; Nova Scotia Health Authority","funders":"","keywords":"Medicine; Pharmacist; Family medicine; Patient education; Internal medicine; Oncology; Nursing; Pharmacy","score_opus":0.07104078666103733,"score_gpt":0.47626981778101385,"score_spread":0.40522903111997655,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2940319705","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.87808615,0.003487774,0.000950893,0.04178005,0.0014626775,0.0008790791,0.000008278883,0.00000608708,0.07333904],"genre_scores_gemma":[0.97829676,0.0010070597,0.01658817,0.0038356448,0.000054188105,0.000020306506,0.0000030845194,0.000007466263,0.00018732391],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9974684,0.0006828634,0.0010129279,0.00015336044,0.0005607372,0.00012168479],"domain_scores_gemma":[0.9904007,0.0016961492,0.00435019,0.0002790875,0.0031507541,0.00012313518],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00096239476,0.00010187615,0.00062038936,0.00039508042,0.000045050325,0.0000033982924,0.00021983252,0.00006846624,0.0009522862],"category_scores_gemma":[0.002712192,0.00006985504,0.00025264395,0.0010454776,0.0001838331,0.00031032326,0.000050030827,0.00054505887,0.0000310607],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.021638185,0.0432303,0.05875844,0.0004961446,0.040929254,0.000122184,0.20415679,0.005581847,0.120953254,0.031002395,0.045993414,0.4271378],"study_design_scores_gemma":[0.0070653465,0.01387155,0.01821816,0.0006715773,0.02347633,0.001196601,0.26868612,0.0059901224,0.01410327,0.00040978717,0.64603317,0.00027795954],"about_ca_topic_score_codex":0.00009411175,"about_ca_topic_score_gemma":0.0000030824876,"teacher_disagreement_score":0.6000398,"about_ca_system_score_codex":0.00056406873,"about_ca_system_score_gemma":0.004215497,"threshold_uncertainty_score":0.99996096},"labels":[],"label_agreement":null},{"id":"W2946596565","doi":"10.1177/1078155219846952","title":"Concomitant use of capecitabine and proton pump inhibitors – Is it safe?","year":2019,"lang":"en","type":"article","venue":"Journal of Oncology Pharmacy Practice","topic":"Gastroesophageal reflux and treatments","field":"Medicine","cited_by":18,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Richmond Hospital","funders":"Association Canadienne de Pharmacie en Oncologie","keywords":"Capecitabine; Medicine; Rabeprazole; Proton-pump inhibitor; Drug; Pharmacology; Seriousness; Concomitant; Oncology; Internal medicine; Drug interaction; Intensive care medicine; Cancer; Colorectal cancer","score_opus":0.0597436009393854,"score_gpt":0.40288855315836125,"score_spread":0.34314495221897584,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2946596565","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9825991,0.0002985998,0.000009000532,0.010928431,0.0004856956,0.00074219616,0.000007652379,0.0000037557177,0.0049255784],"genre_scores_gemma":[0.99021393,0.00090284157,0.0039103394,0.0033561008,0.00019348046,0.0000067199107,0.0000017593878,0.000017853927,0.0013970024],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.9982993,0.00021403295,0.0007446029,0.00015772137,0.00037399764,0.00021035314],"domain_scores_gemma":[0.99673396,0.000978115,0.0012871057,0.00015151742,0.0006011333,0.00024814147],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00071994396,0.00016239178,0.0006282814,0.00016897834,0.000032489108,0.000015169785,0.000071188275,0.000079113044,0.0007013322],"category_scores_gemma":[0.00084279047,0.00011791113,0.00012602384,0.00012460728,0.000087363034,0.0009256112,0.000049433795,0.0005613611,0.00006238217],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.015319381,0.0046134675,0.8538823,0.00041886873,0.0027238803,0.010250671,0.0019451968,0.000009946575,0.06617258,0.00004066742,0.016918052,0.027704988],"study_design_scores_gemma":[0.03537958,0.010097811,0.029018186,0.00020323231,0.0024433914,0.016283123,0.000524423,0.00011870874,0.07262155,0.000020195288,0.8331686,0.0001211913],"about_ca_topic_score_codex":0.00002201272,"about_ca_topic_score_gemma":4.641854e-7,"teacher_disagreement_score":0.82486415,"about_ca_system_score_codex":0.00018653259,"about_ca_system_score_gemma":0.00046937633,"threshold_uncertainty_score":0.7679095},"labels":[],"label_agreement":null},{"id":"W2948116664","doi":"10.1177/1078155219850299","title":"Adherence to human epidermal growth factor receptor-2 testing and adjuvant trastuzumab treatment guidelines in Ontario","year":2019,"lang":"en","type":"article","venue":"Journal of Oncology Pharmacy Practice","topic":"HER2/EGFR in Cancer Research","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"SickKids Foundation; Ontario Institute for Cancer Research; Public Health Ontario; Institute for Clinical Evaluative Sciences; Alberta Bone and Joint Health Institute; University of Calgary; Princess Margaret Cancer Centre; Health Sciences Centre; University Health Network; University of Toronto; Sunnybrook Health Science Centre; Hospital for Sick Children; Cancer Care Ontario; McMaster University; St. Joseph’s Healthcare Hamilton; Canadian Centre for Applied Research in Cancer Control","funders":"Ontario Institute for Cancer Research; Ontario Ministry of Health and Long-Term Care","keywords":"Trastuzumab; Medicine; Oncology; Internal medicine; Breast cancer; Cancer; Epidermal growth factor receptor; Immunohistochemistry; Gynecology","score_opus":0.31022023476033067,"score_gpt":0.5294626497073359,"score_spread":0.21924241494700525,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2948116664","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9760568,0.00050220994,0.000014003201,0.014231389,0.0005518802,0.0007222738,0.000003212536,0.000011445731,0.007906779],"genre_scores_gemma":[0.9716389,0.000442218,0.023035219,0.0026116043,0.0004831803,0.00002394972,0.0000013959329,0.000031546184,0.0017319712],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.9972823,0.0004411247,0.0010926301,0.0002987521,0.00045580338,0.00042933717],"domain_scores_gemma":[0.9953501,0.0021723362,0.000665499,0.0001689207,0.001192671,0.0004504385],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0017751945,0.0002189638,0.0007573773,0.0003289213,0.00006707327,0.00003295043,0.00018035248,0.000087431996,0.0016179628],"category_scores_gemma":[0.0048092613,0.00017149156,0.000083288694,0.00026754627,0.000056380493,0.0005731203,0.00008026162,0.0011510083,0.000095987176],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0042659696,0.0011857346,0.6255597,0.00007531318,0.00029042902,0.0020162899,0.0029721805,0.000038224618,0.10014212,0.000012524927,0.005802374,0.25763914],"study_design_scores_gemma":[0.02343905,0.031401463,0.1794452,0.00054319977,0.0004055029,0.008270529,0.0011853977,0.00014736211,0.011188075,0.000042768395,0.74356735,0.00036411072],"about_ca_topic_score_codex":0.036265675,"about_ca_topic_score_gemma":0.008993416,"teacher_disagreement_score":0.73776495,"about_ca_system_score_codex":0.003283943,"about_ca_system_score_gemma":0.003477005,"threshold_uncertainty_score":0.9992947},"labels":[],"label_agreement":null},{"id":"W2964960971","doi":"10.1177/1078155219862040","title":"Comparison between two premedication regimens of dexamethasone before a pemetrexed-based chemotherapy: A single-center experience study","year":2019,"lang":"en","type":"article","venue":"Journal of Oncology Pharmacy Practice","topic":"Lung Cancer Treatments and Mutations","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institut universitaire de cardiologie et de pneumologie de Québec; Centre intégré universitaire de santé et de services sociaux de la Mauricie-et-du-Centre-du-Québec","funders":"","keywords":"Medicine; Dexamethasone; Pemetrexed; Regimen; Premedication; Chemotherapy; Internal medicine; Chemotherapy regimen; Single Center; Surgery; Anesthesia; Oncology; Cisplatin","score_opus":0.08138048394853586,"score_gpt":0.5062292627131044,"score_spread":0.42484877876456856,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2964960971","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98816824,0.00028447347,0.0006663723,0.007104746,0.00036684072,0.0009909075,0.0000045652423,0.0000122974725,0.0024015745],"genre_scores_gemma":[0.9897888,0.000025032117,0.0086280145,0.001106025,0.00024580417,0.000021320757,0.000008315719,0.000020658088,0.0001560874],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.99797994,0.00032903106,0.0008011635,0.00018386787,0.0005256718,0.00018030504],"domain_scores_gemma":[0.9962444,0.00080054795,0.0018693261,0.00023031644,0.00069147325,0.00016398102],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00087790337,0.00014547442,0.00063873985,0.0002187328,0.000045675202,0.000011550188,0.00014905416,0.000046808815,0.00028712276],"category_scores_gemma":[0.00042477867,0.000112808506,0.00011820605,0.00029698526,0.000077241326,0.00044367817,0.000021334368,0.0004005208,0.000011971205],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0032116259,0.012250032,0.91738504,0.000049492708,0.0014093552,0.000080985956,0.012015473,0.000034494202,0.009473513,0.0000036581712,0.0009371727,0.04314915],"study_design_scores_gemma":[0.18639211,0.050468672,0.20915341,0.0005459652,0.011237001,0.0013857601,0.027219046,0.0012099233,0.035371136,0.000023341032,0.47656643,0.00042718774],"about_ca_topic_score_codex":0.00005671542,"about_ca_topic_score_gemma":0.0000071052773,"teacher_disagreement_score":0.7082316,"about_ca_system_score_codex":0.00054969033,"about_ca_system_score_gemma":0.00078891905,"threshold_uncertainty_score":0.4600197},"labels":[],"label_agreement":null},{"id":"W2966864262","doi":"10.1177/1078155219865931","title":"Evaluation of decontamination strategies for cyclophosphamide","year":2019,"lang":"en","type":"article","venue":"Journal of Oncology Pharmacy Practice","topic":"Medical Device Sterilization and Disinfection","field":"Immunology and Microbiology","cited_by":14,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Université de Montréal; Centre Hospitalier Universitaire Sainte-Justine","funders":"","keywords":"Medicine; Human decontamination; Cyclophosphamide; Intensive care medicine; Internal medicine; Chemotherapy; Pathology","score_opus":0.05720562013633591,"score_gpt":0.4325025211999046,"score_spread":0.3752969010635687,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2966864262","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.93813086,0.0032857338,0.012197154,0.0022274721,0.0061482065,0.0007536202,0.000006730205,0.000012420444,0.03723783],"genre_scores_gemma":[0.99833417,0.00026410611,0.0005036843,0.0006224689,0.000067789326,0.000009405299,0.000013508848,0.0000066380985,0.00017821365],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.9982227,0.0008427272,0.0005820435,0.000092110364,0.0001491865,0.000111253525],"domain_scores_gemma":[0.99493265,0.0012557736,0.0013025333,0.000074578624,0.002411615,0.000022842327],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.005312596,0.00007602972,0.0002543171,0.00012863967,0.000039908206,0.000008843865,0.00009806486,0.000110184876,0.0016642798],"category_scores_gemma":[0.0026067996,0.000064628104,0.00008912948,0.00010312092,0.0000526312,0.00083125615,0.000013336779,0.00021093733,0.0000672797],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.005602759,0.0014308374,0.0022788567,0.00013353772,0.0011079541,0.0000046450277,0.0016337787,0.0010588622,0.5139074,0.005825731,0.010750902,0.45626476],"study_design_scores_gemma":[0.022093404,0.0020895652,0.003714218,0.000052235584,0.0018327754,0.0006873584,0.0048175287,0.0009004298,0.042624835,0.0015777453,0.9194759,0.00013401851],"about_ca_topic_score_codex":0.000012725099,"about_ca_topic_score_gemma":0.000005006252,"teacher_disagreement_score":0.90872496,"about_ca_system_score_codex":0.00014422236,"about_ca_system_score_gemma":0.0010749843,"threshold_uncertainty_score":0.9992483},"labels":[],"label_agreement":null},{"id":"W2968062006","doi":"10.1177/1078155219864406","title":"Implementation of an online chemotherapy checking training module enhances scope of practice and ensures competency","year":2019,"lang":"en","type":"article","venue":"Journal of Oncology Pharmacy Practice","topic":"Simulation-Based Education in Healthcare","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Alberta Health Services","funders":"Alberta Cancer Foundation","keywords":"Scope (computer science); Task (project management); Medicine; Alertness; Variety (cybernetics); Training (meteorology); Computer science; Medical education; Artificial intelligence; Programming language","score_opus":0.10795893989070637,"score_gpt":0.5284234198532434,"score_spread":0.420464479962537,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2968062006","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98141533,0.0013917212,0.00009075198,0.015379491,0.0005845578,0.00039723766,0.0000070721076,0.0000066584007,0.00072715076],"genre_scores_gemma":[0.9451924,0.0015190752,0.050258897,0.0026024291,0.00038330865,0.0000026835476,0.000010913102,0.000017976685,0.000012331657],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99771917,0.0005225015,0.0010484937,0.0001504666,0.00040340828,0.00015593988],"domain_scores_gemma":[0.991663,0.0029864667,0.0030579974,0.00014461846,0.0020091105,0.00013882204],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002177509,0.0001148986,0.0004871,0.00022453794,0.00004525713,0.00000881504,0.0000970003,0.000061616585,0.00039319572],"category_scores_gemma":[0.0008748493,0.00010564968,0.000057700767,0.00021086591,0.00006947106,0.00129138,0.000012853117,0.000443935,0.0000014153009],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.010806204,0.0038510107,0.21797928,0.00088170986,0.0011199971,0.00007196083,0.05580208,0.0008398792,0.32075942,0.0002351748,0.00030917104,0.38734412],"study_design_scores_gemma":[0.039031424,0.013672144,0.3928036,0.0007630107,0.0022041744,0.0052971896,0.23684785,0.0029298144,0.23550904,0.00016524301,0.070359476,0.00041703734],"about_ca_topic_score_codex":0.0002847344,"about_ca_topic_score_gemma":0.000011562541,"teacher_disagreement_score":0.3869271,"about_ca_system_score_codex":0.00015501995,"about_ca_system_score_gemma":0.0022132325,"threshold_uncertainty_score":0.43082687},"labels":[],"label_agreement":null},{"id":"W2969810241","doi":"10.1177/1078155219868525","title":"External contamination of antineoplastic drug containers from a Canadian wholesaler","year":2019,"lang":"en","type":"article","venue":"Journal of Oncology Pharmacy Practice","topic":"Safe Handling of Antineoplastic Drugs","field":"Health Professions","cited_by":17,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Université de Montréal; Centre Hospitalier Universitaire Sainte-Justine","funders":"","keywords":"Docetaxel; Ifosfamide; Vinorelbine; Vial; Drug packaging; Antineoplastic Drugs; Contamination; Medicine; Irinotecan; Paclitaxel; Camptothecin; Pharmacology; Chemotherapy; Surgery; Chromatography; Internal medicine; Cancer; Chemistry; Cisplatin","score_opus":0.034623440308504776,"score_gpt":0.43802260050283515,"score_spread":0.40339916019433036,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2969810241","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96318316,0.00033231528,0.00059762405,0.008968264,0.006113637,0.0004063457,0.00003102086,0.000013027958,0.020354606],"genre_scores_gemma":[0.99105066,0.00021061723,0.0031762384,0.0036443006,0.00083713414,0.0000046506166,0.000007018818,0.000031485266,0.0010378895],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.9961285,0.0013040304,0.0014153982,0.00019719091,0.00047766,0.0004772456],"domain_scores_gemma":[0.9825754,0.0121362535,0.003178619,0.0001834859,0.0015472528,0.00037896165],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.002916581,0.0001908935,0.00068079773,0.0004436601,0.00016696597,0.00001073348,0.00036505933,0.00014808863,0.0018179091],"category_scores_gemma":[0.0039961115,0.00016952708,0.00012480942,0.00019635796,0.00008158675,0.0008564642,0.00006108731,0.0015838151,0.00052491156],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.009043268,0.0008549231,0.8671941,0.00025992264,0.0010293403,0.0014097182,0.013843365,0.00032850454,0.044875927,0.0009834578,0.04424676,0.015930675],"study_design_scores_gemma":[0.022926562,0.00067628,0.13278455,0.0009674801,0.00096481736,0.00050283264,0.013143298,0.0011410906,0.0013227656,0.0001348046,0.8251106,0.00032488586],"about_ca_topic_score_codex":0.032847695,"about_ca_topic_score_gemma":0.009680729,"teacher_disagreement_score":0.7808639,"about_ca_system_score_codex":0.00053747784,"about_ca_system_score_gemma":0.007280507,"threshold_uncertainty_score":0.99909455},"labels":[],"label_agreement":null},{"id":"W2978048836","doi":"10.1177/1078155219876683","title":"Voriconazole prophylaxis in leukemic patients: A retrospective single-center study","year":2019,"lang":"en","type":"article","venue":"Journal of Oncology Pharmacy Practice","topic":"Antifungal resistance and susceptibility","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Health Sciences Centre; Institute for Clinical Evaluative Sciences; Sunnybrook Health Science Centre","funders":"","keywords":"Voriconazole; Medicine; Posaconazole; Internal medicine; Incidence (geometry); Fluconazole; Retrospective cohort study; Myeloid leukemia; Acute leukemia; Leukemia; Surgery; Antifungal; Dermatology","score_opus":0.028973254345573834,"score_gpt":0.3749430525480026,"score_spread":0.34596979820242874,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2978048836","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98537916,0.0001486141,0.0000098928485,0.001153434,0.000823122,0.00092676247,0.0000025940174,0.00000840507,0.0115480395],"genre_scores_gemma":[0.9976867,0.00008461582,0.00034408932,0.0012356262,0.00020058996,0.000005885039,0.0000014376576,0.000017420125,0.00042366443],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99759316,0.00052488537,0.00081949146,0.00025234805,0.0005441766,0.00026592685],"domain_scores_gemma":[0.99712455,0.0005400588,0.0009128652,0.00021125551,0.0010696795,0.00014160718],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0016503412,0.0001563786,0.0006263514,0.00022224907,0.000035242105,0.000016660704,0.00014943676,0.00007916293,0.00033230166],"category_scores_gemma":[0.002094856,0.00012330868,0.00013442348,0.00033998082,0.00005543691,0.0009001008,0.00005515091,0.0012608551,0.00010469563],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.012076123,0.016220631,0.95720583,0.000036601094,0.00020026838,0.00064550043,0.0013660691,0.0000026175287,0.006266875,0.0000057619827,0.00088496506,0.0050887386],"study_design_scores_gemma":[0.03067728,0.01851913,0.9006135,0.00007444105,0.00027074662,0.00045204096,0.0038462325,0.000020081758,0.00035105308,0.000019980147,0.045016147,0.00013937886],"about_ca_topic_score_codex":0.000034332505,"about_ca_topic_score_gemma":0.000022727801,"teacher_disagreement_score":0.05659236,"about_ca_system_score_codex":0.0019951158,"about_ca_system_score_gemma":0.0006952602,"threshold_uncertainty_score":0.5477858},"labels":[],"label_agreement":null},{"id":"W2994312780","doi":"10.1177/1078155219890659","title":"Toxic epidermal necrolysis associated with pembrolizumab","year":2019,"lang":"en","type":"article","venue":"Journal of Oncology Pharmacy Practice","topic":"Drug-Induced Adverse Reactions","field":"Medicine","cited_by":38,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Cégep de l'Outaouais; Centre Hospitalier de l’Université de Montréal","funders":"","keywords":"Toxic epidermal necrolysis; Pembrolizumab; Medicine; Rash; Erythroderma; Dermatology; Maculopapular rash; Skin biopsy; Paraneoplastic pemphigus; Pathology; Biopsy; Cancer; Internal medicine; Immunology; Immunotherapy; Antibody","score_opus":0.03781405407038124,"score_gpt":0.38944784365116236,"score_spread":0.3516337895807811,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2994312780","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.82321304,0.00018293783,0.00006977145,0.022835247,0.0009331552,0.00031836922,0.0000025758682,0.00003614768,0.15240876],"genre_scores_gemma":[0.99076355,0.00027218874,0.0017977305,0.0045526447,0.0004223997,0.000004423865,0.000004672393,0.00003970205,0.0021426864],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.9976807,0.0004901062,0.0006812057,0.00020104458,0.0005794645,0.0003674758],"domain_scores_gemma":[0.99430007,0.0023251423,0.0017820416,0.00023202419,0.0010142516,0.0003464884],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014356744,0.00020003127,0.00073200726,0.0003331051,0.00008622035,0.000023119883,0.00015864274,0.00012526201,0.0003414782],"category_scores_gemma":[0.002750947,0.00015348913,0.00022985974,0.0004622851,0.00007176923,0.0014321645,0.000038906157,0.001572657,0.0003041992],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.02435453,0.022141743,0.08194449,0.00022649564,0.024853691,0.034108967,0.0032126794,0.0023554023,0.44410375,0.00048215713,0.0192709,0.3429452],"study_design_scores_gemma":[0.028897796,0.0014408501,0.025080426,0.0001498955,0.0048441594,0.042930022,0.0013705743,0.00045427596,0.004575673,0.000013724534,0.8900011,0.0002414936],"about_ca_topic_score_codex":0.000026163289,"about_ca_topic_score_gemma":0.000005206904,"teacher_disagreement_score":0.8707302,"about_ca_system_score_codex":0.00096582243,"about_ca_system_score_gemma":0.0018567068,"threshold_uncertainty_score":0.68325},"labels":[],"label_agreement":null},{"id":"W2996559717","doi":"10.1177/1078155219892666","title":"Integration of a nausea and vomiting assessment tool into antineoplastic management of pediatric oncology patients","year":2019,"lang":"en","type":"article","venue":"Journal of Oncology Pharmacy Practice","topic":"Nausea and vomiting management","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Alberta Children's Hospital; Alberta Health Services","funders":"","keywords":"Nausea; Vomiting; Medicine; Chemotherapy; Quality of life (healthcare); Psychological intervention; Intensive care medicine; Internal medicine; Nursing","score_opus":0.02966264793266361,"score_gpt":0.423860209679362,"score_spread":0.3941975617466984,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2996559717","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9852775,0.00018371007,0.00084638403,0.0017233237,0.0007079756,0.0005641293,0.0000016126726,0.0000068558766,0.010688553],"genre_scores_gemma":[0.96130776,0.0018583201,0.03609347,0.0004028461,0.00020861688,0.0000050804197,0.00000385783,0.000015335158,0.000104708335],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99767286,0.00034822643,0.0011492898,0.00017575263,0.00046704742,0.00018681012],"domain_scores_gemma":[0.99503404,0.0013040545,0.0025963571,0.00014021495,0.00082390086,0.00010146284],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0021544793,0.00014876317,0.00062755035,0.0003876534,0.00003713722,0.000010105862,0.00012349579,0.00007364333,0.00008375891],"category_scores_gemma":[0.00061565626,0.00012350926,0.000101497986,0.00026957443,0.00005138883,0.00046798386,0.00013856926,0.0005295009,0.000006892349],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.010482538,0.008192615,0.7349596,0.0032399322,0.002721889,0.00078399514,0.0015113043,0.00009698793,0.026847832,0.0017071665,0.0034974338,0.2059587],"study_design_scores_gemma":[0.08044834,0.024934594,0.71260315,0.0009144693,0.014381265,0.0010653685,0.005734398,0.0025079357,0.0057369363,0.00020654377,0.15094586,0.00052113365],"about_ca_topic_score_codex":0.000014982836,"about_ca_topic_score_gemma":9.613331e-7,"teacher_disagreement_score":0.20543756,"about_ca_system_score_codex":0.00030816844,"about_ca_system_score_gemma":0.00035835535,"threshold_uncertainty_score":0.50365615},"labels":[],"label_agreement":null},{"id":"W3005534920","doi":"10.1177/1078155220904147","title":"Very high-dose methylprednisolone for treatment of nivolumab-induced limbic encephalitis: A case report","year":2020,"lang":"en","type":"article","venue":"Journal of Oncology Pharmacy Practice","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Centre Hospitalier de l’Université de Montréal","funders":"","keywords":"Medicine; Nivolumab; Limbic encephalitis; Prednisone; Adverse effect; Methylprednisolone; Encephalitis; Weakness; Cancer; Internal medicine; Anesthesia; Surgery; Immunotherapy; Immunology","score_opus":0.1220786963557368,"score_gpt":0.446066123515647,"score_spread":0.3239874271599102,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3005534920","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9524636,0.003988892,0.00032569078,0.040832005,0.001088489,0.0006885144,0.000019991347,0.00001626804,0.000576526],"genre_scores_gemma":[0.9827849,0.0027897917,0.009822077,0.0033771438,0.0009727756,0.000030150106,0.0000066783628,0.000027248267,0.0001891917],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.9978319,0.00030753715,0.001143338,0.00021413827,0.00027310845,0.00023000795],"domain_scores_gemma":[0.99539965,0.0013898379,0.002092473,0.00018420191,0.0006700541,0.0002637601],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010484076,0.00018288205,0.000842273,0.00012507237,0.000074005075,0.000011854599,0.00010000075,0.0001018716,0.00018376019],"category_scores_gemma":[0.0013105745,0.00014797001,0.0003979158,0.00023887082,0.00008961328,0.00043119138,0.000018468154,0.00022068642,0.0000035615305],"study_design_candidate":"case_report","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.12579145,0.003690626,0.00027752027,0.00015295102,0.004557018,0.23027517,0.0031851667,0.0000075325015,0.4473372,0.000012910088,0.0059007546,0.17881167],"study_design_scores_gemma":[0.040593475,0.025893262,0.00017550192,0.000049574133,0.0036536606,0.3555865,0.0018821573,0.00009710121,0.09696059,0.000012931913,0.47495368,0.00014154335],"about_ca_topic_score_codex":0.0004830399,"about_ca_topic_score_gemma":0.0000094674915,"teacher_disagreement_score":0.46905294,"about_ca_system_score_codex":0.000514248,"about_ca_system_score_gemma":0.0016141937,"threshold_uncertainty_score":0.6034042},"labels":[],"label_agreement":null},{"id":"W3009614921","doi":"10.1177/1078155220907650","title":"Managing chemotherapy-related toxicities in the community setting: A survey of pharmacists in Ontario","year":2020,"lang":"en","type":"article","venue":"Journal of Oncology Pharmacy Practice","topic":"Safe Handling of Antineoplastic Drugs","field":"Health Professions","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Princess Margaret Cancer Centre; Cancer Care Ontario; University of Toronto","funders":"","keywords":"Medicine; Pharmacy; Family medicine; Socioeconomic status; Pharmaceutical care; Cancer; Pharmacy practice; Nursing; Internal medicine; Population; Environmental health","score_opus":0.2134095114127702,"score_gpt":0.49789875927577887,"score_spread":0.28448924786300867,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3009614921","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9468531,0.00015890673,0.000062431274,0.039461378,0.0006967728,0.00038131882,0.0000045605866,0.000010128175,0.0123713985],"genre_scores_gemma":[0.9820887,0.00032709987,0.0006137159,0.01676816,0.00009692843,0.0000061189953,0.0000042273587,0.000019732566,0.0000753362],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.98620176,0.011253814,0.0016905408,0.00011612038,0.00037072043,0.0003670517],"domain_scores_gemma":[0.97276145,0.02402672,0.002372779,0.00015938214,0.00057717325,0.000102467995],"candidate_categories":["research_integrity"],"consensus_categories":[],"category_scores_codex":[0.017019939,0.00016668082,0.0006091428,0.00021498886,0.00023055675,0.000009710995,0.00066898036,0.000111171095,0.0003966552],"category_scores_gemma":[0.008035576,0.00012947942,0.000068742105,0.00065588823,0.00011278023,0.0005361887,0.0001220934,0.006303285,0.000021479405],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.009979615,0.0015500516,0.65472794,0.00021657532,0.00030718284,0.0006635166,0.31198284,0.00051416125,0.0023182563,0.000042437034,0.01070171,0.0069957017],"study_design_scores_gemma":[0.043794144,0.0014602827,0.73483086,0.00073899614,0.0004066063,0.0009462495,0.0680224,0.0022585276,0.0007565389,0.00044865365,0.14590743,0.0004293047],"about_ca_topic_score_codex":0.033520717,"about_ca_topic_score_gemma":0.02300316,"teacher_disagreement_score":0.24396043,"about_ca_system_score_codex":0.0004363977,"about_ca_system_score_gemma":0.0034829595,"threshold_uncertainty_score":0.9959892},"labels":[],"label_agreement":null},{"id":"W3010072035","doi":"10.1177/1078155220907125","title":"Cross-sectional evaluation of surface contamination with 9 antineoplastic drugs in 93 Canadian healthcare centers: 2019 results","year":2020,"lang":"en","type":"article","venue":"Journal of Oncology Pharmacy Practice","topic":"Safe Handling of Antineoplastic Drugs","field":"Health Professions","cited_by":23,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Université de Montréal; Institut National de Santé Publique du Québec; Centre Hospitalier Universitaire Sainte-Justine","funders":"","keywords":"Medicine; Docetaxel; Antineoplastic Drugs; Cyclophosphamide; Pharmacy; Vinorelbine; Gemcitabine; Internal medicine; Outpatient clinic; Cabazitaxel; Oncology; Cancer; Pharmacology; Chemotherapy; Family medicine","score_opus":0.1376602587389043,"score_gpt":0.5074619643237185,"score_spread":0.3698017055848142,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3010072035","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9467992,0.0002260722,0.00015106627,0.04630959,0.0018933456,0.00066495046,0.00007986977,0.000011621614,0.0038642397],"genre_scores_gemma":[0.9948866,0.00016769016,0.0014487046,0.0028474017,0.000512736,0.000005527632,0.00003083232,0.000024397285,0.00007616097],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9937612,0.0027275274,0.001762127,0.00026846293,0.0010235814,0.00045709868],"domain_scores_gemma":[0.9852758,0.0063890205,0.003212228,0.000118971875,0.004576958,0.00042702153],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.009156203,0.00017621012,0.0004901589,0.0003179527,0.00024516042,0.0000154706,0.00024367038,0.00017297168,0.00022448631],"category_scores_gemma":[0.011567993,0.00015664483,0.00006222841,0.0005139911,0.00009525138,0.0009693434,0.000040071223,0.0016577862,0.00005935468],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.020746702,0.00040057293,0.9417742,0.00024466205,0.00023226412,0.00018625437,0.013501371,0.013567748,0.000859812,0.00007454953,0.0061067888,0.0023050813],"study_design_scores_gemma":[0.05223404,0.0023315006,0.8470263,0.00064293214,0.0005399758,0.00044560406,0.009044933,0.014238312,0.00032994212,0.000024596558,0.07282749,0.00031436325],"about_ca_topic_score_codex":0.023912156,"about_ca_topic_score_gemma":0.013732499,"teacher_disagreement_score":0.09474788,"about_ca_system_score_codex":0.0012466795,"about_ca_system_score_gemma":0.016740635,"threshold_uncertainty_score":0.996758},"labels":[],"label_agreement":null},{"id":"W3010156616","doi":"10.1177/1078155220907129","title":"Quantification of healthcare workers’ exposure to cyclophosphamide, ifosfamide, methotrexate, and 5-fluorouracil by 24-h urine assay: A descriptive pilot study","year":2020,"lang":"en","type":"article","venue":"Journal of Oncology Pharmacy Practice","topic":"Safe Handling of Antineoplastic Drugs","field":"Health Professions","cited_by":14,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Institut National de Santé Publique du Québec; Centre intégré de santé et de services sociaux de la Montérégie-Centre; Centre intégré de santé et de services sociaux de Chaudière-Appalaches; Université de Montréal; Santé Montérégie; Centre Intégré de Santé et de Services Sociaux des Laurentides; Centre Hospitalier Universitaire Sainte-Justine","funders":"","keywords":"Medicine; Urine; Ifosfamide; Cyclophosphamide; Health care; Methotrexate; Internal medicine; Chemotherapy; Etoposide","score_opus":0.17944044003681844,"score_gpt":0.4720080280671828,"score_spread":0.2925675880303643,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3010156616","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8580321,0.0024783562,0.006064237,0.12775792,0.0024048346,0.0019100127,0.000049228478,0.00005678225,0.001246501],"genre_scores_gemma":[0.9699697,0.00075530395,0.020402238,0.007974429,0.0005152136,0.000045514964,0.0000052502955,0.0000542082,0.00027816632],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.9908048,0.0053238454,0.0022037074,0.0004466781,0.00069601263,0.0005249828],"domain_scores_gemma":[0.98273605,0.010330754,0.0037232903,0.0002512619,0.002224275,0.0007343473],"candidate_categories":["metaresearch","metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.007117472,0.0003176618,0.0010711916,0.00023016692,0.00039877123,0.00002099292,0.00041007483,0.00012446257,0.0001328063],"category_scores_gemma":[0.015570015,0.00028210948,0.00008013136,0.00063483516,0.0000948929,0.00088609604,0.00023514238,0.0022213233,0.00007139073],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.07196799,0.008763397,0.5171025,0.00089003023,0.0022344505,0.0011216546,0.1004559,0.0002806146,0.07095434,0.00024385026,0.18845744,0.037527833],"study_design_scores_gemma":[0.03468924,0.052042454,0.105035074,0.0008616833,0.00271049,0.00061708345,0.1874423,0.00035940963,0.0034398593,0.00012185797,0.6117668,0.00091375486],"about_ca_topic_score_codex":0.0009015515,"about_ca_topic_score_gemma":0.00011872131,"teacher_disagreement_score":0.42330936,"about_ca_system_score_codex":0.00032715045,"about_ca_system_score_gemma":0.0023163024,"threshold_uncertainty_score":0.9999631},"labels":[],"label_agreement":null},{"id":"W3010753547","doi":"10.1177/1078155220910252","title":"Safety of trastuzumab after trastuzumab emtansine-induced nodular regenerative hyperplasia: A case report","year":2020,"lang":"en","type":"article","venue":"Journal of Oncology Pharmacy Practice","topic":"HER2/EGFR in Cancer Research","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier de l’Université de Montréal; Université de Montréal","funders":"","keywords":"Medicine; Trastuzumab emtansine; Trastuzumab; Nodular regenerative hyperplasia; Internal medicine; Breast cancer; Oncology; Cirrhosis; Surgery; Gastroenterology; Cancer; Portal hypertension","score_opus":0.10711538175138427,"score_gpt":0.4658162816026355,"score_spread":0.3587008998512512,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3010753547","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.89172244,0.0017296227,0.0009281076,0.09518294,0.0008648166,0.00080053735,0.000028698427,0.00002563374,0.00871723],"genre_scores_gemma":[0.9824621,0.00080391706,0.009540509,0.0053463327,0.0016033544,0.000021559514,0.0000043527357,0.000062576786,0.00015531266],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.99513495,0.0011082741,0.0019049193,0.00041521885,0.0009738932,0.0004627632],"domain_scores_gemma":[0.9932248,0.001586401,0.0018894785,0.00034634926,0.0021748936,0.000778056],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0028154943,0.0003042719,0.0012060514,0.00024921494,0.00010951485,0.000023254064,0.00024130705,0.00018924747,0.000915779],"category_scores_gemma":[0.0075983712,0.00025631688,0.0003437122,0.000652873,0.00019665045,0.0007751638,0.000098936136,0.0023093333,0.000032552463],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.031873878,0.0015084152,0.00089254143,0.00023016158,0.0014194322,0.8321664,0.0046757925,0.000044689667,0.09526591,0.000015048674,0.01252921,0.019378535],"study_design_scores_gemma":[0.010201372,0.005808093,0.00024456155,0.000114725124,0.0014161719,0.6324582,0.0025934686,0.0002951207,0.04153271,0.0000052994037,0.30515838,0.00017188083],"about_ca_topic_score_codex":0.00009420445,"about_ca_topic_score_gemma":0.00002350037,"teacher_disagreement_score":0.29262918,"about_ca_system_score_codex":0.0011293415,"about_ca_system_score_gemma":0.006324484,"threshold_uncertainty_score":0.9999975},"labels":[],"label_agreement":null},{"id":"W3011063999","doi":"10.1177/1078155220908948","title":"Safety of two-hour intermittent intravenous infusions of tacrolimus in the allogeneic hematopoietic stem cell transplantation unit","year":2020,"lang":"en","type":"article","venue":"Journal of Oncology Pharmacy Practice","topic":"Hematopoietic Stem Cell Transplantation","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; University Health Network","funders":"","keywords":"Medicine; Tacrolimus; Nephrotoxicity; Discontinuation; Neurotoxicity; Transplantation; Adverse effect; Hematopoietic stem cell transplantation; Population; Anesthesia; Internal medicine; Toxicity; Gastroenterology; Urology","score_opus":0.0579723187395441,"score_gpt":0.3729555157035169,"score_spread":0.3149831969639728,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3011063999","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97673523,0.0005236405,0.0033323385,0.014362095,0.00024003368,0.0005989497,0.000021737076,0.00000790271,0.0041780733],"genre_scores_gemma":[0.99182045,0.0034110693,0.002031564,0.0025716743,0.00012126435,0.0000057809807,0.000008388297,0.000020569945,0.00000920848],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99649584,0.0010040796,0.0015989441,0.00015129788,0.0005394659,0.00021036199],"domain_scores_gemma":[0.995378,0.0022444453,0.0016133639,0.00015638879,0.0004461194,0.0001616422],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0018301422,0.00017386106,0.00068667537,0.0002053393,0.000040064766,0.00000687275,0.00029487052,0.00008953594,0.000114754854],"category_scores_gemma":[0.00014424657,0.00012738135,0.0001789928,0.00044528503,0.00010469396,0.00026690323,0.000018324432,0.0008237381,0.000010735912],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.030826792,0.005605204,0.024088783,0.0042425515,0.00089556345,0.009431927,0.15635233,0.0028602215,0.7267802,0.00035378258,0.00048120818,0.03808149],"study_design_scores_gemma":[0.11366144,0.018274456,0.05923361,0.0025974917,0.016643938,0.097513184,0.08079246,0.002004914,0.5433213,0.00014630677,0.064909264,0.0009016534],"about_ca_topic_score_codex":0.000034443925,"about_ca_topic_score_gemma":0.000008832363,"teacher_disagreement_score":0.18345886,"about_ca_system_score_codex":0.00008578759,"about_ca_system_score_gemma":0.0006895105,"threshold_uncertainty_score":0.51944613},"labels":[],"label_agreement":null},{"id":"W3014032731","doi":"10.1177/1078155220914349","title":"Stability of extemporaneously compounded temozolomide 10 mg/mL suspensions in Oral Mix SF® in glass and plastic bottles and plastic syringes","year":2020,"lang":"en","type":"article","venue":"Journal of Oncology Pharmacy Practice","topic":"Safe Handling of Antineoplastic Drugs","field":"Health Professions","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Health Sciences Centre; Sunnybrook Health Science Centre; Hospital for Sick Children","funders":"","keywords":"Temozolomide; Medicine; Citric acid; Chromatography; Surgery; Chemistry; Food science; Chemotherapy","score_opus":0.1395919372264321,"score_gpt":0.45628747861382074,"score_spread":0.31669554138738865,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3014032731","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9846261,0.00070263806,0.00009712624,0.012378921,0.0009741949,0.00042971838,0.000010902676,0.000018519822,0.00076188054],"genre_scores_gemma":[0.9951382,0.00081565423,0.002895684,0.00088315754,0.0002099316,0.0000074097184,0.0000021669334,0.000028937178,0.000018850158],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.994585,0.0023225716,0.0018746515,0.00034924867,0.000375405,0.00049312634],"domain_scores_gemma":[0.94758654,0.049492463,0.0019149799,0.00013570611,0.0005006329,0.00036965666],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.0030062802,0.0002634538,0.0010889475,0.00030778558,0.00018169788,0.00001582309,0.00023304259,0.00019749219,0.00023900773],"category_scores_gemma":[0.030480087,0.00023475302,0.000060017326,0.0003582168,0.00034128968,0.000634201,0.00024967265,0.0021419812,0.00002071731],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.04094186,0.0024110028,0.87723744,0.0015634862,0.00038398735,0.004381552,0.018023528,0.00056288845,0.047287602,0.00028556952,0.004858707,0.0020623794],"study_design_scores_gemma":[0.11538115,0.010479084,0.5644982,0.004033829,0.0025787225,0.0060065347,0.077180624,0.029801581,0.0028321564,0.0009111935,0.18451606,0.0017808999],"about_ca_topic_score_codex":0.00033148483,"about_ca_topic_score_gemma":0.001047993,"teacher_disagreement_score":0.31273928,"about_ca_system_score_codex":0.00025396777,"about_ca_system_score_gemma":0.0020723215,"threshold_uncertainty_score":0.9776866},"labels":[],"label_agreement":null},{"id":"W3015742209","doi":"10.1177/1078155219897959","title":"Proceedings of the biosimilars workshop at the International Symposium on Oncology Pharmacy Practice 2019","year":2020,"lang":"en","type":"article","venue":"Journal of Oncology Pharmacy Practice","topic":"Biosimilars and Bioanalytical Methods","field":"Immunology and Microbiology","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Biosimilar; Medicine; Pharmacy; Formulary; Product (mathematics); Pharmacology; Family medicine; Internal medicine","score_opus":0.0693095778245597,"score_gpt":0.4139647923595849,"score_spread":0.3446552145350252,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3015742209","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.027477317,0.00243298,0.000037094953,0.91204816,0.005645997,0.00049684494,0.000040122955,0.000022024149,0.05179944],"genre_scores_gemma":[0.51853913,0.01707904,0.006757121,0.4486342,0.0026320142,0.00003394314,0.000009782197,0.00010773051,0.006207011],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99622834,0.0013381831,0.0012737196,0.00038594665,0.00032489546,0.0004489361],"domain_scores_gemma":[0.98640174,0.008410577,0.0034291653,0.00020050976,0.0014246708,0.00013333352],"candidate_categories":["metaresearch","research_integrity","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.004202939,0.00032261864,0.0006886158,0.00009424412,0.00032522876,0.000044829107,0.0016063984,0.00030643234,0.0014929988],"category_scores_gemma":[0.008670245,0.00018092852,0.00043908582,0.0004967106,0.0007696924,0.00081710366,0.0006490728,0.0028797546,0.00013637717],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.016331814,0.001361917,0.00053408905,0.000018985982,0.0019353741,0.00008504593,0.0010322112,0.000028859375,0.41711584,0.0003770702,0.54383415,0.017344672],"study_design_scores_gemma":[0.005201527,0.0011307679,0.00007884956,0.00003560026,0.0014358999,0.0031883065,0.0013628072,0.000045825338,0.16192852,0.000023857052,0.82541275,0.00015527355],"about_ca_topic_score_codex":0.0000147994515,"about_ca_topic_score_gemma":0.0000029474352,"teacher_disagreement_score":0.49106184,"about_ca_system_score_codex":0.0004870356,"about_ca_system_score_gemma":0.0006446342,"threshold_uncertainty_score":0.99968016},"labels":[],"label_agreement":null},{"id":"W3015995016","doi":"10.1177/1078155219893441","title":"International Society of Oncology Pharmacy Practitioners global position on the use of biosimilars in cancer treatment and supportive care","year":2020,"lang":"en","type":"article","venue":"Journal of Oncology Pharmacy Practice","topic":"Biosimilars and Bioanalytical Methods","field":"Immunology and Microbiology","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Biosimilar; Medicine; Pharmacy; Pharmacovigilance; Health care; Position statement; Product (mathematics); Pharmacy practice; Family medicine; Pharmacology; Adverse effect; Internal medicine","score_opus":0.15815005056833825,"score_gpt":0.4658848871336269,"score_spread":0.30773483656528866,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3015995016","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.47268674,0.0033364021,0.00022482828,0.51715344,0.001711917,0.0006491358,0.0005309566,0.000011254012,0.0036952891],"genre_scores_gemma":[0.95129246,0.018780774,0.005736697,0.023942351,0.00017133166,0.000014617159,0.000016592885,0.000011236827,0.000033948658],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.9976619,0.0011150008,0.0007473971,0.0001952622,0.000091227885,0.00018921008],"domain_scores_gemma":[0.99552447,0.0022513836,0.001538531,0.00007647189,0.00054728176,0.000061872204],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006264932,0.00016874431,0.0004932313,0.0000635813,0.00006124038,0.000010273113,0.00018399765,0.00015738716,0.000498936],"category_scores_gemma":[0.0006397708,0.00011224068,0.00020660288,0.00021329074,0.0003897725,0.0004463272,0.00007049288,0.0006133604,0.000002589131],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.038894422,0.0060270648,0.024539763,0.00012176409,0.0077049513,0.00031488578,0.010371684,0.00035606933,0.5186463,0.00067385216,0.12516461,0.26718464],"study_design_scores_gemma":[0.0071158903,0.0034058548,0.0011749248,0.00004287878,0.0008669737,0.0004602931,0.0034479073,0.0001347654,0.08534823,0.000018864874,0.8978756,0.000107830645],"about_ca_topic_score_codex":0.00017729639,"about_ca_topic_score_gemma":0.000015997482,"teacher_disagreement_score":0.772711,"about_ca_system_score_codex":0.000688891,"about_ca_system_score_gemma":0.0007638576,"threshold_uncertainty_score":0.5462999},"labels":[],"label_agreement":null},{"id":"W3017304434","doi":"10.1177/1078155220915769","title":"Oral sodium bicarbonate protocol for high-dose methotrexate urine alkalinization: A pediatric experience","year":2020,"lang":"en","type":"article","venue":"Journal of Oncology Pharmacy Practice","topic":"Polyomavirus and related diseases","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Alberta Children's Hospital; University of Alberta; Stollery Children's Hospital; Alberta Health Services","funders":"","keywords":"Medicine; Sodium bicarbonate; Methotrexate; Urine; Bicarbonate; Pharmacology; Internal medicine","score_opus":0.11547888598136673,"score_gpt":0.4798205246155273,"score_spread":0.3643416386341606,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3017304434","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.25850284,0.0032278516,0.008393089,0.47794956,0.004751354,0.2313518,0.00008874591,0.00041521163,0.015319537],"genre_scores_gemma":[0.7730574,0.001736876,0.11306451,0.053564545,0.011986361,0.04552352,0.00002011052,0.00019496163,0.00085169234],"study_design_codex":"randomized_trial","study_design_gemma":"not_applicable","domain_scores_codex":[0.9978647,0.00035394295,0.00088213116,0.00023145803,0.0003780432,0.0002897205],"domain_scores_gemma":[0.9961139,0.0008640275,0.0014658194,0.00011978048,0.00082217203,0.000614306],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00072595186,0.00019675188,0.00054824987,0.0001535224,0.00010709486,0.000027459959,0.00020142674,0.00010667708,0.00039046287],"category_scores_gemma":[0.0029235978,0.00014624961,0.00019485153,0.00047354613,0.00007738952,0.00070665125,0.000063552274,0.00064040715,0.000025153082],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.4466759,0.023850448,0.028782753,0.0027507055,0.0052175336,0.025411775,0.010151287,0.0009497144,0.108506545,0.0011845062,0.2386619,0.10785694],"study_design_scores_gemma":[0.037907496,0.0038380728,0.0005379613,0.00003111819,0.0023889723,0.0018367991,0.000276104,0.0011787942,0.0062087835,0.000054985914,0.9455486,0.00019229337],"about_ca_topic_score_codex":0.000011208542,"about_ca_topic_score_gemma":1.7821732e-7,"teacher_disagreement_score":0.7068867,"about_ca_system_score_codex":0.000102960665,"about_ca_system_score_gemma":0.0013164576,"threshold_uncertainty_score":0.59638864},"labels":[],"label_agreement":null},{"id":"W3024661543","doi":"10.1177/1078155220927450","title":"Global oncology pharmacy response to COVID-19 pandemic: Medication access and safety","year":2020,"lang":"en","type":"article","venue":"Journal of Oncology Pharmacy Practice","topic":"COVID-19 and healthcare impacts","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Alberta Health Services","funders":"","keywords":"Medicine; Pharmacy; Pandemic; Coronavirus disease 2019 (COVID-19); Health care; Pharmacy practice; Adverse effect; Pharmaceutical care; Family medicine; Global health; Oncology; Intensive care medicine; Nursing; Public health; Internal medicine; Infectious disease (medical specialty); Disease","score_opus":0.31796318706339144,"score_gpt":0.6090012370732517,"score_spread":0.29103805000986027,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3024661543","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.16842735,0.0010740692,0.003993745,0.82218057,0.00084168866,0.00072256447,0.0000245088,0.000057504774,0.002677996],"genre_scores_gemma":[0.6056185,0.005915296,0.0021274579,0.38506767,0.0012065093,0.000008721366,0.000004093803,0.000017896447,0.000033885182],"study_design_codex":"randomized_trial","study_design_gemma":"not_applicable","domain_scores_codex":[0.99494815,0.0022854705,0.0012603275,0.00037874572,0.0006565474,0.00047073842],"domain_scores_gemma":[0.98564553,0.007884616,0.0015701661,0.00019359066,0.0008250322,0.0038810608],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.006572008,0.0002493606,0.0008676657,0.00024699626,0.00020729135,0.00004503992,0.00039705812,0.00017162321,0.0005016259],"category_scores_gemma":[0.04570928,0.00021564183,0.00012678465,0.0006862517,0.00016485475,0.0011573007,0.00024439985,0.0012757491,0.000048442907],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.372087,0.0011197744,0.11176541,0.00040520536,0.0006779687,0.0072053345,0.005824313,0.00012980332,0.012134772,0.00006533933,0.14201547,0.34656963],"study_design_scores_gemma":[0.021838533,0.0040617283,0.018945666,0.000038736453,0.0009496553,0.018594204,0.00061706326,0.00020691425,0.00012875792,0.00004995416,0.9344064,0.00016236414],"about_ca_topic_score_codex":0.00035333153,"about_ca_topic_score_gemma":0.00006289882,"teacher_disagreement_score":0.79239094,"about_ca_system_score_codex":0.0037750169,"about_ca_system_score_gemma":0.018259104,"threshold_uncertainty_score":0.9873065},"labels":[],"label_agreement":null},{"id":"W3033377324","doi":"10.1177/1078155220929415","title":"Opioid rotation from transdermal fentanyl to continuous subcutaneous hydromorphone in a cachectic patient: A case report and review of the literature","year":2020,"lang":"en","type":"review","venue":"Journal of Oncology Pharmacy Practice","topic":"Pain Management and Opioid Use","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Health Sciences Centre; University of Toronto; Sunnybrook Health Science Centre","funders":"","keywords":"Hydromorphone; Medicine; Transdermal; Fentanyl; Anesthesia; Opioid; Morphine; Pharmacology; Internal medicine","score_opus":0.0346936673618775,"score_gpt":0.39066156994830475,"score_spread":0.35596790258642724,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3033377324","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0046453127,0.9849375,0.000011842805,0.0070684236,0.00062489155,0.0022906442,0.0000358626,0.0000058615847,0.00037968002],"genre_scores_gemma":[0.0014055086,0.99186045,0.0011463212,0.005114056,0.0003143738,0.000035668865,0.0000284341,0.00003587071,0.000059336362],"study_design_codex":"case_report","study_design_gemma":"not_applicable","domain_scores_codex":[0.9955086,0.0014583685,0.0020564364,0.0003142496,0.00045185123,0.00021049817],"domain_scores_gemma":[0.9939347,0.001521013,0.00363496,0.000277519,0.00039218384,0.00023961422],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014553488,0.00033927688,0.002441755,0.00024873216,0.000047636284,0.000025992551,0.00019563152,0.00016079137,0.00007337396],"category_scores_gemma":[0.0037274917,0.00022722024,0.00044824122,0.00080247014,0.000054055618,0.00027088114,0.00008870386,0.0017845186,0.0000059343074],"study_design_candidate":"case_report","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000831657,0.00040747426,0.000051313757,0.025072958,0.00066621247,0.5503833,0.001729815,4.5020988e-7,0.000020967895,8.730389e-7,0.002592843,0.41824213],"study_design_scores_gemma":[0.0013583348,0.0006194433,0.0000075099447,0.04696684,0.0067173433,0.32608083,0.0001393453,0.000005540518,0.0000046231316,0.0000020815726,0.61798996,0.00010811536],"about_ca_topic_score_codex":0.00007728045,"about_ca_topic_score_gemma":0.000012963936,"teacher_disagreement_score":0.61539716,"about_ca_system_score_codex":0.0003922049,"about_ca_system_score_gemma":0.0011173843,"threshold_uncertainty_score":0.92657727},"labels":[],"label_agreement":null},{"id":"W3034836530","doi":"10.1177/1078155220929756","title":"A real-world data approach to determine the optimal dosing strategy for pembrolizumab","year":2020,"lang":"en","type":"article","venue":"Journal of Oncology Pharmacy Practice","topic":"Safe Handling of Antineoplastic Drugs","field":"Health Professions","cited_by":17,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of British Columbia; BC Cancer Agency","funders":"","keywords":"Dosing; Vial; Medicine; Lung cancer; Pharmacy; Pembrolizumab; Cost sharing; Cancer; Emergency medicine; Internal medicine; Nursing; Immunotherapy","score_opus":0.422417440482586,"score_gpt":0.5594710717550829,"score_spread":0.13705363127249692,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3034836530","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.31977087,0.00046906492,0.092386164,0.44415018,0.006116073,0.004875178,0.00021978114,0.00016673148,0.13184594],"genre_scores_gemma":[0.77542573,0.00040095308,0.18087502,0.034810953,0.0077077653,0.000063282256,0.000026434098,0.00009228499,0.0005975482],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9960558,0.0013483486,0.0012784922,0.0003471003,0.00039671615,0.0005735671],"domain_scores_gemma":[0.9819557,0.014188054,0.0022189964,0.00040308374,0.0008055139,0.00042862757],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.0046807774,0.00021196218,0.0006065647,0.0001437861,0.0006344277,0.000041042636,0.0012920169,0.00007256063,0.00007636821],"category_scores_gemma":[0.009224959,0.00014645922,0.00010070402,0.00045660182,0.00009610414,0.0009995069,0.00048200006,0.0018315724,0.000074011594],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.085234754,0.002220441,0.0033645043,0.0007509092,0.0017265684,0.00068895315,0.022946544,0.0107449675,0.0071124705,0.0018853738,0.7534759,0.109848626],"study_design_scores_gemma":[0.008443301,0.0011149247,0.0005563794,0.00006860244,0.00090982,0.00046175052,0.005797375,0.038017854,0.00009850996,0.000016193571,0.94433826,0.00017702166],"about_ca_topic_score_codex":0.00014695077,"about_ca_topic_score_gemma":0.000034506833,"teacher_disagreement_score":0.45565486,"about_ca_system_score_codex":0.0002074817,"about_ca_system_score_gemma":0.0037984236,"threshold_uncertainty_score":0.9991208},"labels":[],"label_agreement":null},{"id":"W3035248893","doi":"10.1177/1078155220929754","title":"Educational needs of oncology pharmacists: A survey by the International Society of Oncology Pharmacy Practitioners","year":2020,"lang":"en","type":"article","venue":"Journal of Oncology Pharmacy Practice","topic":"Pharmaceutical Practices and Patient Outcomes","field":"Medicine","cited_by":16,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Alberta Health Services","funders":"","keywords":"Pharmacy; Medicine; Internal medicine; Oncology; Pharmacy practice; Family medicine; Descriptive statistics; Medical education","score_opus":0.2493643759119361,"score_gpt":0.5229458394202,"score_spread":0.2735814635082639,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3035248893","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.21195647,0.0025520069,0.0006905415,0.72852767,0.0046107606,0.0010790416,0.00025564188,0.000026290443,0.050301556],"genre_scores_gemma":[0.9022764,0.012579721,0.005258794,0.07748848,0.0016992707,0.000026892783,0.00011923977,0.000048036,0.0005031807],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9941186,0.0019880622,0.0021346265,0.00027369166,0.0010775555,0.00040751114],"domain_scores_gemma":[0.97488594,0.016217163,0.0056309826,0.00020601206,0.0024736645,0.0005862128],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.005448789,0.0003298564,0.0011212715,0.00020717409,0.0001438839,0.000026927346,0.000780704,0.00017530879,0.0028753954],"category_scores_gemma":[0.0070096767,0.00024990013,0.0005616792,0.0007808857,0.0005788614,0.0016334918,0.00022363341,0.0025461265,0.000046567868],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.037253544,0.00947044,0.032219745,0.00024210032,0.0055122576,0.00014974283,0.0061701755,0.00010457414,0.10667901,0.00018143577,0.7570014,0.04501559],"study_design_scores_gemma":[0.018812962,0.0028651122,0.0005329905,0.000030287249,0.002195407,0.0037543797,0.002924336,0.0022473433,0.011210731,0.0000349406,0.955199,0.00019252479],"about_ca_topic_score_codex":0.0001390612,"about_ca_topic_score_gemma":0.0000025889387,"teacher_disagreement_score":0.6903199,"about_ca_system_score_codex":0.0009316652,"about_ca_system_score_gemma":0.0059740795,"threshold_uncertainty_score":0.99999535},"labels":[],"label_agreement":null},{"id":"W3038008047","doi":"10.1177/1078155220934163","title":"Tolerability of pemetrexed and oxaliplatin in the treatment of stage III colon cancer during raltitrexed shortage","year":2020,"lang":"en","type":"article","venue":"Journal of Oncology Pharmacy Practice","topic":"Colorectal Cancer Treatments and Studies","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Alberta Health Services","funders":"","keywords":"Oxaliplatin; Medicine; Tolerability; Pemetrexed; Raltitrexed; Colorectal cancer; Internal medicine; Oncology; Regimen; Adverse effect; Discontinuation; Capecitabine; Chemotherapy; Cancer; Cisplatin","score_opus":0.095645687261969,"score_gpt":0.44555424946895417,"score_spread":0.3499085622069852,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3038008047","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.974315,0.005213717,0.0000017892231,0.018601151,0.00010892125,0.00043435633,0.000016093047,0.000002706508,0.0013062792],"genre_scores_gemma":[0.9879075,0.010948633,0.000323733,0.0006162081,0.00012512034,0.000019357807,8.1779154e-7,0.0000067448864,0.000051862127],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99857277,0.00027901612,0.0006487528,0.00012915012,0.00023916004,0.00013118354],"domain_scores_gemma":[0.997848,0.00092230656,0.0008388648,0.00008362952,0.00022301664,0.00008419775],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00045701326,0.00012535784,0.0007143333,0.000070833994,0.000045770106,0.0000045924576,0.000067524015,0.00003472899,0.00015225634],"category_scores_gemma":[0.0003381764,0.00007577024,0.00010723619,0.00021393066,0.0001083695,0.00017352293,0.0000226008,0.00022683143,2.3850734e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.09226311,0.00980111,0.66136706,0.00060709135,0.0031727487,0.0024449262,0.06810525,0.0001772418,0.093664296,0.00002842258,0.00085105235,0.06751769],"study_design_scores_gemma":[0.08058791,0.033220794,0.523718,0.00018654513,0.005047616,0.00072371005,0.02283059,0.00044506346,0.06434653,0.000011390541,0.26860914,0.00027272312],"about_ca_topic_score_codex":0.0006477211,"about_ca_topic_score_gemma":0.00024021463,"teacher_disagreement_score":0.26775807,"about_ca_system_score_codex":0.00032021006,"about_ca_system_score_gemma":0.00031256527,"threshold_uncertainty_score":0.30898207},"labels":[],"label_agreement":null},{"id":"W3046818137","doi":"10.1177/1078155220945374","title":"Off-label infusion of biosimilar bevacizumab: A provincial experience","year":2020,"lang":"en","type":"article","venue":"Journal of Oncology Pharmacy Practice","topic":"Biosimilars and Bioanalytical Methods","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba; CancerCare Manitoba","funders":"","keywords":"Bevacizumab; Biosimilar; Medicine; Pharmacology; Surgery; Internal medicine; Chemotherapy","score_opus":0.09157931705200487,"score_gpt":0.4237562736411736,"score_spread":0.3321769565891687,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3046818137","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.82385075,0.015851539,0.0023806812,0.13810425,0.0042408183,0.0007384516,0.00006759245,0.000061126855,0.014704772],"genre_scores_gemma":[0.9609837,0.0027338546,0.01894616,0.016756028,0.00040839557,0.000004835355,0.0000023367954,0.000022328957,0.00014236802],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.99713063,0.0011244619,0.0010711938,0.00022859618,0.00013596033,0.00030916758],"domain_scores_gemma":[0.9960798,0.0013531988,0.001637533,0.00014133466,0.0006607327,0.00012740625],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0013522852,0.00019789733,0.0006749202,0.000119096185,0.000109564775,0.00001171027,0.0004952066,0.00026438126,0.0010080215],"category_scores_gemma":[0.0039627394,0.000150798,0.00018757452,0.00034110888,0.00042211407,0.0005683334,0.00019362081,0.0011046462,0.0000415756],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008512239,0.0011983018,0.0007057436,0.00004087066,0.00044229656,0.0002388289,0.0019820065,0.0000022690492,0.8342089,0.00016345773,0.018073665,0.13443144],"study_design_scores_gemma":[0.0054500974,0.002775508,0.00014234219,0.000023373559,0.00045854837,0.0010216215,0.0007919401,0.00006395536,0.22917508,0.00002264831,0.7599379,0.0001370292],"about_ca_topic_score_codex":0.000014883282,"about_ca_topic_score_gemma":0.0000015524539,"teacher_disagreement_score":0.7418642,"about_ca_system_score_codex":0.00008502458,"about_ca_system_score_gemma":0.0006019888,"threshold_uncertainty_score":0.99990517},"labels":[],"label_agreement":null},{"id":"W3080500936","doi":"10.1177/1078155220950412","title":"Clinical pharmacy services in an ambulatory oncology clinic: Patient perception and satisfaction","year":2020,"lang":"en","type":"article","venue":"Journal of Oncology Pharmacy Practice","topic":"Pharmaceutical Practices and Patient Outcomes","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Horizon Health Network","funders":"","keywords":"Medicine; Pharmacist; Pharmacy; Ambulatory; Family medicine; Clinical pharmacy; Patient satisfaction; Ambulatory care; Nursing; Health care; Internal medicine","score_opus":0.2740545123783654,"score_gpt":0.5610473654386364,"score_spread":0.286992853060271,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3080500936","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9422884,0.0007882023,0.00003684088,0.052388407,0.0013561411,0.00049518724,0.000003840022,0.000025977177,0.002616979],"genre_scores_gemma":[0.92518926,0.008495599,0.00450444,0.060693752,0.0010674556,0.0000059761564,0.000005584932,0.000027655597,0.000010300921],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.99447745,0.0024099315,0.0019478129,0.00037733724,0.00046640742,0.0003210627],"domain_scores_gemma":[0.9932742,0.0030122683,0.0021502909,0.00014103513,0.00047765026,0.00094455504],"candidate_categories":["research_integrity"],"consensus_categories":[],"category_scores_codex":[0.0029131237,0.00024087707,0.0009140522,0.00018784759,0.00008905153,0.000035492838,0.00014505551,0.00018362388,0.0008404797],"category_scores_gemma":[0.0013447275,0.00020453527,0.00018996057,0.00023990893,0.00015657269,0.0027824119,0.00010391333,0.0025866749,0.00009394307],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.02253807,0.0019294755,0.56922746,0.00012335264,0.00024392465,0.0012318525,0.0025873925,0.000017168928,0.0047826073,0.000004209411,0.00095285656,0.39636165],"study_design_scores_gemma":[0.018863538,0.009732318,0.16180177,0.000052120886,0.0013497999,0.0024400523,0.0039103925,0.005593292,0.00011219607,0.000014890922,0.7959359,0.00019370385],"about_ca_topic_score_codex":0.00008233298,"about_ca_topic_score_gemma":0.000022332604,"teacher_disagreement_score":0.7949831,"about_ca_system_score_codex":0.0003339387,"about_ca_system_score_gemma":0.0007324463,"threshold_uncertainty_score":0.9997144},"labels":[],"label_agreement":null},{"id":"W3081239366","doi":"10.1177/1078155220951845","title":"Evaluating genomic biomarkers associated with resistance or sensitivity to chemotherapy in patients with advanced breast and colorectal cancer","year":2020,"lang":"en","type":"article","venue":"Journal of Oncology Pharmacy Practice","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Medicine; Capecitabine; Oncology; Internal medicine; Colorectal cancer; Breast cancer; Oxaliplatin; Population; Irinotecan; Bevacizumab; Cohort; Cancer; Chemotherapy","score_opus":0.023036834099459485,"score_gpt":0.36349604843974925,"score_spread":0.34045921434028975,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3081239366","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99140066,0.0002959108,0.000096548174,0.007675439,0.00007903502,0.00030041006,0.00004846001,0.0000025390073,0.00010099611],"genre_scores_gemma":[0.98886627,0.0005713155,0.004915086,0.0054652425,0.00013246229,0.000009380306,0.000007313052,0.000024576102,0.000008334782],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9988867,0.00023957997,0.00028100132,0.00023100676,0.00016854182,0.00019317579],"domain_scores_gemma":[0.99837065,0.00034497512,0.00059413677,0.00006090101,0.00045464918,0.00017467022],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00059073395,0.00014160482,0.0002661416,0.000041850297,0.000050589653,0.000020625914,0.00008016347,0.00005454069,0.000011361908],"category_scores_gemma":[0.0009379083,0.000109404966,0.000024739538,0.00017837861,0.000058520942,0.000029037075,0.000046418885,0.00020773825,4.2086754e-7],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.24764305,0.0009323076,0.20801724,0.000033443608,0.0012713185,0.00034426764,0.0009995459,0.0043412102,0.4720112,0.000001587197,0.0024873056,0.061917506],"study_design_scores_gemma":[0.0703912,0.020967927,0.7812793,0.0002557565,0.0007337832,0.0004902427,0.00077345077,0.0007491661,0.03455733,0.0000035046223,0.08890613,0.0008921795],"about_ca_topic_score_codex":0.000020721234,"about_ca_topic_score_gemma":0.0004796669,"teacher_disagreement_score":0.5732621,"about_ca_system_score_codex":0.00020401257,"about_ca_system_score_gemma":0.0008060064,"threshold_uncertainty_score":0.44614053},"labels":[],"label_agreement":null},{"id":"W3090557829","doi":"10.1177/1078155220960823","title":"Assessment of Canadian patient education material for oncology pharmaceutics","year":2020,"lang":"en","type":"article","venue":"Journal of Oncology Pharmacy Practice","topic":"Health Literacy and Information Accessibility","field":"Health Professions","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of British Columbia; BC Cancer Agency","funders":"Canadian Institutes of Health Research","keywords":"Readability; Medicine; Health literacy; Reading (process); Comprehension; Index (typography); Patient education; Health care; Literacy; Medical education; Family medicine; Oncology; Medical physics; Psychology; Pedagogy; World Wide Web","score_opus":0.210418510204725,"score_gpt":0.6111942620725934,"score_spread":0.4007757518678684,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3090557829","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.5294603,0.00033426605,0.004212665,0.26339832,0.020934194,0.004309625,0.00044604426,0.00003667708,0.17686789],"genre_scores_gemma":[0.80110735,0.00075043336,0.0639835,0.13217694,0.001776773,0.000099065364,0.00004445719,0.000019412279,0.00004206254],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.994413,0.0019156485,0.0028849351,0.00013104838,0.00025901996,0.00039630826],"domain_scores_gemma":[0.9889099,0.0023760991,0.0050922753,0.00011804399,0.0027205453,0.00078311516],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0043445593,0.00013043162,0.0005072029,0.00037931756,0.00035445686,0.000011531501,0.00026950912,0.00017850446,0.0015746605],"category_scores_gemma":[0.0031467185,0.00011295294,0.00009894626,0.00037453123,0.0000521243,0.0017475656,0.0000532082,0.001196297,0.000024676043],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.007570586,0.0021106252,0.015734592,0.0019811175,0.00034101226,0.000032513126,0.029224023,0.00013260556,0.0056040077,0.0023791192,0.31716567,0.6177241],"study_design_scores_gemma":[0.0022036664,0.0014105263,0.00075214,0.00004385096,0.00018595117,0.000050496903,0.0061812913,0.0017341048,0.0008566342,0.000043627042,0.9864494,0.00008826844],"about_ca_topic_score_codex":0.0026135813,"about_ca_topic_score_gemma":0.00034200985,"teacher_disagreement_score":0.66928375,"about_ca_system_score_codex":0.0014173335,"about_ca_system_score_gemma":0.028914757,"threshold_uncertainty_score":0.99933803},"labels":[],"label_agreement":null},{"id":"W3092092024","doi":"10.1177/1078155220962192","title":"Impact of dose-capping chemotherapy in concurrent chemoradiotherapy in rectal cancer patients","year":2020,"lang":"en","type":"article","venue":"Journal of Oncology Pharmacy Practice","topic":"Colorectal Cancer Surgical Treatments","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"Alberta Innovates - Health Solutions","keywords":"Medicine; Colorectal cancer; Toxicity; Chemotherapy; Internal medicine; Odds ratio; Chemoradiotherapy; Gastroenterology; Urology; Cancer; Body surface area; Surgery","score_opus":0.07881382300837912,"score_gpt":0.4776368017900626,"score_spread":0.3988229787816835,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3092092024","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98667693,0.0018299343,0.000006304748,0.009072586,0.00037388716,0.00044887696,0.0000068285017,0.0000061764426,0.0015784565],"genre_scores_gemma":[0.99199104,0.005055388,0.00038892566,0.0022446348,0.00027269142,0.000014170143,0.0000020285192,0.000023627581,0.0000074860336],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99799263,0.00030841463,0.00088882004,0.00019038224,0.00036183093,0.00025790362],"domain_scores_gemma":[0.997579,0.0006075484,0.0011230265,0.00007140829,0.00036005562,0.00025898914],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00051020755,0.00018829716,0.0009189799,0.0002008081,0.000013152487,0.000006960857,0.00013478922,0.00008247288,0.0006543175],"category_scores_gemma":[0.0006562245,0.00014809007,0.00023970462,0.0005985308,0.000064496235,0.0004368002,0.000024035178,0.0008227241,0.0000034777258],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.036083207,0.0045709056,0.787112,0.00006185316,0.0007450148,0.0007758185,0.0030381943,0.00013210157,0.013148042,0.0000013061369,0.00085094577,0.15348059],"study_design_scores_gemma":[0.115141325,0.014385147,0.79458493,0.00031489172,0.00035526618,0.00049562735,0.00021769074,0.0010348426,0.006728453,0.0000065196623,0.066471666,0.00026363746],"about_ca_topic_score_codex":0.00029061554,"about_ca_topic_score_gemma":0.000012378089,"teacher_disagreement_score":0.15321694,"about_ca_system_score_codex":0.0018992726,"about_ca_system_score_gemma":0.0012334341,"threshold_uncertainty_score":0.7164318},"labels":[],"label_agreement":null},{"id":"W3092126151","doi":"10.1177/1078155220963550","title":"An exploration of mercaptopurine/methotrexate tolerance during maintenance therapy in children with acute lymphoblastic leukemia","year":2020,"lang":"en","type":"article","venue":"Journal of Oncology Pharmacy Practice","topic":"Acute Lymphoblastic Leukemia research","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Izaak Walton Killam Health Centre; Dalhousie University","funders":"","keywords":"Medicine; Mercaptopurine; Maintenance therapy; Methotrexate; Lymphoblastic Leukemia; Internal medicine; Leukemia; Pediatrics; Chemotherapy","score_opus":0.05078809239460636,"score_gpt":0.3882808544407327,"score_spread":0.3374927620461263,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3092126151","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98546976,0.00029478697,0.0041090306,0.008966993,0.000095288626,0.0005207743,0.0000058620512,0.00001951687,0.00051797053],"genre_scores_gemma":[0.9774741,0.004461788,0.015098191,0.002390361,0.00047748795,0.000016126238,0.0000044362187,0.000047398473,0.000030093406],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99699724,0.0006278841,0.00095548446,0.00031195357,0.00070801284,0.00039940808],"domain_scores_gemma":[0.9965692,0.00060038024,0.0013458062,0.00022989628,0.00085043086,0.00040424932],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010360634,0.00024552888,0.00078755926,0.00027099584,0.000054987522,0.00002121357,0.00035832616,0.00009769594,0.00008553228],"category_scores_gemma":[0.0008977393,0.0001827789,0.00010063525,0.0006783702,0.00017916418,0.0029006703,0.00005024405,0.0009612852,0.000012197091],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.18418342,0.0028165572,0.065290704,0.00019978099,0.0034152323,0.011432163,0.007873499,0.015317088,0.6667967,0.00007978137,0.0010553185,0.041539785],"study_design_scores_gemma":[0.27230752,0.04363801,0.16785423,0.00094241987,0.003101426,0.08084664,0.0037879157,0.040240433,0.36518317,0.00010630273,0.020787321,0.0012045891],"about_ca_topic_score_codex":0.00007741886,"about_ca_topic_score_gemma":0.0000032647238,"teacher_disagreement_score":0.30161348,"about_ca_system_score_codex":0.0014524442,"about_ca_system_score_gemma":0.003543705,"threshold_uncertainty_score":0.74535066},"labels":[],"label_agreement":null},{"id":"W3092974696","doi":"10.1177/1078155220964247","title":"Medication reconciliation in ambulatory oncology new patient clinics","year":2020,"lang":"en","type":"article","venue":"Journal of Oncology Pharmacy Practice","topic":"Pharmaceutical Practices and Patient Outcomes","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Alberta Health Services","funders":"","keywords":"Medicine; Ambulatory; Pharmacist; Flexibility (engineering); Medical emergency; Patient safety; Health care; Ambulatory care; Family medicine; Pharmacy; Internal medicine","score_opus":0.2883116566109833,"score_gpt":0.5292934698727221,"score_spread":0.2409818132617388,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3092974696","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.46559376,0.00325359,0.0011069435,0.50361335,0.0032053303,0.00084517204,0.0000032478981,0.000037385154,0.022341188],"genre_scores_gemma":[0.8475101,0.0062670987,0.015553004,0.12911698,0.0014493511,0.000005236927,0.000007254815,0.00002581246,0.00006517547],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9967528,0.000779346,0.0014798458,0.00021393257,0.00052576704,0.00024828344],"domain_scores_gemma":[0.9928357,0.0035149415,0.0023504607,0.000121634715,0.0004427033,0.00073456333],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0020306613,0.00015742143,0.0006175486,0.0001400573,0.000041570274,0.00001234367,0.00015517605,0.0001695239,0.0005386131],"category_scores_gemma":[0.0082619265,0.0001351093,0.00018925456,0.00032526176,0.00006249006,0.0011863355,0.000056885725,0.0018067528,0.000104210885],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.025423901,0.002822173,0.047867596,0.00012262614,0.0006342351,0.0018401685,0.007366238,0.00023924284,0.0046646805,0.00009755573,0.064084455,0.8448371],"study_design_scores_gemma":[0.012498143,0.0045656376,0.0019353859,0.00003651698,0.0007823851,0.0011735404,0.0009838366,0.0050342283,0.0006810172,0.0000431886,0.97215337,0.00011272851],"about_ca_topic_score_codex":0.000025500824,"about_ca_topic_score_gemma":0.0000034525772,"teacher_disagreement_score":0.90806895,"about_ca_system_score_codex":0.00067717704,"about_ca_system_score_gemma":0.0028302153,"threshold_uncertainty_score":0.9890894},"labels":[],"label_agreement":null},{"id":"W3094894289","doi":"10.1177/1078155220969797","title":"Risks of hepatitis C virus reactivation in a real-life population of oncology patients treated in an academic center","year":2020,"lang":"en","type":"article","venue":"Journal of Oncology Pharmacy Practice","topic":"Hepatitis C virus research","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier de l’Université de Montréal; Université de Montréal","funders":"","keywords":"Medicine; Internal medicine; Hepatitis C virus; Population; Hepatocellular carcinoma; Gastroenterology; Entecavir; Chemotherapy; Hepatitis C; Decompensation; Immunology; Hepatitis B virus; Virus; Lamivudine","score_opus":0.26556071281829735,"score_gpt":0.5367321290823053,"score_spread":0.2711714162640079,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3094894289","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9914288,0.000065892884,0.000016938002,0.005675241,0.00015977182,0.00055112,0.000023440098,0.0000073923343,0.0020713853],"genre_scores_gemma":[0.9911556,0.006421574,0.00066585845,0.0014986737,0.00017192024,0.000010371343,0.0000464307,0.000025415966,0.0000041098633],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99467164,0.0023671675,0.0018525339,0.00021418292,0.00062337815,0.0002710822],"domain_scores_gemma":[0.9948495,0.0013422209,0.002392468,0.00013129013,0.0009555924,0.000328909],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.002075296,0.00015178115,0.00086843385,0.0006588244,0.000023623703,0.0000043182617,0.00018764436,0.00026860277,0.00016473139],"category_scores_gemma":[0.00884676,0.00014404977,0.00008708303,0.00072141766,0.00008032499,0.0013714238,0.00005792101,0.0020086702,0.000007731335],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.014369412,0.0026145729,0.8853759,0.0000755603,0.000107627864,0.00035045482,0.0020180563,0.00005728348,0.03640618,0.000009707442,0.00038388124,0.058231357],"study_design_scores_gemma":[0.018630072,0.006673165,0.95051605,0.00013386598,0.00018711943,0.00007250982,0.00019995307,0.0019318195,0.0057766386,0.00001137596,0.015766323,0.000101136444],"about_ca_topic_score_codex":0.012404711,"about_ca_topic_score_gemma":0.0010217489,"teacher_disagreement_score":0.06514012,"about_ca_system_score_codex":0.0010769193,"about_ca_system_score_gemma":0.0009029006,"threshold_uncertainty_score":0.9995021},"labels":[],"label_agreement":null},{"id":"W3095755590","doi":"10.1177/1078155220968613","title":"Actual body weight dosing of temozolomide and overall survival in patients with glioblastoma","year":2020,"lang":"en","type":"article","venue":"Journal of Oncology Pharmacy Practice","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Alberta Health; Alberta Health Services; Fraser Health","funders":"","keywords":"Temozolomide; Medicine; Body surface area; Dosing; Toxicity; Clinical endpoint; Glioblastoma; Phases of clinical research; Internal medicine; Dacarbazine; Body weight; Chemotherapy; Oncology; Clinical trial","score_opus":0.024541129886818922,"score_gpt":0.3406331577519476,"score_spread":0.31609202786512863,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3095755590","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.983878,0.00032112838,0.0000078406465,0.014620233,0.00015279284,0.00020968022,0.0000037326604,0.00000426719,0.0008022807],"genre_scores_gemma":[0.99569577,0.00035131036,0.0020033796,0.0017734845,0.00015514315,0.000002002453,0.0000014662388,0.000014612443,0.0000028426853],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.998631,0.00022064193,0.0005163236,0.00013711139,0.0003311952,0.00016373444],"domain_scores_gemma":[0.9976505,0.0008837941,0.0008478276,0.00006653564,0.00032323063,0.00022813224],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00037847378,0.00013326791,0.0005374037,0.00013841169,0.000027066259,0.000010140398,0.000062507475,0.000048350958,0.00006487412],"category_scores_gemma":[0.00063663546,0.00009283198,0.000057699468,0.00016154122,0.000063276646,0.0005038609,0.000038734957,0.00041874967,0.0000032700048],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.04963061,0.005005582,0.9175537,0.000073611984,0.0009804323,0.0032266658,0.0012026866,0.000021091939,0.011184678,0.00003720746,0.0016614936,0.009422229],"study_design_scores_gemma":[0.12990701,0.031791832,0.675051,0.0002898106,0.0030722595,0.0019923144,0.0006954906,0.00029114628,0.025836172,0.000014846147,0.13077395,0.00028422524],"about_ca_topic_score_codex":0.000022887241,"about_ca_topic_score_gemma":0.0000038121168,"teacher_disagreement_score":0.24250276,"about_ca_system_score_codex":0.000142494,"about_ca_system_score_gemma":0.0002739213,"threshold_uncertainty_score":0.37855783},"labels":[],"label_agreement":null},{"id":"W3097320822","doi":"10.1177/1078155220967738","title":"A multicenter review of infusion-related reactions to daratumumab for relapsed multiple myeloma in the real world setting","year":2020,"lang":"en","type":"review","venue":"Journal of Oncology Pharmacy Practice","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Research Institute in Oncology and Hematology; University of Manitoba; CancerCare Manitoba","funders":"","keywords":"Daratumumab; Medicine; Multiple myeloma; Internal medicine; Oncology","score_opus":0.12117873050926282,"score_gpt":0.5053502990464438,"score_spread":0.384171568537181,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3097320822","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000045822704,0.96814173,0.000017362436,0.021643365,0.0005371457,0.005691226,0.00008467496,0.000013539295,0.0038251395],"genre_scores_gemma":[0.00021729675,0.9874665,0.008665419,0.002523039,0.00040020453,0.00031898494,0.000097740005,0.00006436755,0.00024642673],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9927708,0.002540934,0.0030664585,0.00037253814,0.00077640207,0.0004728956],"domain_scores_gemma":[0.9801883,0.0137889,0.0041300245,0.00041043333,0.0010501671,0.00043219156],"candidate_categories":["metaresearch","metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.0049248454,0.00043582593,0.0029059926,0.00075579423,0.00013941756,0.000023461027,0.0005271897,0.00018388098,0.00013760611],"category_scores_gemma":[0.023922475,0.0002700464,0.0009971581,0.0014338089,0.000077604345,0.00040308823,0.00013868547,0.0027272047,0.00005541583],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004233257,0.0018793108,0.000112272726,0.040376794,0.0020036788,0.0031353117,0.00056255114,0.0000010084652,0.000047995247,0.00001000574,0.018465815,0.929172],"study_design_scores_gemma":[0.010325019,0.0014545699,0.000072526054,0.06202361,0.0060564056,0.002774776,0.00015793486,0.00005984271,0.000009640596,0.0000019762356,0.9169022,0.00016151629],"about_ca_topic_score_codex":0.000090124995,"about_ca_topic_score_gemma":0.00003435918,"teacher_disagreement_score":0.9290105,"about_ca_system_score_codex":0.0010004162,"about_ca_system_score_gemma":0.0027425217,"threshold_uncertainty_score":0.99997514},"labels":[],"label_agreement":null},{"id":"W3105095529","doi":"10.1177/1078155220974085","title":"A retrospective review of the real-world experience of the Pegfilgrastim biosimilar (Lapelga®) to the reference biologic (Neulasta®)","year":2020,"lang":"en","type":"review","venue":"Journal of Oncology Pharmacy Practice","topic":"Neutropenia and Cancer Infections","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; Sunnybrook Health Science Centre","funders":"","keywords":"Pegfilgrastim; Medicine; Biosimilar; Febrile neutropenia; Filgrastim; Retrospective cohort study; Internal medicine; Neutropenia; Adverse effect; Incidence (geometry); Surgery; Oncology; Chemotherapy","score_opus":0.15253540125523035,"score_gpt":0.5035109893388551,"score_spread":0.3509755880836247,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3105095529","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00008014232,0.9429077,0.00001189055,0.040213887,0.0018707028,0.0020912406,0.000057660145,0.000009431949,0.01275738],"genre_scores_gemma":[0.0014805,0.9875858,0.00023239215,0.009690204,0.00058863265,0.000100909136,0.0000016044088,0.000032449003,0.00028750158],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9942446,0.002496413,0.001935771,0.00035064426,0.0006909603,0.00028162426],"domain_scores_gemma":[0.98998904,0.0015579279,0.0062348475,0.0007871111,0.0012447924,0.00018628081],"candidate_categories":["research_integrity"],"consensus_categories":[],"category_scores_codex":[0.0018607068,0.00039866488,0.0025523717,0.00014961127,0.0001991986,0.000014755246,0.0013748398,0.00012917798,0.00038408508],"category_scores_gemma":[0.004360312,0.00016418842,0.0011045837,0.002137936,0.00041951836,0.00020537917,0.00046265917,0.0027936513,0.000020870219],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0026194572,0.0019746784,0.0015799897,0.046587195,0.004377845,0.000513875,0.0022242013,0.0000064036713,0.0012155005,0.0009396694,0.14717396,0.7907872],"study_design_scores_gemma":[0.00061030575,0.001059415,0.00028465976,0.028468804,0.0072530075,0.0028792534,0.0001473404,5.3682606e-7,0.00014582076,0.000007900837,0.95900893,0.00013405035],"about_ca_topic_score_codex":0.000069926115,"about_ca_topic_score_gemma":0.00003242683,"teacher_disagreement_score":0.81183493,"about_ca_system_score_codex":0.000765835,"about_ca_system_score_gemma":0.003562702,"threshold_uncertainty_score":0.99950695},"labels":[],"label_agreement":null},{"id":"W3112230402","doi":"10.1177/1078155220978446","title":"Accurate determination of glomerular filtration rate in adults for carboplatin dosing: Moving beyond Cockcroft and Gault","year":2020,"lang":"en","type":"review","venue":"Journal of Oncology Pharmacy Practice","topic":"Chemotherapy-induced organ toxicity mitigation","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Cégep de l'Outaouais; University of Ottawa; Ottawa Hospital","funders":"","keywords":"Carboplatin; Dosing; Medicine; Renal function; Extrapolation; Urology; Intensive care medicine; Internal medicine; Oncology; Chemotherapy; Cisplatin; Statistics; Mathematics","score_opus":0.06847210940845423,"score_gpt":0.44502727345405246,"score_spread":0.37655516404559825,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3112230402","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.010147157,0.97959065,0.0014572312,0.0055225645,0.0005735847,0.0023494288,0.000037146558,0.000014879531,0.0003073687],"genre_scores_gemma":[0.0066555603,0.9815375,0.01046115,0.00062601524,0.000571388,0.000024273002,0.000045025874,0.00006144167,0.000017633214],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99672705,0.0007457908,0.0017667271,0.0002770263,0.0002848325,0.000198555],"domain_scores_gemma":[0.9905099,0.0034505108,0.0050881696,0.0001244517,0.0006676951,0.0001592636],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0019564652,0.00030795802,0.0018093712,0.0004471039,0.000048699396,0.000027078633,0.00013019644,0.0003050145,0.000021536744],"category_scores_gemma":[0.005221041,0.0002808442,0.00025222564,0.00041810714,0.00006693204,0.00081386144,0.000030509942,0.0011105111,0.0000016044067],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0021362663,0.00031360233,0.000022414273,0.0101575665,0.00029165015,0.00032085375,0.0011103948,0.0000026329396,0.013022728,0.000007674403,0.00015816333,0.97245604],"study_design_scores_gemma":[0.01439009,0.0020150028,0.00006525331,0.011000344,0.00533791,0.004618042,0.00043115322,0.0021332297,0.0125474455,0.00004707969,0.947064,0.00035046713],"about_ca_topic_score_codex":0.00001301726,"about_ca_topic_score_gemma":0.000008073042,"teacher_disagreement_score":0.97210556,"about_ca_system_score_codex":0.0006308628,"about_ca_system_score_gemma":0.001768927,"threshold_uncertainty_score":0.99996436},"labels":[],"label_agreement":null},{"id":"W3112738960","doi":"10.1177/1078155220979047","title":"Blinatumomab use in pediatric ALL: Taking a BiTE out of preparation, administration and toxicity challenges","year":2020,"lang":"en","type":"article","venue":"Journal of Oncology Pharmacy Practice","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Blinatumomab; Medicine; Food and drug administration; Toxicity; Pharmacy; Minimal residual disease; Pharmacology; Monoclonal antibody; CD19; Oncology; Intensive care medicine; Immunology; Antibody; Internal medicine; Family medicine; Leukemia","score_opus":0.23883833877160415,"score_gpt":0.4993435177847658,"score_spread":0.26050517901316167,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3112738960","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.94150895,0.0029000554,0.00006062248,0.0520932,0.00016701277,0.00032760017,0.0000019832146,0.000007803734,0.002932752],"genre_scores_gemma":[0.9774445,0.018465292,0.0019086482,0.0015149422,0.0005849344,0.0000038751155,0.0000014288606,0.000013600815,0.000062747844],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.99802804,0.00055567187,0.00068932545,0.00016295623,0.00040215228,0.00016186747],"domain_scores_gemma":[0.996344,0.0015871917,0.0012192458,0.00008908466,0.00055372616,0.00020677659],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0017218736,0.00010453944,0.00039756732,0.0002388504,0.000023023036,0.000020899824,0.00009176229,0.00008013938,0.00016824587],"category_scores_gemma":[0.0046321484,0.00009513528,0.00006530109,0.00021799811,0.000051348936,0.00095868023,0.000042749798,0.0007820851,0.0000033953206],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.10766957,0.006162295,0.07444525,0.0011207979,0.0010351088,0.008960331,0.026850075,0.00010340559,0.6817323,0.00019819269,0.0052109337,0.08651174],"study_design_scores_gemma":[0.04238403,0.02947216,0.064172156,0.00015188649,0.0024863232,0.011756153,0.0028361657,0.004206711,0.094818175,0.0000890868,0.7471681,0.00045904264],"about_ca_topic_score_codex":0.000010496824,"about_ca_topic_score_gemma":0.000031362877,"teacher_disagreement_score":0.7419572,"about_ca_system_score_codex":0.0001293743,"about_ca_system_score_gemma":0.000849963,"threshold_uncertainty_score":0.55454487},"labels":[],"label_agreement":null},{"id":"W3115308691","doi":"10.1177/1078155220980051","title":"Results of a pre-implementation analysis of Ethiopia’s National Pediatric Cancer Registry","year":2020,"lang":"en","type":"article","venue":"Journal of Oncology Pharmacy Practice","topic":"Tuberculosis Research and Epidemiology","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; Hospital for Sick Children; University of Toronto","funders":"","keywords":"Medicine; Cancer registry; Documentation; Workflow; Cancer; Pediatric cancer; Family medicine; Database","score_opus":0.15330059917364128,"score_gpt":0.5543706569300876,"score_spread":0.40107005775644633,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3115308691","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.76580167,0.001500733,0.0002442541,0.2271224,0.00020969212,0.00024856383,0.00014395187,0.0000062603303,0.0047224597],"genre_scores_gemma":[0.9827215,0.006589518,0.003107482,0.006743485,0.0007541291,0.000006073388,0.000026594289,0.000007754538,0.00004345229],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.9967886,0.0008300174,0.0013678346,0.00015426349,0.00067675073,0.00018251638],"domain_scores_gemma":[0.9916472,0.0030009842,0.0029743216,0.00009235926,0.0020340644,0.00025110441],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.0032210078,0.00009208406,0.00071710936,0.0004631699,0.000026559459,0.0000033841725,0.00015883875,0.00008507035,0.00041798878],"category_scores_gemma":[0.01480778,0.000076042365,0.0002653471,0.001036272,0.00007649506,0.00033887595,0.00004483488,0.0007271331,0.0000027264214],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.083172336,0.0023931174,0.4150536,0.00063175266,0.02077281,0.00054083543,0.005731219,0.005234837,0.065361135,0.000242929,0.3764851,0.024380308],"study_design_scores_gemma":[0.028194765,0.0068374667,0.34664962,0.00003867625,0.026019137,0.0006320912,0.0021492306,0.0050814655,0.008351311,0.000046443365,0.5757951,0.0002046722],"about_ca_topic_score_codex":0.00048625303,"about_ca_topic_score_gemma":0.00004245674,"teacher_disagreement_score":0.2203789,"about_ca_system_score_codex":0.00021938758,"about_ca_system_score_gemma":0.0023545397,"threshold_uncertainty_score":0.99349093},"labels":[],"label_agreement":null},{"id":"W3123927868","doi":"10.1177/1078155220984252","title":"Safety and efficacy analysis of pembrolizumab dosing patterns in patients with advanced melanoma and non-small cell lung cancer","year":2021,"lang":"en","type":"article","venue":"Journal of Oncology Pharmacy Practice","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"","keywords":"Medicine; Pembrolizumab; Internal medicine; Adverse effect; Lung cancer; Oncology; Melanoma; Dosing; Cancer; Clinical endpoint; Ipilimumab; Area under the curve; Retrospective cohort study; Immunotherapy; Clinical trial","score_opus":0.013520859069533205,"score_gpt":0.34912054884712973,"score_spread":0.3355996897775965,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3123927868","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99293107,0.0044295774,0.000118652555,0.0017802392,0.00013225539,0.00018268246,0.00001266383,0.000001951097,0.00041092557],"genre_scores_gemma":[0.98768467,0.009998858,0.0012545396,0.00097277266,0.00004281028,0.0000020979203,0.0000056639838,0.000011937193,0.000026665346],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9987139,0.0002006723,0.00056415633,0.0001647905,0.00020039256,0.00015605256],"domain_scores_gemma":[0.99787223,0.0005887684,0.0009213722,0.00010093082,0.00041642218,0.000100244964],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00045615938,0.00012325919,0.0006114154,0.00027515317,0.000038874106,0.0000116861365,0.00005079381,0.000050837807,0.000107251064],"category_scores_gemma":[0.000101250385,0.00009620432,0.00008374583,0.0004717525,0.0000551947,0.00030255987,0.000031544056,0.00036870915,6.8334934e-8],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.06164818,0.0011007357,0.85767627,0.00013198718,0.0030771731,0.00040311896,0.0011716203,0.00016480859,0.009246784,3.942999e-7,0.000031666255,0.06534727],"study_design_scores_gemma":[0.051794823,0.0011932872,0.92705184,0.00021485618,0.006365562,0.00021957268,0.0004764553,0.00036362075,0.003539326,1.6586665e-7,0.008672576,0.00010793665],"about_ca_topic_score_codex":0.000132641,"about_ca_topic_score_gemma":0.00010199368,"teacher_disagreement_score":0.06937556,"about_ca_system_score_codex":0.00024846548,"about_ca_system_score_gemma":0.0005369154,"threshold_uncertainty_score":0.39230984},"labels":[],"label_agreement":null},{"id":"W3128155601","doi":"10.1177/1078155221991202","title":"Development of a process map for the delivery of virtual clinical pharmacy services at Odette Cancer Centre during the COVID-19 pandemic","year":2021,"lang":"en","type":"article","venue":"Journal of Oncology Pharmacy Practice","topic":"Telemedicine and Telehealth Implementation","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Thunder Bay Regional Health Sciences Centre; University of Toronto; Sunnybrook Health Science Centre","funders":"","keywords":"Pharmacy; Medicine; Workflow; Pandemic; Clinical pharmacy; Telemedicine; Medical emergency; Coronavirus disease 2019 (COVID-19); Family medicine; Health care; Internal medicine; Disease","score_opus":0.1941331107015844,"score_gpt":0.555415230940486,"score_spread":0.36128212023890155,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3128155601","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.91177005,0.00286136,0.00020372617,0.0837484,0.0007891854,0.0005694577,0.000019550424,0.0000070718447,0.000031181833],"genre_scores_gemma":[0.9543501,0.008049346,0.002921115,0.033416886,0.0010386985,0.00003839247,0.000011642287,0.000020564845,0.0001532287],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.99692225,0.00047796746,0.0016832625,0.00016593406,0.00049334613,0.0002572378],"domain_scores_gemma":[0.99095875,0.004488511,0.002877221,0.00013565442,0.001301631,0.00023825577],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003133658,0.00013595977,0.00051196036,0.00007428779,0.00024290834,0.000006156158,0.00022248639,0.000048550737,0.00050915754],"category_scores_gemma":[0.0010654337,0.00008023456,0.00014686631,0.00019562211,0.00011419258,0.00029482003,0.00009029364,0.0005918689,0.0000020901396],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.04388689,0.0022507617,0.6718408,0.0044839056,0.0045680217,0.0005399337,0.025855135,0.00026272956,0.033885475,0.00001608565,0.021979483,0.19043076],"study_design_scores_gemma":[0.020551424,0.0003486554,0.007167657,0.000107165986,0.0020428803,0.0016146048,0.015352187,0.0002768738,0.014655202,0.000004157167,0.93780273,0.00007645303],"about_ca_topic_score_codex":0.00010752185,"about_ca_topic_score_gemma":0.0004109713,"teacher_disagreement_score":0.9158233,"about_ca_system_score_codex":0.00045917084,"about_ca_system_score_gemma":0.005771315,"threshold_uncertainty_score":0.99986506},"labels":[],"label_agreement":null},{"id":"W3128521569","doi":"10.1177/1078155221992103","title":"Surface contamination with nine antineoplastic drugs in 109 canadian centers; 10 years of a monitoring program","year":2021,"lang":"en","type":"article","venue":"Journal of Oncology Pharmacy Practice","topic":"Safe Handling of Antineoplastic Drugs","field":"Health Professions","cited_by":23,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Université de Montréal; Institut National de Santé Publique du Québec; Centre Hospitalier Universitaire Sainte-Justine","funders":"","keywords":"Medicine; Contamination; Docetaxel; Antineoplastic Drugs; Cabazitaxel; Drug packaging; Body surface area; Adverse effect; Cyclophosphamide; Ifosfamide; Biological safety; Toxicology; Internal medicine; Pharmacology; Cancer; Chemotherapy","score_opus":0.053062162136837086,"score_gpt":0.45872665097134774,"score_spread":0.4056644888345107,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3128521569","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98573434,0.00033183774,0.000048015496,0.0051769526,0.0018561325,0.0003546164,0.0000068545637,0.000015073604,0.0064761685],"genre_scores_gemma":[0.9872289,0.00042236637,0.010954334,0.00030940273,0.00036396654,0.000007749581,0.0000049025593,0.000028892207,0.000679536],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.9968011,0.0010816919,0.0010270552,0.0001844386,0.0004099387,0.0004958025],"domain_scores_gemma":[0.9908556,0.005535022,0.0016582718,0.00013515493,0.0015357459,0.00028023063],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0021844804,0.00014933517,0.0005214036,0.0003145072,0.00012902472,0.000012524702,0.00019058927,0.00012361388,0.00034370812],"category_scores_gemma":[0.0041533327,0.00014370175,0.00005943061,0.00056959694,0.000071104194,0.0005919475,0.000052182633,0.0013418033,0.0000361467],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0070208055,0.0024634067,0.8930434,0.00042411094,0.0006463885,0.0066080615,0.015117413,0.0012136882,0.007491808,0.00006720432,0.004942615,0.06096109],"study_design_scores_gemma":[0.029374734,0.0021394659,0.26246357,0.0023504212,0.0008860069,0.0019165641,0.028880412,0.0011062386,0.003412612,0.000008836613,0.66703814,0.0004229739],"about_ca_topic_score_codex":0.006533459,"about_ca_topic_score_gemma":0.006178304,"teacher_disagreement_score":0.66209555,"about_ca_system_score_codex":0.0005987654,"about_ca_system_score_gemma":0.008943016,"threshold_uncertainty_score":0.9966754},"labels":[],"label_agreement":null},{"id":"W3139398038","doi":"10.1177/10781552211004705","title":"Assessing the risk of venous thromboembolism (VTE) in ambulatory patients with cancer: Rationale and implementation of a pharmacist-led VTE risk assessment program in an ambulatory cancer centre","year":2021,"lang":"en","type":"article","venue":"Journal of Oncology Pharmacy Practice","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Waterloo","funders":"","keywords":"Medicine; Ambulatory; Risk assessment; Cancer; Pharmacist; Pharmacy; Intensive care medicine; Venous thromboembolism; Framingham Risk Score; Guideline; Clinical trial; Emergency medicine; Internal medicine; Thrombosis; Family medicine; Pathology","score_opus":0.031344573049732226,"score_gpt":0.45946471313867665,"score_spread":0.42812014008894445,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3139398038","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.994012,0.0019858596,0.000026978914,0.002183876,0.000372199,0.0012083576,0.000038394533,0.0000060255597,0.00016631212],"genre_scores_gemma":[0.98152983,0.013299946,0.0041722823,0.0007268304,0.00014323046,0.000083847954,0.000016420643,0.00002393534,0.0000036840104],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99685633,0.0010742613,0.0009867179,0.0002443164,0.00057915953,0.00025921853],"domain_scores_gemma":[0.9955311,0.000549926,0.0025829584,0.00016860712,0.0010471646,0.00012023406],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0017164439,0.00018680455,0.0008260719,0.00018826746,0.00010158267,0.000040325365,0.00011557081,0.00005477876,0.00017740917],"category_scores_gemma":[0.00013659523,0.00013844072,0.00009070192,0.00036037466,0.00011857202,0.0011633502,0.00006714327,0.00072441925,2.0324823e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00060255616,0.008136132,0.8554588,0.00020306863,0.0012785391,0.00013858652,0.0044625085,0.0013242459,0.0014355822,0.000023552331,0.000386088,0.12655036],"study_design_scores_gemma":[0.016621718,0.0010342919,0.9573189,0.00023844102,0.0031912753,0.000038225025,0.006594253,0.0012290365,0.0015033071,0.000018686475,0.012084083,0.00012775711],"about_ca_topic_score_codex":0.0015447127,"about_ca_topic_score_gemma":0.0013321959,"teacher_disagreement_score":0.1264226,"about_ca_system_score_codex":0.000577377,"about_ca_system_score_gemma":0.0020334986,"threshold_uncertainty_score":0.56454486},"labels":[],"label_agreement":null},{"id":"W3159791832","doi":"10.1177/10781552211007535","title":"Education strategy for the implementation of oncology biosimilars essential for operational and patient safety in Alberta, Canada","year":2021,"lang":"en","type":"article","venue":"Journal of Oncology Pharmacy Practice","topic":"Biosimilars and Bioanalytical Methods","field":"Immunology and Microbiology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Alberta Health Services; Alberta Cancer Foundation","funders":"","keywords":"Biosimilar; Medicine; Pharmacy; Harm; Patient safety; Oncology; Internal medicine; Family medicine; Health care","score_opus":0.0369520180908905,"score_gpt":0.4361260698854512,"score_spread":0.3991740517945607,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3159791832","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.28628498,0.019510876,0.007075451,0.6686357,0.011907021,0.0031032225,0.0005349684,0.0000058900473,0.0029418755],"genre_scores_gemma":[0.97634816,0.0017586291,0.010062518,0.011406918,0.00016569902,0.000049061793,0.000043728785,0.000011069198,0.00015423825],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99819565,0.0006590089,0.0007685887,0.00014310496,0.00005409922,0.00017956833],"domain_scores_gemma":[0.99268746,0.0056277732,0.00076623424,0.00007094377,0.00081538525,0.000032213014],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010659796,0.00010027554,0.0003166849,0.00005889709,0.00012637027,0.000010544777,0.000106520594,0.000114008835,0.00028946894],"category_scores_gemma":[0.0009349245,0.00007317482,0.00007677864,0.00010626267,0.000106559724,0.0002012042,0.000034441895,0.0002984969,2.1775509e-7],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.006435655,0.0015781734,0.0013071032,0.00006800338,0.0012391745,0.000020816698,0.00088351005,0.00012741373,0.09918984,0.0037115936,0.07701407,0.80842465],"study_design_scores_gemma":[0.004675235,0.001077742,0.0013616702,0.00001036774,0.00048762266,0.0006569046,0.0059094764,0.00006196885,0.072485074,0.00014306542,0.91305226,0.00007862514],"about_ca_topic_score_codex":0.017323423,"about_ca_topic_score_gemma":0.11019644,"teacher_disagreement_score":0.8360382,"about_ca_system_score_codex":0.00025869004,"about_ca_system_score_gemma":0.007163127,"threshold_uncertainty_score":0.99846536},"labels":[],"label_agreement":null},{"id":"W3160148357","doi":"10.1177/10781552211010928","title":"Closed-system transfer device use with oncology biologics: A survey of Canadian healthcare practitioners","year":2021,"lang":"en","type":"article","venue":"Journal of Oncology Pharmacy Practice","topic":"Safe Handling of Antineoplastic Drugs","field":"Health Professions","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Roche (Canada); University of Toronto","funders":"","keywords":"Medicine; Health care; Healthcare system; Family medicine","score_opus":0.25366092318314876,"score_gpt":0.5006360324424663,"score_spread":0.2469751092593176,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3160148357","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8902742,0.0009983956,0.00094202237,0.08338389,0.005269267,0.00088552915,0.00030160803,0.000048739246,0.017896334],"genre_scores_gemma":[0.9746316,0.0019861124,0.011740573,0.010822436,0.0004863886,0.000020538251,0.000050360653,0.0000480276,0.0002139674],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.986375,0.01016146,0.0019084461,0.0003319413,0.0004655565,0.00075763],"domain_scores_gemma":[0.96458906,0.024449665,0.0023967098,0.00028944953,0.0075554308,0.000719705],"candidate_categories":["metaresearch","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.0077205636,0.00027169872,0.0011131555,0.00078515965,0.00051902607,0.000017500595,0.00032798282,0.00042340823,0.0002977897],"category_scores_gemma":[0.010966088,0.00021813005,0.00012213271,0.0013745569,0.0001738522,0.0010587756,0.000052139087,0.00279909,0.00007625611],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.049899705,0.0043642744,0.7672281,0.0025635378,0.005461195,0.032715406,0.027648259,0.0006859064,0.009141776,0.00541735,0.070625514,0.024248922],"study_design_scores_gemma":[0.008866543,0.0019500104,0.047719058,0.0005273862,0.0007440645,0.0047826283,0.021390606,0.000062350875,0.0005009828,0.000006040376,0.91319567,0.00025466722],"about_ca_topic_score_codex":0.19651057,"about_ca_topic_score_gemma":0.35826123,"teacher_disagreement_score":0.8425701,"about_ca_system_score_codex":0.0016848829,"about_ca_system_score_gemma":0.049134355,"threshold_uncertainty_score":0.99950147},"labels":[],"label_agreement":null},{"id":"W3160237041","doi":"10.1177/10781552211013878","title":"Bendamustine-induced nephrogenic diabetes insipidus – A case report","year":2021,"lang":"en","type":"article","venue":"Journal of Oncology Pharmacy Practice","topic":"Chemotherapy-related skin toxicity","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hôpital du Sacré-Cœur de Montréal; Université de Montréal","funders":"","keywords":"Medicine; Bendamustine; Salvage therapy; Etoposide; Diabetes insipidus; Nephrogenic diabetes insipidus; Rituximab; Chemoimmunotherapy; Surgery; Internal medicine; Oncology; Chemotherapy; Lymphoma","score_opus":0.05946062220933491,"score_gpt":0.4267024205602352,"score_spread":0.3672417983509003,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3160237041","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9517586,0.0020007414,0.000061204,0.035974506,0.0013445712,0.00020101503,0.000002668604,0.0000356947,0.008621002],"genre_scores_gemma":[0.97196805,0.0006512212,0.012183782,0.013263861,0.0013992792,0.0000049382465,0.000005221335,0.000052592746,0.00047102946],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.9969283,0.0006292828,0.0012659745,0.0002927782,0.00049227464,0.00039141785],"domain_scores_gemma":[0.9934456,0.001927262,0.0020042309,0.0003857218,0.0017926174,0.0004445847],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.0022184046,0.00023595485,0.00077664107,0.00020532812,0.00012986494,0.000031357136,0.00012734739,0.0002128584,0.000874716],"category_scores_gemma":[0.0085187415,0.00021371551,0.00034030667,0.00055831583,0.0000788621,0.0007140916,0.00008241413,0.0020656278,0.000038337617],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010729359,0.0015557171,0.001442796,0.00003567435,0.0013894873,0.6366163,0.00041039445,0.000008114743,0.3256929,0.0000065434524,0.0069470233,0.02482213],"study_design_scores_gemma":[0.005979778,0.00048737993,0.00012082781,0.000039332408,0.0013570577,0.52709246,0.00039416685,0.00007394541,0.145471,0.000016245966,0.31886646,0.00010131975],"about_ca_topic_score_codex":0.000027518825,"about_ca_topic_score_gemma":0.000010141195,"teacher_disagreement_score":0.31191942,"about_ca_system_score_codex":0.0005708417,"about_ca_system_score_gemma":0.003063772,"threshold_uncertainty_score":0.9998329},"labels":[],"label_agreement":null},{"id":"W3165284022","doi":"10.1177/10781552211017199","title":"International Society of Oncology Pharmacy Practitioners (ISOPP) position statement: Role of the oncology pharmacy team in cancer care","year":2021,"lang":"en","type":"article","venue":"Journal of Oncology Pharmacy Practice","topic":"Safe Handling of Antineoplastic Drugs","field":"Health Professions","cited_by":35,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Alberta Health Services","funders":"","keywords":"Medicine; Pharmacy; Specialty; Health care; Clinical pharmacy; Pharmacy practice; Certification; Oncology; Position statement; Internal medicine; Hospital pharmacy; Family medicine; Nursing; Management","score_opus":0.0796815553989943,"score_gpt":0.5282888441346095,"score_spread":0.44860728873561523,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3165284022","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.6810445,0.004095714,0.00027899485,0.1947431,0.016354188,0.0014737714,0.00027566848,0.000037364494,0.10169671],"genre_scores_gemma":[0.9552776,0.02105192,0.008994032,0.01213407,0.0018222502,0.0001045201,0.000048513608,0.00006048783,0.000506584],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.99167675,0.003739343,0.0027763366,0.0003677611,0.0008443532,0.00059548276],"domain_scores_gemma":[0.9812851,0.006976583,0.0072476296,0.000250559,0.0040274044,0.00021271275],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0037301334,0.0003023492,0.0009685577,0.00029025142,0.00035636817,0.000012237958,0.0006835888,0.00022623214,0.002114021],"category_scores_gemma":[0.002264594,0.00025754495,0.0003973154,0.0006405206,0.00029351565,0.0013827457,0.0004171075,0.0032698724,0.000027362716],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.019672383,0.011307373,0.12958078,0.0010402462,0.0043367865,0.00079274405,0.08562227,0.003909334,0.40801296,0.00048928655,0.19943208,0.13580377],"study_design_scores_gemma":[0.01982803,0.00045466243,0.001449062,0.00036315643,0.000943776,0.00066628214,0.04672205,0.0010102309,0.02492969,0.000078950456,0.9033653,0.00018882018],"about_ca_topic_score_codex":0.0013445922,"about_ca_topic_score_gemma":0.00031280142,"teacher_disagreement_score":0.70393324,"about_ca_system_score_codex":0.003985344,"about_ca_system_score_gemma":0.023512352,"threshold_uncertainty_score":0.99998766},"labels":[],"label_agreement":null},{"id":"W3165558536","doi":"10.1177/10781552211019116","title":"Oncology boot camp: A preparatory curriculum for advanced pharmacy practice experience students","year":2021,"lang":"en","type":"article","venue":"Journal of Oncology Pharmacy Practice","topic":"Pharmaceutical Practices and Patient Outcomes","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Boot camp; Medicine; Pharmacy; Curriculum; Intervention (counseling); Oncology; Medical education; Internal medicine; Pharmacy practice; Family medicine; Nursing; Psychology; Pedagogy","score_opus":0.15549518125223413,"score_gpt":0.577359489756687,"score_spread":0.4218643085044529,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3165558536","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8378396,0.014660078,0.0016008678,0.09591447,0.010362276,0.0028207388,0.0000314007,0.00010709015,0.036663495],"genre_scores_gemma":[0.8394402,0.016266529,0.06393622,0.07618583,0.0022904477,0.00024104032,0.00002352342,0.00011290107,0.0015032737],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99349445,0.0019532742,0.0018829806,0.0006059888,0.0012759586,0.0007873402],"domain_scores_gemma":[0.98020846,0.010852531,0.0036464655,0.00041704878,0.0039165923,0.00095888245],"candidate_categories":["metaresearch","metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0037974073,0.00044225904,0.0012720453,0.00023115645,0.0003039348,0.00009816954,0.00048052953,0.0001793735,0.00076618895],"category_scores_gemma":[0.02292495,0.00038713583,0.00050890865,0.00054547034,0.00021501204,0.004441668,0.0002821284,0.0021950675,0.00010218017],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.18859491,0.083011754,0.09806373,0.00115351,0.0115197925,0.06539085,0.019957932,0.00040447703,0.1675288,0.0006715309,0.13201736,0.23168536],"study_design_scores_gemma":[0.034179803,0.003262403,0.00021143373,0.00009429354,0.004073146,0.02798889,0.0075594014,0.0005660314,0.014454732,0.000024387535,0.90724856,0.00033695158],"about_ca_topic_score_codex":0.000024076904,"about_ca_topic_score_gemma":0.0000038917246,"teacher_disagreement_score":0.7752312,"about_ca_system_score_codex":0.0011464973,"about_ca_system_score_gemma":0.0040707085,"threshold_uncertainty_score":0.9998581},"labels":[],"label_agreement":null},{"id":"W3168852790","doi":"10.1177/10781552211024723","title":"Preventing drug vial wastage and reducing expenditure associated with injectable cancer drugs: International oncology pharmacy survey","year":2021,"lang":"en","type":"article","venue":"Journal of Oncology Pharmacy Practice","topic":"Safe Handling of Antineoplastic Drugs","field":"Health Professions","cited_by":13,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Alberta Health Services","funders":"","keywords":"Vial; Pharmacy; Medicine; Economic shortage; Legislation; Government (linguistics); Family medicine","score_opus":0.08597447481179106,"score_gpt":0.5003286322502933,"score_spread":0.4143541574385023,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3168852790","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.94922763,0.0014508945,0.00019554884,0.02343105,0.009582441,0.00039816866,0.00007015597,0.000045276185,0.015598851],"genre_scores_gemma":[0.97961646,0.0034828414,0.004347103,0.005307026,0.0028394018,0.0000389784,0.000051147406,0.00007579625,0.0042412193],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.99116266,0.005602543,0.0014586895,0.00041624642,0.00067227014,0.0006876214],"domain_scores_gemma":[0.9757201,0.01716756,0.004063823,0.00015909245,0.002569895,0.0003194999],"candidate_categories":["metaresearch","metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.008547015,0.00029846482,0.0008414296,0.00025616935,0.0006854752,0.00005181115,0.00037922332,0.00017319186,0.0017853215],"category_scores_gemma":[0.011728171,0.00025897013,0.00010067876,0.00039032643,0.0001328472,0.0015450163,0.00033651356,0.003339252,0.000022782415],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.029886054,0.006374692,0.49887356,0.00045384179,0.008923799,0.009514696,0.078105524,0.001694608,0.030000566,0.00009098577,0.2420282,0.09405348],"study_design_scores_gemma":[0.030441023,0.00041757163,0.014017109,0.0012681213,0.0014226541,0.002025399,0.021961438,0.0013693321,0.0032165912,0.000026970029,0.92333746,0.0004963084],"about_ca_topic_score_codex":0.0015081314,"about_ca_topic_score_gemma":0.00094628194,"teacher_disagreement_score":0.6813093,"about_ca_system_score_codex":0.0012586312,"about_ca_system_score_gemma":0.010730377,"threshold_uncertainty_score":0.99998623},"labels":[],"label_agreement":null},{"id":"W3199660051","doi":"10.1177/10781552211034473","title":"Defining cytotoxic drugs – you know it when you see it?","year":2021,"lang":"en","type":"review","venue":"Journal of Oncology Pharmacy Practice","topic":"Safe Handling of Antineoplastic Drugs","field":"Health Professions","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Antineoplastic Drugs; Medicine; Confusion; Cytotoxic T cell; Drug; Cancer chemotherapy; Intensive care medicine; Pharmacology; Risk analysis (engineering); Chemotherapy; Surgery; Biology","score_opus":0.15725876243317632,"score_gpt":0.5466091430940703,"score_spread":0.38935038066089395,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3199660051","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000014149537,0.899635,0.00017807678,0.021232096,0.013874384,0.001004188,0.000057146754,0.000060830364,0.0639441],"genre_scores_gemma":[0.0000075006456,0.96158683,0.012635989,0.010525482,0.00511293,0.00009093507,0.00005687246,0.0002259322,0.009757519],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9808317,0.010339205,0.0054652565,0.0007621913,0.0012202609,0.0013814035],"domain_scores_gemma":[0.9372382,0.04458701,0.01428167,0.0006840369,0.0024818312,0.0007272554],"candidate_categories":["metaresearch","metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.013603732,0.0009819168,0.0053936676,0.00089712837,0.0010078482,0.00007758438,0.0014095916,0.0011655239,0.004985917],"category_scores_gemma":[0.02662575,0.0008198883,0.0013422612,0.00078138645,0.00018160632,0.0013653152,0.00075580913,0.012167223,0.0039155255],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00040684044,0.00066437334,0.000028784018,0.007164146,0.002120556,0.0032575466,0.004571425,0.000005644642,0.0000031819047,0.00016488088,0.3701736,0.611439],"study_design_scores_gemma":[0.00430577,0.0003580777,9.1882976e-7,0.032756574,0.01077212,0.007021927,0.00610616,0.000015273843,0.0000018004034,0.000022863202,0.93802655,0.00061195216],"about_ca_topic_score_codex":0.00007373632,"about_ca_topic_score_gemma":0.000015197165,"teacher_disagreement_score":0.610827,"about_ca_system_score_codex":0.0018740696,"about_ca_system_score_gemma":0.03700075,"threshold_uncertainty_score":0.9994252},"labels":[],"label_agreement":null},{"id":"W3202818939","doi":"10.1177/10781552211040176","title":"Barriers and facilitators for the safe handling of antineoplastic drugs","year":2021,"lang":"en","type":"review","venue":"Journal of Oncology Pharmacy Practice","topic":"Safe Handling of Antineoplastic Drugs","field":"Health Professions","cited_by":23,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Government of Canada; Simon Fraser University; Government of Prince Edward Island; University of Calgary; University of British Columbia; World Wildlife Fund Canada; Alberta Health Services","funders":"WorkSafeBC","keywords":"Antineoplastic Drugs; Medicine; Patient safety; Work (physics); Nursing; Health care; Pharmacology; Political science","score_opus":0.14212217737960584,"score_gpt":0.5553594440900238,"score_spread":0.41323726671041794,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3202818939","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00016271486,0.9865995,0.0015740615,0.0024783977,0.0066884873,0.0012658684,0.00010346764,0.000011542139,0.0011159796],"genre_scores_gemma":[0.00013970089,0.99271756,0.0044995854,0.0006872276,0.0013693968,0.00006675137,0.0000073354463,0.00006977931,0.0004426449],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99217975,0.003255163,0.0031291686,0.00034273678,0.0005025331,0.0005906343],"domain_scores_gemma":[0.87172306,0.1188687,0.0071384157,0.00027576106,0.0016733694,0.00032070398],"candidate_categories":["metaresearch","metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.009283836,0.0004587222,0.0031460898,0.00036457065,0.0007695028,0.000022201099,0.00056793034,0.00041684083,0.00030783386],"category_scores_gemma":[0.046704274,0.00029356228,0.0006919062,0.00041901294,0.00029516083,0.00041353147,0.00025308895,0.0032544131,0.000021212185],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011732051,0.00015674287,0.000217209,0.022042582,0.0037491617,0.00020243367,0.0038448882,0.000023181816,0.0000073661836,0.0002904616,0.023922643,0.94437015],"study_design_scores_gemma":[0.0034905395,0.00031321647,0.000003687218,0.011430988,0.010369308,0.0009807467,0.0064476687,0.00006543324,0.0000026069824,0.000011983682,0.96666116,0.00022266676],"about_ca_topic_score_codex":0.00003432623,"about_ca_topic_score_gemma":0.000004338518,"teacher_disagreement_score":0.94414747,"about_ca_system_score_codex":0.00027499435,"about_ca_system_score_gemma":0.015305339,"threshold_uncertainty_score":0.99995166},"labels":[],"label_agreement":null},{"id":"W3203264829","doi":"10.1177/10781552211038031","title":"Case report: Proton pump inhibitor drug-related problem in pancreatic cancer patient unmasks pancreatic enzyme insufficiency","year":2021,"lang":"en","type":"article","venue":"Journal of Oncology Pharmacy Practice","topic":"Pancreatitis Pathology and Treatment","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Alberta Health Services","funders":"","keywords":"Medicine; Palliative care; Gemcitabine; Proton-pump inhibitor; Cancer; Intensive care medicine; Pancreatic cancer; Internal medicine; Nursing","score_opus":0.03216640220981898,"score_gpt":0.37754402234664647,"score_spread":0.3453776201368275,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3203264829","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9696443,0.007240553,0.000021208221,0.009990377,0.000864857,0.001412879,0.000011068876,0.000031370597,0.010783406],"genre_scores_gemma":[0.9878672,0.0036679453,0.0055208313,0.0015127558,0.00025544566,0.00031365114,0.000016069978,0.000042073185,0.00080407003],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.9950522,0.00144589,0.0019948322,0.0004708584,0.0005069151,0.0005293092],"domain_scores_gemma":[0.99464965,0.0012101254,0.0023317977,0.00035758765,0.001081231,0.00036962243],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0017641891,0.00035101105,0.0011696666,0.00036633707,0.00016146134,0.00002550994,0.000104561615,0.00021234421,0.00048707522],"category_scores_gemma":[0.0024900641,0.0002890298,0.0002301645,0.0007567704,0.00017327986,0.0007114706,0.00008585147,0.0015956752,0.00003449256],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0022952189,0.008488334,0.07223144,0.00020644882,0.00094800326,0.8979453,0.0033975765,0.00017128066,0.005129095,0.000042357984,0.000776916,0.008368032],"study_design_scores_gemma":[0.014092802,0.00253081,0.0029370233,0.00061154604,0.0033836165,0.8892747,0.0017314007,0.00015634771,0.025172671,0.000083074876,0.05976257,0.00026341202],"about_ca_topic_score_codex":0.0004186278,"about_ca_topic_score_gemma":0.00007485883,"teacher_disagreement_score":0.06929442,"about_ca_system_score_codex":0.0012668903,"about_ca_system_score_gemma":0.0037611697,"threshold_uncertainty_score":0.9999562},"labels":[],"label_agreement":null},{"id":"W3203377226","doi":"10.1177/10781552211041680","title":"A randomized controlled trial to assess the influence of a picture-based antiemetic medication calendar on medication-taking behavior in adults receiving chemotherapy","year":2021,"lang":"en","type":"article","venue":"Journal of Oncology Pharmacy Practice","topic":"Pharmaceutical Practices and Patient Outcomes","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dalhousie University; Western University; London Health Sciences Centre; University of Waterloo","funders":"","keywords":"Medicine; Antiemetic; Randomized controlled trial; Chemotherapy; Emergency medicine; Intensive care medicine; Pediatrics; Internal medicine","score_opus":0.11864104330982754,"score_gpt":0.496285031150853,"score_spread":0.37764398784102543,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3203377226","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9176481,0.00046122927,0.00044315992,0.07676596,0.0009853173,0.0029813086,0.0000033677804,0.000008147805,0.0007034096],"genre_scores_gemma":[0.97527164,0.0013401896,0.0023676385,0.020451037,0.0003307467,0.0001925749,0.0000030938775,0.000017888355,0.000025175446],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9931177,0.0035250427,0.0018832396,0.00022141724,0.0010163795,0.00023621257],"domain_scores_gemma":[0.9675335,0.026659276,0.0041722413,0.00026221614,0.0011286241,0.00024412414],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.00973947,0.00019430225,0.0015532725,0.00030760936,0.00007419716,0.00001573237,0.0002512408,0.000112085145,0.00030242372],"category_scores_gemma":[0.055776462,0.00011798278,0.00036832958,0.0004590573,0.00015820624,0.0004034894,0.000027797641,0.0012813159,0.0000049070204],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9779949,0.0029704373,0.002341841,0.00007319547,0.0004835625,0.00032759373,0.0009633688,0.00034069002,0.0058669155,0.000028287073,0.00018760002,0.008421601],"study_design_scores_gemma":[0.96169627,0.0014996999,0.004762659,0.00047634236,0.0024546182,0.00036150333,0.00038380382,0.0015018741,0.0041014417,0.000011954723,0.022640575,0.00010925892],"about_ca_topic_score_codex":0.000029940022,"about_ca_topic_score_gemma":0.0000053866884,"teacher_disagreement_score":0.057623558,"about_ca_system_score_codex":0.00024656265,"about_ca_system_score_gemma":0.0019747156,"threshold_uncertainty_score":0.9521771},"labels":[],"label_agreement":null},{"id":"W3203670468","doi":"10.1177/10781552211038677","title":"Use of <i>nab</i> -paclitaxel and gemcitabine in pancreatic cancer without granulocyte colony-stimulating factor: A multicenter real-world experience","year":2021,"lang":"en","type":"article","venue":"Journal of Oncology Pharmacy Practice","topic":"Pancreatic and Hepatic Oncology Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Alberta Health Services","funders":"Alberta Cancer Foundation; Celgene","keywords":"Medicine; Gemcitabine; Neutropenia; Pancreatic cancer; Internal medicine; Progression-free survival; Granulocyte colony-stimulating factor; Oncology; Cancer; Surgery; Chemotherapy","score_opus":0.1481114958646065,"score_gpt":0.4937965166833536,"score_spread":0.3456850208187471,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3203670468","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9889494,0.0017310929,0.000084806095,0.0053782198,0.0002676941,0.00046322338,0.00001333267,0.000008812155,0.0031033824],"genre_scores_gemma":[0.96833605,0.011823071,0.017028386,0.0017073316,0.00018943514,0.00003387043,0.0000028698214,0.000025824384,0.00085314485],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99650615,0.0009705587,0.0012657574,0.00029236506,0.00053416454,0.00043098888],"domain_scores_gemma":[0.99204904,0.004981008,0.0012006502,0.00023120521,0.0012022324,0.00033584834],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012559779,0.0002209372,0.0013444885,0.0003413462,0.00008146936,0.00002683669,0.00012500607,0.00011422684,0.00039541323],"category_scores_gemma":[0.0047456217,0.00018404417,0.00012006979,0.000491921,0.0003372015,0.0009197124,0.00012112687,0.0010613204,0.0000033424692],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.007471543,0.0011852764,0.93385255,0.00019259806,0.0004686854,0.002501977,0.0029529613,0.000041474294,0.045852695,0.000024354307,0.00038037298,0.0050755073],"study_design_scores_gemma":[0.029412076,0.002091548,0.83381516,0.0010228774,0.0024791695,0.0037796453,0.0028181814,0.009114476,0.009084651,0.000019785055,0.106031366,0.00033109402],"about_ca_topic_score_codex":0.0019525664,"about_ca_topic_score_gemma":0.0006140121,"teacher_disagreement_score":0.105651,"about_ca_system_score_codex":0.00056241895,"about_ca_system_score_gemma":0.0021369979,"threshold_uncertainty_score":0.75051033},"labels":[],"label_agreement":null},{"id":"W3204094393","doi":"10.1177/10781552211043525","title":"Evaluation of a patient self-medication program in allogeneic hematopoietic stem cell transplantation","year":2021,"lang":"en","type":"article","venue":"Journal of Oncology Pharmacy Practice","topic":"Medication Adherence and Compliance","field":"Medicine","cited_by":16,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network","funders":"","keywords":"Medicine; Pharmacist; Hematopoietic stem cell transplantation; Medication adherence; Adverse effect; Patient satisfaction; Physical therapy; Transplantation; Pharmacy; Emergency medicine; Internal medicine; Family medicine; Nursing","score_opus":0.08769869127573136,"score_gpt":0.44874665385146856,"score_spread":0.3610479625757372,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3204094393","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97873294,0.003052992,0.00039719313,0.008922277,0.0003765297,0.0006064573,0.0000010225981,0.0000118476555,0.007898721],"genre_scores_gemma":[0.9873757,0.003398452,0.008038158,0.0010018286,0.000075346165,0.000054008484,0.000008320427,0.000007588318,0.000040624167],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9969549,0.00093502126,0.0008459855,0.00013304867,0.0010110621,0.000119950535],"domain_scores_gemma":[0.9960294,0.0003809997,0.0013257562,0.00013227486,0.0020135136,0.00011806894],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002939254,0.00008254296,0.00028996586,0.00013811422,0.000021161182,0.0000055667283,0.00007940853,0.00006492576,0.00039008088],"category_scores_gemma":[0.0003538575,0.00007403727,0.000068983616,0.00032820646,0.000032655647,0.00029869244,0.000008897495,0.00036848598,0.000031723033],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0019295395,0.013603521,0.010745591,0.00075879076,0.00043863064,0.0011129109,0.009908392,0.00029845038,0.0573101,0.000066674016,0.0026532197,0.9011742],"study_design_scores_gemma":[0.060494732,0.007901764,0.033019304,0.0015031202,0.014815824,0.025689939,0.023255978,0.011557864,0.33930808,0.00045718078,0.48149163,0.0005045717],"about_ca_topic_score_codex":0.0000045659135,"about_ca_topic_score_gemma":0.0000019371544,"teacher_disagreement_score":0.90066963,"about_ca_system_score_codex":0.00029572114,"about_ca_system_score_gemma":0.0030684674,"threshold_uncertainty_score":0.544333},"labels":[],"label_agreement":null},{"id":"W3209911848","doi":"10.1177/10781552211048892","title":"Impact of coronavirus of 2019 on the delivery of pharmacy services to patients with cancer: An international survey of oncology pharmacy practitioners","year":2021,"lang":"en","type":"article","venue":"Journal of Oncology Pharmacy Practice","topic":"COVID-19 and healthcare impacts","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Waterloo; Alberta Health Services","funders":"","keywords":"Medicine; Pharmacy; Pandemic; Family medicine; Workforce; Personal protective equipment; Pharmacist; Nursing; Coronavirus disease 2019 (COVID-19); Internal medicine","score_opus":0.1597021314677648,"score_gpt":0.5447627895809734,"score_spread":0.38506065811320855,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3209911848","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9820944,0.00060925813,0.000015466077,0.014641091,0.0008656832,0.00050200033,0.0004811176,0.000005044233,0.0007859428],"genre_scores_gemma":[0.9878328,0.0061446214,0.00061199395,0.0050555617,0.00022790789,0.0000071090944,0.00006338646,0.000028908416,0.000027754006],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9953917,0.0016593789,0.0014516268,0.00024178447,0.0009585965,0.0002968756],"domain_scores_gemma":[0.98207843,0.0049565714,0.0047351564,0.00028943495,0.0075392937,0.00040113725],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0025494501,0.00024062402,0.0010052319,0.00039122958,0.00005778626,0.000009322387,0.00040864537,0.000075248805,0.0012728719],"category_scores_gemma":[0.0019333769,0.00016605789,0.00020863404,0.0005785839,0.00016565346,0.001184797,0.00010029244,0.0008886117,0.0000042857023],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.09315338,0.009191163,0.78369075,0.000320095,0.0028681946,0.0002655876,0.0022173722,0.0010407586,0.042489212,0.00001677776,0.0024027678,0.06234395],"study_design_scores_gemma":[0.025447398,0.011375486,0.83891577,0.00040107555,0.0016098116,0.00058303226,0.00066476857,0.00024313248,0.029786551,0.000004539275,0.09078532,0.0001831342],"about_ca_topic_score_codex":0.029514713,"about_ca_topic_score_gemma":0.0010615821,"teacher_disagreement_score":0.08838255,"about_ca_system_score_codex":0.0010255526,"about_ca_system_score_gemma":0.010786251,"threshold_uncertainty_score":0.9996401},"labels":[],"label_agreement":null},{"id":"W3213957885","doi":"10.1177/10781552211053253","title":"Application of the Failure Mode and Effects Analysis (FMEA) to identify vulnerabilities and opportunities for improvement prior to implementing a computerized prescription order entry (CPOE) system in a university hospital oncology clinic","year":2021,"lang":"en","type":"article","venue":"Journal of Oncology Pharmacy Practice","topic":"Electronic Health Records Systems","field":"Health Professions","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier Universitaire de Sherbrooke; Université de Sherbrooke","funders":"Eli Lilly Canada; Amgen Canada; Novartis Pharmaceuticals Canada; Astellas Pharma Canada; Merck Canada; AstraZeneca Canada; F. Hoffmann-La Roche; Takeda Pharmaceuticals North America; Celgene; Bristol-Myers Squibb Canada; Seattle Genetics; Gilead Sciences","keywords":"Medicine; Medical prescription; Order entry; Computerized physician order entry; Failure mode and effects analysis; Medical emergency; Emergency medicine; Intensive care medicine; Nursing; Health care; Reliability engineering","score_opus":0.07289850436393183,"score_gpt":0.4934987644334726,"score_spread":0.42060026006954077,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3213957885","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9385906,0.0002200469,0.031062147,0.026228113,0.00076362083,0.0029393774,0.000024757728,0.000010307931,0.00016105967],"genre_scores_gemma":[0.9875505,0.0002945804,0.0097400015,0.0018336069,0.00021147678,0.00014167797,0.0000047469016,0.000014000392,0.00020943639],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99399,0.00381636,0.001285297,0.00026946823,0.0002232496,0.000415618],"domain_scores_gemma":[0.9914008,0.004952964,0.0020601968,0.0001877639,0.0011920057,0.00020630102],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.005688313,0.00013764852,0.0007498854,0.0003085033,0.00037991808,0.0000146907305,0.0001784201,0.00013695925,0.000010302803],"category_scores_gemma":[0.001186942,0.00011924224,0.00009959757,0.00046241915,0.00004046248,0.0003941221,0.00028175034,0.0006771809,8.79115e-7],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.021543032,0.0046728184,0.17041148,0.025805658,0.009439741,0.00049121625,0.14238843,0.00084024854,0.15232033,0.0058368696,0.018433759,0.44781643],"study_design_scores_gemma":[0.017479064,0.00398318,0.017080948,0.00064638717,0.0032310132,0.00016092652,0.15100928,0.008533068,0.00067762256,0.00005884609,0.7968393,0.00030036026],"about_ca_topic_score_codex":0.0008616486,"about_ca_topic_score_gemma":0.0018681879,"teacher_disagreement_score":0.77840555,"about_ca_system_score_codex":0.0015953984,"about_ca_system_score_gemma":0.0025838905,"threshold_uncertainty_score":0.48625576},"labels":[],"label_agreement":null},{"id":"W3216845069","doi":"10.1177/10781552211061133","title":"Evaluation and clinical impact of a pharmacist-led, interdisciplinary service focusing on education, monitoring and toxicity management of immune checkpoint inhibitors","year":2021,"lang":"en","type":"article","venue":"Journal of Oncology Pharmacy Practice","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dalhousie University; Saint John Regional Hospital; Horizon Health Network; Moncton Hospital","funders":"Association Canadienne de Pharmacie en Oncologie","keywords":"Medicine; Ipilimumab; Discontinuation; Pharmacist; Adverse effect; Cohort; Hazard ratio; Immune checkpoint; Internal medicine; Retrospective cohort study; Oncology; Emergency medicine; Pharmacy; Cancer; Confidence interval; Immunotherapy; Family medicine","score_opus":0.09540476578122901,"score_gpt":0.5345291494025659,"score_spread":0.4391243836213369,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3216845069","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98473835,0.0067127696,0.00002449029,0.0057690376,0.0011683323,0.00026872978,0.0000019370045,0.000002871567,0.0013135042],"genre_scores_gemma":[0.9878003,0.008854428,0.0027013791,0.00020480646,0.00040100393,0.0000039530623,0.000001672987,0.0000111664285,0.000021318489],"study_design_codex":"design_other","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.997455,0.00068440294,0.0011948162,0.00015388416,0.00039971407,0.000112185466],"domain_scores_gemma":[0.99599725,0.0005647938,0.001659158,0.00012853324,0.0015391209,0.00011115004],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.005711993,0.00012160342,0.00044472842,0.0001415256,0.000055892502,0.0000122360225,0.000061880826,0.000058194004,0.000066182445],"category_scores_gemma":[0.0003965118,0.00010021688,0.00020580098,0.0002485185,0.00008681827,0.00038733415,0.00011910036,0.00041176233,5.18994e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.02183922,0.0035224382,0.016935563,0.00035396477,0.0037153945,0.00015298884,0.0014144543,0.000020469464,0.35351002,0.0000017095421,0.00026324842,0.59827054],"study_design_scores_gemma":[0.05514882,0.008120974,0.33387655,0.0034839842,0.011899987,0.010139696,0.013898666,0.0010140219,0.5534479,0.00014168351,0.008490429,0.00033727274],"about_ca_topic_score_codex":0.000044402583,"about_ca_topic_score_gemma":0.0000013888287,"teacher_disagreement_score":0.59793323,"about_ca_system_score_codex":0.0004742596,"about_ca_system_score_gemma":0.0013425723,"threshold_uncertainty_score":0.40867257},"labels":[],"label_agreement":null},{"id":"W3217493071","doi":"10.1177/10781552211055405","title":"Asparaginase activity monitoring and management of asparaginase hypersensitivity reactions in Canada","year":2021,"lang":"en","type":"article","venue":"Journal of Oncology Pharmacy Practice","topic":"Acute Lymphoblastic Leukemia research","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Izaak Walton Killam Health Centre; Dalhousie University","funders":"","keywords":"Asparaginase; Medicine; Guideline; Intensive care medicine; Economic shortage; Pediatrics; Internal medicine; Lymphoblastic Leukemia; Leukemia; Pathology","score_opus":0.052131353991888514,"score_gpt":0.40391779820269563,"score_spread":0.3517864442108071,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3217493071","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97737753,0.00060702884,0.00011299903,0.013592919,0.0004973131,0.000162713,0.000004006014,0.0000035382197,0.0076419604],"genre_scores_gemma":[0.9889808,0.004714559,0.005717351,0.0002596913,0.00015346412,0.000004431288,6.737269e-7,0.000013524012,0.00015549132],"study_design_codex":"case_report","study_design_gemma":"not_applicable","domain_scores_codex":[0.99797994,0.0005305668,0.00048115343,0.00018673937,0.0005502607,0.00027132174],"domain_scores_gemma":[0.9964638,0.001839958,0.0005908529,0.00018169313,0.00065197505,0.00027175547],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012098665,0.00012766548,0.00048902316,0.000167518,0.000048876114,0.000010136765,0.00007379364,0.000046562895,0.00002912145],"category_scores_gemma":[0.0010249849,0.00012294078,0.00005469929,0.00038140433,0.00007756198,0.00053936767,0.00011266365,0.0008980299,0.0000019442873],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.01785146,0.00504065,0.07216505,0.0015068037,0.0031928713,0.39931685,0.0006697258,0.0007330885,0.26015455,0.00014151559,0.004283047,0.23494442],"study_design_scores_gemma":[0.039901916,0.0010951123,0.25083765,0.0010489544,0.0028544255,0.112048276,0.0106671825,0.0029811685,0.2639414,0.000030486173,0.3141768,0.00041664642],"about_ca_topic_score_codex":0.12641753,"about_ca_topic_score_gemma":0.012395578,"teacher_disagreement_score":0.30989373,"about_ca_system_score_codex":0.0037730949,"about_ca_system_score_gemma":0.008700126,"threshold_uncertainty_score":0.99691963},"labels":[],"label_agreement":null},{"id":"W4205535522","doi":"10.1177/10781552211072877","title":"Canadian monitoring program of the surface contamination with 11 antineoplastic drugs in 122 centers","year":2022,"lang":"en","type":"article","venue":"Journal of Oncology Pharmacy Practice","topic":"Safe Handling of Antineoplastic Drugs","field":"Health Professions","cited_by":17,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Université de Montréal; Institut National de Santé Publique du Québec; Centre Hospitalier Universitaire Sainte-Justine","funders":"","keywords":"Medicine; Docetaxel; Antineoplastic Drugs; Vinorelbine; Contamination; Therapeutic drug monitoring; Cyclophosphamide; Paclitaxel; Pharmacology; Internal medicine; Drug; Chemotherapy","score_opus":0.042896651219423244,"score_gpt":0.43967635355610424,"score_spread":0.396779702336681,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4205535522","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9768341,0.000097154814,0.000017856499,0.015663246,0.003928198,0.00065832766,0.000009393533,0.000011430459,0.0027803006],"genre_scores_gemma":[0.99711025,0.00006599885,0.0017222055,0.0005865312,0.00021273592,0.000024639236,0.0000014054252,0.000024089468,0.00025217462],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.99582833,0.0020938597,0.0009078521,0.00014588328,0.0005652982,0.00045877192],"domain_scores_gemma":[0.9920635,0.004806024,0.0022008405,0.00014471618,0.0006122437,0.0001726285],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0034811455,0.00013797867,0.00036980465,0.00026992543,0.0005050395,0.000007811594,0.00041586318,0.000055045974,0.00013017403],"category_scores_gemma":[0.0017013488,0.000103389655,0.00006486581,0.0006074745,0.0000727951,0.00041855275,0.00013030347,0.0019941968,0.000005499276],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0018709429,0.0011122869,0.9789451,0.0000804711,0.00012598885,0.0002725742,0.008860657,0.0028555053,0.0006768076,0.00005007265,0.0017131572,0.0034364804],"study_design_scores_gemma":[0.026250029,0.0019015531,0.2518174,0.00063629355,0.0006546721,0.0012161378,0.06881065,0.0016515711,0.00074203324,0.000012952375,0.6459995,0.00030721806],"about_ca_topic_score_codex":0.025461793,"about_ca_topic_score_gemma":0.00970532,"teacher_disagreement_score":0.7271277,"about_ca_system_score_codex":0.0014475323,"about_ca_system_score_gemma":0.0075918725,"threshold_uncertainty_score":0.9980342},"labels":[],"label_agreement":null},{"id":"W4205891771","doi":"10.1177/10781552211073470","title":"Role of clinical pharmacist in the palliative care of adults and elderly patients with cancer: A scoping review","year":2022,"lang":"en","type":"review","venue":"Journal of Oncology Pharmacy Practice","topic":"Pharmaceutical Practices and Patient Outcomes","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Pharmacist; Psychological intervention; MEDLINE; Palliative care; Family medicine; Clinical pharmacy; Data extraction; Scopus; Ambulatory; Nursing; Pharmacy; Internal medicine","score_opus":0.3675907298714855,"score_gpt":0.616885904520953,"score_spread":0.24929517464946754,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4205891771","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0019796416,0.99230474,7.678724e-7,0.0010136885,0.00041830997,0.0029654189,0.00006197286,0.000002680857,0.0012527527],"genre_scores_gemma":[0.0014191009,0.9956422,0.00040373675,0.0022001362,0.00018919747,0.00008688455,0.000024042185,0.000031175692,0.000003552565],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99153984,0.0038236834,0.0031971566,0.00028899018,0.00090538576,0.0002449561],"domain_scores_gemma":[0.9758479,0.01304141,0.009907985,0.00023049959,0.00078007113,0.00019215271],"candidate_categories":["research_integrity"],"consensus_categories":[],"category_scores_codex":[0.0037957018,0.0003405564,0.0036516835,0.0002038762,0.000062710475,0.000008605881,0.00039856017,0.00011682983,0.00034811796],"category_scores_gemma":[0.0039298264,0.00019377496,0.0005171598,0.0005323955,0.00019278059,0.00048405418,0.00012416119,0.0031260124,0.0000014142918],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0054271976,0.0016505051,0.0148080615,0.09382561,0.0010805499,0.00021101059,0.0008913285,6.133913e-7,1.9300161e-7,0.0000021683363,0.00019755904,0.8819052],"study_design_scores_gemma":[0.009430721,0.0035565468,0.00023951399,0.12160885,0.014184358,0.00031916774,0.00071104727,0.0000048496927,0.0000011337503,6.596469e-7,0.84979767,0.00014549322],"about_ca_topic_score_codex":0.000049955186,"about_ca_topic_score_gemma":0.000009452924,"teacher_disagreement_score":0.8817597,"about_ca_system_score_codex":0.00021468931,"about_ca_system_score_gemma":0.0030490397,"threshold_uncertainty_score":0.9991738},"labels":[],"label_agreement":null},{"id":"W4206137847","doi":"10.1177/10781552211073673","title":"Biomarkers of everolimus efficacy in breast cancer therapy","year":2022,"lang":"en","type":"article","venue":"Journal of Oncology Pharmacy Practice","topic":"PI3K/AKT/mTOR signaling in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"NOSM University; Essar Steel Algoma (Canada); Sault Area Hospital","funders":"","keywords":"Everolimus; Medicine; Breast cancer; Oncology; Internal medicine; Biomarker; PTEN; PI3K/AKT/mTOR pathway; Predictive marker; Cancer; Hormonal therapy; Signal transduction","score_opus":0.035185080806225365,"score_gpt":0.40571748754187237,"score_spread":0.370532406735647,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4206137847","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98115027,0.007985451,0.000029846791,0.0081201615,0.0013265357,0.00016434587,0.000042446645,0.000003147103,0.0011778106],"genre_scores_gemma":[0.9899855,0.006031975,0.0005364,0.0028935215,0.00044810845,0.000021805006,0.000004045767,0.000024867164,0.00005377856],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.99789375,0.0007763647,0.0005908895,0.00019151559,0.0003187334,0.00022875561],"domain_scores_gemma":[0.9979443,0.00029783716,0.0011940083,0.00017058637,0.00030642317,0.0000868399],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0017012678,0.00013670218,0.00029567737,0.00015906787,0.00006855291,0.0000070599035,0.000428356,0.00006546792,0.0005353486],"category_scores_gemma":[0.00020520056,0.00013165096,0.00014734655,0.00026379502,0.00009265154,0.000028044582,0.00013263906,0.0005337621,0.0000013003016],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.016080841,0.0017344437,0.010149321,0.000011339418,0.0008232929,0.00020988031,0.0002695409,0.0037917513,0.90089214,0.0000047812405,0.019849079,0.046183575],"study_design_scores_gemma":[0.0112262415,0.0015325571,0.005566103,0.00001531679,0.00013334608,0.002652367,0.0003624482,0.00006218708,0.08257787,0.000009637044,0.89568067,0.00018125476],"about_ca_topic_score_codex":0.00012984037,"about_ca_topic_score_gemma":0.00000591695,"teacher_disagreement_score":0.8758316,"about_ca_system_score_codex":0.00027053914,"about_ca_system_score_gemma":0.001237254,"threshold_uncertainty_score":0.5861692},"labels":[],"label_agreement":null},{"id":"W4213004141","doi":"10.1177/10781552221078207","title":"Evaluation of a pediatric pre-chemotherapy rapid hydration protocol: A quality assurance project","year":2022,"lang":"en","type":"article","venue":"Journal of Oncology Pharmacy Practice","topic":"Chemotherapy-induced organ toxicity mitigation","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Alberta Children's Hospital","funders":"","keywords":"Medicine; Ifosfamide; Chemotherapy; Methotrexate; Urine; Nephrotoxicity; Cyclophosphamide; Ambulatory; Protocol (science); Cisplatin; Internal medicine; Toxicity","score_opus":0.1480628172170722,"score_gpt":0.5164670749098501,"score_spread":0.3684042576927779,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4213004141","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.946179,0.00027871982,0.00047535237,0.014991038,0.0004228624,0.03418544,0.000008738791,0.000029729776,0.0034291248],"genre_scores_gemma":[0.9825665,0.0002135465,0.007178689,0.0024525628,0.0010761019,0.0063953456,0.0000074004583,0.00004404713,0.00006582764],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.99190724,0.0040854495,0.0013424129,0.00022793072,0.002240061,0.0001969326],"domain_scores_gemma":[0.9917221,0.0012045782,0.0042574964,0.00023672375,0.0024861353,0.00009293156],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.01840835,0.00017118234,0.00053101056,0.00039624926,0.00013762279,0.000014568727,0.00019081999,0.00007748899,0.00093561696],"category_scores_gemma":[0.0045839692,0.00016331908,0.00018572867,0.0007719811,0.000050980812,0.0008384254,0.00003772668,0.0010095934,0.000002871735],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.036294237,0.010281088,0.010294963,0.00046251775,0.0013432462,0.000088833855,0.009804001,0.0011039785,0.6710016,0.000026030984,0.020816792,0.23848271],"study_design_scores_gemma":[0.10804063,0.014150688,0.032807715,0.000067830115,0.00583401,0.005963418,0.0026520372,0.0073576644,0.34388185,0.0003985156,0.47829363,0.0005520103],"about_ca_topic_score_codex":0.00004823147,"about_ca_topic_score_gemma":0.000003847932,"teacher_disagreement_score":0.45747682,"about_ca_system_score_codex":0.0014309468,"about_ca_system_score_gemma":0.006173274,"threshold_uncertainty_score":0.99997765},"labels":[],"label_agreement":null},{"id":"W4221038733","doi":"10.1177/10781552221084616","title":"Real-world incidence of venetoclax toxicities in British Columbia","year":2022,"lang":"en","type":"article","venue":"Journal of Oncology Pharmacy Practice","topic":"Methemoglobinemia and Tumor Lysis Syndrome","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Venetoclax; Medicine; Neutropenia; Incidence (geometry); Internal medicine; Clinical trial; Toxicity; Oncology; Chronic lymphocytic leukemia; Pediatrics; Leukemia","score_opus":0.03711518437483042,"score_gpt":0.3877993800557443,"score_spread":0.3506841956809139,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4221038733","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9805854,0.0005960042,0.0000048677944,0.002916228,0.00058416196,0.00021350665,0.000008402116,0.0000075590556,0.015083849],"genre_scores_gemma":[0.9901331,0.0011288283,0.003827045,0.0015704264,0.00018557892,0.000016473108,0.0000025990682,0.000018575101,0.0031173695],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.99705034,0.00088099635,0.001067857,0.00015178531,0.00061930314,0.00022969539],"domain_scores_gemma":[0.9963123,0.0013958088,0.0015728553,0.00015823073,0.0004263906,0.00013441926],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0031997408,0.000084489126,0.00072484557,0.00026886005,0.00009422015,0.000023798157,0.0002509188,0.00003215205,0.0027754633],"category_scores_gemma":[0.0016196502,0.00012285946,0.00013902572,0.000749754,0.000105621686,0.00042166322,0.00013661994,0.0011933951,0.000004407117],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00837896,0.0059650596,0.5859707,0.0005526537,0.0013121647,0.09077549,0.0030818663,0.0012628565,0.1440092,0.000134507,0.117868066,0.040688485],"study_design_scores_gemma":[0.016316822,0.004553633,0.09372662,0.00024453402,0.0013299179,0.121435165,0.005007618,0.00042457154,0.0031714255,0.00031427105,0.7531967,0.0002787013],"about_ca_topic_score_codex":0.014713542,"about_ca_topic_score_gemma":0.0028107408,"teacher_disagreement_score":0.63532865,"about_ca_system_score_codex":0.001246916,"about_ca_system_score_gemma":0.0023802249,"threshold_uncertainty_score":0.99813616},"labels":[],"label_agreement":null},{"id":"W4224230859","doi":"10.1177/10781552221089667","title":"Pharmacists’ practices and views regarding management of sexual health in patients with cancer","year":2022,"lang":"en","type":"article","venue":"Journal of Oncology Pharmacy Practice","topic":"Cancer survivorship and care","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Alberta Cancer Foundation","funders":"","keywords":"Medicine; Family medicine; Cancer; Nursing; Internal medicine","score_opus":0.09509897474524641,"score_gpt":0.4605347049710721,"score_spread":0.36543573022582565,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4224230859","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9675236,0.006758184,0.000021562322,0.020671433,0.0009216344,0.0005300802,0.000017074362,0.0000056627223,0.0035508014],"genre_scores_gemma":[0.98583966,0.00660774,0.0013167966,0.0058244676,0.00014158661,0.000033777418,0.000004744219,0.000020264179,0.00021093528],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9978265,0.0006606997,0.0006234592,0.00017345161,0.0005171316,0.00019874756],"domain_scores_gemma":[0.996047,0.00034144963,0.003079696,0.00010705156,0.00027867712,0.00014608967],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0023341773,0.00011697123,0.00049246947,0.00020981148,0.00009229841,0.00000892678,0.00011242756,0.000017199636,0.00026306228],"category_scores_gemma":[0.00009568612,0.00009649234,0.000033993852,0.00033787754,0.000046409372,0.0005512617,0.00010661974,0.00082617183,4.327591e-7],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.065690726,0.004921865,0.34735402,0.0014369047,0.0021104058,0.0018607292,0.009184834,0.00027269032,0.00041395132,0.00004990914,0.018267877,0.5484361],"study_design_scores_gemma":[0.022922136,0.004923606,0.020458268,0.00012437686,0.001117275,0.0012676248,0.00854256,0.000036030935,0.00008641364,0.0000044502376,0.9403933,0.00012395806],"about_ca_topic_score_codex":0.00030030194,"about_ca_topic_score_gemma":0.00005656141,"teacher_disagreement_score":0.9221254,"about_ca_system_score_codex":0.00069550215,"about_ca_system_score_gemma":0.0006786978,"threshold_uncertainty_score":0.39348432},"labels":[],"label_agreement":null},{"id":"W4226254150","doi":"10.1177/10781552221090199","title":"International society of oncology pharmacy practitioners (ISOPP) position statement: The role of oncology pharmacy practitioners in immunotherapy treatment with immune checkpoint inhibitors for malignant conditions","year":2022,"lang":"en","type":"article","venue":"Journal of Oncology Pharmacy Practice","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Alberta Health Services; Cancer Care Ontario; CancerCare Manitoba","funders":"","keywords":"Medicine; Pharmacy; Oncology nursing; Pharmacy practice; Oncology; Clinical pharmacy; Internal medicine; Immunotherapy; Position statement; Immune checkpoint; Cancer; Family medicine; Nursing; Nurse education","score_opus":0.03706517425586087,"score_gpt":0.4121058449302516,"score_spread":0.37504067067439073,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4226254150","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.71034044,0.00696444,0.00065602275,0.26108998,0.0036155013,0.004878112,0.00067784364,0.000043873708,0.011733769],"genre_scores_gemma":[0.95968884,0.02764481,0.0061135716,0.004746802,0.0005203707,0.00072108454,0.00029268916,0.00006483899,0.00020696089],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.9948737,0.001384122,0.0022619742,0.00033615137,0.00072974386,0.000414318],"domain_scores_gemma":[0.99013865,0.0023973102,0.0060037985,0.00024005999,0.0010893663,0.0001308381],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.004307176,0.00034321952,0.00093327335,0.0004636072,0.00039696967,0.000022540351,0.0003487774,0.00008871391,0.0016143991],"category_scores_gemma":[0.00014201064,0.00026032494,0.00065193744,0.00055511115,0.00047249076,0.0011886733,0.00008034509,0.0011786841,0.0000023490284],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.11723346,0.013074168,0.0010866314,0.00006805757,0.0070447545,0.00025738424,0.008352769,0.0007583267,0.7675775,0.00011956233,0.0072323494,0.07719503],"study_design_scores_gemma":[0.051386733,0.012073034,0.00019392227,0.00007141772,0.0012793252,0.005153183,0.021355841,0.0006374371,0.12359947,0.00008081364,0.7839786,0.00019023911],"about_ca_topic_score_codex":0.0010993686,"about_ca_topic_score_gemma":0.000029519653,"teacher_disagreement_score":0.7767462,"about_ca_system_score_codex":0.005854603,"about_ca_system_score_gemma":0.005360247,"threshold_uncertainty_score":0.9999849},"labels":[],"label_agreement":null},{"id":"W4238227307","doi":"10.1191/1078155205jp152oa","title":"Antineoplastic agent workplace contamination study: the Alberta Cancer Board Pharmacy perspective","year":2005,"lang":"en","type":"article","venue":"Journal of Oncology Pharmacy Practice","topic":"Safe Handling of Antineoplastic Drugs","field":"Health Professions","cited_by":34,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Alberta Cancer Foundation","funders":"","keywords":"Medicine; Pharmacy; Antineoplastic Drugs; Perspective (graphical); Cancer; Contamination; Cancer drugs; Family medicine; Intensive care medicine; Pharmacology; Internal medicine","score_opus":0.09123418649140072,"score_gpt":0.5188351417491699,"score_spread":0.4276009552577692,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4238227307","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7394579,0.001730362,0.0007067419,0.21048535,0.008698495,0.0016771724,0.0000073382616,0.000046158446,0.037190486],"genre_scores_gemma":[0.9762637,0.0017257043,0.0009783418,0.0107164085,0.0048485175,0.00008643746,0.0000010584534,0.00005332705,0.005326501],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99334735,0.003428602,0.0014817597,0.00032797025,0.0007621144,0.0006522191],"domain_scores_gemma":[0.97027606,0.023507485,0.0032826047,0.00024768518,0.0024258606,0.00026031517],"candidate_categories":["metaresearch","research_integrity","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.004886447,0.00031530962,0.0006438861,0.00025643545,0.0009712197,0.00003611245,0.0006048158,0.00009842295,0.0017339726],"category_scores_gemma":[0.009385177,0.00021922303,0.00016494613,0.00045438012,0.00014058665,0.0012937547,0.00018774734,0.0029818672,0.00051929516],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.033277974,0.012366597,0.2848058,0.0001537397,0.0065665883,0.001477719,0.20304516,0.004858393,0.0030561609,0.001639831,0.3571702,0.091581844],"study_design_scores_gemma":[0.016370902,0.000543406,0.010046319,0.00013000134,0.0020210356,0.00039988587,0.047590666,0.0016922468,0.00014843827,0.00001708552,0.9208124,0.0002276113],"about_ca_topic_score_codex":0.0031330762,"about_ca_topic_score_gemma":0.002468588,"teacher_disagreement_score":0.5636422,"about_ca_system_score_codex":0.0015528209,"about_ca_system_score_gemma":0.0042981626,"threshold_uncertainty_score":0.9993183},"labels":[],"label_agreement":null},{"id":"W4282017708","doi":"10.1177/10781552221104422","title":"Toxicity analysis of busulfan pharmacokinetic therapeutic dose monitoring","year":2022,"lang":"en","type":"article","venue":"Journal of Oncology Pharmacy Practice","topic":"Hematopoietic Stem Cell Transplantation","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Inimex Pharmaceuticals (Canada)","funders":"","keywords":"Busulfan; Medicine; Pharmacokinetics; Therapeutic drug monitoring; Therapeutic index; Toxicity; Drug; Pharmacology; Therapeutic effect; Cyclophosphamide; Internal medicine; Chemotherapy","score_opus":0.07412746311896341,"score_gpt":0.4379495859559921,"score_spread":0.3638221228370287,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4282017708","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9863982,0.001321604,0.0008152197,0.0047427234,0.0011481175,0.00032788134,0.000009723435,0.000014826108,0.005221688],"genre_scores_gemma":[0.994617,0.0011886456,0.0027142104,0.0010883355,0.0002446035,0.000015027637,0.0000042021043,0.000019675923,0.000108332424],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.9969858,0.0008552774,0.0009925246,0.00015977073,0.000790709,0.00021591947],"domain_scores_gemma":[0.99591875,0.0017116334,0.0015309594,0.0001700246,0.0004936444,0.00017500957],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0023008722,0.00014347736,0.0007206756,0.0007253424,0.00011348465,0.000007764813,0.00021938402,0.00003910538,0.0013637783],"category_scores_gemma":[0.00021580055,0.00013256299,0.00033215564,0.0012533885,0.000059641883,0.00030739824,0.00004470303,0.000910075,0.0000046338105],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.02734548,0.005219089,0.063082695,0.00022750767,0.016567662,0.0031808133,0.0059908093,0.008476051,0.8110538,0.00006315823,0.00050419464,0.058288738],"study_design_scores_gemma":[0.06446274,0.0065485956,0.081910074,0.00010925392,0.1270486,0.022107242,0.00879451,0.0069621056,0.29617298,0.00004983208,0.38528532,0.00054875965],"about_ca_topic_score_codex":0.000023298388,"about_ca_topic_score_gemma":4.6428198e-7,"teacher_disagreement_score":0.51488084,"about_ca_system_score_codex":0.00038539636,"about_ca_system_score_gemma":0.00055993954,"threshold_uncertainty_score":0.9995491},"labels":[],"label_agreement":null},{"id":"W4282018015","doi":"10.1177/10781552221102884","title":"Cyclin-dependent kinase 4/6 inhibitor treatment use in women treated for advanced breast cancer: Integrating ASCO/NCODA patient-centered standards in a community pharmacy","year":2022,"lang":"en","type":"article","venue":"Journal of Oncology Pharmacy Practice","topic":"Advanced Breast Cancer Therapies","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Centre Hospitalier de l’Université de Montréal; AMT Die Casting (Canada)","funders":"Pfizer","keywords":"Medicine; Discontinuation; Fulvestrant; Internal medicine; Pharmacy; Breast cancer; Oncology; Palbociclib; Letrozole; Cancer; Metastatic breast cancer; Tamoxifen; Family medicine","score_opus":0.05411267099891534,"score_gpt":0.42878351827453065,"score_spread":0.3746708472756153,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4282018015","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9878926,0.0016685221,0.000079788675,0.0069442536,0.00091326504,0.0015419518,0.00081322587,0.000030213436,0.000116140145],"genre_scores_gemma":[0.9912757,0.0019081753,0.0025666514,0.0029239622,0.00024972475,0.0009117353,0.000024798994,0.000073836476,0.0000654033],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99461675,0.0021896386,0.0015002149,0.00031952985,0.00070659054,0.0006672698],"domain_scores_gemma":[0.9944581,0.0021192315,0.0019316445,0.00028834044,0.00087396725,0.0003287631],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0024183197,0.0004009918,0.0011109115,0.0006104438,0.0003169956,0.00003701208,0.0002735182,0.000054446493,0.0003682253],"category_scores_gemma":[0.00093181396,0.0003563766,0.00020502332,0.0005746989,0.00010136362,0.0015759718,0.00015821104,0.0021742466,8.3117357e-7],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.22502494,0.012128496,0.02928368,0.00009799315,0.0008664372,0.0024478557,0.01580948,0.0029679518,0.054336768,0.0000046680084,0.00023335242,0.65679836],"study_design_scores_gemma":[0.19346718,0.014531605,0.0031224606,0.0006374167,0.000816307,0.00829841,0.052594554,0.0010179313,0.017151695,0.00005388142,0.7077116,0.00059696427],"about_ca_topic_score_codex":0.0024745732,"about_ca_topic_score_gemma":0.00075977936,"teacher_disagreement_score":0.7074782,"about_ca_system_score_codex":0.019891635,"about_ca_system_score_gemma":0.002806639,"threshold_uncertainty_score":0.99988884},"labels":[],"label_agreement":null},{"id":"W4289838535","doi":"10.1177/10781552221118535","title":"Developing wipe sampling strategy guidance for assessing environmental contamination of antineoplastic drugs","year":2022,"lang":"en","type":"article","venue":"Journal of Oncology Pharmacy Practice","topic":"Safe Handling of Antineoplastic Drugs","field":"Health Professions","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Alberta Health Services; University of British Columbia","funders":"Alberta Health Services","keywords":"Medicine; Antineoplastic Drugs; Percentile; Sampling (signal processing); Pharmacy; Contamination; Environmental health; Statistics; Pharmacology; Family medicine; Computer science; Telecommunications","score_opus":0.15113008029559152,"score_gpt":0.5187497198166111,"score_spread":0.3676196395210196,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4289838535","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9013865,0.00070446625,0.08497473,0.005260994,0.00446597,0.0006932105,0.000042206637,0.000022767732,0.0024491346],"genre_scores_gemma":[0.94805723,0.00020136627,0.049580846,0.0013447952,0.00057415775,0.000041329982,0.000013472001,0.000036193716,0.00015061052],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.9956717,0.0014524028,0.0016848475,0.00021056263,0.00055335375,0.0004271397],"domain_scores_gemma":[0.97703797,0.017435547,0.0048336666,0.00011518372,0.00047726103,0.0001004038],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.006117456,0.00017826153,0.00055342255,0.00027461915,0.0010066621,0.000014386031,0.00033156874,0.00007680281,0.00030195733],"category_scores_gemma":[0.0039652633,0.00018117974,0.00012149032,0.00021594054,0.00008214569,0.0009819666,0.00019123749,0.0013363067,0.000008603708],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.030712068,0.0067175347,0.15235281,0.0030329179,0.003130031,0.0008528094,0.04768277,0.035410322,0.3480785,0.010333499,0.019103134,0.3425936],"study_design_scores_gemma":[0.022826727,0.0017702852,0.017971762,0.00063277344,0.0012350283,0.0013071835,0.081173144,0.0067894626,0.003174615,0.00049146556,0.86209357,0.0005339695],"about_ca_topic_score_codex":0.00002141921,"about_ca_topic_score_gemma":0.0000019562765,"teacher_disagreement_score":0.84299046,"about_ca_system_score_codex":0.0009540657,"about_ca_system_score_gemma":0.0041692914,"threshold_uncertainty_score":0.7742533},"labels":[],"label_agreement":null},{"id":"W4292870479","doi":"10.1177/10781552221122005","title":"Ocular toxicity following carboplatin chemotherapy for neuroendocrine tumour of the bladder","year":2022,"lang":"en","type":"article","venue":"Journal of Oncology Pharmacy Practice","topic":"Drug-Induced Ocular Toxicity","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Thomas Hospital","funders":"","keywords":"Carboplatin; Medicine; Chemotherapy; Cisplatin; Toxicity; Blurred vision; Etoposide; Surgery; Oncology; Internal medicine","score_opus":0.039022091257262415,"score_gpt":0.3936813237783743,"score_spread":0.35465923252111187,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4292870479","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.942725,0.0004308356,0.0002535911,0.0513872,0.0018003114,0.00073258125,0.000009724133,0.0000126851,0.0026480583],"genre_scores_gemma":[0.9828523,0.00007390031,0.004197309,0.012098042,0.0004366109,0.000022320317,0.0000014661958,0.000044166758,0.00027393267],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.9970521,0.0008535568,0.0008366203,0.00019520531,0.0007541673,0.00030836317],"domain_scores_gemma":[0.9962382,0.0012602342,0.0017060194,0.00027689672,0.0003693382,0.00014931713],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0021730147,0.00017982602,0.00063086423,0.00014653121,0.0002390609,0.000010444682,0.00040427258,0.000028928993,0.0001665631],"category_scores_gemma":[0.0028214501,0.0001379664,0.00066287955,0.0003644621,0.00006428092,0.0003421663,0.00016672252,0.0013613101,0.0000013562614],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004945922,0.002751477,0.0033267012,0.00006311916,0.001763709,0.0020606376,0.0007378002,0.000704319,0.9611258,0.000067186455,0.008734063,0.013719272],"study_design_scores_gemma":[0.01772899,0.00159808,0.0021464652,0.000023086597,0.0019308373,0.01232856,0.0009366211,0.0008665916,0.29702482,0.00007402333,0.66519517,0.00014676688],"about_ca_topic_score_codex":0.000024570752,"about_ca_topic_score_gemma":0.0000018549196,"teacher_disagreement_score":0.66410094,"about_ca_system_score_codex":0.00044724756,"about_ca_system_score_gemma":0.0011174363,"threshold_uncertainty_score":0.5914291},"labels":[],"label_agreement":null},{"id":"W4293213938","doi":"10.1177/10781552221122057","title":"Elevated transaminases and development of cardiomyopathy in a 32-year-old woman with metastatic breast cancer after treatment with ribociclib followed by palbociclib","year":2022,"lang":"en","type":"article","venue":"Journal of Oncology Pharmacy Practice","topic":"Advanced Breast Cancer Therapies","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta; Alberta Health Services","funders":"","keywords":"Palbociclib; Medicine; Discontinuation; Metastatic breast cancer; Breast cancer; Internal medicine; Cardiomyopathy; Heart failure; Adverse effect; Cancer; Oncology","score_opus":0.024529496821787684,"score_gpt":0.3570514982484372,"score_spread":0.3325220014266495,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4293213938","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98861504,0.005447423,0.00029178517,0.0048722504,0.00008240023,0.00052884745,0.00008255432,0.000010515158,0.00006917127],"genre_scores_gemma":[0.98425275,0.00089404295,0.013365511,0.0010571451,0.000046794452,0.00021826853,0.000007014825,0.000044580356,0.0001139156],"study_design_codex":"randomized_trial","study_design_gemma":"not_applicable","domain_scores_codex":[0.9978707,0.00042212577,0.00064480567,0.00024310872,0.000517052,0.0003022144],"domain_scores_gemma":[0.99812526,0.00038831634,0.00089428347,0.0001281356,0.00028133308,0.00018264727],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006431807,0.00025571568,0.00083130854,0.00022969495,0.00008778083,0.0000091967495,0.00008803471,0.000024735971,0.00029603112],"category_scores_gemma":[0.00002120965,0.00017830105,0.0000670135,0.00037940044,0.00013850295,0.00045799508,0.00002727703,0.0004822327,5.301381e-7],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.33383125,0.008542422,0.28402412,0.0003316584,0.008935471,0.011721854,0.02412646,0.0006839895,0.05024991,0.0000042223414,0.00031192644,0.27723673],"study_design_scores_gemma":[0.14663266,0.018424954,0.058296006,0.0004493944,0.0060685365,0.04594554,0.024363337,0.00006417435,0.021042459,0.000007812963,0.67798567,0.00071945606],"about_ca_topic_score_codex":0.00013427333,"about_ca_topic_score_gemma":0.00009407804,"teacher_disagreement_score":0.67767376,"about_ca_system_score_codex":0.0012007118,"about_ca_system_score_gemma":0.0016497774,"threshold_uncertainty_score":0.7270906},"labels":[],"label_agreement":null},{"id":"W4294843065","doi":"10.1177/10781552221103551","title":"Switching to daratumumab SC from IV is safe and preferred by patients with multiple myeloma","year":2022,"lang":"en","type":"article","venue":"Journal of Oncology Pharmacy Practice","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":17,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen Elizabeth II Health Sciences Centre; Dalhousie University","funders":"Janssen Research and Development","keywords":"Daratumumab; Medicine; Lenalidomide; Adverse effect; Multiple myeloma; Internal medicine; Expanded access; Oncology","score_opus":0.03477357326497679,"score_gpt":0.37979663970437233,"score_spread":0.3450230664393955,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4294843065","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98564506,0.00077098055,0.000121009114,0.010655876,0.00027219136,0.00064558,0.00014578356,0.000011942579,0.0017315567],"genre_scores_gemma":[0.98594254,0.00016488614,0.0084876,0.004900597,0.00014871075,0.000034299832,0.000045731405,0.000031414605,0.00024423745],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.99752086,0.0005014581,0.00048064496,0.00027852374,0.0008741985,0.00034432398],"domain_scores_gemma":[0.9969188,0.0012527046,0.00063085445,0.00018381707,0.00042645182,0.00058739714],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006385954,0.00019017611,0.00046803502,0.00020085827,0.0003587621,0.00003813457,0.00017870973,0.000038138136,0.0007757361],"category_scores_gemma":[0.0010370234,0.00014567649,0.00006572437,0.00022782742,0.00003778702,0.0006420666,0.0002090322,0.0010709424,0.000023033825],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.09820741,0.006539627,0.5287045,0.000030285204,0.002803932,0.0031325587,0.003163865,0.000026330905,0.016309973,0.0000020723962,0.08760268,0.2534767],"study_design_scores_gemma":[0.044751137,0.0067843217,0.10189048,0.00003667298,0.0006681828,0.0010126097,0.0006582679,0.0004018695,0.00177651,0.000008053744,0.84184706,0.00016480501],"about_ca_topic_score_codex":0.0002546825,"about_ca_topic_score_gemma":0.000013533855,"teacher_disagreement_score":0.7542444,"about_ca_system_score_codex":0.00056285696,"about_ca_system_score_gemma":0.00049716874,"threshold_uncertainty_score":0.8493767},"labels":[],"label_agreement":null},{"id":"W4296041784","doi":"10.1177/10781552221112603","title":"Oral oncolytic monitoring pilot with patient-reported outcomes and adherence assessments","year":2022,"lang":"en","type":"article","venue":"Journal of Oncology Pharmacy Practice","topic":"Medication Adherence and Compliance","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Pharmacist; Adverse effect; Internal medicine; Pharmacy; Emergency medicine; Intensive care medicine; Family medicine","score_opus":0.17346339030429375,"score_gpt":0.4920311052374802,"score_spread":0.3185677149331865,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4296041784","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98334706,0.00043373337,0.00021356196,0.008173404,0.00090614037,0.00032914535,0.0000012304384,0.000016531083,0.0065791877],"genre_scores_gemma":[0.9855568,0.00027956528,0.00977539,0.003321435,0.0001131479,0.000044366145,0.0000011739055,0.000013765973,0.00089438574],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.9979782,0.0003367167,0.0006113874,0.00016713493,0.00071810134,0.00018843655],"domain_scores_gemma":[0.9969386,0.00061493757,0.001604894,0.00015279214,0.00044024538,0.00024852902],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009774762,0.00012691232,0.0004060885,0.000121351935,0.00017530652,0.000019027972,0.00013696124,0.000018975528,0.0007745849],"category_scores_gemma":[0.00053898734,0.00009683824,0.000041454052,0.0002342786,0.00007006705,0.0005388768,0.00008497519,0.0009614339,0.000017033655],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.010343729,0.0038350832,0.8177863,0.000053885717,0.0012327551,0.006023346,0.00062406,0.000048057536,0.006616815,0.000029087732,0.007928421,0.14547849],"study_design_scores_gemma":[0.027528603,0.02999714,0.16643025,0.00014711176,0.002141229,0.039402068,0.007977425,0.00026895155,0.00114038,0.000049304257,0.7246275,0.0002900664],"about_ca_topic_score_codex":0.000034411314,"about_ca_topic_score_gemma":4.3607798e-7,"teacher_disagreement_score":0.71669906,"about_ca_system_score_codex":0.00032813504,"about_ca_system_score_gemma":0.001358156,"threshold_uncertainty_score":0.84811616},"labels":[],"label_agreement":null},{"id":"W4308959566","doi":"10.1177/10781552221135121","title":"Safe handling of hazardous drugs","year":2022,"lang":"en","type":"article","venue":"Journal of Oncology Pharmacy Practice","topic":"Safe Handling of Antineoplastic Drugs","field":"Health Professions","cited_by":29,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Lakeridge Health; McMaster University; Cancer Care Ontario; Southlake Regional Health Center; Regional Municipality of Durham; University of Toronto; Kingston Health Sciences Centre","funders":"","keywords":"Guideline; Medicine; Accidental; Hazardous waste; Health care; Pharmacy; Medical emergency; Family medicine","score_opus":0.08298654180514832,"score_gpt":0.5078588193423224,"score_spread":0.42487227753717405,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4308959566","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.807747,0.0018908513,0.0013924069,0.045254912,0.016116302,0.0006521002,0.000033284115,0.000047327678,0.12686579],"genre_scores_gemma":[0.9781512,0.00056175684,0.011307165,0.0070366524,0.0012769084,0.000022340531,0.0000028643453,0.00004276955,0.0015983521],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9938456,0.0029893224,0.0017368707,0.00017665667,0.0007940836,0.00045748413],"domain_scores_gemma":[0.98021394,0.013668542,0.004641475,0.00020229464,0.0010795116,0.0001942446],"candidate_categories":["research_integrity","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.008437256,0.00016286611,0.000675352,0.00036105872,0.0008905897,0.0000056583103,0.00052013126,0.000078606856,0.0030063249],"category_scores_gemma":[0.0055242083,0.000151657,0.00018574657,0.0003873508,0.00009710343,0.00053684996,0.00037615694,0.0031124402,0.00009240317],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.06302177,0.009324479,0.064166054,0.0010292276,0.0039251614,0.0056328997,0.105570324,0.010407005,0.048893053,0.0036887901,0.5235239,0.1608173],"study_design_scores_gemma":[0.008627719,0.00089307415,0.0004088572,0.00007400102,0.0005390689,0.001225118,0.018596057,0.0003658436,0.0005227972,0.00013349908,0.9684818,0.0001321885],"about_ca_topic_score_codex":0.00012243044,"about_ca_topic_score_gemma":0.0000036859537,"teacher_disagreement_score":0.44495782,"about_ca_system_score_codex":0.0005379792,"about_ca_system_score_gemma":0.0055630356,"threshold_uncertainty_score":0.9991874},"labels":[],"label_agreement":null},{"id":"W4312018881","doi":"10.1177/10781552221145667","title":"Exploration of current pharmacy practice in cardio-oncology: Experiences &amp; perspectives","year":2022,"lang":"en","type":"article","venue":"Journal of Oncology Pharmacy Practice","topic":"Chemotherapy-induced cardiotoxicity and mitigation","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Waterloo; Alberta Pharmacists Association; Alberta Health Services","funders":"","keywords":"Medicine; Cardiotoxicity; Pharmacy; Oncology; Pharmacy practice; Family medicine; Clinical pharmacy; Nursing; Internal medicine","score_opus":0.13177719943355853,"score_gpt":0.48809345303582236,"score_spread":0.3563162536022638,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4312018881","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9273994,0.014535721,0.0010451914,0.039404463,0.002646753,0.0008238168,0.000007814485,0.000024663374,0.014112209],"genre_scores_gemma":[0.9822873,0.011389979,0.0033662254,0.001886646,0.0008691008,0.00011208594,0.0000073463634,0.000023622306,0.00005771125],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.9952493,0.002321807,0.0010386349,0.00027078975,0.00085523754,0.00026428478],"domain_scores_gemma":[0.99413747,0.0022244812,0.0022403726,0.00018784477,0.0010379686,0.00017189396],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0046527227,0.00019089892,0.0007462077,0.00046945017,0.00016973879,0.00001681334,0.00022321023,0.000059636575,0.00041732632],"category_scores_gemma":[0.003767001,0.00018744028,0.00027469793,0.00064850727,0.00016983411,0.0028966032,0.000093816365,0.0018753394,0.0000067449646],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.027445886,0.00977449,0.0007947658,0.00010720969,0.0012800792,0.0013559888,0.32922313,0.0013427458,0.3758713,0.00023892931,0.01043266,0.24213283],"study_design_scores_gemma":[0.009855579,0.0013062558,0.00004819983,0.000031302603,0.0006293334,0.0060646096,0.18930936,0.000052636904,0.036452465,0.000046269135,0.7560791,0.00012489459],"about_ca_topic_score_codex":0.000067061635,"about_ca_topic_score_gemma":0.0000057507896,"teacher_disagreement_score":0.7456464,"about_ca_system_score_codex":0.0016321347,"about_ca_system_score_gemma":0.002486593,"threshold_uncertainty_score":0.8147521},"labels":[],"label_agreement":null},{"id":"W4312095782","doi":"10.1177/10781552221146801","title":"Etoposide hypersensitivity reactions associated with in-line filter use: A retrospective cohort study at CHU de Québec-Université Laval","year":2022,"lang":"en","type":"article","venue":"Journal of Oncology Pharmacy Practice","topic":"Drug-Induced Adverse Reactions","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Université Laval","funders":"Fondation CHU de Québec; Université Laval","keywords":"Medicine; Retrospective cohort study; Incidence (geometry); Etoposide; Cohort; Medical record; Population; Cumulative incidence; Surgery; Internal medicine; Chemotherapy","score_opus":0.04226150017374332,"score_gpt":0.35635523560713916,"score_spread":0.31409373543339586,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4312095782","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97068,0.00004343665,0.000013710295,0.015107317,0.00040931426,0.0006444668,0.00001938369,0.00003451866,0.013047866],"genre_scores_gemma":[0.99551207,0.0001581993,0.00036660914,0.0012821303,0.00017013258,0.000019552555,0.0000072768753,0.000035811496,0.002448205],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9966118,0.0015163943,0.00053257955,0.0002843388,0.00071477616,0.00034012442],"domain_scores_gemma":[0.9951265,0.0023574748,0.0013218632,0.00021650888,0.000728694,0.0002489593],"candidate_categories":["research_integrity"],"consensus_categories":[],"category_scores_codex":[0.002749229,0.00019767495,0.00065750495,0.00043487945,0.00047586736,0.000016437274,0.000114848786,0.000065487046,0.00013581518],"category_scores_gemma":[0.0032629354,0.00018660215,0.00014478592,0.00067200925,0.00007804322,0.0009956456,0.00014895177,0.0026212349,0.00000938731],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0051270225,0.012591429,0.9038758,0.0000062432105,0.003315055,0.03116783,0.0062235724,0.0011144945,0.032552388,0.000008336977,0.002113201,0.0019045789],"study_design_scores_gemma":[0.011600472,0.0016553306,0.77284735,0.00002667385,0.0028749835,0.029511467,0.011534771,0.00020543642,0.0005287441,0.0000019833562,0.16905174,0.0001610421],"about_ca_topic_score_codex":0.012484586,"about_ca_topic_score_gemma":0.00959545,"teacher_disagreement_score":0.16693853,"about_ca_system_score_codex":0.016993988,"about_ca_system_score_gemma":0.0032575352,"threshold_uncertainty_score":0.99967974},"labels":[],"label_agreement":null},{"id":"W4312200106","doi":"10.1177/10781552221147500","title":"An overview of the role of selpercatinib and pralsetinib in RET-fusion-positive non-small cell lung cancer (NSCLC)","year":2022,"lang":"en","type":"review","venue":"Journal of Oncology Pharmacy Practice","topic":"Lung Cancer Treatments and Mutations","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"CancerCare Manitoba; University of Manitoba","funders":"","keywords":"Medicine; Tolerability; Lung cancer; Internal medicine; Context (archaeology); Oncology; Adverse effect; Clinical trial; Neutropenia; non-small cell lung cancer (NSCLC); Intensive care medicine; Toxicity","score_opus":0.08405027830177551,"score_gpt":0.5071884258990789,"score_spread":0.42313814759730334,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4312200106","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.002825842,0.988203,0.000001351279,0.00094395084,0.0004607712,0.0013350635,0.000107064574,0.000002514549,0.0061204545],"genre_scores_gemma":[0.0017030666,0.9964257,0.000877602,0.0005404526,0.0001894244,0.00009554366,0.000016783388,0.000037688438,0.0001137618],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9966949,0.0012631642,0.0012761559,0.00022764242,0.00035147957,0.00018663569],"domain_scores_gemma":[0.9933073,0.0017871849,0.0041330275,0.0002537315,0.00038227622,0.00013648994],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013012666,0.00025966938,0.0016496594,0.00023691033,0.00008251598,0.000008538052,0.0002779433,0.00012753693,0.00046782484],"category_scores_gemma":[0.0003005934,0.0001663156,0.00032940763,0.00044496468,0.00008456298,0.00029148575,0.0001233028,0.0012725128,5.973893e-7],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008041282,0.0029208097,0.0019143051,0.008345407,0.0018126371,0.00027342315,0.004933645,0.0000160634,0.00027816955,0.00002584353,0.0008640487,0.9778115],"study_design_scores_gemma":[0.0037860766,0.0009453162,0.00031415006,0.0060808663,0.016073192,0.0013814061,0.0010661598,0.000030310677,0.000112529844,0.0000060967354,0.97007996,0.00012392088],"about_ca_topic_score_codex":0.00045291203,"about_ca_topic_score_gemma":0.000028076041,"teacher_disagreement_score":0.9776876,"about_ca_system_score_codex":0.00075597403,"about_ca_system_score_gemma":0.0059750564,"threshold_uncertainty_score":0.99966013},"labels":[],"label_agreement":null},{"id":"W4323809563","doi":"10.1177/10781552231160678","title":"The role of the pharmacist in the hospital discharge of cancer patients: an integrative review","year":2023,"lang":"en","type":"review","venue":"Journal of Oncology Pharmacy Practice","topic":"Pharmaceutical Practices and Patient Outcomes","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Pharmacist; MEDLINE; Medical prescription; Family medicine; Hospital discharge; Pharmaceutical care; Clinical pharmacy; Multidisciplinary approach; Pharmacotherapy; Cancer; Pharmacy; Nursing; Intensive care medicine; Internal medicine","score_opus":0.19189831728090095,"score_gpt":0.5697733033055442,"score_spread":0.37787498602464326,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4323809563","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0005110576,0.9837789,5.158232e-7,0.00928814,0.0018606497,0.0025132783,0.00008243155,0.0000047379112,0.001960301],"genre_scores_gemma":[0.0015858706,0.99493456,0.000034941313,0.002796099,0.0003973294,0.000109045635,0.000011589456,0.000044258846,0.00008629941],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9911573,0.004674945,0.0025791703,0.00023292248,0.0010146196,0.00034103682],"domain_scores_gemma":[0.97901195,0.011026382,0.008407218,0.00044139515,0.0009579521,0.00015507668],"candidate_categories":["research_integrity"],"consensus_categories":[],"category_scores_codex":[0.005371723,0.00040561496,0.0022204805,0.0001412693,0.00014942074,0.000023549657,0.00126707,0.00012830339,0.000106222236],"category_scores_gemma":[0.0071453773,0.00015315451,0.00097395567,0.0009799692,0.00035391553,0.0008030304,0.00019146079,0.0035565633,0.000014432949],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010902231,0.0038059014,0.0025665618,0.011974755,0.0023155417,0.000089909525,0.001324233,6.1315797e-7,0.000007713681,0.00012787544,0.0065259123,0.97017074],"study_design_scores_gemma":[0.0022267345,0.0009809126,0.00009592705,0.01744986,0.012409552,0.00026131497,0.00078414765,0.000017618255,0.00001954721,0.000026301464,0.9655865,0.000141573],"about_ca_topic_score_codex":0.00007658361,"about_ca_topic_score_gemma":0.00001665333,"teacher_disagreement_score":0.9700292,"about_ca_system_score_codex":0.0003423177,"about_ca_system_score_gemma":0.0018006408,"threshold_uncertainty_score":0.9987423},"labels":[],"label_agreement":null},{"id":"W4323812920","doi":"10.1177/10781552231162012","title":"Prescribing practices of oncology pharmacists working in ambulatory cancer centers in Alberta","year":2023,"lang":"en","type":"article","venue":"Journal of Oncology Pharmacy Practice","topic":"Pharmaceutical Practices and Patient Outcomes","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Alberta Cancer Foundation; University of Alberta; Alberta Children's Hospital","funders":"Alberta Health Services","keywords":"Medicine; Medical prescription; Interquartile range; Ambulatory; Pharmacist; Family medicine; Emergency medicine; Pharmacy; Internal medicine; Nursing","score_opus":0.30627243002902105,"score_gpt":0.5438910268885448,"score_spread":0.2376185968595238,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4323812920","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9341836,0.0020663657,0.000008616299,0.045355417,0.0026491806,0.0006591817,0.000003112398,0.000020319578,0.015054227],"genre_scores_gemma":[0.9769434,0.015492683,0.0010700667,0.0057221553,0.0004390261,0.000023822893,0.00000415258,0.00003872188,0.00026600878],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.99535376,0.0013304176,0.0017653096,0.00031977677,0.000635265,0.00059548015],"domain_scores_gemma":[0.98400545,0.010459164,0.004674791,0.0001895851,0.0003503318,0.00032069962],"candidate_categories":["research_integrity"],"consensus_categories":[],"category_scores_codex":[0.004764821,0.00026019503,0.0010234545,0.00083567644,0.000054664008,0.000020471683,0.00032465204,0.00017118709,0.00030076967],"category_scores_gemma":[0.00619018,0.00023210583,0.00024507137,0.0012143205,0.00014586152,0.0018631545,0.00016231062,0.0023581607,0.000031081956],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.030342886,0.004731678,0.7952628,0.00043673557,0.001195148,0.007391717,0.005661862,0.0016039021,0.037027355,0.00005741506,0.0075622164,0.108726285],"study_design_scores_gemma":[0.023657808,0.0012174044,0.012706413,0.00050862617,0.0012442783,0.0023880268,0.0016749239,0.008292413,0.0039989958,0.000029532752,0.9440298,0.00025177843],"about_ca_topic_score_codex":0.0009500233,"about_ca_topic_score_gemma":0.00023727957,"teacher_disagreement_score":0.9364676,"about_ca_system_score_codex":0.00095419434,"about_ca_system_score_gemma":0.0015604309,"threshold_uncertainty_score":0.99994344},"labels":[],"label_agreement":null},{"id":"W4362657402","doi":"10.1177/10781552231167329","title":"Canadian monitoring program of the surface contamination with 11 antineoplastic drugs in 124 centers","year":2023,"lang":"en","type":"article","venue":"Journal of Oncology Pharmacy Practice","topic":"Safe Handling of Antineoplastic Drugs","field":"Health Professions","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Université de Montréal; Institut National de Santé Publique du Québec; Centre Hospitalier Universitaire Sainte-Justine","funders":"","keywords":"Medicine; Docetaxel; Gemcitabine; Antineoplastic Drugs; Cyclophosphamide; Internal medicine; Cancer; Pharmacology; Chemotherapy","score_opus":0.05560200019666819,"score_gpt":0.4623512739777416,"score_spread":0.40674927378107345,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4362657402","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97648966,0.000045372697,0.000015325753,0.01667626,0.0036772888,0.0005904861,0.0000056841186,0.000025501615,0.0024744184],"genre_scores_gemma":[0.9974897,0.00019894593,0.0013418954,0.00028999604,0.0002973698,0.000011725163,0.0000015324475,0.000026272934,0.00034254653],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9968262,0.0011470082,0.00090647733,0.00014461695,0.00044665343,0.0005290803],"domain_scores_gemma":[0.9908443,0.006283628,0.0017260428,0.00014259192,0.00080610986,0.00019728891],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0031383617,0.00014534366,0.00038135875,0.000354745,0.0002737296,0.000010104622,0.00033347862,0.00010227231,0.0000372414],"category_scores_gemma":[0.0030533702,0.000101233825,0.000054524808,0.0009413041,0.00008564118,0.00050023675,0.000070387236,0.0013196104,0.0000351455],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00097560853,0.00035322542,0.98271596,0.00012732894,0.000117632895,0.0002850573,0.006476678,0.0012561291,0.0012274642,0.000035508696,0.0025161826,0.0039132396],"study_design_scores_gemma":[0.016113631,0.0013170766,0.6477638,0.0020076763,0.00060551503,0.0004796651,0.038123246,0.0024335862,0.0014967703,0.000016928272,0.28934014,0.00030194785],"about_ca_topic_score_codex":0.018514533,"about_ca_topic_score_gemma":0.014242142,"teacher_disagreement_score":0.33495215,"about_ca_system_score_codex":0.0006989749,"about_ca_system_score_gemma":0.005794431,"threshold_uncertainty_score":0.9998418},"labels":[],"label_agreement":null},{"id":"W4378952203","doi":"10.1177/10781552231179190","title":"Implementation and evaluation of a shared care model between oncologists and pharmacists for breast cancer patients at a Canadian regional ambulatory cancer centre","year":2023,"lang":"en","type":"article","venue":"Journal of Oncology Pharmacy Practice","topic":"Advanced Breast Cancer Therapies","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Pharmacist; Ambulatory; Family medicine; Breast cancer; Medical prescription; Cancer; Pharmaceutical care; Ambulatory care; Pharmacy; Internal medicine; Health care; Nursing","score_opus":0.13863132179766358,"score_gpt":0.5167725657152309,"score_spread":0.3781412439175673,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4378952203","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98271626,0.002544977,0.00001814257,0.012232703,0.00026006575,0.0009488573,0.0012077652,0.000009866206,0.00006137012],"genre_scores_gemma":[0.9953693,0.0018217602,0.0009980086,0.0012347985,0.00033990934,0.00009184398,0.0000792446,0.00002738717,0.000037717564],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9982736,0.00020076292,0.00052405027,0.00021148336,0.0005065495,0.00028356814],"domain_scores_gemma":[0.99557924,0.0003931603,0.0010501496,0.00007086752,0.002577479,0.00032912],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008886458,0.00015602069,0.0004034637,0.00027927308,0.0001349559,0.00000953646,0.00007190003,0.000071260874,0.00016033307],"category_scores_gemma":[0.00012648558,0.00014474342,0.00006551812,0.00017585204,0.0001039368,0.0005952712,0.000039472936,0.00022882497,7.3013433e-7],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.006740303,0.00014050482,0.35953078,0.00028711316,0.0010200714,0.000039696028,0.0069850967,0.0014015532,0.0040851664,0.0000057320954,0.0059370273,0.61382693],"study_design_scores_gemma":[0.09218881,0.0012378194,0.73637694,0.00036410792,0.009746476,0.0013337894,0.0071911225,0.014973507,0.0024196703,0.00018715336,0.13346548,0.00051510835],"about_ca_topic_score_codex":0.0027945007,"about_ca_topic_score_gemma":0.0055016414,"teacher_disagreement_score":0.6133118,"about_ca_system_score_codex":0.0030563425,"about_ca_system_score_gemma":0.0034831618,"threshold_uncertainty_score":0.79922295},"labels":[],"label_agreement":null},{"id":"W4383872302","doi":"10.1177/10781552231188309","title":"Pilot study evaluating feasibility and utility of pharmacist-driven oral antineoplastic agent monitoring program","year":2023,"lang":"en","type":"article","venue":"Journal of Oncology Pharmacy Practice","topic":"Medication Adherence and Compliance","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Pharmacist; Pharmacy; Psychological intervention; Adverse effect; Patient satisfaction; Clinical pharmacy; Patient safety; Medication therapy management; Health care; Medical emergency; Emergency medicine; Family medicine; Nursing; Internal medicine","score_opus":0.5216673933825094,"score_gpt":0.5890936689976283,"score_spread":0.06742627561511882,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4383872302","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99523264,0.00032839607,0.00006932011,0.001496479,0.00095328275,0.0009804338,0.0000018203261,0.000040414994,0.0008971955],"genre_scores_gemma":[0.9935019,0.0006295303,0.0052495166,0.00015607609,0.00028490208,0.00002997526,0.0000012621371,0.000011277078,0.0001355614],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9971684,0.00079244736,0.00092379254,0.00022309499,0.00066440203,0.00022785191],"domain_scores_gemma":[0.99574584,0.0015191367,0.0013013994,0.00018591063,0.0009908798,0.00025683545],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004584214,0.00013750054,0.0005198563,0.00014839153,0.000092145965,0.000015379013,0.00015889981,0.000022198776,0.00023005779],"category_scores_gemma":[0.005024512,0.000113972055,0.00006268564,0.00046346744,0.0001238778,0.00038863978,0.00009027235,0.00070031267,0.000054711156],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.007640767,0.008246896,0.8082065,0.00020686314,0.00044463147,0.00059133826,0.00078839087,0.000020486372,0.027649432,0.0000010592887,0.002350672,0.14385295],"study_design_scores_gemma":[0.035270527,0.041194405,0.8602931,0.00032027747,0.0030623183,0.0028890953,0.0063705957,0.019139823,0.0038378707,0.000034542314,0.027348286,0.00023914325],"about_ca_topic_score_codex":0.000021166223,"about_ca_topic_score_gemma":9.055978e-7,"teacher_disagreement_score":0.1436138,"about_ca_system_score_codex":0.000100410536,"about_ca_system_score_gemma":0.0007347462,"threshold_uncertainty_score":0.6015173},"labels":[],"label_agreement":null},{"id":"W4384818836","doi":"10.1177/10781552231188320","title":"Initial assessment of multi-compound antineoplastic drug surface contamination in Argentinean healthcare centers: Insights into occupational exposures in South America","year":2023,"lang":"en","type":"article","venue":"Journal of Oncology Pharmacy Practice","topic":"Safe Handling of Antineoplastic Drugs","field":"Health Professions","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"Fondo para la Investigación Científica y Tecnológica","keywords":"Antineoplastic Drugs; Contamination; Medicine; Drug; Toxicology; Environmental health; Pharmacology","score_opus":0.12636622964018557,"score_gpt":0.5322894968150766,"score_spread":0.4059232671748911,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4384818836","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9890531,0.00019209912,0.0013846969,0.0052860985,0.0030684501,0.0005652215,0.00001699985,0.000027487762,0.00040588048],"genre_scores_gemma":[0.991426,0.00043495008,0.0066743726,0.0009835876,0.00033266481,0.00001288928,0.000046694036,0.000030695886,0.00005817127],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9929226,0.0033003604,0.002315324,0.0002820695,0.0006769233,0.0005027357],"domain_scores_gemma":[0.9847566,0.010350451,0.0034188067,0.00014720495,0.0011519208,0.00017500482],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0035128684,0.00023228674,0.00077406556,0.0009695381,0.00020138042,0.000012524679,0.0003043038,0.00013429296,0.00007751451],"category_scores_gemma":[0.003805405,0.00021923562,0.00010047632,0.001010791,0.00012190067,0.00079624925,0.00014962743,0.0018046398,0.000053472657],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0031701755,0.0016312348,0.94533217,0.00045436277,0.00014436657,0.0008980314,0.03835193,0.0038346772,0.0028389704,0.00008187992,0.0012578041,0.0020044185],"study_design_scores_gemma":[0.025063805,0.00069427193,0.87422687,0.0010993057,0.000165837,0.00008439447,0.03599161,0.03165568,0.00031643515,0.000049197846,0.030342273,0.00031030123],"about_ca_topic_score_codex":0.0010608999,"about_ca_topic_score_gemma":0.00090280036,"teacher_disagreement_score":0.07110526,"about_ca_system_score_codex":0.00061858265,"about_ca_system_score_gemma":0.004550942,"threshold_uncertainty_score":0.8940169},"labels":[],"label_agreement":null},{"id":"W4385330812","doi":"10.1177/10781552231189695","title":"Single center evaluation on the use of conditionally ordered low molecular weight heparins in malignant hematology patients with venous thromboembolism","year":2023,"lang":"en","type":"article","venue":"Journal of Oncology Pharmacy Practice","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; University Health Network","funders":"","keywords":"Medicine; Concordance; Internal medicine; Hematology; Venous thromboembolism; Low molecular weight heparin; Cancer; Pediatrics; Heparin; Thrombosis","score_opus":0.07901018509527911,"score_gpt":0.36657191374363096,"score_spread":0.28756172864835183,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4385330812","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97943556,0.00008636369,0.00004689497,0.017304312,0.00046017428,0.0009473778,0.000010081015,0.000010471281,0.0016987887],"genre_scores_gemma":[0.9926974,0.000417827,0.0005995267,0.0060952315,0.00007204383,0.000038361875,0.000038396644,0.000026248648,0.000014946352],"study_design_codex":"not_applicable","study_design_gemma":"observational","domain_scores_codex":[0.9973401,0.0007100897,0.00070289394,0.00018744988,0.00078699336,0.00027246866],"domain_scores_gemma":[0.9963077,0.0012382766,0.001140359,0.00021149406,0.0010122929,0.00008991183],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013254767,0.00016311523,0.0006965176,0.00035657655,0.00006340839,0.000017519378,0.00014941153,0.00006877539,0.0002593123],"category_scores_gemma":[0.0011503344,0.00010565724,0.00009996523,0.0004000643,0.000106354484,0.0003907485,0.00006082726,0.00042587027,0.000026219788],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.036099263,0.24716492,0.23219337,0.0011113707,0.018265363,0.018532546,0.011501763,0.025079962,0.035572566,0.022915047,0.27207166,0.07949217],"study_design_scores_gemma":[0.06250144,0.020058254,0.49994203,0.0016619299,0.0065904898,0.0022449787,0.0010935891,0.0030754132,0.0147535615,0.000717168,0.3867414,0.0006197461],"about_ca_topic_score_codex":0.0000325413,"about_ca_topic_score_gemma":0.000015850044,"teacher_disagreement_score":0.26774868,"about_ca_system_score_codex":0.00029573007,"about_ca_system_score_gemma":0.00047741242,"threshold_uncertainty_score":0.4308577},"labels":[],"label_agreement":null},{"id":"W4386346756","doi":"10.1177/10781552231199048","title":"Utilization and toxicity patterns of 2-weekly (Q2W) versus 4-weekly (Q4W) nivolumab for treatment of adjuvant and metastatic melanoma at BC cancer","year":2023,"lang":"en","type":"article","venue":"Journal of Oncology Pharmacy Practice","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Dosing; Medicine; Incidence (geometry); Nivolumab; Adverse effect; Cancer; Internal medicine; Immunotherapy","score_opus":0.16286691192930697,"score_gpt":0.46567016003911027,"score_spread":0.3028032481098033,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4386346756","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9843185,0.0068295477,0.00009845473,0.007478296,0.0005759621,0.0004512462,0.00007969329,0.000006920596,0.00016141428],"genre_scores_gemma":[0.9487074,0.04951691,0.0008440882,0.00029628194,0.00014147868,0.000023778532,0.000011712529,0.000018908837,0.0004394647],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99869555,0.00017685675,0.0006097793,0.00014256894,0.00021029753,0.00016493059],"domain_scores_gemma":[0.9969143,0.001417158,0.0011390555,0.000092625516,0.00033505715,0.000101792284],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006397212,0.0001354109,0.00059339835,0.00017222001,0.000060283484,0.0000060648304,0.000051444047,0.00004847719,0.00013632755],"category_scores_gemma":[0.00025528602,0.00010487304,0.00012317522,0.00015907286,0.00009773192,0.0002488361,0.000024482079,0.00008122729,6.8475356e-7],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.17692369,0.0021909724,0.02948644,0.0006754681,0.0054788115,0.0003375566,0.003582089,0.000023302593,0.21041617,0.000016853564,0.005197063,0.56567156],"study_design_scores_gemma":[0.12854986,0.038604878,0.054737084,0.00031601498,0.008808143,0.0019618087,0.004515697,0.0017084075,0.22493027,0.00002705788,0.53554803,0.0002927307],"about_ca_topic_score_codex":0.00043821035,"about_ca_topic_score_gemma":0.0001350047,"teacher_disagreement_score":0.56537884,"about_ca_system_score_codex":0.00039974166,"about_ca_system_score_gemma":0.00041691907,"threshold_uncertainty_score":0.42765987},"labels":[],"label_agreement":null},{"id":"W4387001864","doi":"10.1177/10781552231200169","title":"Managing opioids and mitigating opioid risks in patients with cancer: An environmental scan of the attitudes, confidence, and practices of ambulatory, community and hospital pharmacists practicing in Canada","year":2023,"lang":"en","type":"article","venue":"Journal of Oncology Pharmacy Practice","topic":"Pain Management and Opioid Use","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Beatrice Hunter Cancer Research Institute; Nova Scotia Health Authority; Centre for Addiction and Mental Health; University of Toronto; University Health Network; Sinai Health System","funders":"","keywords":"Medicine; Ambulatory; Opioid; Confidence interval; Family medicine; Emergency medicine; Medical emergency; Intensive care medicine; Internal medicine","score_opus":0.03970063577060555,"score_gpt":0.3882419813998531,"score_spread":0.34854134562924755,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4387001864","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9966077,0.00065422175,0.0000011149035,0.0020346125,0.00014737065,0.00040793465,0.000008639787,0.0000027646358,0.00013563137],"genre_scores_gemma":[0.99495757,0.0041547283,0.00039365448,0.0004335973,0.000034268498,0.0000052030055,0.0000029768182,0.000012835385,0.000005187552],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99794745,0.00077657227,0.00055336155,0.00014050497,0.00038861705,0.00019346664],"domain_scores_gemma":[0.99604136,0.0014625337,0.0021561554,0.00013509384,0.000086626555,0.00011825025],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0020358048,0.0001376294,0.00040146976,0.0001902701,0.000109087894,0.00001693666,0.00014082174,0.000031255542,0.000009694206],"category_scores_gemma":[0.0006804702,0.00010670788,0.000017479946,0.00023589945,0.00021862457,0.0010300005,0.00016614317,0.0009389547,6.0764506e-8],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011989793,0.00046188987,0.9836099,0.00025585887,0.00019153845,0.00016437477,0.0023320462,0.00009563204,0.0010495739,0.00000410371,0.00007529935,0.010560773],"study_design_scores_gemma":[0.0074145645,0.00062743126,0.9814517,0.00032320045,0.00041817728,0.000065236214,0.0073723593,0.0010168114,0.00047629167,0.000011051993,0.00072271854,0.00010048886],"about_ca_topic_score_codex":0.19213371,"about_ca_topic_score_gemma":0.042139303,"teacher_disagreement_score":0.1499944,"about_ca_system_score_codex":0.00037347715,"about_ca_system_score_gemma":0.000732634,"threshold_uncertainty_score":0.9753392},"labels":[],"label_agreement":null},{"id":"W4388975236","doi":"10.1177/10781552231216101","title":"National survey of safe handling of hazardous drugs in hospital settings: Use of an innovative approach","year":2023,"lang":"en","type":"article","venue":"Journal of Oncology Pharmacy Practice","topic":"Safe Handling of Antineoplastic Drugs","field":"Health Professions","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Université de Montréal; Centre Hospitalier de l’Université de Montréal; Université Laval; Centre Hospitalier Universitaire Sainte-Justine","funders":"","keywords":"Medicine; Hazardous waste; Pharmacy; Environmental health; Health care; Hygiene; Medical emergency; Family medicine","score_opus":0.1727510979722796,"score_gpt":0.5090317187183417,"score_spread":0.33628062074606213,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4388975236","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99316937,0.000054462496,0.00023970848,0.0022837806,0.001265583,0.00039804293,0.000093507115,0.000013307074,0.0024822347],"genre_scores_gemma":[0.9823287,0.00016907939,0.016714752,0.00039980304,0.00022414445,0.000008523705,0.000036924026,0.000030078869,0.00008797421],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99288833,0.003109071,0.0025489426,0.00021468515,0.00086243957,0.00037654763],"domain_scores_gemma":[0.9627858,0.023807812,0.006289275,0.00015142778,0.0068594604,0.000106267165],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.015785879,0.00017802873,0.00089822814,0.000947059,0.00012063889,0.0000060887974,0.00034826246,0.00018339795,0.000053937838],"category_scores_gemma":[0.03858064,0.0001638264,0.000082092556,0.0019635505,0.00020408453,0.0013296397,0.00016411876,0.0015650175,0.00001090497],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.027375959,0.01362725,0.75611836,0.0019822111,0.0022752779,0.00035910294,0.11659501,0.013810689,0.017411845,0.00094204297,0.03418018,0.015322071],"study_design_scores_gemma":[0.03554247,0.004480427,0.83855414,0.001667323,0.0005692938,0.0003064018,0.042415936,0.023900831,0.005719185,0.0002588075,0.04589496,0.000690195],"about_ca_topic_score_codex":0.00081321574,"about_ca_topic_score_gemma":0.000040229894,"teacher_disagreement_score":0.0824358,"about_ca_system_score_codex":0.00023937014,"about_ca_system_score_gemma":0.0063514616,"threshold_uncertainty_score":0.9992816},"labels":[],"label_agreement":null},{"id":"W4392365446","doi":"10.1177/10781552241233489","title":"Palonosetron in pediatric patients: A single-center, retrospective evaluation of policy and clinical practice guideline discordance","year":2024,"lang":"en","type":"article","venue":"Journal of Oncology Pharmacy Practice","topic":"Nausea and vomiting management","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute for Clinical Evaluative Sciences; SickKids Foundation; Pediatric Oncology Group; Hospital for Sick Children; University of Toronto","funders":"","keywords":"Palonosetron; Medicine; Chemotherapy-induced nausea and vomiting; Antiemetic; Nausea; Chemotherapy; Vomiting; Oncology; Internal medicine; Anesthesia","score_opus":0.09609602017322073,"score_gpt":0.5257986027666897,"score_spread":0.42970258259346894,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4392365446","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.93823814,0.0039813374,0.00035417054,0.041563798,0.0017649514,0.00082216406,0.000008797742,0.000016077163,0.013250561],"genre_scores_gemma":[0.9801525,0.0059088725,0.009558686,0.002470389,0.0018392385,0.0000061751152,0.00000603978,0.000021016194,0.000037072932],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.99578625,0.0012471692,0.0016807381,0.00025132517,0.00082958257,0.0002049626],"domain_scores_gemma":[0.9926054,0.003275355,0.0016974243,0.00014032355,0.0021362258,0.00014526278],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.010846409,0.00014081679,0.0004948786,0.00058059493,0.00002926776,0.000031001306,0.00009808689,0.00007187652,0.00003112486],"category_scores_gemma":[0.043810632,0.00011749073,0.00012064222,0.00062104256,0.00007309408,0.0012168632,0.000084550236,0.00091155514,0.0000058109295],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.013853734,0.018634807,0.5309364,0.00042135836,0.0013493426,0.001360554,0.0011602463,0.00005759877,0.0005923108,0.00055466447,0.03218031,0.39889863],"study_design_scores_gemma":[0.049259663,0.012565771,0.15758851,0.00046298746,0.011315628,0.002076087,0.0012670722,0.00459652,0.00010327108,0.00035866757,0.7601258,0.00028002285],"about_ca_topic_score_codex":0.000047612924,"about_ca_topic_score_gemma":0.000008331242,"teacher_disagreement_score":0.7279455,"about_ca_system_score_codex":0.0012287168,"about_ca_system_score_gemma":0.0013730364,"threshold_uncertainty_score":0.96424377},"labels":[],"label_agreement":null},{"id":"W4393988990","doi":"10.1177/10781552241243042","title":"The relationship between immune-related adverse events during ipilimumab monotherapy and survival outcomes among melanoma patients: A systematic review","year":2024,"lang":"en","type":"review","venue":"Journal of Oncology Pharmacy Practice","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"","keywords":"Ipilimumab; Medicine; Adverse effect; Internal medicine; Discontinuation; Oncology; Hazard ratio; Incidence (geometry); Melanoma; Clinical trial; Confounding; Cancer; Immunotherapy; Confidence interval","score_opus":0.07369751300540853,"score_gpt":0.44483823801374756,"score_spread":0.37114072500833906,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4393988990","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0035311326,0.9896791,0.0000013974216,0.0020251048,0.0016008829,0.0028834045,0.000016210925,0.000025289502,0.00023747169],"genre_scores_gemma":[0.0019143118,0.99655974,0.000044638968,0.0002690263,0.00019210434,0.000101262565,0.000017991733,0.000089920395,0.0008110132],"study_design_codex":"systematic_review","study_design_gemma":"not_applicable","domain_scores_codex":[0.9918017,0.0029748573,0.0039397134,0.00030333851,0.00065355113,0.00032685863],"domain_scores_gemma":[0.9834709,0.009216396,0.0062890565,0.00043378185,0.00040303497,0.00018683191],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.0059820805,0.00054355105,0.0040373937,0.00033543684,0.00029006656,0.000034650417,0.00038964313,0.0002867451,0.000036296206],"category_scores_gemma":[0.0045605623,0.0002921258,0.0014272678,0.0005490601,0.00016022201,0.0005789914,0.00009120395,0.0023269234,0.000040813185],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0022430667,0.0005360271,0.03582183,0.85467315,0.028626757,0.00062213215,0.00039959713,9.666379e-8,8.1140445e-7,0.000016349177,0.0006416781,0.076418534],"study_design_scores_gemma":[0.008850988,0.0006683844,0.01296495,0.4248449,0.07528842,0.002438161,0.00015009702,7.0247137e-7,2.8368146e-7,0.00001391318,0.47443086,0.0003483567],"about_ca_topic_score_codex":0.000020442629,"about_ca_topic_score_gemma":0.0000022681695,"teacher_disagreement_score":0.4737892,"about_ca_system_score_codex":0.0010807388,"about_ca_system_score_gemma":0.0009699061,"threshold_uncertainty_score":0.9999747},"labels":[],"label_agreement":null},{"id":"W4396778056","doi":"10.1177/10781552241238198","title":"Review of drug-drug interactions in patients with prostate cancer","year":2024,"lang":"en","type":"review","venue":"Journal of Oncology Pharmacy Practice","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Waterloo","funders":"","keywords":"Medicine; Polypharmacy; Prostate cancer; Drug; Cancer drugs; Cancer; Drug-drug interaction; Intensive care medicine; Pharmacology; Oncology; Internal medicine","score_opus":0.1037906823693015,"score_gpt":0.5476061643329013,"score_spread":0.4438154819635998,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4396778056","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00008529627,0.9877228,2.412494e-7,0.007187747,0.0009883879,0.0018185513,0.0000641496,0.000006945508,0.0021258758],"genre_scores_gemma":[0.000025534304,0.9962193,0.00027098082,0.0008739245,0.00030529447,0.00014230721,0.000043516833,0.000059102706,0.0020600366],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9965833,0.0007593945,0.0015558674,0.0002580699,0.0005507706,0.0002926255],"domain_scores_gemma":[0.99483144,0.0008989516,0.0025704287,0.00020354205,0.0012902684,0.00020537434],"candidate_categories":["research_integrity"],"consensus_categories":[],"category_scores_codex":[0.0015163266,0.00034077803,0.0024245947,0.0006539028,0.000031094805,0.000015116857,0.00020801976,0.000044006152,0.00032437977],"category_scores_gemma":[0.0004733352,0.00018869698,0.0004262135,0.0008541096,0.000112102854,0.00057658594,0.0000855154,0.0026348382,0.00003840101],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0030992592,0.0016819615,0.0005209524,0.16259558,0.002531603,0.0012168074,0.00026761615,3.3583225e-7,3.848625e-7,0.0000014071021,0.07593946,0.75214463],"study_design_scores_gemma":[0.0036985236,0.00040366198,0.000019458901,0.22505842,0.012924503,0.00070747663,0.000046147703,4.930486e-7,0.000002582388,0.0000012601322,0.7570273,0.00011013179],"about_ca_topic_score_codex":0.000091953305,"about_ca_topic_score_gemma":0.000019587416,"teacher_disagreement_score":0.7520345,"about_ca_system_score_codex":0.0016954495,"about_ca_system_score_gemma":0.006484958,"threshold_uncertainty_score":0.9996661},"labels":[],"label_agreement":null},{"id":"W4400983376","doi":"10.1177/10781552241262248","title":"Hypokalemia, hypomagnesemia, and hyponatremia are associated with acute kidney injury in patients treated with cisplatin","year":2024,"lang":"en","type":"article","venue":"Journal of Oncology Pharmacy Practice","topic":"Chemotherapy-induced organ toxicity mitigation","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Centre Hospitalier de l’Université de Montréal","funders":"","keywords":"Hypomagnesemia; Hypokalemia; Medicine; Hyponatremia; Acute kidney injury; Cisplatin; Internal medicine; Diabetes mellitus; Tolvaptan; Gastroenterology; Endocrinology; Chemotherapy; Magnesium","score_opus":0.01600358763426598,"score_gpt":0.3375553216395489,"score_spread":0.3215517340052829,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4400983376","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.984072,0.00019633055,0.000011620011,0.013125981,0.00015101422,0.00041227636,0.000034494824,0.00004344943,0.0019528011],"genre_scores_gemma":[0.9938219,0.00038802152,0.0016180236,0.0035875735,0.00018016393,0.000007204496,0.00002895864,0.00006492345,0.0003032411],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99791867,0.0003308186,0.0006315137,0.00028712262,0.00053590065,0.00029595318],"domain_scores_gemma":[0.99709445,0.00084486866,0.0009362756,0.00013194057,0.000629359,0.0003630742],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00085218786,0.0002671629,0.0006091921,0.00047204495,0.000058089245,0.000054172142,0.00010116414,0.00018168055,0.00010405819],"category_scores_gemma":[0.0015076946,0.00019449384,0.000059398084,0.000783094,0.00012474674,0.0011278815,0.000027096057,0.0014905621,0.0000085186475],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.038708776,0.0035277214,0.7071647,0.00020796456,0.0039807158,0.016115878,0.0020721953,0.0000056246786,0.13821353,0.000008997379,0.027003763,0.06299012],"study_design_scores_gemma":[0.090983585,0.023548298,0.6282655,0.003814328,0.009380715,0.020747451,0.0007256504,0.00089882966,0.1320517,0.00007016793,0.0884451,0.0010686618],"about_ca_topic_score_codex":0.000028375569,"about_ca_topic_score_gemma":0.000008362747,"teacher_disagreement_score":0.0788992,"about_ca_system_score_codex":0.001073593,"about_ca_system_score_gemma":0.0013025996,"threshold_uncertainty_score":0.7931229},"labels":[],"label_agreement":null},{"id":"W4401392027","doi":"10.1177/10781552241269722","title":"Assessing the impact of aprepitant on response to dose-intensive cyclophosphamide, etoposide, and cisplatin (DICEP)","year":2024,"lang":"en","type":"article","venue":"Journal of Oncology Pharmacy Practice","topic":"Nausea and vomiting management","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Foothills Medical Centre; Alberta Health Services","funders":"","keywords":"Aprepitant; Medicine; Etoposide; Oncology; Internal medicine; Cyclophosphamide; Antiemetic; Nausea; Chemotherapy","score_opus":0.06942844549734552,"score_gpt":0.5093144953916011,"score_spread":0.4398860498942556,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4401392027","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9232565,0.0014303337,0.0001663814,0.06839864,0.0007167751,0.0003693333,0.000002814562,0.00001640768,0.005642784],"genre_scores_gemma":[0.991052,0.0006522733,0.0018027596,0.005820491,0.0003515084,0.00000417205,4.291299e-7,0.000024466788,0.00029195347],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.99772114,0.00076479046,0.00070126826,0.00019164683,0.0003926118,0.00022854225],"domain_scores_gemma":[0.990801,0.007361992,0.0006591227,0.00018917544,0.000771074,0.00021763024],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.005157034,0.00016818495,0.00046116693,0.00034031674,0.000089648776,0.000098007265,0.000132057,0.00005540856,0.00008677522],"category_scores_gemma":[0.0077909594,0.00009762314,0.0001941173,0.00036904856,0.000092186216,0.0005823061,0.00008793511,0.0009346584,0.000020526855],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.11933873,0.0017788645,0.00924948,0.00037494648,0.005862136,0.027006416,0.009674997,0.0008658788,0.44219995,0.0004895298,0.16183151,0.22132757],"study_design_scores_gemma":[0.016917009,0.024010193,0.23480451,0.002496791,0.0059103733,0.03087554,0.013025971,0.0031949375,0.02040702,0.0003873997,0.6474898,0.00048046798],"about_ca_topic_score_codex":0.000059988135,"about_ca_topic_score_gemma":5.7278885e-7,"teacher_disagreement_score":0.48565826,"about_ca_system_score_codex":0.00042056182,"about_ca_system_score_gemma":0.0008433441,"threshold_uncertainty_score":0.9327069},"labels":[],"label_agreement":null},{"id":"W4401890998","doi":"10.1177/10781552241276530","title":"Assessment of chemical contamination by cancer drugs during use of the RIVA <sup>TM</sup> compounding robot: A pilot study","year":2024,"lang":"en","type":"article","venue":"Journal of Oncology Pharmacy Practice","topic":"Safe Handling of Antineoplastic Drugs","field":"Health Professions","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Compounding; Contamination; Medicine; Toxicology; Environmental science; Pharmacology; Biology","score_opus":0.12154416299849577,"score_gpt":0.5185561525477776,"score_spread":0.39701198954928185,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4401890998","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9886234,0.00035837817,0.00032333797,0.006512382,0.0025898714,0.0007188377,0.000027261538,0.000020565714,0.00082600303],"genre_scores_gemma":[0.99701256,0.00033408587,0.0013944596,0.00043429626,0.0005154182,0.000028420542,0.0000018394782,0.000033801767,0.00024510146],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.9950546,0.0020537132,0.0015996185,0.00021585614,0.000740669,0.0003355177],"domain_scores_gemma":[0.981658,0.014732633,0.0023989268,0.00019406072,0.00090033613,0.000116063784],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0035566469,0.00018953772,0.0006324399,0.00020572553,0.00024484436,0.000027370237,0.0003756163,0.00007850985,0.00020582811],"category_scores_gemma":[0.002943119,0.00013740266,0.00012003545,0.0003884699,0.00012138014,0.0011433191,0.00023924674,0.0021041685,0.000006096553],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.006167623,0.010567341,0.23104382,0.0017470014,0.0035038176,0.0004840772,0.034689076,0.0034273793,0.68081796,0.00031862178,0.021452796,0.005780483],"study_design_scores_gemma":[0.07941682,0.0101021165,0.2383644,0.011012127,0.015108715,0.0022259133,0.09795623,0.059362385,0.06775023,0.00010178429,0.41712344,0.0014758371],"about_ca_topic_score_codex":0.00046075493,"about_ca_topic_score_gemma":0.000011469787,"teacher_disagreement_score":0.61306775,"about_ca_system_score_codex":0.0009794456,"about_ca_system_score_gemma":0.0029415211,"threshold_uncertainty_score":0.91416824},"labels":[],"label_agreement":null},{"id":"W4402650936","doi":"10.1177/10781552241284528","title":"Evaluation of voriconazole therapeutic drug monitoring in malignant hematology patients","year":2024,"lang":"en","type":"article","venue":"Journal of Oncology Pharmacy Practice","topic":"Antifungal resistance and susceptibility","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; University Health Network","funders":"","keywords":"Voriconazole; Medicine; Therapeutic drug monitoring; Internal medicine; Neutropenia; Adverse effect; Clinical endpoint; Chemotherapy; Clinical trial; Pharmacokinetics; Dermatology","score_opus":0.09446946036107214,"score_gpt":0.47140486505762913,"score_spread":0.376935404696557,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4402650936","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97957456,0.012487141,0.000057302328,0.0032595452,0.0014440956,0.0002515749,0.0000010415862,0.0000066455395,0.0029180814],"genre_scores_gemma":[0.99776804,0.001263489,0.0004883047,0.00020748058,0.0002002775,0.000005181386,8.3943956e-7,0.000011376783,0.000054991946],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99728644,0.0008600822,0.0007786892,0.00014377927,0.00076346786,0.00016754273],"domain_scores_gemma":[0.9967182,0.00115462,0.0005054261,0.000111309506,0.0014305593,0.00007987227],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.006616027,0.000099251716,0.0004130494,0.00023448744,0.00002302725,0.000008910548,0.000089942,0.00006297822,0.00012937633],"category_scores_gemma":[0.001769942,0.00007656087,0.00011522737,0.0002632838,0.000059082762,0.00053577044,0.0000215711,0.0006196508,0.000014115001],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0034418586,0.0024454608,0.7815202,0.0002552429,0.0006148919,0.00067912997,0.001967737,0.000054573124,0.018008262,0.00019893378,0.0008698703,0.18994385],"study_design_scores_gemma":[0.025119886,0.0027956867,0.80101156,0.0014875518,0.0082139,0.002515628,0.005406085,0.005002224,0.06535111,0.0015740119,0.08117909,0.0003432389],"about_ca_topic_score_codex":0.000022927234,"about_ca_topic_score_gemma":0.00000587878,"teacher_disagreement_score":0.18960062,"about_ca_system_score_codex":0.00058194256,"about_ca_system_score_gemma":0.0014499581,"threshold_uncertainty_score":0.31220618},"labels":[],"label_agreement":null},{"id":"W4405247699","doi":"10.1177/10781552241304638","title":"An assessment of seven closed system transfer devices in accordance with the 2015 NIOSH vapor containment performance protocol","year":2024,"lang":"en","type":"article","venue":"Journal of Oncology Pharmacy Practice","topic":"Safe Handling of Antineoplastic Drugs","field":"Health Professions","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"UNC Eshelman School of Pharmacy, University of North Carolina at Chapel Hill; BD","keywords":"Protocol (science); Compounding; Spectrum analyzer; Isopropyl alcohol; Medicine; Computer science; Chemistry; Telecommunications","score_opus":0.061425612386984074,"score_gpt":0.5479265178218267,"score_spread":0.4865009054348426,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405247699","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.93466985,0.0002025158,0.0031472917,0.021140387,0.0018178016,0.029447868,0.000012916782,0.000054820495,0.009506522],"genre_scores_gemma":[0.9904665,0.00005876487,0.0028200576,0.0010516648,0.00049592304,0.004980743,0.0000010496769,0.000032258016,0.00009305387],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.99530035,0.0021436003,0.0013261499,0.00021777321,0.00062148937,0.00039064573],"domain_scores_gemma":[0.99325794,0.0046611098,0.0010795965,0.0002120483,0.0006555534,0.00013376233],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.007281616,0.00020431887,0.00056150934,0.00019890661,0.00021955345,0.000024763345,0.00044230872,0.000098853634,0.00010397801],"category_scores_gemma":[0.00014543877,0.0001187432,0.000068148736,0.00034898907,0.00009285761,0.0012838861,0.00003946037,0.0019902347,0.000016915528],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.10072513,0.012200908,0.53585714,0.03301045,0.0056447424,0.010045412,0.097979374,0.014965705,0.031197092,0.006284039,0.03552499,0.11656502],"study_design_scores_gemma":[0.020759663,0.005826935,0.05093783,0.0050310106,0.0010383185,0.0017144817,0.040159542,0.023604652,0.0009977337,0.000007873776,0.8495536,0.00036837425],"about_ca_topic_score_codex":0.000090039546,"about_ca_topic_score_gemma":0.00009776265,"teacher_disagreement_score":0.8140286,"about_ca_system_score_codex":0.000716408,"about_ca_system_score_gemma":0.006373748,"threshold_uncertainty_score":0.9992592},"labels":[],"label_agreement":null},{"id":"W4405249277","doi":"10.1177/10781552241300517","title":"Hospital pharmacists’ perceived competence in providing care to oncology patients – (HoPP-CoP2)","year":2024,"lang":"en","type":"article","venue":"Journal of Oncology Pharmacy Practice","topic":"Pharmaceutical Practices and Patient Outcomes","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Royal Alexandra Hospital; University of British Columbia; Alberta Health Services; Foothills Medical Centre","funders":"","keywords":"Medicine; Competence (human resources); Likert scale; Psychological intervention; Family medicine; Nursing; Oncology; Internal medicine; Psychology","score_opus":0.10078368443882381,"score_gpt":0.49695682027557814,"score_spread":0.39617313583675434,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405249277","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.91946274,0.002973854,0.00010538612,0.04051585,0.00679976,0.0015170842,0.000017064993,0.000064639826,0.028543591],"genre_scores_gemma":[0.9802226,0.0015130856,0.005702815,0.011523298,0.0007773718,0.000029211478,0.000009983993,0.0000491113,0.00017252461],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99618447,0.0008097702,0.0012708276,0.00042372762,0.00073967385,0.00057154626],"domain_scores_gemma":[0.9939002,0.003536461,0.0007097756,0.0001786116,0.0009786584,0.00069630623],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.0015368175,0.00032248814,0.0008457052,0.0006228634,0.000103690596,0.00008180983,0.00034434593,0.00014902427,0.00041558835],"category_scores_gemma":[0.0031258906,0.000266054,0.0002695297,0.0006677442,0.00010689166,0.0019543248,0.00016502495,0.0024095117,0.0002455725],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.033743486,0.0126040075,0.20214403,0.0018706036,0.0019674597,0.0399064,0.040147338,0.00028920794,0.027491821,0.00021897822,0.033557042,0.6060596],"study_design_scores_gemma":[0.011808283,0.0066071064,0.005865977,0.0003172728,0.0012212835,0.0025382447,0.002550372,0.0011183758,0.0010893156,0.00001553375,0.96657,0.00029821903],"about_ca_topic_score_codex":0.000026348458,"about_ca_topic_score_gemma":0.0000036415997,"teacher_disagreement_score":0.93301296,"about_ca_system_score_codex":0.0019550964,"about_ca_system_score_gemma":0.0017996633,"threshold_uncertainty_score":0.99997914},"labels":[],"label_agreement":null},{"id":"W4405953371","doi":"10.1177/10781552241296516","title":"Pharmacist interventions in optimising opioid medication therapy in pain management for palliative care patients: A systematic review","year":2024,"lang":"en","type":"review","venue":"Journal of Oncology Pharmacy Practice","topic":"Pain Management and Opioid Use","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Alberta","funders":"","keywords":"Medicine; Palliative care; Pharmacist; PsycINFO; Psychological intervention; MEDLINE; Opioid; Pain medicine; Systematic review; Medication therapy management; Pain management; Intensive care medicine; Family medicine; Pharmacy; Nursing; Physical therapy; Psychiatry; Internal medicine; Anesthesiology","score_opus":0.19040569478577227,"score_gpt":0.5321862582065203,"score_spread":0.34178056342074803,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405953371","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0000033744723,0.9864801,0.0006000389,0.0018171454,0.0008847883,0.009499503,0.00001433913,0.000015138572,0.000685574],"genre_scores_gemma":[0.000019684203,0.9918501,0.003466748,0.0028627554,0.00021799408,0.0011932022,0.00013885048,0.000060664042,0.00019000155],"study_design_codex":"systematic_review","study_design_gemma":"not_applicable","domain_scores_codex":[0.992874,0.0026900128,0.0032782857,0.00035233746,0.0005027724,0.0003025562],"domain_scores_gemma":[0.9928687,0.002452426,0.0037445426,0.000265583,0.00053526025,0.00013349026],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.009429035,0.00042472902,0.003077574,0.0012046837,0.00004483235,0.00004279116,0.00041148002,0.00013112635,0.00004749827],"category_scores_gemma":[0.003334766,0.0003044617,0.0011122859,0.00077439967,0.000039918115,0.00039226067,0.00009206391,0.0013002732,0.000027498987],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00019913232,0.000861183,0.000023092638,0.6678458,0.0016466529,0.00049123244,0.00044093502,7.9948177e-7,4.0135582e-8,0.000014792622,0.0063763866,0.32209995],"study_design_scores_gemma":[0.0034083775,0.00043365057,0.0000032951461,0.4427962,0.01679216,0.000025106894,0.00041679404,0.000043993634,7.3127225e-8,0.00000778497,0.5359451,0.00012745087],"about_ca_topic_score_codex":0.00000415016,"about_ca_topic_score_gemma":0.000002983827,"teacher_disagreement_score":0.52956873,"about_ca_system_score_codex":0.0021273526,"about_ca_system_score_gemma":0.00054924126,"threshold_uncertainty_score":0.99994075},"labels":[],"label_agreement":null},{"id":"W4406127406","doi":"10.1177/10781552241306741","title":"Analysis of real-world safety, tolerability, and cost efficiency of Sub-Cutaneous administration of Daratumumab in Manitoba","year":2025,"lang":"en","type":"article","venue":"Journal of Oncology Pharmacy Practice","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"CancerCare Manitoba","funders":"","keywords":"Daratumumab; Medicine; Tolerability; Retrospective cohort study; Toxicity; Subcutaneous injection; Internal medicine; Emergency medicine; Oncology; Surgery; Multiple myeloma; Adverse effect","score_opus":0.054436104547021545,"score_gpt":0.45732928911255444,"score_spread":0.4028931845655329,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4406127406","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9665962,0.00046532965,0.000093695584,0.0042249663,0.00015966693,0.000441709,0.00001260357,0.0000028104776,0.028003056],"genre_scores_gemma":[0.99513316,0.0039315047,0.00048072851,0.00015383438,0.00004276787,0.000002863266,0.0000047383332,0.000007467567,0.00024292995],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9968653,0.00071644876,0.0015579744,0.00017355349,0.00050802855,0.00017872722],"domain_scores_gemma":[0.9934962,0.003540055,0.0015153339,0.00023737612,0.0011080769,0.00010296842],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003158544,0.00011936737,0.0010635153,0.0013684301,0.00003176514,0.0000073481297,0.00017534946,0.000077165445,0.0003134574],"category_scores_gemma":[0.0016713862,0.00010789223,0.00018613979,0.0018879774,0.0002804434,0.00022446483,0.000068734815,0.0006818977,4.229392e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.08808579,0.008176772,0.24938811,0.00062836066,0.0044587655,0.0017632863,0.0011227683,0.0006603708,0.5204874,0.0002887033,0.00041469836,0.124524914],"study_design_scores_gemma":[0.042208634,0.01755091,0.32461107,0.00078355765,0.024643801,0.0066094543,0.0056264596,0.0115486765,0.44937307,0.0002246538,0.11635834,0.00046138783],"about_ca_topic_score_codex":0.0005988724,"about_ca_topic_score_gemma":0.0018307503,"teacher_disagreement_score":0.12406352,"about_ca_system_score_codex":0.0004738282,"about_ca_system_score_gemma":0.0015639736,"threshold_uncertainty_score":0.43997175},"labels":[],"label_agreement":null},{"id":"W4406301109","doi":"10.1177/10781552241312925","title":"Continuous versus intermittent tacrolimus for graft-versus-host disease prophylaxis in pediatric hematopoietic stem cell transplantation patients (Tic Tac)","year":2025,"lang":"en","type":"article","venue":"Journal of Oncology Pharmacy Practice","topic":"Hematopoietic Stem Cell Transplantation","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Children's & Women's Health Centre of British Columbia; University of British Columbia","funders":"","keywords":"Medicine; Tacrolimus; Hematopoietic stem cell transplantation; Adverse effect; Graft-versus-host disease; Trough level; Internal medicine; Cohort; Retrospective cohort study; Therapeutic index; Transplantation; Surgery; Gastroenterology; Pharmacology; Drug","score_opus":0.029811183535875602,"score_gpt":0.3629448806622035,"score_spread":0.3331336971263279,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4406301109","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98465395,0.00095681363,0.0022312754,0.00315889,0.0041028243,0.0018081472,0.000033826476,0.00002681372,0.0030274373],"genre_scores_gemma":[0.99549025,0.0021912898,0.0011872749,0.0005814663,0.00023779205,0.00008291883,0.000029583125,0.00003464603,0.00016479118],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9970046,0.0004404279,0.0013481587,0.0003209077,0.00048690246,0.00039900356],"domain_scores_gemma":[0.9938936,0.0036946489,0.0010878866,0.0001902414,0.0008293472,0.00030424193],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0010345064,0.0002801241,0.0006821063,0.0006289869,0.00008469633,0.000034007913,0.00021720793,0.00013775537,0.00003653563],"category_scores_gemma":[0.00048913946,0.00025652788,0.00026351484,0.00048592262,0.00006161622,0.0005841735,0.00002044949,0.0007168165,0.000020404277],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.6958932,0.020001361,0.16365038,0.018133258,0.0016331107,0.010227846,0.0131673515,0.0002941826,0.005902986,0.00028580122,0.004616453,0.06619405],"study_design_scores_gemma":[0.6354732,0.033484273,0.15204881,0.0022358643,0.041117974,0.0018856325,0.009384239,0.001327854,0.021121968,0.00011691478,0.10008607,0.0017172035],"about_ca_topic_score_codex":0.000009855953,"about_ca_topic_score_gemma":0.0000058409164,"teacher_disagreement_score":0.095469624,"about_ca_system_score_codex":0.0006000282,"about_ca_system_score_gemma":0.0011669026,"threshold_uncertainty_score":0.9999887},"labels":[],"label_agreement":null},{"id":"W4408715532","doi":"10.1177/10781552251324522","title":"Evaluating the impact of a pharmacist-led venetoclax ramp-up clinic for chronic lymphocytic leukemia patients: A retrospective chart review","year":2025,"lang":"en","type":"article","venue":"Journal of Oncology Pharmacy Practice","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta; Alberta Health Services","funders":"","keywords":"Medicine; Venetoclax; Pharmacist; Tumor lysis syndrome; Adverse effect; Pharmacy; Psychological intervention; Retrospective cohort study; Internal medicine; Pediatrics; Chronic lymphocytic leukemia; Leukemia; Family medicine; Chemotherapy; Psychiatry","score_opus":0.12355402321022381,"score_gpt":0.5734759596261295,"score_spread":0.4499219364159057,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4408715532","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.89804244,0.07230589,0.00049138226,0.0068029673,0.0036404647,0.008606902,0.000059896425,0.00005059829,0.009999462],"genre_scores_gemma":[0.9393626,0.051073987,0.0013538369,0.005068606,0.0011140456,0.00024905716,0.000019599775,0.00006932554,0.0016889599],"study_design_codex":"not_applicable","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99420106,0.0014805612,0.0021947576,0.00040302702,0.0010537156,0.0006668921],"domain_scores_gemma":[0.9834057,0.007971977,0.003331789,0.00057968334,0.0044367397,0.0002740939],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.010053868,0.00036070726,0.001573823,0.00032543062,0.00020906722,0.000029717217,0.0006459856,0.00015194369,0.0007428768],"category_scores_gemma":[0.025990043,0.00023426808,0.0010299113,0.00096184906,0.00033617855,0.0005992886,0.00019469578,0.0014083819,0.0000468617],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.16143617,0.0024696807,0.0025679772,0.013318505,0.020936118,0.0008482002,0.0022354384,0.0023009067,0.030586295,0.000110164605,0.5262435,0.23694706],"study_design_scores_gemma":[0.42112976,0.037323087,0.0015951085,0.009358207,0.017760053,0.007327414,0.00037462907,0.20689657,0.0074385297,0.00030581563,0.28987855,0.0006122927],"about_ca_topic_score_codex":0.00025864382,"about_ca_topic_score_gemma":0.000002770557,"teacher_disagreement_score":0.2596936,"about_ca_system_score_codex":0.2525817,"about_ca_system_score_gemma":0.220848,"threshold_uncertainty_score":0.98221445},"labels":[],"label_agreement":null},{"id":"W4410578130","doi":"10.1177/10781552251343180","title":"Canadian monitoring program of the surface contamination with 11 antineoplastic drugs in 131 centres","year":2025,"lang":"en","type":"article","venue":"Journal of Oncology Pharmacy Practice","topic":"Safe Handling of Antineoplastic Drugs","field":"Health Professions","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Université de Montréal; Institut National de Santé Publique du Québec; Centre Hospitalier Universitaire Sainte-Justine","funders":"","keywords":"Medicine; Docetaxel; Antineoplastic Drugs; Contamination; Gemcitabine; Vinorelbine; Biological safety; Cabazitaxel; Pharmacology; Internal medicine; Cancer; Chemotherapy","score_opus":0.033438886374667035,"score_gpt":0.4536011380359748,"score_spread":0.4201622516613078,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4410578130","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9645581,0.00020522585,0.000051398674,0.022340313,0.003359584,0.0006438444,0.0000037447653,0.000012538691,0.008825246],"genre_scores_gemma":[0.9957653,0.00018432217,0.0026722567,0.00052358373,0.00020290195,0.000009456505,6.6194315e-7,0.000014629697,0.0006268444],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9968816,0.0012540052,0.0009493372,0.000141208,0.00033320562,0.0004406659],"domain_scores_gemma":[0.98968965,0.007324077,0.0016287504,0.0001499698,0.001067364,0.00014021534],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0023253316,0.00014535115,0.00040854185,0.00031202778,0.00028628486,0.000011332023,0.00034273657,0.00011299928,0.00004452882],"category_scores_gemma":[0.0038936555,0.000099808545,0.000058535657,0.0006877867,0.00009250722,0.00044165406,0.0000678342,0.0013609367,0.0000076207416],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011513963,0.00047653096,0.9844851,0.00015057051,0.00014098063,0.00010483319,0.003375506,0.00063128915,0.0005657636,0.0001824795,0.001940801,0.006794763],"study_design_scores_gemma":[0.014344093,0.00052374107,0.53842705,0.0025528253,0.0007708202,0.00018721807,0.021184409,0.0009618986,0.002576632,0.000034169883,0.41822854,0.00020861087],"about_ca_topic_score_codex":0.025813553,"about_ca_topic_score_gemma":0.026563395,"teacher_disagreement_score":0.44605803,"about_ca_system_score_codex":0.00081129844,"about_ca_system_score_gemma":0.01017728,"threshold_uncertainty_score":0.9954341},"labels":[],"label_agreement":null},{"id":"W4411574384","doi":"10.1177/10781552251351324","title":"Collaborative team-based care implementation in ambulatory gynecological and lung cancer clinics","year":2025,"lang":"en","type":"article","venue":"Journal of Oncology Pharmacy Practice","topic":"Interprofessional Education and Collaboration","field":"Health Professions","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Medicine; Ambulatory; Cancer; Lung cancer; Ambulatory care; Patient care; Intensive care medicine; Health care; Family medicine; Oncology; Nursing; Internal medicine","score_opus":0.038029446536404166,"score_gpt":0.6164147498208262,"score_spread":0.5783853032844221,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4411574384","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9151718,0.0048509985,0.00034905222,0.060145315,0.006339116,0.001196558,0.000024210165,0.000015049583,0.011907912],"genre_scores_gemma":[0.9659497,0.0011176217,0.0032679935,0.028959736,0.0002778051,0.0001603089,0.00000904323,0.000008336033,0.00024943345],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.9963446,0.0021430007,0.00097569,0.00015023084,0.00018155131,0.0002049295],"domain_scores_gemma":[0.9925389,0.003952836,0.0012737783,0.00007054261,0.0020785497,0.00008538162],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0018423196,0.00011012199,0.00029806205,0.00024403757,0.0003398592,0.000011810284,0.00010789601,0.00015783549,0.00056272343],"category_scores_gemma":[0.0012569049,0.00009275173,0.00004072242,0.0005336764,0.000053833282,0.00053351274,0.00004571551,0.0011887819,0.00000517025],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.009165472,0.000885802,0.7466567,0.00036732393,0.00031620514,0.000053360152,0.02527081,0.00029925455,0.0016913884,0.0025704785,0.1659342,0.046789],"study_design_scores_gemma":[0.010030352,0.00033940072,0.07677551,0.00023987136,0.00031412294,0.00000499591,0.13736713,0.0011713929,0.00024561005,0.000109753004,0.77328056,0.00012127094],"about_ca_topic_score_codex":0.0001095844,"about_ca_topic_score_gemma":0.0007464886,"teacher_disagreement_score":0.66988117,"about_ca_system_score_codex":0.0014717238,"about_ca_system_score_gemma":0.016372671,"threshold_uncertainty_score":0.9892036},"labels":[],"label_agreement":null},{"id":"W4411712910","doi":"10.1177/10781552251352203","title":"Lactose intolerance or gastrointestinal adverse drug effect? guidance for oncology pharmacists","year":2025,"lang":"en","type":"review","venue":"Journal of Oncology Pharmacy Practice","topic":"Digestive system and related health","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Medicine; Lactose intolerance; Lactose; Excipient; Pharmacy; Adverse effect; Drug; Flow chart; Intensive care medicine; Internal medicine; Pharmacology; Family medicine; Food science","score_opus":0.051892064629447655,"score_gpt":0.4897379446891053,"score_spread":0.43784588005965763,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4411712910","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000046584722,0.9845094,0.0011822194,0.00081757235,0.0038073238,0.0021408626,0.000099813435,0.000017016942,0.007379219],"genre_scores_gemma":[0.000068516216,0.9840274,0.0076163984,0.0012652219,0.0022683737,0.00021423105,0.00007402639,0.000080436555,0.004385415],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9927186,0.0033202637,0.0023140225,0.00064784347,0.00030823055,0.00069103757],"domain_scores_gemma":[0.9876752,0.004633568,0.0056416513,0.0003776325,0.0012659504,0.000405991],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0049146847,0.0007295742,0.0028275533,0.00034480836,0.00020512742,0.000027333559,0.00091213785,0.000491912,0.00005467954],"category_scores_gemma":[0.0062281517,0.0005176692,0.0010761219,0.00036205188,0.00020193237,0.00005714782,0.00021430111,0.0018104207,0.000036221914],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.009008481,0.0011127555,0.000022438384,0.025146337,0.0016295519,0.0019944878,0.0000709329,0.000028239576,0.0004746031,0.000016296475,0.10400336,0.8564925],"study_design_scores_gemma":[0.007088301,0.004793366,8.5398773e-7,0.00895275,0.0038676742,0.028138345,0.000044070155,0.00000774572,0.00020608152,0.000003291254,0.94650805,0.00038946472],"about_ca_topic_score_codex":0.0000058579913,"about_ca_topic_score_gemma":0.0000040531113,"teacher_disagreement_score":0.85610306,"about_ca_system_score_codex":0.0006931413,"about_ca_system_score_gemma":0.010931962,"threshold_uncertainty_score":0.9997275},"labels":[],"label_agreement":null},{"id":"W4416087502","doi":"10.1177/10781552251388113","title":"Antimicrobial prophylaxis in pediatric patients with leukemia: Reducing incidence of febrile neutropenia episodes and bloodborne infections","year":2025,"lang":"en","type":"article","venue":"Journal of Oncology Pharmacy Practice","topic":"Neutropenia and Cancer Infections","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"CancerCare Manitoba; Dalhousie University","funders":"","keywords":"Antimicrobial; Fungemia; Bacteremia; Incidence (geometry); Febrile neutropenia; Neutropenia; Antibiotic prophylaxis","score_opus":0.011305527879133668,"score_gpt":0.33962719111917694,"score_spread":0.32832166324004325,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4416087502","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9936725,0.00046459638,0.000057765454,0.002250013,0.00047654627,0.00036725574,0.0000030621884,0.000007974472,0.0027003246],"genre_scores_gemma":[0.9960219,0.0017970471,0.0013172617,0.0005839276,0.00019372797,0.00000915189,0.000001093555,0.000011907036,0.000063961044],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99856424,0.00025176673,0.0006486037,0.00017603721,0.00017879247,0.00018057445],"domain_scores_gemma":[0.9975543,0.0005882203,0.0008475884,0.00012146846,0.0007913964,0.000096997996],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00057619123,0.00013253989,0.00047231404,0.0005497676,0.00009560316,0.000018115396,0.000089545836,0.00007402165,0.000029792838],"category_scores_gemma":[0.00061455276,0.00010663723,0.000060466788,0.0008410377,0.00012008682,0.0007690529,0.000063643325,0.00094437617,0.0000019813024],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004122704,0.0021680307,0.97030586,0.00023701957,0.00022443137,0.00022657105,0.00032151086,0.00037807523,0.011271642,0.00003771626,0.001861609,0.008844812],"study_design_scores_gemma":[0.03153939,0.0075854273,0.9036943,0.0005020337,0.0035605785,0.003148737,0.00022151251,0.00003673602,0.015405111,0.00002610016,0.03402238,0.0002577325],"about_ca_topic_score_codex":0.00029395003,"about_ca_topic_score_gemma":0.00005814274,"teacher_disagreement_score":0.06661162,"about_ca_system_score_codex":0.00042323867,"about_ca_system_score_gemma":0.00201966,"threshold_uncertainty_score":0.434854},"labels":[],"label_agreement":null},{"id":"W4417362519","doi":"10.1177/10781552251405216","title":"Comparative incidence of peripheral neuropathy associated with taxane chemotherapy in patients with breast cancer: A network meta-analysis","year":2025,"lang":"en","type":"article","venue":"Journal of Oncology Pharmacy Practice","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Windsor Clinical Research","funders":"","keywords":"Taxane; Peripheral neuropathy; Paclitaxel; Docetaxel; Incidence (geometry); Breast cancer; Chemotherapy-induced peripheral neuropathy","score_opus":0.05753993388737121,"score_gpt":0.4269587812516558,"score_spread":0.3694188473642846,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417362519","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.982598,0.0020952383,0.00008074209,0.013212512,0.0001802809,0.0005229093,0.000029034127,0.000007694826,0.0012736069],"genre_scores_gemma":[0.99291533,0.00055663293,0.00082752446,0.00533118,0.00008668847,0.000030235053,0.000008036859,0.000012622806,0.00023173622],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99759936,0.0008334171,0.0007127481,0.00021309486,0.00038002737,0.00026137332],"domain_scores_gemma":[0.9953485,0.0010576866,0.0020261474,0.0001285785,0.0013262003,0.000112881804],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00080420997,0.00022667488,0.0019556799,0.0003311343,0.000053744458,0.000010355489,0.00014891977,0.0000612821,0.00072699256],"category_scores_gemma":[0.00007795906,0.0001444824,0.00031797125,0.0017019833,0.00016003502,0.0004210411,0.000024358264,0.0006876096,5.478727e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.066393435,0.0052657146,0.7226539,0.000021297077,0.19295788,0.00047655057,0.0008965662,0.0070508597,0.0002108311,0.000006563766,0.0027089498,0.0013574249],"study_design_scores_gemma":[0.035427075,0.004787491,0.64055616,0.00005396744,0.30731672,0.00020531063,0.00019042725,0.0004297419,0.00028438805,0.0000046665928,0.01058261,0.0001614587],"about_ca_topic_score_codex":0.0003051124,"about_ca_topic_score_gemma":0.00040627152,"teacher_disagreement_score":0.11435885,"about_ca_system_score_codex":0.0006205822,"about_ca_system_score_gemma":0.0012900437,"threshold_uncertainty_score":0.79600585},"labels":[],"label_agreement":null}]}